<html lang="en"><head><!-- Shady DOM styles for custom-style --><!-- Shady DOM styles for dom-template --><!-- Shady DOM styles for dom-repeat --><!-- Shady DOM styles for array-selector --><!-- Shady DOM styles for dom-if --><!-- Shady DOM styles for state-modifier --><style scope="state-modifier">a[inherit].state-modifier {
  color: inherit;
}</style><!-- Shady DOM styles for browser-ui --><!-- Shady DOM styles for outlined-text-field --><style scope="outlined-text-field">outlined-text-field {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: column;
}

outlined-text-field span.outlined-text-field {
  display: flex;
  flex-direction: row;
  align-items: center;
}

outlined-text-field input.outlined-text-field {
  height: 40px;
  padding: 0 33px 0 16px;
  
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  flex-grow: 1;
}

outlined-text-field[orig] input.outlined-text-field {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-text-field[dense] input.outlined-text-field {
  height: 32px;
}

outlined-text-field[uppercase] input.outlined-text-field {
  text-transform: uppercase;
}

outlined-text-field:not([wizard-focused]):hover input.outlined-text-field {
  border-color: #737375;
  color: #414447;
}

outlined-text-field:not([wizard-focused]):focus-within input.outlined-text-field,outlined-text-field[wizard-focused] input.outlined-text-field {
  border-color: #3574e0;
  caret-color: #80a5f1;
}

outlined-text-field[wizard-focused] input.outlined-text-field {
  border-width: 2px;
}

outlined-text-field input.outlined-text-field::placeholder {
  color: #65686c;
}

outlined-text-field[uppercase] input.outlined-text-field::placeholder {
  text-transform: none;
}</style><!-- Shady DOM styles for mat-keyword-editor --><!-- Shady DOM styles for mat-chips-input --><!-- Shady DOM styles for mat-input-chip --><!-- Shady DOM styles for pat-dialog --><style scope="pat-dialog">pat-dialog {
  background: white;
  position: absolute;
  border-radius: 8px;
  
  box-shadow: 0 24px 38px 3px rgb(0 0 0 / 14%),
              0 9px 46px 8px rgb(0 0 0 / 12%),
              0 11px 15px -7px rgb(0 0 0 / 20%);
  z-index: 1;
  display: flex;
  flex-direction: column;
}

pat-dialog:not([open]) {
  display: none;
}</style><!-- Shady DOM styles for mat-tabs --><!-- Shady DOM styles for filter-chip --><style scope="filter-chip">filter-chip {
  align-items: center;
  background-color: #fff;
  border-color: #dadce0;
  border-radius: 8px;
  border-style: solid;
  border-width: 1px;
  color: #606368;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 32px;
  letter-spacing: 0.2px;
  padding: 0 16px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

filter-chip[disabled] {
  background-color: #e8e8e8;
  border-color: #e8e8e8;
  color: #a9abad;
  cursor: auto;
}

filter-chip svg.filter-chip {
  visibility: collapse;
  font-size: 18px;
  width: 0;
  height: 18px;
}

filter-chip[selected] svg.filter-chip {
  visibility: visible;
  margin: 0 8px;
  width: 18px;
}

filter-chip[selected] svg.filter-chip path.filter-chip {
  fill: #4577d1;
}

filter-chip:not([disabled]):hover {
  background-color: #f7f8f8;
  border-color: #d7d9dc;
  color: #454649;
}

filter-chip:not([disabled]):hover:active {
  background-color: #eff0f0;
  border-color: #d2d5d8;
  color: #222326;
}

filter-chip:not([disabled]):focus {
  background-color: #e7e8e8;
  border-color: #232528;
  color: #202124;
}

filter-chip:not([disabled])[selected] {
  background-color: #e9f0fd;
  border-color: #e9f0fd;
  color: #4577d1;
  padding-left: 0;
}

filter-chip:not([disabled]):focus[selected] {
  background-color: #d5e1fb;
  border-color: #d5e1fb;
  color: #2550a0;
}

filter-chip:not([disabled]):hover[selected] {
  box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 1px -2px,
    rgba(0, 0, 0, 0.14) 0px 2px 2px 0px, rgba(0, 0, 0, 0.12) 0px 1px 5px 0px;
}

filter-chip:not([disabled]):hover:active[selected] {
  background-color: #abc8f2;
  border-color: #abc8f2;
  color: #2a54a3;
}</style><!-- Shady DOM styles for figure-callout --><!-- Shady DOM styles for mat-button --><style scope="mat-button-0">.mat-button-0 {
  ;
  align-items: center;
  border-radius: 4px;
  color: hsl(217 4% 39%); 
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: 0.2px;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

.mat-button-0[filled] {
  background-color: hsl(217 73% 54%); 
  color: white;
}

.mat-button-0[filled]:hover {
  background-color: hsl(217 60% 47%);
}

.mat-button-0[filled]:focus {
  background-color: hsl(217 59% 44%);
}

.mat-button-0[filled]:active {
  background-color: hsl(217 59% 45%);
}

.mat-button-0[filled][disabled] {
  background-color: hsl(217 2% 90%); 
  color: hsl(217 1% 65%);
}</style><!-- Shady DOM styles for search-term-wizard --><style scope="search-term-wizard">search-term-wizard:not([open]) {
  display: none;
}

search-term-wizard .header.search-term-wizard {
  border-bottom: 1px solid #e5e5e5;
  padding: 24px;
  padding-bottom: 0;
}

search-term-wizard .title.search-term-wizard {
  color: #3c4043;
  font-family: Google Sans,Roboto,Arial,sans-serif;
  font-size: 22px;
  user-select: none;
  margin: 0 48px;
}

search-term-wizard #panels.search-term-wizard > *.search-term-wizard:not([selected]) {
  display: none;
}</style><!-- Shady DOM styles for outlined-textarea --><style scope="outlined-textarea">outlined-textarea {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: row;
  
  position: relative;
}

outlined-textarea span.outlined-textarea {
  display: flex;
  flex-direction: column;
  flex-grow: 1;
  justify-content: center;
}

outlined-textarea span.right-button-container.outlined-textarea {
  position: absolute;
  right: 0;
  height: 100%;
}

outlined-textarea textarea.outlined-textarea {
  padding: 16px 16px 0 16px;
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  resize: none;
}

outlined-textarea[dense] textarea.outlined-textarea {
  padding: 8px;
}

outlined-textarea[has-icon] textarea.outlined-textarea {
  padding-right: 38px;
}

outlined-textarea[orig] textarea.outlined-textarea {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-textarea:not([rows]) textarea.outlined-textarea {
  height: 40px;
}

outlined-textarea textarea.resizable.outlined-textarea {
  resize: vertical;
}

outlined-textarea textarea.outlined-textarea:focus,outlined-textarea[wizard-focused] textarea.outlined-textarea,outlined-textarea textarea.outlined-textarea:focus:hover {
  border-color: #3574e0 !important;
  
  outline: none !important;
}

outlined-textarea textarea.outlined-textarea:hover {
  border-color: #202124;
  color: #414447;
}

outlined-textarea.hasValue textarea.outlined-textarea {
  border-color: #888d91;
  color: #45474a;
}

outlined-textarea #helperText.outlined-textarea {
  color: #6a6c71;
  font-size: 12px;
  letter-spacing: 0.3px;
  margin-left: 17px;
  margin-top: 6px;
  user-select: none;
}

outlined-textarea:not([helper-text]) #helperText.outlined-textarea {
  display: none;
}

outlined-textarea[error] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
  color: #3d4043;
}

outlined-textarea textarea.outlined-textarea::placeholder {
  font-size: 14px;
  font-weight: 400;
}

outlined-textarea:not([error]):not([disabled]) textarea.outlined-textarea::placeholder {
  color: #6a6c71;
}

outlined-textarea[error] textarea.outlined-textarea::placeholder {
  color: #c84132;
}

outlined-textarea[error] #helperText.outlined-textarea {
  color: #cd5648;
}

outlined-textarea[error] textarea.outlined-textarea:focus {
  border-color: #c84031;
  border-width: 2px;
  outline: none !important;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover {
  border-color: #97231b;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover::placeholder,outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover + #helperText.outlined-textarea {
  color: #a94945;
}

outlined-textarea[disabled] textarea.outlined-textarea {
  border-color: #e9e9e9;
  color: #b5b6b8;
}

outlined-textarea[disabled] #helperText.outlined-textarea {
  color: #c4c6c7;
}

outlined-textarea[error][disabled] {
  opacity: 50%;
}

outlined-textarea[error][disabled] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
}

outlined-textarea[error][disabled] #helperText.outlined-textarea,outlined-textarea[error][disabled] textarea.outlined-textarea {
  color: #a94945;
}

outlined-textarea[error][disabled] textarea.outlined-textarea::placeholder {
  color: #c84132;
}</style><!-- Shady DOM styles for chemistry-search-term-wizard --><style scope="chemistry-search-term-wizard">chemistry-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

chemistry-search-term-wizard .suggestions.chemistry-search-term-wizard {
  margin-top: 4px;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard svg.chemistry-search-term-wizard {
  margin-right: 24px;
}

chemistry-search-term-wizard path.chemistry-search-term-wizard {
  fill: #5f6368;
}

chemistry-search-term-wizard .help.chemistry-search-term-wizard {
  margin-left: 12px;
  margin-right: 0;
  cursor: pointer;
}

chemistry-search-term-wizard outlined-text-field.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard mat-button.chemistry-search-term-wizard {
  margin-left: 48px;
}

chemistry-search-term-wizard filter-chip.chemistry-search-term-wizard {
  margin-right: 4px;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard outlined-text-field[batchMode].chemistry-search-term-wizard {
  display: none;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard:not([batchMode]) {
  display: none;
}</style><!-- Shady DOM styles for text-search-term-wizard --><style scope="text-search-term-wizard">text-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

text-search-term-wizard > span.text-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

text-search-term-wizard > span.text-search-term-wizard svg.text-search-term-wizard {
  margin-right: 24px;
}

text-search-term-wizard path.text-search-term-wizard {
  fill: #5f6368;
}

text-search-term-wizard outlined-text-field.text-search-term-wizard {
  flex-grow: 1;
}

text-search-term-wizard mat-button.text-search-term-wizard {
  margin-left: 48px;
}

text-search-term-wizard filter-chip.text-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for classification-wizard --><style scope="classification-wizard">classification-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

classification-wizard > span.classification-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

classification-wizard .suggestions.classification-wizard {
  margin-top: 4px;
}

classification-wizard > span.classification-wizard svg.classification-wizard {
  margin-right: 24px;
}

classification-wizard path.classification-wizard {
  fill: #5f6368;
}

classification-wizard outlined-text-field.classification-wizard {
  flex-grow: 1;
}

classification-wizard mat-button.classification-wizard {
  margin-left: 48px;
}

classification-wizard filter-chip.classification-wizard {
  margin-right: 4px;
}

classification-wizard .no-matches.classification-wizard {
  margin-left: 64px;
}

classification-wizard .table-container.classification-wizard {
  max-height: 300px;
  overflow: scroll;
  margin-top: 8px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar {
  -webkit-appearance: none;
  width: 10px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar-thumb {
  border-radius: 5px;
  background-color: #5f636880;
  -webkit-box-shadow: 0 0 1px rgba(255,255,255,.5);
}

classification-wizard table.classification-wizard {
  margin-left: 51px;
  max-width: 575px;
}

classification-wizard tr.classification-wizard {
  margin-top: 4px;
}

classification-wizard tr.classification-wizard suggestive-chip.classification-wizard {
  margin-right: 8px;
}

classification-wizard #spinner.classification-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}</style><!-- Shady DOM styles for suggestive-chip --><!-- Shady DOM styles for mat-checkbox --><!-- Shady DOM styles for measure-search-term-wizard --><style scope="measure-search-term-wizard">measure-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

measure-search-term-wizard > span.measure-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

measure-search-term-wizard .suggestions.measure-search-term-wizard {
  margin-top: 4px;
}

measure-search-term-wizard > span.measure-search-term-wizard svg.measure-search-term-wizard {
  margin-right: 24px;
}

measure-search-term-wizard path.measure-search-term-wizard {
  fill: #5f6368;
}

measure-search-term-wizard outlined-text-field.measure-search-term-wizard {
  flex-grow: 1;
}

measure-search-term-wizard mat-button.measure-search-term-wizard {
  margin-left: 48px;
}

measure-search-term-wizard filter-chip.measure-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for numerical-search-term-wizard --><style scope="numerical-search-term-wizard">numerical-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

numerical-search-term-wizard .suggestions.numerical-search-term-wizard {
  margin-top: 4px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard svg.numerical-search-term-wizard {
  margin-right: 24px;
}

numerical-search-term-wizard path.numerical-search-term-wizard {
  fill: #5f6368;
}

numerical-search-term-wizard outlined-text-field.numerical-search-term-wizard,numerical-search-term-wizard outlined-textarea.numerical-search-term-wizard {
  flex-grow: 1;
}

numerical-search-term-wizard mat-button.numerical-search-term-wizard {
  margin-left: 48px;
}

numerical-search-term-wizard filter-chip.numerical-search-term-wizard {
  margin-right: 4px;
}

numerical-search-term-wizard #spinner.numerical-search-term-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}

numerical-search-term-wizard #suggestions.numerical-search-term-wizard {
  margin-left: 58px;
  display: flex;
  flex-direction: column;
  align-items: flex-start;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard mat-checkbox.numerical-search-term-wizard {
  margin-right: 8px;
}</style><!-- Shady DOM styles for text-button --><style scope="text-button">text-button {
  align-items: center;
  border-radius: 4px;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: .25px;
  margin: 6px 0;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
  line-height: 36px;
  text-decoration: none;
  text-transform: none;
  color: #5f6368;
}

text-button:hover {
  background-color: #f8f9fa;
}

text-button:active {
  background-color: #d5e2fa;
}

text-button[selected] {
  background-color: #e8f0fe;
  color: #1967d2;
}

text-button[selected]:active {
  background-color: #d2e3fc;
}</style><!-- Shady DOM styles for mat-spinner --><!-- Shady DOM styles for requery-tile --><style scope="requery-tile">requery-tile {
  display: flex;
  justify-content: space-between;
  align-items: center;
  box-sizing: border-box;
  min-height: 40px;
  padding: 8px 12px 8px 8px;
  gap: 8px;

  border-radius: 16px;
  background: #f7f8f9;
  color: #1f1f1f;
}

requery-tile:hover {
  background: #d7d8d9;
}

requery-tile > [slot="image"] {
  flex-shrink: 0;

  border-radius: 8px;

  background: #fff;
}

.label.requery-tile {
  flex-grow: 999;

  font: 16px/20px "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
}

.search-icon.requery-tile {
  flex-shrink: 0;

  width: 24px;
  height: 24px;
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/search/default/24px.svg');
}</style><!-- Shady DOM styles for s-more-inline --><style scope="s-more-inline">s-more-inline {
  display: block;
  margin-top: 24px;
  padding: 16px;
  padding-top: 0;
  position: relative;

  line-height: 18px;
  text-overflow: ellipsis;
  white-space: nowrap;
  cursor: pointer;
}

hr.s-more-inline {
  background-color: #dadce0;
  margin-top: 18px;
  position: absolute;
  border: 0;
  height: 1px;
  left: 0;
  width: 100%;
}

.button.s-more-inline {
  display: flex;
  align-items: center;
  justify-content: center;

  position: relative; 
  margin: 0 auto;

  font: 400 14px Roboto, arial, sans-serif;
  height: 36px;
  width: 300px;
  border-radius: 18px;
  background-color: #f1f3f4;
}

.button.s-more-inline:hover {
  background-color: #d8d7dc;
}

.button.s-more-inline > [slot] {
  padding-right: 8px;
}

.expand.s-more-inline {
  display: inline-block;
  width: 20px;
  height: 20px;
}

.expand.less.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_less/default/20px.svg');
}

.expand.more.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_more/default/20px.svg');
}</style><!-- Shady DOM styles for workspace-ui-search --><!-- Shady DOM styles for keyword-wizard --><style scope="keyword-wizard">keyword-wizard {
  display: inline-block;
}

iron-icon.keyword-wizard {
  height: 20px;
    width: 20px;
    color: #999;
    cursor: pointer;
}

iron-icon[active].keyword-wizard {
  color: #4285f4 !important;
}

iron-icon.keyword-wizard:hover {
  color: #ccc;
}

#wizardIcon.keyword-wizard {
  padding-left: 1px;
    height: 16px;
    width: 16px;
    margin: 4px 1px 1px 1px;
}

#wizard.keyword-wizard {
  padding: 0;
    left: 0;
    top: 37px;
    position: absolute;
    background-color: white;
    z-index: 2;
    overflow: hidden;
}

.wizard-header.keyword-wizard {
  display: block;
    width: 100%;
    color: #737373;
    text-transform: uppercase;
    font-size: 13px;
    margin: 16px 0 6px 12px;
}

.filter-chips.keyword-wizard {
  margin-left: 20px;
}

.chip.keyword-wizard {
  background-color: #ebebeb;
    color: #6a6a6a;
    display: inline-block;
    font-size: 13px;
    font-family: inherit;
    border-radius: 12px;
    padding: 6px 12px;
}

.chip.keyword-wizard:hover {
  cursor: pointer;
}

.chip[selected].keyword-wizard {
  background-color: #4285f4;
    color: white;
}

.input-label.keyword-wizard {
  display: inline-block;
    font-size: 13px;
    font-family: inherit;
}

.keyword-input.keyword-wizard {
  display: inline-block;
    border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    padding: 3px;
}

.keyword-input.keyword-wizard::placeholder {
  font-style: italic;
}

.keyword-input.keyword-wizard:hover,.keyword-input.keyword-wizard:focus {
  border-color: #4284f4;
    border-width: 1px;
    outline: none;
}

.cpc-field.keyword-wizard {
  display: inline-block;
    margin: 6px 0 0 24px;
}

#checkboxCPC.keyword-wizard:hover {
  cursor: pointer;
}

.checkbox-label.keyword-wizard {
  font-size: 13px;
    font-style: italic;
    color: #737373;
}

.chemistry-field.keyword-wizard {
  display: block;
}

#inputChem.input-batch.keyword-wizard {
  height: 150px;
    border: 1px solid #dfe1e5;
    padding: 6px;
}

#inputChem.keyword-wizard {
  resize: none;
    height: 15px;
    vertical-align: text-top;
    font-size: 13px;
    font-family: inherit;
    padding: 2px;
}

.chem-type-label.keyword-wizard {
  display: inline;
    font-size: 13px;
    margin-left: 12px;
    margin-right: 4px;
}

#chemType.keyword-wizard {
  border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    margin: 6px;
    padding: 2px;
    outline: none;
    font-family: inherit;
    font-size: 13px;
}

.import.keyword-wizard {
  font-size: 13px;
    font-family: inherit;
}

.import-text.keyword-wizard {
  vertical-align: middle;
    display: inline-block;
}

.import-button.keyword-wizard {
  margin: 6px 0 0 24px;
}

.import-button.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.import-button.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard {
  float: right;
    padding: 12px;
}

.wizard-buttons.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    margin: 2px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
}

@media screen and (max-width: 700px) {
#wizard.keyword-wizard {
  width: 275px;
}

.chip.keyword-wizard {
  margin: 4px 2px;
}

.keyword-input.keyword-wizard {
  width: 82%;
      margin: 4px 12px 12px 24px;
}

.search-within.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 225px;
      margin: 12px 0 6px 0;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  margin-top: 6px;
}

#inputChem.keyword-wizard {
  width: 82%;
      padding: 2px;
      margin: 8px 12px 12px 24px;
}

#inputChem.input-batch.keyword-wizard {
  width: 220px;
      padding: 4px;
}

#chemType.keyword-wizard {
  width: 150px;
}

.import-text.keyword-wizard {
  margin: 6px 12px 6px 24px;
      width: 220px;
}

iron-icon.help-header.keyword-wizard {
  display: none;
}

}

@media screen and (min-width: 700px) {
#wizard.keyword-wizard {
  width: 540px;
}

.chip.keyword-wizard {
  margin: 0 2px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 240px;
      margin: 12px 16px 6px 6px;
}

.cpc-inputs.keyword-wizard {
  display: inline;
}

.find-patents.keyword-wizard .keyword-input.keyword-wizard {
  width: 53%;
      margin: 4px 10px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard::placeholder,#inputAnd.keyword-wizard::placeholder,#inputExact.keyword-wizard::placeholder,#inputOr.keyword-wizard::placeholder,#inputMinus.keyword-wizard::placeholder {
  color: white;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  width: 35%;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  width: 42%;
      margin: 6px 4px;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

#inputChem.keyword-wizard {
  width: 290px;
      margin: 2px 12px 2px 6px;
}

#inputChem.input-batch.keyword-wizard {
  width: 280px;
      padding: 6px;
}

.import-text.keyword-wizard {
  margin: 6px 12px;
      width: 415px;
}

#chemType.keyword-wizard {
  width: 105px;
}

iron-icon.keyword-wizard:hover.help-header {
  cursor: default;
}

iron-icon.help-header.keyword-wizard {
  height: 16px;
      padding: 0 2px 2px 2px;
      color: #a3a3a3;
}

.help.keyword-wizard p.keyword-wizard {
  margin: 0 0 8px 0
}

.help.keyword-wizard .q.keyword-wizard {
  font-family: monospace;
      color: #0b8043;
      white-space: nowrap;
}

.help.keyword-wizard {
  z-index: 4;
      position: absolute;
      right: 10px;
      padding: 12px;
      border-radius: 2px;
      border: 1px solid #e0e0e0;
      box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2), 0 6px 10px 0 rgba(0, 0, 0, 0.3);
      background: white;
      font-size: 13px;
      line-height: 20px;
      width: 450px;
      max-height: 400px;
      overflow: auto;
}

#withinHelp.keyword-wizard {
  top: 75px;
}

#chemHelp.keyword-wizard {
  top: 0;
}

#searchBooleanHelp.keyword-wizard {
  top: 140px;
}

}</style><!-- Shady DOM styles for bottom-bar --><style scope="bottom-bar">.fixed.bottom-bar {
  display: block;
  position: fixed;
  height: 46px;
  bottom: 0;
}

.fixed[medium].bottom-bar {
  height: 280px;
}

.fixed[large].bottom-bar {
  height: 480px;
}

.shadow.bottom-bar {
  background: white;
  padding: 16px;
  border-radius: 8px 8px 0px 0px;
  box-shadow: 0px 8px 10px 1px rgba(0,0,0,.14), 0px 3px 14px 2px rgba(0,0,0,.12), 0px 5px 5px -3px rgba(0,0,0,.2);
}

.oneline.bottom-bar {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
  cursor: pointer;
}

.button.bottom-bar {
  cursor: pointer;
}

.buttonAlign.bottom-bar {
  margin-top: -4px;
}

.header.bottom-bar {
  height: 30px;
  font-family: 'Google Sans';
  font-size: 18px;
  padding-bottom: 8px;
}

.list.bottom-bar {
  overflow-y: auto;
  line-height: 20px;
}

.definition.bottom-bar {
  padding: 0px 0px 4px 0px;
  cursor: pointer;
}

[medium].bottom-bar .content.bottom-bar {
  height: 230px;
}

[large].bottom-bar .content.bottom-bar {
  height: 430px;
}

[medium].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 200px;
}

[large].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 400px;
}

[hidden].bottom-bar {
  display: none;
}

.label.bottom-bar {
  font-family: 'Google Sans';
  font-size: 12px;
  line-height: 16px;
  font-weight: 400;
  padding: 6px 0px 4px 0px;
  color: #1f1f1f;
}

[pad].bottom-bar {
  margin-left: 16px;
}

.layout.vertical.bottom-bar {
  display: flex;
  flex-direction: column;
}

.layout.horizontal.bottom-bar {
  display: flex;
  flex-direction: row;
}

.flex.bottom-bar {
  flex: 1;
  flex-basis: 0.000000001px;
}

.layout.start.bottom-bar {
  align-items: flex-start;
}

.layout.center.bottom-bar {
  align-items: center;
}

.layout.end.bottom-bar {
  align-items: flex-end;
}

.flex-2.bottom-bar {
  flex: 2;
}

.flex-3.bottom-bar {
  flex: 3;
}

.flex-4.bottom-bar {
  flex: 4;
}

.flex-5.bottom-bar {
  flex: 5;
}

.flex-6.bottom-bar {
  flex: 6;
}

.flex-7.bottom-bar {
  flex: 7;
}

.flex-8.bottom-bar {
  flex: 8;
}

.flex-9.bottom-bar {
  flex: 9;
}

.flex-10.bottom-bar {
  flex: 10;
}

.flex-11.bottom-bar {
  flex: 11;
}

.flex-12.bottom-bar {
  flex: 12;
}</style><!-- Shady DOM styles for landscape-link --><!-- Shady DOM styles for landscape-summary-box --><!-- Shady DOM styles for search-state --><!-- Shady DOM styles for iron-overlay-backdrop --><!-- Shady DOM styles for opaque-animation --><!-- Shady DOM styles for iron-dropdown --><style scope="iron-dropdown">iron-dropdown {
  position: fixed;
}

#contentWrapper.iron-dropdown  > * {
  overflow: auto;
}

#contentWrapper.animating.iron-dropdown  > * {
  overflow: hidden;
}</style><!-- Shady DOM styles for iron-meta --><!-- Shady DOM styles for iron-icon --><style scope="iron-icon-0">.iron-icon-0 {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;-ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;-ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
        position: relative;

        vertical-align: middle;

        fill: currentcolor;
        stroke: none;

        width: 24px;
        height: 24px;;
}

.iron-icon-0[hidden] {
  display: none;
}</style><!-- Shady DOM styles for iron-iconset-svg --><!-- Shady DOM styles for iron-list --><!-- Shady DOM styles for paper-icon-item --><!-- Shady DOM styles for paper-item-body --><!-- Shady DOM styles for paper-item --><!-- Shady DOM styles for dropdown-menu --><style scope="dropdown-menu">dropdown-menu {
  display: inline-block;
        line-height: 24px;
}

.label.dropdown-menu {
  cursor: pointer;
        color: #666;
        align-items: center;
        margin-right: 8px;
        display: inline-block;
        padding: 2px 0;
}

#selected.dropdown-menu {
  color: #212121;
}

.label[open].dropdown-menu {
  border-color: #e0e0e0;
}

iron-dropdown.dropdown-menu {
  margin-top: 26px;
}

iron-icon.dropdown-menu {
  height: 15px;
        width: 15px;
}

#menu.dropdown-menu {
  max-height: 300px;
        padding: 8px 0;
        background: white;
        display: block;
        border-radius: 2px;
        box-shadow: 0 0 2px rgba(0,0,0,0.12), 0 2px 2px rgba(0,0,0,0.24);
}

.item.dropdown-menu {
  cursor: pointer;
        color: rgba(0,0,0,.87);
        font-size: 13px;
        line-height: 18px;
        padding: 6px 18px;
}

.item.dropdown-menu:hover {
  background-color: #e0e0e0;
}

.item[selected].dropdown-menu {
  background-color: #e0e0e0;
}

[multi].dropdown-menu .item.dropdown-menu {
  padding: 6px 18px 6px 34px;
}

[multi].dropdown-menu .item[selected].dropdown-menu {
  background-image: url('https://www.gstatic.com/images/icons/material/system/2x/done_grey600_24dp.png');
        background-position: 8px center;
        background-size: 16px;
        background-repeat: no-repeat;
}</style><!-- Shady DOM styles for chips-input --><!-- Shady DOM styles for input-chip --><!-- Shady DOM styles for keyword-editor --><!-- Shady DOM styles for paper-ripple --><!-- Shady DOM styles for paper-button --><!-- Shady DOM styles for date-editor --><!-- Shady DOM styles for metadata-editor --><!-- Shady DOM styles for restrict-editor --><!-- Shady DOM styles for overlay-tooltip --><style scope="overlay-tooltip">overlay-tooltip {
  display: none;
        color: #fff;
        background-color: #000;
        padding: 10px 12px;
        border-radius: 3px;
        font-size: 13px;
        font-weight: normal;
        line-height: normal;
        position: fixed;
        z-index: 100;
}

#arrow.overlay-tooltip {
  width: 0;
        height: 0;
        border-style: solid;
        border-width: 0 6px 8px 6px;
        border-color: transparent transparent #000 transparent;
        position: absolute;
        top: -8px;
        left: calc(50% - 6px);
}</style><!-- Shady DOM styles for query-renderer --><!-- Shady DOM styles for result-nav --><style scope="result-nav">result-nav {
  display: block;
        white-space: nowrap;
        padding: 0 30px;
        line-height: 30px;
        height: 30px;
        margin-top: 17px;
        font-weight: 500;
        font-size: 15px;
}

state-modifier.result-nav {
  color: #333;
}

state-modifier[disabled].result-nav {
  pointer-events: none;
        color: #ccc;
}</style><!-- Shady DOM styles for raw-html --><!-- Shady DOM styles for paper-material --><style scope="paper-material-0">.paper-material-0 {
  display: block;
        position: relative;
}

.paper-material-0[elevation="1"] {
  box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14),
                    0 1px 5px 0 rgba(0, 0, 0, 0.12),
                    0 3px 1px -2px rgba(0, 0, 0, 0.2);
}

.paper-material-0[elevation="2"] {
  box-shadow: 0 4px 5px 0 rgba(0, 0, 0, 0.14),
                    0 1px 10px 0 rgba(0, 0, 0, 0.12),
                    0 2px 4px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="3"] {
  box-shadow: 0 6px 10px 0 rgba(0, 0, 0, 0.14),
                    0 1px 18px 0 rgba(0, 0, 0, 0.12),
                    0 3px 5px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="4"] {
  box-shadow: 0 8px 10px 1px rgba(0, 0, 0, 0.14),
                    0 3px 14px 2px rgba(0, 0, 0, 0.12),
                    0 5px 5px -3px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="5"] {
  box-shadow: 0 16px 24px 2px rgba(0, 0, 0, 0.14),
                    0  6px 30px 5px rgba(0, 0, 0, 0.12),
                    0  8px 10px -5px rgba(0, 0, 0, 0.4);
}

.paper-material-0[animated] {
  transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
}

.paper-material-0 {
  ;
}</style><!-- Shady DOM styles for search-box --><style scope="search-box">.layout.horizontal.search-box,.layout.vertical.search-box {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-box {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-box {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-box {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-box {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-box {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-box,.layout.center-center.search-box {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-box,.layout.center-center.search-box {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-box {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-box {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-box {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.inputbox.search-box {
  border: 1px solid #ccc;
        padding: 0 12px;
        background: white;
}

.inputbox[focused].search-box {
  border: 1px solid #4285f4 !important;
}

.inputbox.search-box:hover {
  border: 1px solid #999;
}

#searchInput.search-box {
  font-family: inherit;
        font-size: 16px;
        padding: 8px 0;
        outline: none;
        border-right: none;
        width: 100%;
        margin-right: 0;
        border: 0;
}

#searchButton.search-box {
  cursor: pointer;
        background-color: #4285f4;
        border: none;
        color: #fff;
        vertical-align: top;
        width: 70px;
        height: 37px;
        outline: none;
}

.suggest-bg.search-box {
  display: inline-block;
        min-width: 0;
        white-space: nowrap;
}

#suggestMenu.search-box {
  position: absolute;
        margin-top: 38px;
        width: 100%;
        background: white;
        z-index: 1;
}

#suggestMenu.search-box .row.search-box {
  font-size: 13px;
        line-height: 28px;
        white-space: nowrap;
        overflow: hidden;
        text-overflow: ellipsis;
        padding: 4px 2px;
        cursor: pointer;
}

.row[selected].search-box {
  background: rgba(0, 0, 0, 0.05);
}

.suggest-icon.search-box {
  height: 20px;
        width: 20px;
        padding: 0 12px 0 6px;
        transition: transform .15s linear;
        transform: scale(1);
}

.suggest-icon[hide].search-box {
  transform: scale(0);
}

#corpora.search-box {
  padding: 6px 0;
        user-select: none;
}

#corpora.search-box iron-icon.search-box {
  height: 20px;
        width: 20px;
        color: #ccc;
        cursor: pointer;
}

#corpora.search-box iron-icon[active].search-box {
  color: #4285f4 !important;
}

#corpora.search-box iron-icon.search-box:hover {
  color: #999;
}</style><!-- Shady DOM styles for iron-media-query --><!-- Shady DOM styles for paper-header-panel --><!-- Shady DOM styles for iron-a11y-announcer --><style scope="iron-a11y-announcer">iron-a11y-announcer {
  display: inline-block;
        position: fixed;
        clip: rect(0px,0px,0px,0px);
}</style><!-- Shady DOM styles for iron-autogrow-textarea --><!-- Shady DOM styles for iron-input --><!-- Shady DOM styles for paper-input-char-counter --><!-- Shady DOM styles for paper-input-container --><!-- Shady DOM styles for paper-input-error --><!-- Shady DOM styles for paper-input --><!-- Shady DOM styles for paper-textarea --><!-- Shady DOM styles for paper-toast --><style scope="paper-toast-0">.paper-toast-0 {
  display: block;
        position: fixed;
        background-color: #323232;
        color: #f1f1f1;
        min-height: 48px;
        min-width: 288px;
        padding: 16px 24px;
        box-sizing: border-box;
        box-shadow: 0 2px 5px 0 rgba(0, 0, 0, 0.26);
        border-radius: 2px;
        margin: 12px;
        font-size: 14px;
        cursor: default;
        -webkit-transition: -webkit-transform 0.3s, opacity 0.3s;
        transition: transform 0.3s, opacity 0.3s;
        opacity: 0;
        -webkit-transform: translateY(100px);
        transform: translateY(100px);font-family: 'Roboto', 'Noto', sans-serif;
        -webkit-font-smoothing: antialiased;
}

.paper-toast-0.capsule {
  border-radius: 24px;
}

.paper-toast-0.fit-bottom {
  width: 100%;
        min-width: 0;
        border-radius: 0;
        margin: 0;
}

.paper-toast-0.paper-toast-open {
  opacity: 1;
        -webkit-transform: translateY(0px);
        transform: translateY(0px);
}</style><!-- Shady DOM styles for paper-toolbar --><!-- Shady DOM styles for search-footer --><style scope="search-footer">#footer.search-footer {
  font-size: 13px;
        margin-top: 10px;
        background: #fafafa;
        padding: 20px 10px;
        align-items: center;
        border-top: 1px solid #ebebeb;
}

#footer.search-footer .links.search-footer > *.search-footer {
  display: inline-block;
        margin: 0 12px;
}

.layout.horizontal.search-footer,.layout.vertical.search-footer {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-footer {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-footer {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-footer {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-footer {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-footer {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-footer {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-footer {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-footer {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-footer {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-footer {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-footer {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-footer {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-footer {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-footer {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-footer {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-footer {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-footer {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-footer {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-footer {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-footer {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-footer {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-footer {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-footer {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-footer {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-footer {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-header --><style scope="search-header">search-header {
  display: block;
}

.lockup-logo.search-header,.lockup-text.search-header {
  display: inline-block;
}

.lockup-logo.search-header {
  width: 74px;
        height: 24px;
        background-image: url('https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_74x24dp.png');
        background-size: 74px 24px;
}

.lockup-text.search-header {
  font-family: "Product Sans", Arial, Helvetica, sans-serif;

        
        font-size: 22.1px;

        
        text-rendering: optimizeLegibility;

        
        position: relative;
        top: -6px;
        left: -5px;

        
        -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
}

.lockup-brand.search-header {
  opacity: 0.54;
}

@media (-webkit-min-device-pixel-ratio: 1.5), (min-resolution: 144dpi) {
.lockup-logo.search-header {
  background-image: url('https://www.gstatic.com/images/branding/googlelogo/2x/googlelogo_color_74x24dp.png');
}

.lockup-text.search-header {
  font-size: 21.3px;
          left: -7px;
}

}

header.search-header {
  background-color: #fafafa;
        border-bottom: 1px solid #ebebeb;
        color: #333;
        height: 60px;
        width: 100%;
        z-index: 1;
        display: block;
}

[latestStyle].search-header header.search-header {
  background-color: transparent;
}

.headerpad.search-header {
  margin-left: 16px;
}

[wide].search-header .headerpad.search-header {
  margin-left: 32px;
}

.leftheader.search-header {
  width: 322px;
}

header.search-header h1.search-header {
  display: none;
}

header.search-header h1.search-header state-modifier.search-header {
  color: #777;
        text-decoration: none;
        display: inline-block;
}

[wide].search-header header.search-header h1.search-header {
  box-sizing: border-box;
        margin: 0;
        padding: 20px 0 10px;
        font-size: 20px;
        font-weight: 400;
        white-space: nowrap;
        display: block;
}

search-box.search-header {
  height: 37px;
        padding: 0 16px;
        width: 900px;
        align-self: center;
}

.layout.horizontal.search-header,.layout.vertical.search-header {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-header {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-header {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-header {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-header {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-header {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-header {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-header {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-header {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-header {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-header {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-header {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-header {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-header {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-header {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-header {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-header {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-header {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-header {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-header {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-header {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-header {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-header {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-header {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-header {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-header {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-ui --><style scope="search-ui-0">.search-ui-0 paper-button.search-ui {
  display: inline-block;
        text-align: center;
        font-family: inherit;
}

.search-ui-0 .layout.horizontal.search-ui,.search-ui-0 .layout.vertical.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.search-ui-0 .layout.inline.search-ui {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.search-ui-0 .layout.horizontal.search-ui {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.search-ui-0 .layout.vertical.search-ui {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.search-ui-0 .layout.wrap.search-ui {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.search-ui-0 .layout.no-wrap.search-ui {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .flex.search-ui {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.search-ui-0 .flex-auto.search-ui {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.search-ui-0 .flex-none.search-ui {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.search-ui-0 .layout.start.search-ui {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.end.search-ui {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.search-ui-0 .layout.baseline.search-ui {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.search-ui-0 .layout.start-justified.search-ui {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .layout.end-justified.search-ui {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.search-ui-0 .layout.around-justified.search-ui {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.search-ui-0 .layout.justified.search-ui {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.search-ui-0 .self-start.search-ui {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.search-ui-0 .self-center.search-ui {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.search-ui-0 .self-end.search-ui {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.search-ui-0 .self-stretch.search-ui {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.search-ui-0 .self-baseline.search-ui {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.search-ui-0 .layout.start-aligned.search-ui {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.search-ui-0 .layout.end-aligned.search-ui {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.search-ui-0 .layout.center-aligned.search-ui {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.search-ui-0 .layout.between-aligned.search-ui {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.search-ui-0 .layout.around-aligned.search-ui {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.search-ui-0 {
  display: block;
        min-width: 350px;
        height: 100%;
}

.search-ui-0 #content.search-ui {
  height: 100%;
}

.search-ui-0 #leftBarOverflow.search-ui {
  padding-right: 16px;
}

.search-ui-0 [wide].search-ui #leftBarOverflow.search-ui {
  overflow: auto;
}

.search-ui-0 #leftBar.search-ui {
  box-sizing: border-box;
        color: #666;
        font-size: 13px;
        padding: 16px 0 16px 16px;
        border-bottom: 1px solid #e5e5e5;
}

.search-ui-0 [wide].search-ui #leftBar.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;

        -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
        position: relative;
        width: 350px;
        margin-bottom: 0;
        padding-bottom: 0;
        border-bottom: none;
}

@media print {
.search-ui-0 #leftBar.search-ui {
  display: none !important;
}

}

.search-ui-0 #leftBar.search-ui h3.search-ui {
  text-transform: uppercase;
        font-size: 13px;
        font-weight: normal;
        margin-top: 6px;
        margin-bottom: 6px;
        cursor: default;
        display: inline-block;
        color: #a3a3a3;
}

.search-ui-0 #closeButton.search-ui {
  position: absolute;
        right: 0;
}

.search-ui-0 #searchTermsHeader.search-ui {
  position: relative;
}

.search-ui-0 #searchTermsQ.search-ui iron-icon.search-ui {
  height: 16px;
        padding: 0 2px 2px 2px;
        color: #a3a3a3;
}

.search-ui-0 #searchTermsHeader.search-ui:hover iron-icon.search-ui {
  color: #4285f4;
}

.search-ui-0 #closeLeftBar.search-ui {
  height: 16px;
        width: 16px;
        padding: 0 0 8px 0;
        cursor: pointer;
}

.search-ui-0 #compactQuery.search-ui iron-icon.search-ui {
  height: 20px;
}

.search-ui-0 #backToResultsButton.search-ui {
  color: #fff;
        background: #4285f4;
        margin-top: 20px;
        text-align: center;
}

.search-ui-0 #main.search-ui {
  display: block;
        min-height: calc(100vh - 127px);
}

@media print {
.search-ui-0 [wide].search-ui main.search-ui {
  margin-left: 0;
}

}</style><!-- Shady DOM styles for import-list --><!-- Shady DOM styles for iron-request --><!-- Shady DOM styles for iron-ajax --><!-- Shady DOM styles for paper-dialog --><!-- Shady DOM styles for coverage-stats --><!-- Shady DOM styles for iron-image --><!-- Shady DOM styles for iron-selector --><!-- Shady DOM styles for paper-card --><!-- Shady DOM styles for paper-checkbox --><!-- Shady DOM styles for landing-page --><!-- Shady DOM styles for remote-fetch --><!-- Shady DOM styles for paper-spinner --><style scope="paper-spinner-0">.paper-spinner-0 {
  display: inline-block;
        position: relative;
        width: 28px;
        height: 28px;
}

.paper-spinner-0 #spinnerContainer.paper-spinner {
  width: 100%;
        height: 100%;

        
        direction: ltr;
}

.paper-spinner-0 #spinnerContainer.active.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite;
        animation: container-rotate-paper-spinner-0 1568ms linear infinite;
}

@-webkit-keyframes container-rotate-paper-spinner-0 {
to {
  -webkit-transform: rotate(360deg)
}

}

@keyframes container-rotate-paper-spinner-0 {
to {
  transform: rotate(360deg)
}

}

.paper-spinner-0 .spinner-layer.paper-spinner {
  position: absolute;
        width: 100%;
        height: 100%;
        opacity: 0;
        white-space: nowrap;
        color: #4285f4;
}

.paper-spinner-0 .layer-1.paper-spinner {
  color: #4285f4;
}

.paper-spinner-0 .layer-2.paper-spinner {
  color: #db4437;
}

.paper-spinner-0 .layer-3.paper-spinner {
  color: #f4b400;
}

.paper-spinner-0 .layer-4.paper-spinner {
  color: #0f9d58;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0;
        -webkit-animation-duration: 5332ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-name: fill-unfill-rotate-paper-spinner-0;
        animation-duration: 5332ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
        opacity: 1;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-1.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-2.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-3.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-4.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
}

@-webkit-keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  -webkit-transform: rotate(135deg)
}

25% {
  -webkit-transform: rotate(270deg)
}

37.5% {
  -webkit-transform: rotate(405deg)
}

50% {
  -webkit-transform: rotate(540deg)
}

62.5% {
  -webkit-transform: rotate(675deg)
}

75% {
  -webkit-transform: rotate(810deg)
}

87.5% {
  -webkit-transform: rotate(945deg)
}

to {
  -webkit-transform: rotate(1080deg)
}

}

@keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  transform: rotate(135deg)
}

25% {
  transform: rotate(270deg)
}

37.5% {
  transform: rotate(405deg)
}

50% {
  transform: rotate(540deg)
}

62.5% {
  transform: rotate(675deg)
}

75% {
  transform: rotate(810deg)
}

87.5% {
  transform: rotate(945deg)
}

to {
  transform: rotate(1080deg)
}

}

@-webkit-keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@-webkit-keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

.paper-spinner-0 .circle-clipper.paper-spinner {
  display: inline-block;
        position: relative;
        width: 50%;
        height: 100%;
        overflow: hidden;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after {
  left: 45%;
        width: 10%;
        border-top-style: solid;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after,.paper-spinner-0 .circle-clipper.paper-spinner::after {
  content: '';
        box-sizing: border-box;
        position: absolute;
        top: 0;
        border-width: 3px;
        border-radius: 50%;
}

.paper-spinner-0 .circle-clipper.paper-spinner::after {
  bottom: 0;
        width: 200%;
        border-style: solid;
        border-bottom-color: transparent !important;
}

.paper-spinner-0 .circle-clipper.left.paper-spinner::after {
  left: 0;
        border-right-color: transparent !important;
        -webkit-transform: rotate(129deg);
        transform: rotate(129deg);
}

.paper-spinner-0 .circle-clipper.right.paper-spinner::after {
  left: -100%;
        border-left-color: transparent !important;
        -webkit-transform: rotate(-129deg);
        transform: rotate(-129deg);
}

.paper-spinner-0 .active.paper-spinner .gap-patch.paper-spinner::after,.paper-spinner-0 .active.paper-spinner .circle-clipper.paper-spinner::after {
  -webkit-animation-duration: 1333ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-duration: 1333ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.left.paper-spinner::after {
  -webkit-animation-name: left-spin-paper-spinner-0;
        animation-name: left-spin-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.right.paper-spinner::after {
  -webkit-animation-name: right-spin-paper-spinner-0;
        animation-name: right-spin-paper-spinner-0;
}

@-webkit-keyframes left-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(130deg)
}

50% {
  -webkit-transform: rotate(-5deg)
}

to {
  -webkit-transform: rotate(130deg)
}

}

@keyframes left-spin-paper-spinner-0 {
0% {
  transform: rotate(130deg)
}

50% {
  transform: rotate(-5deg)
}

to {
  transform: rotate(130deg)
}

}

@-webkit-keyframes right-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(-130deg)
}

50% {
  -webkit-transform: rotate(5deg)
}

to {
  -webkit-transform: rotate(-130deg)
}

}

@keyframes right-spin-paper-spinner-0 {
0% {
  transform: rotate(-130deg)
}

50% {
  transform: rotate(5deg)
}

to {
  transform: rotate(-130deg)
}

}

.paper-spinner-0 #spinnerContainer.cooldown.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
        animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
}

@-webkit-keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}</style><!-- Shady DOM styles for paper-spinner-lite --><!-- Shady DOM styles for concept-card --><!-- Shady DOM styles for concept-mention --><style scope="concept-mention">.block.concept-mention {
  display: block;
}

[hidden].concept-mention {
  display: none !important;
}

.invisible.concept-mention {
  visibility: hidden !important;
}

.relative.concept-mention {
  position: relative;
}

.fit.concept-mention {
  position: absolute;
        top: 0;
        right: 0;
        bottom: 0;
        left: 0;
}

body.fullbleed.concept-mention {
  margin: 0;
        height: 100vh;
}

.scroll.concept-mention {
  -webkit-overflow-scrolling: touch;
        overflow: auto;
}

.fixed-bottom.concept-mention,.fixed-left.concept-mention,.fixed-right.concept-mention,.fixed-top.concept-mention {
  position: fixed;
}

.fixed-top.concept-mention {
  top: 0;
        left: 0;
        right: 0;
}

.fixed-right.concept-mention {
  top: 0;
        right: 0;
        bottom: 0;
}

.fixed-bottom.concept-mention {
  right: 0;
        bottom: 0;
        left: 0;
}

.fixed-left.concept-mention {
  top: 0;
        bottom: 0;
        left: 0;
}

#target.concept-mention:hover {
  background-color: #e8f0fe;
}

#target[noicon].concept-mention {
  padding: 1px;
}

#target.concept-mention:hover[noicon] {
  border: 1px solid #e8f0fe;
        padding: 0;
}

#target.concept-mention {
  display: inline-block;
}

.inline-icon.concept-mention {
  cursor: pointer;
        height: 12px;
        width: 12px;
        padding-left: 4px;
        color: #5e6368;
}

concept-card.concept-mention {
  z-index: 1;
        position: absolute;
}</style><!-- Shady DOM styles for fterm-concept-card --><!-- Shady DOM styles for fterm-concept-mention --><!-- Shady DOM styles for paper-fab --><!-- Shady DOM styles for paper-icon-button --><!-- Shady DOM styles for paper-icon-button-light --><!-- Shady DOM styles for classification-tree --><style scope="classification-tree">.layout.horizontal.classification-tree,.layout.vertical.classification-tree {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.classification-tree {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.classification-tree {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.classification-tree {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.classification-tree {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.classification-tree {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.classification-tree {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.classification-tree {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.classification-tree {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

classification-tree {
  display: block;
        line-height: 20px;
}

.wrap.classification-tree {
  padding: 6px 12px;
}

.wrap.classification-tree:hover {
  background: #fafafa;
}

.description.classification-tree {
  padding-left: 4px;
}

iron-icon.classification-tree {
  color: #eaeaea;
}

.code[first].classification-tree {
  font-weight: 500;
}

.code[additional].classification-tree {
  font-style: italic;
}</style><!-- Shady DOM styles for classification-viewer --><style scope="classification-viewer">.table.classification-viewer {
  border: 1px solid #eaeaea;
        display: block;
}

.more.classification-viewer {
  padding: 6px 12px;
        cursor: pointer;
        font-style: italic;
        color: #aaa;
}

.more.classification-viewer:hover {
  background: #fafafa;
}

.chip.classification-viewer {
  display: inline-block;
        padding: 4px 6px;
        border-radius: 2px;
}

.chip[additional].classification-viewer {
  font-style: italic;
}</style><!-- Shady DOM styles for image-carousel --><!-- Shady DOM styles for image-viewer --><!-- Shady DOM styles for patent-result --><style scope="patent-result">#wrapper.patent-result {
  padding: 20px;
        max-width: 1050px;
        outline: 0;
}

.scroll-target.patent-result:before {
  display: block;
        content: '';
        visibility: hidden;
}

h1.patent-result {
  font-weight: 500;
        font-size: 20px;
        margin: 0 0 20px 0;
}

h3.patent-result {
  font-size: 15px;
        font-weight: 500;
        margin: 28px 0 18px 0;
}

dl.patent-result {
  line-height: 1.5;
        font-size: 0;
}

dt.patent-result,dd.patent-result {
  display: inline;
        font-size: 13px;
        margin: 0;
}

dt.patent-result {
  font-weight: 500;
        color: #000;
}

dt.patent-result::after {
  content: ': ';
}

dd.patent-result {
  color: #aaa;
}

dd.patent-result ~ dd.patent-result::before {
  content: ', ';
}

dt.patent-result + dd.patent-result::before {
  content: '';
}

dd.patent-result ~ dt.patent-result::before {
  display: block;
        content: '';
        margin-top: 8px;
}

dd.patent-result core-icon.patent-result {
  width: 14px;
        height: 14px;
        vertical-align: top;
        color: inherit;
}

.table.patent-result {
  display: table;
        border-collapse: collapse;
        border-spacing: 0;
        border: 1px solid #eaeaea;
        width: 100%;
        box-sizing: border-box;
}

.tr.patent-result {
  display: table-row;
        border-bottom: 1px solid #eaeaea;
}

.th.patent-result,.td.patent-result {
  display: table-cell;
        padding: 10px 12px;
}

.thead.patent-result {
  display: table-header-group;
}

.tbody.patent-result {
  display: table-row-group;
}

.th.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.td.patent-result {
  vertical-align: top;
}

.td.patent-result > p.patent-result {
  margin-top: 0;
}

.nowrap.patent-result {
  white-space: nowrap;
}

.knowledge-card.patent-result {
  border: 1px solid #e5e5e5;
        border-radius: 2px;
}

.knowledge-card.patent-result > header.patent-result {
  -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
        background: #4285f4;
        color: #fff;
        padding: 20px 12px;
}

.knowledge-card.patent-result > header.patent-result state-modifier.patent-result,.knowledge-card.patent-result > header.patent-result a.patent-result {
  color: inherit;
        margin: 0 12px 0 0;
        display: inline-block;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result,.knowledge-card.patent-result > header.patent-result .tagline.patent-result {
  margin: 0;
        font-weight: normal;
        padding-top: 4px;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result {
  font-size: 20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result {
  background: #3367d6;
        padding: 10px 12px;
        margin: 20px -12px -20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result core-icon.patent-result {
  margin-right: 12px;
        width: 24px;
        height: 24px;
}

.knowledge-card.patent-result dl.patent-result {
  padding: 16px 12px;
}

.knowledge-card.patent-result hr.patent-result {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 0;
}

.main-link.patent-result {
  margin: 14px;
        font-weight: 500;
}

.footer.patent-result h3.patent-result state-modifier.patent-result,.footer.patent-result h3.patent-result a.patent-result {
  float: right;
        font-weight: 400;
        font-size: 13px;
        line-height: 24px;
}

.footer.patent-result dl.patent-result {
  margin-left: 30px;
}

.footer.patent-result > ul.patent-result > li.patent-result {
  margin-bottom: 8px;
}

h3.patent-result .righthead.patent-result {
  color: #aaa;
        font-weight: 400;
        font-size: 13px;
        cursor: help;
}

.tooltip-hint.patent-result {
  border-bottom: 1px dotted #ccc;
}

[marginRight].patent-result {
  margin-right: 60px;
}

.flex-width.patent-result {
  min-width: 0;
        word-break: break-word;
}

.responsive-table.patent-result {
  width: 100%;
        overflow-x: auto;
        overflow-y: hidden;
}

.layout.horizontal.patent-result,.layout.vertical.patent-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.flex.patent-result,.flex-1.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-2.patent-result {
  -ms-flex: 2;
        -webkit-flex: 2;
        flex: 2;
}

.flex-3.patent-result {
  -ms-flex: 3;
        -webkit-flex: 3;
        flex: 3;
}

.flex-4.patent-result {
  -ms-flex: 4;
        -webkit-flex: 4;
        flex: 4;
}

.flex-5.patent-result {
  -ms-flex: 5;
        -webkit-flex: 5;
        flex: 5;
}

.flex-6.patent-result {
  -ms-flex: 6;
        -webkit-flex: 6;
        flex: 6;
}

.flex-7.patent-result {
  -ms-flex: 7;
        -webkit-flex: 7;
        flex: 7;
}

.flex-8.patent-result {
  -ms-flex: 8;
        -webkit-flex: 8;
        flex: 8;
}

.flex-9.patent-result {
  -ms-flex: 9;
        -webkit-flex: 9;
        flex: 9;
}

.flex-10.patent-result {
  -ms-flex: 10;
        -webkit-flex: 10;
        flex: 10;
}

.flex-11.patent-result {
  -ms-flex: 11;
        -webkit-flex: 11;
        flex: 11;
}

.flex-12.patent-result {
  -ms-flex: 12;
        -webkit-flex: 12;
        flex: 12;
}

@media print {
#text.patent-result {
  flex-direction: column-reverse !important;
}

}

patent-result-ref-list.patent-result {
  width: 100%;
}

patent-result-ref-list.patent-result + patent-result-ref-list.patent-result {
  margin-left: 10px;
}

[narrow].patent-result {
  flex-direction: column-reverse !important;
}

.famheader.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.collapse.patent-result {
  color: #616161;
        font-size: 13px;
        cursor: pointer;
}

#imageDrag.patent-result {
  position: fixed;
        cursor: col-resize;
}

#imageDrag.patent-result div.patent-result {
  width: 4px;
        height: 100%;
        margin: 0 4px;
        background: #eee;
}

#imageDrag.patent-result:hover {
  background: #eee;
}

#imageDrag.patent-result:hover div.patent-result {
  background: #ccc;
}

.imageWrapper.patent-result {
  position: fixed;
        top: 60px;
        background: white;
        margin-left: 12px;
}

#notices.patent-result {
  padding: 20px;
}

#figures.patent-result {
  background: #efefef;
}

.headerButton.patent-result {
  color: #3c80f6;
        cursor: pointer;
        display: inline-block;
        padding: 0 14px;
        line-height: 27px;
}

.headerButton.patent-result iron-icon.patent-result {
  width: 16px;
        height: 16px;
}

.tr.conceptDomain.patent-result {
  display: table-row;
}

.responsive-grid.patent-result {
  display: grid;
        gap: 8px;
        grid-template-columns: none;
}</style><!-- Shady DOM styles for family-viewer --><!-- Shady DOM styles for app-row --><!-- Shady DOM styles for application-timeline --><style scope="application-timeline">.layout.horizontal.application-timeline,.layout.vertical.application-timeline {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.application-timeline {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.application-timeline {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.application-timeline {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.application-timeline {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.application-timeline {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.application-timeline {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.application-timeline {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.application-timeline {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.wrap.application-timeline {
  padding: 16px 12px;
}

.event.application-timeline {
  padding: 3px 0;
}

[date].application-timeline {
  color: #5f6368;
        font-size: 13px;
        padding: 3px 0;
        width: 70px;
        line-height: 16px;
}

[critical].application-timeline [date].application-timeline {
  color: #202124;
        font-weight: 500;
        line-height: 18px;
}

.line.application-timeline {
  margin: 9px 6px;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
}

.dot.application-timeline {
  margin: 3px 0;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
        display: inline-block;
}

[critical].application-timeline .line.application-timeline {
  background: #4285f4;
}

[current].application-timeline .line.application-timeline {
  background: #81c995;
}

[current][critical].application-timeline .line.application-timeline {
  background: #81c995;
}

.title.application-timeline {
  font-size: 13px;
        padding: 3px 0;
        line-height: 16px;
}

.title-text.application-timeline {
  color: #5f6368;
}

.description-item.application-timeline {
  font-size: 12px;
        padding: 6px 0;
        max-width: 300px;
}

#legal.application-timeline {
  height: 14px;
        width: 14px;
        padding: 0 3px 1px 3px;
        vertical-align: text-bottom;
}

#icon.application-timeline {
  height: 12px;
        width: 12px;
        padding: 0 3px 3px 3px;
        vertical-align: text-bottom;
}

.unknown.application-timeline {
  font-style: italic;
}

.not_active.application-timeline {
  text-decoration: line-through;
}

.active.application-timeline {
  font-weight: 500;
}

#cc[this].application-timeline {
  color: #202124 !important;
        text-decoration: underline;
}

#cc[this].not_active.application-timeline {
  text-decoration: line-through underline;
}

hr.application-timeline {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 10px 0 16px 0;
}

.header.application-timeline {
  font-size: 13px;
        line-height: 20px;
        font-weight: 500;
        color: #202124;
        padding-bottom: 8px;
}

.block.application-timeline {
  padding: 0 6px 0 0;
}

.year.application-timeline {
  color: #5f6368;
        font-size: 13px;
        font-weight: 500;
        padding: 3px 1px;
        width: 70px;
}

.expand.application-timeline {
  cursor: pointer;
        padding: 6px 0 3px 0;
}</style><!-- Shady DOM styles for patent-text --><style scope="patent-text">.layout.horizontal.patent-text,.layout.vertical.patent-text {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-text {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-text {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-text {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-text {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-text {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-text {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-text {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-text {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-text {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-text {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-text {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-text {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-text {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-text {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-text {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-text {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-text {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-text {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-text {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-text {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-text {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-text {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-text {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-text {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-text {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

patent-text {
  display: block;
}

#text.patent-text {
  line-height: 20px;
        min-width: 0;
}

#margin.patent-text {
  width: 16px;
}

#createHighlight.patent-text {
  position: relative;
        width: 16px;
        height: 16px;
        cursor: pointer;
}

.notranslate.patent-text > .google-src-text.patent-text {
  display: none;
}

.notranslate.patent-text:hover,mark.patent-text {
  background-color: #fbfcae;
}

.description-paragraph.patent-text {
  margin-block-start: 1em;
        margin-block-end: 1em;
}

.claim-text.patent-text {
  margin: 14px 0 0 20px;
}

.claim-dependent.patent-text {
  margin-left: 40px;
        color: #888;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim-text.patent-text {
  height: 0;
        width: 0;
        visibility: hidden;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim.patent-text:after {
  content: "…"
}

.patent-full-image.patent-text {
  max-width: 100%;
        height: auto;
}

.small-patent-image.patent-text {
  display: inline;
}

ul.patent-text {
  padding: 0 0 0 50px;
}

li.patent-text {
  list-style-type: none;
        position: relative;
}

ol.claims.patent-text li.patent-text {
  list-style-type: decimal;
        font-weight: bold;
}

ol.claims.patent-text li.patent-text > *.patent-text {
  font-weight: normal;
}

li.patent-text > para-num.patent-text {
  position: absolute;
        left: -45px;
        color: #888;
}

mark.patent-text {
  background: #fff59d;
}

mark.searchText.patent-text {
  background: #80deea;
}

.searchTextHeader.patent-text {
  font-weight: 500;
}

pre.patent-text {
  white-space: pre-wrap;
}

heading.patent-text {
  display: block;
        font-weight: 500;
        font-size: 13px;
}

#comment.patent-text {
  width: 16px;
        height: 16px;
}

[has-search][no-results].patent-text {
  display: none;
}

.highlight.patent-text {
  background-color: #fef7e0;
}</style><!-- Shady DOM styles for para-num --><!-- Shady DOM styles for result-container --><style scope="result-container">paper-spinner.result-container {
  position: absolute;
        
        top: calc(50%  + 56px - 16px);
        left: calc(50% + 175px - 16px);
}</style><!-- Shady DOM styles for scholar-result --><!-- Shady DOM styles for search-result --><style scope="search-result">.layout.horizontal.search-result,.layout.vertical.search-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

search-result {
  display: block;
        font-size: 13px;
}

#mainContainer.search-result {
  min-height: calc(100vh - 127px);
        color: #333;
}

#compactQuery.search-result {
  padding: 18px 20px 10px 20px;
        cursor: pointer;
}

#compactQuery.search-result > span.search-result {
  padding: 0 14px 0 0;
}

#compactQuery.search-result iron-icon.search-result {
  padding-right: 6px;
        height: 16px;
        width: 16px;
}</style><!-- Shady DOM styles for webdoc-result --><!-- Shady DOM styles for iron-pages --><!-- Shady DOM styles for paper-tab --><!-- Shady DOM styles for paper-tabs --><!-- Shady DOM styles for debug-info --><!-- Shady DOM styles for search-paging --><!-- Shady DOM styles for search-result-item --><!-- Shady DOM styles for search-result-image --><!-- Shady DOM styles for search-result-entities --><!-- Shady DOM styles for search-result-measures --><!-- Shady DOM styles for search-results --><!-- Shady DOM styles for summary-box --><!-- Shady DOM styles for timeline-page --><!-- Shady DOM styles for iron-localstorage --><!-- Shady DOM styles for search-app --><style scope="search-app">search-app {
  display: block;
        height: 100%;
}

#toast.search-app {
  min-height: 64px;
        min-width: 742px;
}</style><style>body {transition: opacity ease-in 0.2s; } 
body[unresolved] {opacity: 0; display: block; overflow: hidden; position: relative; } 
</style>
    <title>AU2013366490B9 - Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases 
        - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/AU2013366490B9/en">
    <meta name="description" content="
     A compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein: R 
   
   ">
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases 
       ">
    <meta name="DC.date" content="2013-12-20" scheme="dateSubmitted">
    <meta name="DC.description" content="
     A compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein: R 
   
   ">
    <meta name="citation_patent_application_number" content="AU:2013366490A">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/31/aa/f9/38775e16a08925/AU2013366490B9.pdf">
    <meta name="citation_patent_number" content="AU:2013366490:B9">
    <meta name="DC.date" content="2018-02-01" scheme="issue">
    <meta name="DC.contributor" content="Philip Wilson Howard" scheme="inventor">
    <meta name="DC.contributor" content="MedImmune Ltd" scheme="assignee">
    <meta name="DC.relation" content="WO:2010043880:A1" scheme="references">
    <meta name="DC.relation" content="WO:2012112708:A1" scheme="references">
    <meta name="DC.relation" content="WO:2013041606:A1" scheme="references">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      body { transition: none; }
    </style>

    <script src="https://apis.google.com/_/scs/abc-static/_/js/k=gapi.lb.en.IKZeRvoAYNY.O/m=client/rt=j/sv=1/d=1/ed=1/am=AAAQ/rs=AHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw/cb=gapi.loaded_0?le=scs" async=""></script><script>
      window.version = 'patent-search.search_20240531_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <style>[hidden]:not([style-scope]):not(.style-scope) {
  display: none !important;
}

</style><style></style><style></style><style></style><style></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic,500,500italic,700,700italic"><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,700"><style></style><style></style><style>
  html, body {
    min-width: 100%;
    width: 100%;
    min-height: 100%;
    height: 100%;
  }

  body {
    background-color: #fff;
    font-family: 'Roboto', sans-serif;
    color: #333;
    margin: 0;
    padding: 0;
    /*
     * Turn off https://github.com/WICG/ScrollAnchoring/blob/master/explainer.md
     * https://memegen.googleplex.com/5230756293246976
     */
    overflow-anchor: none;
  }

  body h1, body h2, body h3 {
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
  }

  body a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  body a:visited {
    color: #3c80f6;
  }

  body a[open-result]:visited {
    color: #7e57c2;
  }

  /* For Firefox */
  a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  a:visited {
    color: #3c80f6;
  }

  a[open-result]:visited {
    color: #7e57c2;
  }

  ::selection , body ::selection {
    background-color: #c6dafc;
    color: #333;
  }
</style><link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.html">
  <style>[hidden] { display: none !important; }</style><script type="text/javascript" charset="UTF-8" src="https://apis.google.com/js/client.js" gapi_processed="true"></script></head>
  <body>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.js"></script><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span>
    <search-app>
    
    <remote-fetch class="style-scope search-app"></remote-fetch>
    <search-state class="style-scope search-app"></search-state>
    <browser-ui class="style-scope search-app"></browser-ui>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    
      <search-result id="result" class="style-scope search-app">
    
    
    <search-ui mode="result" class="style-scope search-result x-scope search-ui-0">
    
    
    
    <div id="content" class="style-scope search-ui" wide="">
      <search-header show-search="" class="style-scope search-ui">
    
    
    <div class="style-scope search-header" wide="">
      <header class="style-scope search-header">
        <div class="layout horizontal headerpad style-scope search-header">
          <div class="layout horizontal leftheader style-scope search-header">
            <h1 class="style-scope search-header">
              <state-modifier inherit="" act="{&quot;type&quot;: &quot;HOME&quot;}" class="style-scope search-header"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                <div class="lockup style-scope search-header">
                  <span class="lockup-logo style-scope search-header"></span>
                  <span class="lockup-text style-scope search-header">
                    <span class="lockup-brand style-scope search-header">&nbsp;Patents</span>
                  </span>
                </div>
              </a></state-modifier>
            </h1>
          </div>
          
            <search-box class="style-scope search-header">
    
    <div class="layout horizontal style-scope search-box" style="position: relative;">
      <div class="inputbox flex layout horizontal style-scope search-box">
        <div class="suggest-bg flex style-scope search-box">
          <input name="q" id="searchInput" data-proto="SEARCH_INPUT" autocomplete="off" class="style-scope search-box">
        </div>
        <div id="corpora" class="style-scope search-box">
          <iron-icon icon="icons:lightbulb-outline" id="patentIcon" class="style-scope search-box x-scope iron-icon-0" active=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M9 21c0 .55.45 1 1 1h4c.55 0 1-.45 1-1v-1H9v1zm3-19C8.14 2 5 5.14 5 9c0 2.38 1.19 4.47 3 5.74V17c0 .55.45 1 1 1h6c.55 0 1-.45 1-1v-2.26c1.81-1.27 3-3.36 3-5.74 0-3.86-3.14-7-7-7zm2.85 11.1l-.85.6V16h-4v-2.3l-.85-.6C7.8 12.16 7 10.63 7 9c0-2.76 2.24-5 5-5s5 2.24 5 5c0 1.63-.8 3.16-2.15 4.1z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#patentIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include patents
    </div>
  </overlay-tooltip>
          <iron-icon icon="social:school" id="nplIcon" class="style-scope search-box x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M5 13.18v4L12 21l7-3.82v-4L12 17l-7-3.82zM12 3L1 9l11 6 9-4.91V17h2V9L12 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#nplIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include non-patent literature
    </div>
  </overlay-tooltip>
          <keyword-wizard id="wizardIcon" class="style-scope search-box">


<div id="wizardContainer" class="style-scope keyword-wizard">
  <iron-icon icon="image:tune" id="wizardIcon" class="style-scope keyword-wizard x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M3 17v2h6v-2H3zM3 5v2h10V5H3zm10 16v-2h8v-2h-8v-2h-2v6h2zM7 9v2H3v2h4v2h2V9H7zm14 4v-2H11v2h10zm-6-4h2V7h4V5h-4V3h-2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
  <paper-material elevation="2" id="wizard" class="style-scope keyword-wizard x-scope paper-material-0" hidden="">
    
    

    
    
    <div class="search-within style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Search within
        <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="within"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="withinHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search within the title, abstract, claims, or full patent document</b>: You can
          restrict your search to a specific field using field names.</p>
        <p class="style-scope keyword-wizard">Use <span class="q style-scope keyword-wizard">TI=</span> to search in the title, <span class="q style-scope keyword-wizard">AB=</span> for the
          abstract, <span class="q style-scope keyword-wizard">CL=</span> for the claims, or <span class="q style-scope keyword-wizard">TAC=</span> for
          all three. For example, <span class="q style-scope keyword-wizard">TI=(safety belt)</span>.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search by Cooperative Patent Classifications (CPCs)</b>: These are commonly used to
          represent ideas in place of keywords, and can also be entered in a search term box. If
          you're searching for<span class="q style-scope keyword-wizard">seat belts</span>, you could also search for
          <span class="q style-scope keyword-wizard">B60R22/00</span> to retrieve documents that mention safety belts or body
          harnesses. <span class="q style-scope keyword-wizard">CPC=B60R22</span> will match documents with exactly this CPC,
          <span class="q style-scope keyword-wizard">CPC=B60R22/low</span> matches documents with this CPC or a child
          classification of this CPC.
        </p>
          <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="filter-chips style-scope keyword-wizard">
        <span class="chip style-scope keyword-wizard" id="title" selected="">Title</span>
        <span class="chip style-scope keyword-wizard" id="abstract" selected="">Abstract</span>
        <span class="chip style-scope keyword-wizard" id="claims" selected="">Claims</span>
        <span class="chip style-scope keyword-wizard" id="fullDoc" selected="">Full Document</span>
      </div>
      
      <div class="cpc-field style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputCPC" class="style-scope keyword-wizard">or CPC</label></span>
        <div class="cpc-inputs style-scope keyword-wizard">
          <input class="keyword-input style-scope keyword-wizard" id="inputCPC" placeholder="Or search with CPC">
          <input type="checkbox" id="childCPC" checked="" class="style-scope keyword-wizard">
          <label class="checkbox-label style-scope keyword-wizard" for="childCPC">
            Include child classifications
          </label>
        </div>
      </div>
    </div>
    
    <div class="find-patents style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Find patents
        <iron-icon class="help-header style-scope keyword-wizard x-scope iron-icon-0" icon="icons:help-outline" id="searchBoolean"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="searchBooleanHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Keywords and boolean syntax (USPTO or EPO format)</b>:
          <span class="q style-scope keyword-wizard">seat belt</span> searches these two words, or their plurals and close
          synonyms. <span class="q style-scope keyword-wizard">"seat belt"</span> searches this exact phrase, in order.
          <span class="q style-scope keyword-wizard">-seat -belt</span> searches for documents not containing either word.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">For searches using boolean logic</b>, the default operator is
          <span class="q style-scope keyword-wizard">AND</span> with left associativity. <i class="style-scope keyword-wizard">Note:</i> this means
          <span class="q style-scope keyword-wizard">safety OR seat belt</span> is searched as <span class="q style-scope keyword-wizard">(safety OR seat)
          AND belt</span>. Each word automatically includes plurals and close synonyms. Adjacent
          words that are implicitly ANDed together, such as <span class="q style-scope keyword-wizard">(safety belt)</span>,
          are treated as a phrase when generating synonyms.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputAnd" class="style-scope keyword-wizard">with ALL of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputAnd" placeholder="with ALL of the words">
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputExact" class="style-scope keyword-wizard">with the EXACT PHRASE</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputExact" placeholder="with the EXACT PHRASE"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputOr" class="style-scope keyword-wizard">with AT LEAST ONE of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputOr" placeholder="with AT LEAST ONE of the words"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputMinus" class="style-scope keyword-wizard">WITHOUT the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputMinus" placeholder="WITHOUT the words"></div>
    </div>
    <div class="search-by style-scope keyword-wizard">
      <div class="wizard-header style-scope keyword-wizard">
          Search by
          <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="chem"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </div>
      
      <div class="help style-scope keyword-wizard" id="chemHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Chemistry searches</b> match terms (trade names, IUPAC names, etc.
          extracted from the entire document, and processed from .MOL files.)
        </p>
        <p class="style-scope keyword-wizard">Substructure (use <span class="q style-scope keyword-wizard">SSS=</span>) and similarity (use
          <span class="q style-scope keyword-wizard">~</span>) searches are limited to one per search at the top-level
          <span class="q style-scope keyword-wizard">AND</span> condition. Exact searches can be used multiple times throughout
          the search query.
        </p>
        <p class="style-scope keyword-wizard">Searching by SMILES or InChi key requires no special syntax. To search by SMARTS, use
          <span class="q style-scope keyword-wizard">SMARTS=</span>.
        </p>
        <p class="style-scope keyword-wizard">To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple
          molecules separated by whitespace or by comma.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      
      <div class="chemistry-field style-scope keyword-wizard">
          <span class="input-label style-scope keyword-wizard"><label for="inputChem" class="style-scope keyword-wizard">Chemistry</label></span>
          <span class="chem-type-label style-scope keyword-wizard"><label for="chemType" hidden="" class="style-scope keyword-wizard">Type</label></span>
          <select id="chemType" class="style-scope keyword-wizard">
            <option value="identical" class="style-scope keyword-wizard">Identical</option>
            <option value="substructure" class="style-scope keyword-wizard">Substructure</option>
            <option value="smarts" class="style-scope keyword-wizard">SMARTS</option>
            <option value="similarity" class="style-scope keyword-wizard">Similarity</option>
            <option value="batch" class="style-scope keyword-wizard">Batch</option>
          </select>
          <textarea class="keyword-input style-scope keyword-wizard" id="inputChem" placeholder="Trade name, SMILES, InChiKey"></textarea>
      </div>
      <div class="import style-scope keyword-wizard">
        <div class="wizard-header style-scope keyword-wizard">
          Patent numbers
        </div>
        <span class="import-button style-scope keyword-wizard">
          <a href="https://patents.google.com/import" class="style-scope keyword-wizard"><button class="style-scope keyword-wizard">Import</button></a>
        </span>
        <p class="import-text style-scope keyword-wizard">
          Search specific patents by importing a CSV or list of patent publication or application numbers.
        </p>
      </div>
    </div>
    
    <div class="wizard-buttons style-scope keyword-wizard">
      <button type="reset" class="style-scope keyword-wizard">Close</button>
      <button type="button" autofocus="" class="style-scope keyword-wizard">Add</button>
    </div>
  
  </paper-material>
</div>
</keyword-wizard>
          <overlay-tooltip positioning-target="#wizardIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Display advanced search options
    </div>
  </overlay-tooltip>
        </div>
      </div>
      <paper-material id="suggestMenu" class="style-scope search-box x-scope paper-material-0" elevation="1" hidden="">
    
    

    
        <template is="dom-repeat" class="style-scope search-box"></template>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Sorry, we couldn't find this patent number.
        </div>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> 
        </div>
      
  </paper-material>
      <button id="searchButton" class="style-scope search-box"><iron-icon class="style-scope search-box x-scope iron-icon-0" icon="search"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></button>
    </div>
  </search-box>
          <template is="dom-if" class="style-scope search-header"></template>
          <div class="flex style-scope search-header"></div>
          
            <div id="header-container" class="style-scope search-header">
              <result-nav class="style-scope search-header">
    
    <div class="style-scope result-nav" hidden="">
      <state-modifier id="current" act="{&quot;type&quot;: &quot;BACK_TO_RESULTS&quot;}" inherit="" class="style-scope result-nav"><a id="link" href="#" class="style-scope state-modifier" inherit=""><span class="style-scope result-nav"></span> of
      <template is="dom-if" class="style-scope result-nav"></template>
      0<template is="dom-if" class="style-scope result-nav"></template></a></state-modifier>
      <state-modifier id="prevResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-left" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.41 7.41L14 6l-6 6 6 6 1.41-1.41L10.83 12z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier><state-modifier id="nextResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-right" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M10 6L8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier>
      <overlay-tooltip positioning-target="#prevResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Previous result
    </div>
  </overlay-tooltip>
      <overlay-tooltip positioning-target="#nextResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Next result
    </div>
  </overlay-tooltip>
    </div>
  </result-nav>
            </div>
          <template is="dom-if" class="style-scope search-header"></template>
        </div>
      </header>
    </div>
  </search-header>

      <div class="layout horizontal style-scope search-ui">
        <template is="dom-if" class="style-scope search-ui"></template>

        <div id="main" class="style-scope search-ui">
          <search-term-wizard class="style-scope search-ui"><pat-dialog open="" class="style-scope search-term-wizard">
  <span class="header style-scope search-term-wizard">
    <span class="title style-scope search-term-wizard">Search tools</span>
    <span id="language" class="style-scope search-term-wizard">
      <text-button id="textButton" selected="" class="style-scope search-term-wizard">Text
</text-button>
      <text-button id="classificationButton" class="style-scope search-term-wizard">Classification
</text-button>
      <text-button id="chemistryButton" class="style-scope search-term-wizard">Chemistry
</text-button>
      <text-button id="measureButton" class="style-scope search-term-wizard">Measure
</text-button>
      <text-button id="numbersButton" class="style-scope search-term-wizard">Numbers
</text-button>
    </span>
  </span>
  <span id="panels" class="style-scope search-term-wizard">
    <text-search-term-wizard id="textPanel" class="style-scope search-term-wizard" selected=""><span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Type a concept you want to search for here" class="style-scope text-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Type a concept you want to search for here">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="title" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Title</filter-chip>
  <filter-chip id="abstract" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Abstract</filter-chip>
  <filter-chip id="claims" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="all" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
All</filter-chip>
  <filter-chip id="any" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Any</filter-chip>
  <filter-chip id="exact" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="not" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Not</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope text-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope text-search-term-wizard">Add AND condition</span></mat-button></span></text-search-term-wizard>
    <classification-wizard id="classificationPanel" class="style-scope search-term-wizard"><span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope classification-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Enter a CPC here" uppercase="" class="style-scope classification-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Enter a CPC here">
  
</span>
</outlined-text-field>
</span>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope classification-wizard"></path>
  </svg>
  <filter-chip id="notExact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These CPCs and their children
  </filter-chip>
  <filter-chip selected="" id="exact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These exact CPCs
  </filter-chip>
</span>
<span class="style-scope classification-wizard">
  <mat-button id="button" filled="" class="style-scope classification-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope classification-wizard">Add AND condition</span></mat-button>
</span></classification-wizard>
    <chemistry-search-term-wizard id="chemistryPanel" class="style-scope search-term-wizard"><span class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Trade name, SMILES, InChI Key" class="style-scope chemistry-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Trade name, SMILES, InChI Key">
  
</span>
</outlined-text-field>
  <outlined-textarea id="textArea" placeholder="Enter multiple SMILES or InChI Keys, one per line" rows="4" class="style-scope chemistry-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple SMILES or InChI Keys, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
  <a href="https://support.google.com/faqs/answer/7049475#zippy=%2Csearching-by-chemistry" target="_blank" class="style-scope chemistry-search-term-wizard">
    <svg class="help style-scope chemistry-search-term-wizard" xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49">
      <path d="M11.95 18q.525 0 .888-.363.362-.362.362-.887t-.362-.887q-.363-.363-.888-.363t-.888.363q-.362.362-.362.887t.362.887q.363.363.888.363Zm-.9-3.85h1.85q0-.825.188-1.3.187-.475 1.062-1.3.65-.65 1.025-1.238.375-.587.375-1.412 0-1.4-1.025-2.15T12.1 6q-1.425 0-2.312.75-.888.75-1.238 1.8l1.65.65q.125-.45.563-.975Q11.2 7.7 12.1 7.7q.8 0 1.2.437.4.438.4.963 0 .5-.3.937-.3.438-.75.813-1.1.975-1.35 1.475-.25.5-.25 1.825ZM12 22q-2.075 0-3.9-.788-1.825-.787-3.175-2.137-1.35-1.35-2.137-3.175Q2 14.075 2 12t.788-3.9q.787-1.825 2.137-3.175 1.35-1.35 3.175-2.138Q9.925 2 12 2t3.9.787q1.825.788 3.175 2.138 1.35 1.35 2.137 3.175Q22 9.925 22 12t-.788 3.9q-.787 1.825-2.137 3.175-1.35 1.35-3.175 2.137Q14.075 22 12 22Zm0-2q3.35 0 5.675-2.325Q20 15.35 20 12q0-3.35-2.325-5.675Q15.35 4 12 4 8.65 4 6.325 6.325 4 8.65 4 12q0 3.35 2.325 5.675Q8.65 20 12 20Zm0-8Z" class="style-scope chemistry-search-term-wizard"></path>
    </svg>
  </a>
</span>
<span id="chemQuantifiers" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M5 21.2q-1.4 0-2-1.25-.6-1.25.3-2.325l5.5-6.7V5.15h-.825q-.475 0-.8-.338Q6.85 4.475 6.85 4q0-.475.325-.813.325-.337.8-.337h8.05q.475 0 .8.337.325.338.325.813 0 .475-.325.812-.325.338-.8.338H15.2v5.775l5.5 6.7q.9 1.075.3 2.325-.6 1.25-2 1.25Zm2.15-3.275h9.7l-3.275-3.85h-3.15Zm-2 1h13.7l-5.925-7.2V5.15h-1.85v6.575Zm6.85-6.9Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="exact" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="exactBatch" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact Batch</filter-chip>
  <filter-chip id="similar" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Similar</filter-chip>
  <filter-chip id="substructure" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure</filter-chip>
  <filter-chip id="smarts" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure (SMARTS)</filter-chip>
</span>
<span id="location" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="claims" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims only</filter-chip>
</span>
<span class="style-scope chemistry-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope chemistry-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope chemistry-search-term-wizard">Add AND condition</span></mat-button>
</span>
</chemistry-search-term-wizard>
    <measure-search-term-wizard id="measurePanel" class="style-scope search-term-wizard"><span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M4.1 18.15q-.95 0-1.612-.663-.663-.662-.663-1.612v-7.75q0-.95.663-1.613Q3.15 5.85 4.1 5.85h15.8q.95 0 1.613.662.662.663.662 1.613v7.75q0 .95-.662 1.612-.663.663-1.613.663Zm0-2.275h15.8v-7.75H17V12h-2V8.125h-2V12h-2V8.125H9V12H7V8.125H4.1v7.75ZM7 12h2Zm4 0h2Zm4 0h2Zm-3 0Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="measureExpression" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M3.875 20.15V8.85h4.25v11.3Zm6 0V3.85h4.25v16.3Zm6 0v-7.3h4.25v7.3Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="context" placeholder="activity, wavelength, embossing depth, absorption" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="activity, wavelength, embossing depth, absorption">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope measure-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope measure-search-term-wizard">Add AND condition</span></mat-button>
</span>
</measure-search-term-wizard>
    <numerical-search-term-wizard id="numericalPanel" class="style-scope search-term-wizard"><span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-textarea id="batch" placeholder="Enter multiple Patent Application and Publication Numbers, one per line" rows="4" class="style-scope numerical-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple Patent Application and Publication Numbers, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
</span>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="m10.825 23.45-1.6-1.625L10.9 20.15H8q-.35.9-1.162 1.488-.813.587-1.838.587-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.025.588-1.837Q2.95 16.35 3.85 16V8q-.9-.35-1.487-1.163Q1.775 6.025 1.775 5q0-1.35.938-2.288Q3.65 1.775 5 1.775q1.025 0 1.838.587Q7.65 2.95 8 3.85h2.9L9.225 2.175l1.6-1.625L15.275 5l-4.45 4.45-1.6-1.625L10.9 6.15H8q-.25.65-.725 1.125T6.15 8v8q.65.25 1.125.725T8 17.85h2.9l-1.675-1.675 1.6-1.625 4.45 4.45ZM19 22.225q-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.05.588-1.863.587-.812 1.487-1.137V8q-.9-.325-1.487-1.137-.588-.813-.588-1.863 0-1.35.938-2.288.937-.937 2.287-.937 1.35 0 2.288.937.937.938.937 2.288 0 1.05-.587 1.863Q21.05 7.675 20.15 8v8q.9.35 1.488 1.163.587.812.587 1.837 0 1.35-.937 2.288-.938.937-2.288.937ZM5 19.95q.4 0 .675-.275T5.95 19q0-.4-.275-.675T5 18.05q-.4 0-.675.275T4.05 19q0 .4.275.675T5 19.95Zm14 0q.4 0 .675-.275T19.95 19q0-.4-.275-.675T19 18.05q-.4 0-.675.275T18.05 19q0 .4.275.675t.675.275Zm-14-14q.4 0 .675-.275T5.95 5q0-.4-.275-.675T5 4.05q-.4 0-.675.275T4.05 5q0 .4.275.675T5 5.95Zm14 0q.4 0 .675-.275T19.95 5q0-.4-.275-.675T19 4.05q-.4 0-.675.275T18.05 5q0 .4.275.675T19 5.95ZM5 19Zm14 0ZM5 5Zm14 0Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <filter-chip id="applicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Application Numbers</filter-chip>
  <filter-chip id="publicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Publication Numbers</filter-chip>
  <filter-chip id="either" selected="" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Either</filter-chip>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M12 22.2q-2.1 0-3.962-.8-1.863-.8-3.25-2.175Q3.4 17.85 2.6 15.988 1.8 14.125 1.8 12t.8-3.988q.8-1.862 2.188-3.237Q6.175 3.4 8.038 2.6 9.9 1.8 12 1.8q2.125 0 3.988.8 1.862.8 3.237 2.175Q20.6 6.15 21.4 8.012q.8 1.863.8 3.988t-.8 3.988q-.8 1.862-2.175 3.237Q17.85 20.6 15.988 21.4q-1.863.8-3.988.8Zm-1-2.325v-1.95q-.8 0-1.387-.575-.588-.575-.588-1.4v-.975L4.275 10.2q-.075.45-.137.9-.063.45-.063.9 0 3 1.975 5.25T11 19.875Zm6.85-2.525q.5-.55.888-1.175.387-.625.65-1.313.262-.687.4-1.412.137-.725.137-1.45 0-2.425-1.338-4.438-1.337-2.012-3.612-2.887v.375q0 .825-.587 1.4-.588.575-1.388.575h-2v2q0 .4-.287.687-.288.288-.688.288h-2v2h5.95q.425 0 .713.287.287.288.287.688v2.975h1q.65 0 1.163.387.512.388.712 1.013Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryFilter" placeholder="Restrict search to these countries" class="style-scope numerical-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Restrict search to these countries">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M2.85 18.225V15.95h6.3v2.275Zm0-5.075v-2.3h12.3v2.3Zm0-5.1V5.775h18.3V8.05Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryOrder" placeholder="Prefer results from these countries in this order" class="style-scope numerical-search-term-wizard" value="US, EP, WO, JP, CN"><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Prefer results from these countries in this order">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope numerical-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope numerical-search-term-wizard">Add AND condition</span></mat-button>
</span>
</numerical-search-term-wizard>
  </span>

</pat-dialog>
</search-term-wizard>
          
      <div content="" class="style-scope search-result">
        <div id="mainContainer" class="vertical layout style-scope search-result">
          <template is="dom-if" class="style-scope search-result"></template>
          <result-container class="style-scope search-result">
    

    <paper-spinner class="style-scope result-container x-scope paper-spinner-0" aria-hidden="true" hidden=""><div id="spinnerContainer" class="  style-scope paper-spinner"><div class="spinner-layer layer-1 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-2 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-3 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-4 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div></div></paper-spinner>
    
      <patent-result class="style-scope result-container">
    
    
    <div class="layout horizontal style-scope patent-result">
      <div style="width: 1200px; height: auto; overflow: auto;" class="style-scope patent-result">
        <div id="wrapper" tabindex="0" class="style-scope patent-result">
          <result-tags class="style-scope patent-result"></result-tags>
          <h1 id="title" class="scroll-target style-scope patent-result">
            Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases 
       </h1>
          <div class="horizontal layout style-scope patent-result">
            
            <div class="flex-3 style-scope patent-result" style="margin-top:-20px;overflow:hidden;" marginright="">
              <section id="abstract" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Abstract</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="abstract" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><abstract mxw-id="PA218753787" lang="EN" source="national office" load-source="docdb" class="style-scope patent-text">
    <div class="abstract style-scope patent-text">A compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein: R</div>
  </abstract>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <section id="classifications" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Classifications</div>
                  <div id="machineClassifiedWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">machine-classified</div>
                  <div id="machineClassifiedCPCWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">cpc-machine-classified</div>
                  <div id="machineClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-machine-classified</div>
                  <div class="style-scope patent-result" hidden="">&nbsp;</div>
                  <div id="familyClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-family-classified</div>
                </h3>
                <overlay-tooltip positioning-target="#machineClassifiedWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedCPCWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The CPC classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#familyClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned based on a patent family member containing these classification codes.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <classification-viewer class="style-scope patent-result">
    
    <div class="table style-scope classification-viewer">
      
        <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D"><a id="link" href="#" class="style-scope state-modifier">C07D</a></state-modifier>
                  <span class="description style-scope classification-tree">HETEROCYCLIC COMPOUNDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D487/00"><a id="link" href="#" class="style-scope state-modifier">C07D487/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D487/02"><a id="link" href="#" class="style-scope state-modifier">C07D487/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="C07D487/04"><a id="link" href="#" class="style-scope state-modifier">C07D487/04</a></state-modifier>
                  <span class="description style-scope classification-tree">Ortho-condensed systems</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
      <template is="dom-repeat" class="style-scope classification-viewer"></template>
      
      <div class="style-scope classification-viewer">
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/00"><a id="link" href="#" class="style-scope state-modifier">A61K47/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/06"><a id="link" href="#" class="style-scope state-modifier">A61K47/06</a></state-modifier>
                  <span class="description style-scope classification-tree">Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/22"><a id="link" href="#" class="style-scope state-modifier">A61K47/22</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P19/00"><a id="link" href="#" class="style-scope state-modifier">A61P19/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Drugs for skeletal disorders</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P35/00"><a id="link" href="#" class="style-scope state-modifier">A61P35/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antineoplastic agents</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P35/00"><a id="link" href="#" class="style-scope state-modifier">A61P35/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antineoplastic agents</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P35/02"><a id="link" href="#" class="style-scope state-modifier">A61P35/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Antineoplastic agents specific for leukemia</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P37/00"><a id="link" href="#" class="style-scope state-modifier">A61P37/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Drugs for immunological or allergic disorders</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P37/02"><a id="link" href="#" class="style-scope state-modifier">A61P37/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunomodulators</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P37/06"><a id="link" href="#" class="style-scope state-modifier">A61P37/06</a></state-modifier>
                  <span class="description style-scope classification-tree">Immunosuppressants, e.g. drugs for graft rejection</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P43/00"><a id="link" href="#" class="style-scope state-modifier">A61P43/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K"><a id="link" href="#" class="style-scope state-modifier">C07K</a></state-modifier>
                  <span class="description style-scope classification-tree">PEPTIDES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K5/00"><a id="link" href="#" class="style-scope state-modifier">C07K5/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K5/04"><a id="link" href="#" class="style-scope state-modifier">C07K5/04</a></state-modifier>
                  <span class="description style-scope classification-tree">Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K5/06"><a id="link" href="#" class="style-scope state-modifier">C07K5/06</a></state-modifier>
                  <span class="description style-scope classification-tree">Dipeptides</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K5/06008"><a id="link" href="#" class="style-scope state-modifier">C07K5/06008</a></state-modifier>
                  <span class="description style-scope classification-tree">Dipeptides with the first amino acid being neutral</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K5/06017"><a id="link" href="#" class="style-scope state-modifier">C07K5/06017</a></state-modifier>
                  <span class="description style-scope classification-tree">Dipeptides with the first amino acid being neutral and aliphatic</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K5/06026"><a id="link" href="#" class="style-scope state-modifier">C07K5/06026</a></state-modifier>
                  <span class="description style-scope classification-tree">Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        <template is="dom-repeat" class="style-scope classification-viewer"></template>
        <div class="more style-scope classification-viewer" style="" hidden="">View 7 more classifications</div>
        <div class="more style-scope classification-viewer">Hide more classifications</div>
      </div>
      <template is="dom-if" class="style-scope classification-viewer"></template>
    </div>
  </classification-viewer>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              
                <section class="style-scope patent-result">
                  <h3 class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Landscapes</div>
                  </h3>
                  <div class="responsive-grid style-scope patent-result">
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Health &amp; Medical Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Health &amp; Medical Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Chemical &amp; Material Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Chemical &amp; Material Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    <template is="dom-repeat" class="style-scope patent-result"></template>
                  </div>
                  <s-more-inline class="style-scope patent-result"><hr aria-hidden="true" class="style-scope s-more-inline">

<div class="button style-scope s-more-inline">
  <span slot="expand_text" class="style-scope patent-result">Show more</span>
  <span class="expand more style-scope s-more-inline"></span>
</div>
<div class="button style-scope s-more-inline" hidden="">
  <span slot="collapse_text" class="style-scope patent-result">Show less</span>
  <span class="expand less style-scope s-more-inline"></span>
</div>
</s-more-inline>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
            <div class="flex-2 style-scope patent-result">
              <section class="knowledge-card style-scope patent-result">
                <header class="style-scope patent-result">
                  <h2 id="pubnum" class="style-scope patent-result">AU2013366490B9</h2>
                  <p class="tagline style-scope patent-result">Australia</p>
                  <overlay-tooltip positioning-target="#pubnum" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                    <div style="max-width: 300px;" class="style-scope patent-result">Complete corrected granted patent</div>
                  
    </div>
  </overlay-tooltip>

                  <div class="knowledge-card-action-bar style-scope patent-result">
                    <a target="_blank" class="style-scope patent-result" href="https://patentimages.storage.googleapis.com/31/aa/f9/38775e16a08925/AU2013366490B9.pdf"><iron-icon icon="description" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download PDF</a>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_FIND_PRIOR_ART&quot;, &quot;keywords&quot;: $keywords, &quot;before&quot;: &quot;$before&quot;}" class="style-scope patent-result" data-keywords="[&quot;group&quot;,&quot;attachment&quot;,&quot;genbank&quot;,&quot;alkyl&quot;,&quot;point&quot;]" data-before="20121221"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="find-in-page" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 19.59V8l-6-6H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c.45 0 .85-.15 1.19-.4l-4.43-4.43c-.8.52-1.74.83-2.76.83-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5c0 1.02-.31 1.96-.83 2.75L20 19.59zM9 13c0 1.66 1.34 3 3 3s3-1.34 3-3-1.34-3-3-3-3 1.34-3 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Find Prior Art
                    </a></state-modifier>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_SIMILAR_DOCUMENTS&quot;, &quot;id&quot;: &quot;$id&quot;}" class="style-scope patent-result" data-id="patent/AU2013366490B9"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="editor:functions" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M18 4H6v2l6.5 6L6 18v2h12v-3h-7l5-5-5-5h7z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Similar
                    </a></state-modifier>
                  </div>
                </header>

                <dl class="important-people style-scope patent-result">
                  <template is="dom-if" class="style-scope patent-result"></template>
                  
                  <dt class="style-scope patent-result">Inventor</dt>
                  <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Philip Wilson Howard"><a id="link" href="#" class="style-scope state-modifier">Philip Wilson Howard</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>

                  
                  <dt class="style-scope patent-result">
                    <span class="tooltip-hint style-scope patent-result" id="assigneeWarning">Current Assignee</span>
                    <overlay-tooltip positioning-target="#assigneeWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                      The listed assignees may be inaccurate.<br class="style-scope patent-result">
                      Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.
                    
    </div>
  </overlay-tooltip>
                  </dt>
                  <dd class="style-scope patent-result">
                    
    MedImmune Ltd
  
                  </dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                </dl>

                <hr class="style-scope patent-result">

                <application-timeline class="style-scope patent-result">
    
    
    <div class="wrap style-scope application-timeline">
      <div class="header style-scope application-timeline">Worldwide applications</div>
      <div class="event style-scope application-timeline">
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2013</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US9567340B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US14/654,070</div>
                <div class="style-scope application-timeline">Filing date: 2013-12-20</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AU2013366490B9/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline" this="">AU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: AU2013366490A</div>
                <div class="style-scope application-timeline">Filing date: 2013-12-20</div>
                <div class="style-scope application-timeline">Legal status: Ceased</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/WO2014096365A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">WO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PCT/EP2013/077695</div>
                <div class="style-scope application-timeline">Filing date: 2013-12-20</div>
                <div class="style-scope application-timeline">Legal status: Application Filing</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CN110627797A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">CN</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CN201910920109.XA</div>
                <div class="style-scope application-timeline">Filing date: 2013-12-20</div>
                <div class="style-scope application-timeline">Legal status: Pending</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CA2894959C/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">CA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CA2894959A</div>
                <div class="style-scope application-timeline">Filing date: 2013-12-20</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JP6527466B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">JP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: JP2015548633A</div>
                <div class="style-scope application-timeline">Filing date: 2013-12-20</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EA032986B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">EA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EA201591000A</div>
                <div class="style-scope application-timeline">Filing date: 2013-12-20</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CN105246894A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">CN</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CN201380073646.6A</div>
                <div class="style-scope application-timeline">Filing date: 2013-12-20</div>
                <div class="style-scope application-timeline">Legal status: Pending</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP2935273A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP13821469.7A</div>
                <div class="style-scope application-timeline">Filing date: 2013-12-20</div>
                <div class="style-scope application-timeline">Legal status: Pending</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2016</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/HK1216176A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">HK</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: HK16104190.2A</div>
                <div class="style-scope application-timeline">Filing date: 2016-04-13</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        <template is="dom-repeat" class="style-scope application-timeline"></template>
      </div>
      <hr class="style-scope application-timeline">
      <div class="header style-scope application-timeline">Application AU2013366490A events <iron-icon id="legal" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        <overlay-tooltip positioning-target="#legal" direction="right" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
          <div style="max-width: 300px;" class="style-scope application-timeline">
            A timeline of key events for this patent application, including priority claims, publications, legal status, reassignments, and litigation.<br class="style-scope application-timeline"><br class="style-scope application-timeline">
            Google has not performed a legal analysis and makes no representation as to the accuracy or completeness of the events listed.
          </div>
        
    </div>
  </overlay-tooltip>
      </div>
      <div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="filed style-scope application-timeline">2013-12-20</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="MedImmune Ltd"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Application filed by MedImmune Ltd</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2015-07-09</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AU2013366490A1/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of AU2013366490A1</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline"><div date="" class="reassignment style-scope application-timeline">2015-11-19</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="MEDIMMUNE LIMITED"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Assigned to MEDIMMUNE LIMITED</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><iron-icon id="icon" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><overlay-tooltip positioning-target="#icon" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      <div class="description-item style-scope application-timeline">Request for Assignment</div><div class="description-item style-scope application-timeline">Assignors: SPIROGEN SARL</div><template is="dom-repeat" class="style-scope application-timeline"></template>
    </div>
  </overlay-tooltip><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2018-01-18</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AU2013366490B2/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of AU2013366490B2</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="granted style-scope application-timeline">2018-02-01</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Application granted</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2018-02-01</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AU2013366490B9/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of AU2013366490B9</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" current="" critical=""><div date="" class="legal-status style-scope application-timeline">Status</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Ceased</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="legal-status style-scope application-timeline">2033-12-20</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Anticipated expiration</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><template is="dom-repeat" strip-whitespace="" class="style-scope application-timeline"></template>
      <template is="dom-if" class="style-scope application-timeline"></template>
    </div>
  </application-timeline>
                <hr class="style-scope patent-result">

                <dl class="links style-scope patent-result">
                  <dt class="style-scope patent-result">Info</dt>

                  
                  <dd class="style-scope patent-result"><a href="#patentCitations" class="style-scope patent-result">Patent citations (329)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#citedBy" class="style-scope patent-result">Cited by (54)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#legalEvents" class="style-scope patent-result">Legal events</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#similarDocuments" class="style-scope patent-result">Similar documents</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#relatedApplications" class="style-scope patent-result">Priority and Related Applications</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <dt class="style-scope patent-result">External links</dt>

                  <dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=AU&amp;NR=2013366490B9&amp;KC=B9&amp;FT=D">Espacenet</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://globaldossier.uspto.gov/#/result/publication/AU/2013366490/1">Global Dossier</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patents.stackexchange.com/questions/tagged/AU2013366490B9">Discuss</a></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                </dl>
              </section>
            </div>
          </div>

          <div id="text" class="horizontal layout style-scope patent-result">
            <div class="flex flex-width style-scope patent-result" marginright="">
              <section id="description" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Description</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="description" id="descriptionText" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><div mxw-id="PDES240682872" lang="EN" load-source="patent-office" class="description style-scope patent-text">
    <div class="description-paragraph style-scope patent-text">WO 2012112708 A1 WO 2010043880 A1 WO 2013041606 A1 (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization</div>
    <div class="description-paragraph style-scope patent-text">International Bureau (43) International Publication Date 26 June 2014 (26.06.2014)</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/84/61/e8/9dd8eb7447bd8c/AU2013366490B9_D0001.png" class="style-scope patent-text"><img file="AU2013366490B9_D0001.tif" img-format="tif" alt="Figure AU2013366490B9_D0001" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/84/61/e8/9dd8eb7447bd8c/AU2013366490B9_D0001.png"></a></div>
    <div class="description-paragraph style-scope patent-text">(10) International Publication Number</div>
    <div class="description-paragraph style-scope patent-text">WIPOIPCT</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365 Al (51) International Patent Classification:</div>
    <div class="description-paragraph style-scope patent-text">C07D 487/04 (2006.01) A61P19/00 (2006.01)</div>
    <div class="description-paragraph style-scope patent-text">A61K 31/5517 (2006.01) A61P 35/00 (2006.01) (21) International Application Number:</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695 (22) International Filing Date:</div>
    <div class="description-paragraph style-scope patent-text">December 2013 (20.12.2013) (25) Filing Uanguage: English (26) Publication Uanguage: English (30) Priority Data:</div>
    <div class="description-paragraph style-scope patent-text">61/740,605 21 December 2012 (21.12.2012) US (71) Applicant: SPIROGEN SARL [CH/CH]; Rue Saint-Pierre 2, CH-1003 Lausanne (CH).</div>
    <div class="description-paragraph style-scope patent-text">(72) Inventor: HOWARD, Philip Wilson; Medimmune Spirogen Business Unit, The QMB Innovation Centre, 42 New Road, London Greater London El 2AX (GB).</div>
    <div class="description-paragraph style-scope patent-text">(74) Agents: WATSON, Robert et al.; Mewbum Ellis LLP, 33 Gutter Lane, London Greater London EC2V 8AS (GB).</div>
    <div class="description-paragraph style-scope patent-text">(81) Designated States (unless otherwise indicated, for every kind of national protection available)·. AE, AG, AL, AM,</div>
    <div class="description-paragraph style-scope patent-text">AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR,</div>
    <div class="description-paragraph style-scope patent-text">KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME,</div>
    <div class="description-paragraph style-scope patent-text">MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.</div>
    <div class="description-paragraph style-scope patent-text">(84) Designated States (unless otherwise indicated, for every kind of regional protection available)·. ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, ΓΓ, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).</div>
    <div class="description-paragraph style-scope patent-text">Declarations under Rule 4.17:</div>
    <div class="description-paragraph style-scope patent-text">— of inventorship (Rule 4.17(iv))</div>
    <div class="description-paragraph style-scope patent-text">Published:</div>
    <div class="description-paragraph style-scope patent-text">— with international search report (Art. 21(3)) (54) Title: UNSYMMETRICAL PYRROLOBENZODIAZEPINES-DIMERS FOR USE IN THE TREATMENT OF PROLIFERΑΤΓΥΕ AND AUTOIMMUNE DISEASES</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365 Al (57) Abstract: A compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein: R<sup class="style-scope patent-text">2</sup> is of formula (Ha), formula (lib) or formula (lie): (a) where A is a C57 aryl group, and either (i) Q<sup class="style-scope patent-text">1</sup> is a single bond, and Q<sup class="style-scope patent-text">2</sup> is selected from a single bond and -Z-(CH<sub class="style-scope patent-text">2</sub>)n-, where Z is selected from a single bond, O, S and NH and n is from 1 to 3; or (ii) Q<sup class="style-scope patent-text">1</sup> is -CH=CH-, and Q<sup class="style-scope patent-text">2</sup> is a single bond; (b) where: R<sup class="style-scope patent-text">cl</sup>, R<sup class="style-scope patent-text">C2 </sup>and R<sup class="style-scope patent-text">C3</sup> are independently selected from H and unsubstituted C1-2 alkyl; (c) where Q is selected from OH, SH and NR<sup class="style-scope patent-text">N</sup>, and If, R<sup class="style-scope patent-text">N</sup> is selected from H, methyl and ethyl X is selected from the group comprising: OH, SH, CO<sub class="style-scope patent-text">2</sub>H, COH, N=C=O, NHNH<sub class="style-scope patent-text">2</sub>, CONHNH2, (formula (x)), (formular (y), NHR<sup class="style-scope patent-text">N</sup>, wherein R<sup class="style-scope patent-text">N</sup> is selected from the group comprising H and Cm '<sub class="style-scope patent-text">N</sub>i-i y alkyl; and either: when there is a double bond present <sup class="style-scope patent-text">4</sup> between C2’ and C3’, R<sup class="style-scope patent-text">12</sup> is selected from the group consisting of: (ia) C5-10 aryl group, optionally substituted by one or more substituents selected from the group comprising: halo, nitro, cyano, ether, carboxy, ester, C1-7 alkyl, C3.7 heterocyclyl and bis-oxy-Ci-3 alkylene; (ib) C1-5 saturated aliphatic alkyl; (ic) C3-6 saturated cycloalkyl; (id), wherein each of R<sup class="style-scope patent-text">21</sup>, R<sup class="style-scope patent-text">22 </sup>and R<sup class="style-scope patent-text">23</sup> are independently selected from H, C1-3 saturated alkyl, C2-3 alkenyl, C2-3 alkynyl and cyclopropyl, where the total number of carbon atoms in the R<sup class="style-scope patent-text">12</sup> group is no more than 5; (ie), wherein one of R<sup class="style-scope patent-text">25a</sup> and R<sup class="style-scope patent-text">25b</sup> is H and the other is <sup class="style-scope patent-text">K</sup> selected from: phenyl, which phenyl is optionally substituted by a group selected from halo, methyl, methoxy; pyridyl; and thiophenyl; and (if), where R<sup class="style-scope patent-text">24</sup> is selected from: H; C1-3 saturated alkyl; C2-3 alkenyl; C2-3 alkynyl; cyclopropyl; phenyl, which phenyl is optionally substituted by a group selected from halo, methyl, methoxy; pyridyl; and thiophenyl; when there is a single bond present between C2’ and C3’, R<sup class="style-scope patent-text">12</sup> is (formula (z)), where R<sup class="style-scope patent-text">26a</sup> and R<sup class="style-scope patent-text">26b</sup> are independently selected from H, F, Cm saturated alkyl, C2-3 alkenyl, which alkyl and alkenyl groups are optionally substituted by a group selected from Cm alkyl amido and Cm alkyl ester; or, when one of R<sup class="style-scope patent-text">26a</sup> and R<sup class="style-scope patent-text">26b</sup> is</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/d3/b7/c5/8be3c3f0b515dd/AU2013366490B9_D0002.png" class="style-scope patent-text"><img file="AU2013366490B9_D0002.tif" img-format="tif" alt="Figure AU2013366490B9_D0002" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/d3/b7/c5/8be3c3f0b515dd/AU2013366490B9_D0002.png"></a></div>
    <div class="description-paragraph style-scope patent-text">lie</div>
    <div class="description-paragraph style-scope patent-text">NH X (id) (ie) (if) [Continued on next page] wo 2014/096365 Al lllllllllllllllllllllllllllllllllllll^</div>
    <div class="description-paragraph style-scope patent-text">H, the other is selected from nitrile and a Cm alkyl ester; R<sup class="style-scope patent-text">6</sup> and R<sup class="style-scope patent-text">9</sup> are independently selected from H, R, OH, OR, SH, SR, NH2, NHR, NRR', nitro, Me iSn and halo; where R and R' are independently selected from optionally substituted C1-12 alkyl, C3-20 heterocyclyl and C5-20 aryl groups; R<sup class="style-scope patent-text">7</sup> is selected from H, R, OH, OR, SH, SR, NH2, NHR, NHRR', nitro, MCiSn and halo; R is a C3. 12 alkylene group, which chain may be interrupted by one or more heteroatoms, e.g. O, S, NR<sup class="style-scope patent-text">N2</sup> (where R<sup class="style-scope patent-text">N2</sup> is H or Cm alkyl), and/or aromatic rings, e.g. benzene or pyridine; Y and Y are selected from O, S, or NH; R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7</sup>, R<sup class="style-scope patent-text">9</sup> are selected from the same groups as R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7</sup> and R<sup class="style-scope patent-text">9</sup> respectively; either: (A) R<sup class="style-scope patent-text">20</sup> is H or Me and R<sup class="style-scope patent-text">21a</sup> and R<sup class="style-scope patent-text">21b</sup> are both H or together form =O and either: (i) R<sup class="style-scope patent-text">10</sup> is H, R<sup class="style-scope patent-text">lla</sup> is H and R<sup class="style-scope patent-text">llb</sup> is OH or OR<sup class="style-scope patent-text">A</sup>, where R<sup class="style-scope patent-text">A</sup> is Cm alkyl; or (ii) R<sup class="style-scope patent-text">10</sup> and R<sup class="style-scope patent-text">llb</sup> form a nitrogen-carbon double bond between the nitrogen and carbon atoms to which they are bound and R<sup class="style-scope patent-text">lla</sup> is H; or (iii) R<sup class="style-scope patent-text">10</sup> is H, R<sup class="style-scope patent-text">lla</sup> is H and R<sup class="style-scope patent-text">llb</sup> is SOZM, where z is 2 or 3 and M is a monovalent pharmaceutically acceptable cation; or (B) R<sup class="style-scope patent-text">10</sup> is H or Me and R<sup class="style-scope patent-text">lla</sup> and R<sup class="style-scope patent-text">llb</sup> are both H or together form =O and either: (i) R<sup class="style-scope patent-text">20</sup> is H, R<sup class="style-scope patent-text">21a</sup> is H and R<sup class="style-scope patent-text">21b</sup> is OH or ORA, where R<sup class="style-scope patent-text">A</sup> is Cm alkyl; or (ii) R<sup class="style-scope patent-text">20</sup> and R<sup class="style-scope patent-text">21b</sup> form a nitrogen-carbon double bond between the nitrogen and carbon atoms to which they are bound and R<sup class="style-scope patent-text">lla</sup> is H; or (iii) R<sup class="style-scope patent-text">20</sup> is H, R<sup class="style-scope patent-text">21a</sup> is H and R<sup class="style-scope patent-text">21b</sup> is SOZM, where z is 2 or 3 and M is a monovalent pharmaceutically acceptable cation.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">UNSYMMETRICAL PYRROLOBENZODIAZEPINES-DIMERS FOR USE IN THE TREATMENT OF PROLIFERATIVE AND AUTOIMMUNE DISEASES</div>
    <div class="description-paragraph style-scope patent-text">The present invention relates to pyrrolobenzodiazepines (PBDs), and their inclusion in targeted conjugates. The PBDs of the present invention are in a mixed dimer where one PBD moiety compises an imine or equivalent group and the other moiety comprises either an amine or amido group. The PBDs are linked to a cell binding agent via a substituent on the C2 position.</div>
    <div class="description-paragraph style-scope patent-text">Background to the invention</div>
    <div class="description-paragraph style-scope patent-text">Some pyrrolobenzodiazepines (PBDs) have the ability to recognise and bond to specific sequences of DNA; the preferred sequence is PuGPu. The first PBD antitumour antibiotic, anthramycin, was discovered in 1965 (Leimgruber, et al., J. Am. Chem. Soc., 87, 57935795 (1965); Leimgruber, et al., J. Am. Chem. Soc., 87, 5791-5793 (1965)). Since then, a number of naturally occurring PBDs have been reported, and numerous synthetic routes have been developed to a variety of analogues (Thurston, etal., Chem. Rev. 1994, 433465 (1994); Antonow, D. and Thurston, D.E., Chem. Rev. 2011 111 (4), 2815-2864).</div>
    <div class="description-paragraph style-scope patent-text">Family members include abbeymycin (Hochlowski, et al., J. Antibiotics, 40, 145-148 (1987)), chicamycin (Konishi, et al., J. Antibiotics, 37, 200-206 (1984)), DC-81 (Japanese Patent 58-180 487; Thurston, et al., Chem. Brit., 26, 767-772 (1990); Bose, et al.,</div>
    <div class="description-paragraph style-scope patent-text">Tetrahedron, 48, 751-758 (1992)), mazethramycin (Kuminoto, et al., J. Antibiotics, 33, 665667 (1980)), neothramycins A and B (Takeuchi, et al., J. Antibiotics, 29, 93-96 (1976)), porothramycin (Tsunakawa, et al., J. Antibiotics, 41, 1366-1373 (1988)), prothracarcin (Shimizu, et al, J. Antibiotics, 29, 2492-2503 (1982); Langley and Thurston, J. Org. Chem.,</div>
    <div class="description-paragraph style-scope patent-text">52, 91-97 (1987)), sibanomicin (DC-102)(Hara, etal., J. Antibiotics, 41, 702-704 (1988);</div>
    <div class="description-paragraph style-scope patent-text">Itoh, etal., J. Antibiotics, 41, 1281-1284 (1988)), sibiromycin (Leber, etal., J. Am. Chem.</div>
    <div class="description-paragraph style-scope patent-text">Soc., 110, 2992-2993 (1988)) and tomamycin (Arima, etal., J. Antibiotics, 25, 437-444 (1972)). PBDs are of the general structure:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/83/b0/51/38c82be49c9e2b/AU2013366490B9_D0003.png" class="style-scope patent-text"><img file="AU2013366490B9_D0003.tif" img-format="tif" alt="Figure AU2013366490B9_D0003" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/83/b0/51/38c82be49c9e2b/AU2013366490B9_D0003.png"></a></div>
    <div class="description-paragraph style-scope patent-text">They differ in the number, type and position of substituents, in both their aromatic A rings and pyrrolo C rings, and in the degree of saturation of the C ring. In the B-ring there is either an imine (N=C), a carbinolamine(NH-CH(OH)), or a carbinolamine methyl ether (NHWO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">CH(OMe)) at the N10-C11 position which is the electrophilic centre responsible for alkylating DNA. All of the known natural products have an (S)-configuration at the chiral C11a position which provides them with a right-handed twist when viewed from the C ring towards the A ring. This gives them the appropriate three-dimensional shape for isohelicity with the minor groove of B-form DNA, leading to a snug fit at the binding site (Kohn, In Antibiotics III. Springer-Verlag, New York, pp. 3-11 (1975); Hurley and NeedhamVanDevanter, Acc. Chem. Res., 19, 230-237 (1986)). Their ability to form an adduct in the minor groove, enables them to interfere with DNA processing, hence their use as antitumour agents.</div>
    <div class="description-paragraph style-scope patent-text">It has been previously disclosed that the biological activity of these molecules can be potentiated by joining two PBD units together through their C8/C’-hydroxyl functionalities via a flexible alkylene linker (Bose, D.S., et al., J. Am. Chem. Soc., 114, 4939-4941 (1992); Thurston, D.E., etal., J. Org. Chem., 61, 8141-8147 (1996)). The PBD dimers are thought to form sequence-selective DNA lesions such as the palindromic 5’-Pu-GATC-Py-3’ interstrand cross-link (Smellie, M., etal., Biochemistry, 42, 8232-8239 (2003); Martin, C., et al., Biochemistry, 44, 4135-4147) which is thought to be mainly responsible for their biological activity. One example of a PBD dimmer, SG2000 (SJG-136):</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/08/e4/b6/0d99bfcffa5068/AU2013366490B9_D0004.png" class="style-scope patent-text"><img file="AU2013366490B9_D0004.tif" img-format="tif" alt="Figure AU2013366490B9_D0004" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/08/e4/b6/0d99bfcffa5068/AU2013366490B9_D0004.png"></a></div>
    <div class="description-paragraph style-scope patent-text">has recently entered Phase II clinical trials in the oncology area (Gregson, S., et al., J. Med. Chem., 44, 737-748 (2001); Alley, M.C., etal., Cancer Research, 64, 6700-6706 (2004); Hartley, J.A., et al., Cancer Research, 64, 6693-6699 (2004)).</div>
    <div class="description-paragraph style-scope patent-text">WO 2010/043880 discloses unsymmetrical dimeric PBD compound bearing aryl groups in the C2 position of each monomer, where one of these aryl groups bears a substituent designed to provide an anchor for linking the compound to another moiety. WO 2011/130613, discloses the inclusion of these PBD dimer compounds in targeted conjugates. WO 2011/130616, discloses unsymmetrical dimeric PBD compound bearing an aryl group in the C2 position of one monomer bearing a substituent designed to provide an anchor for linking the compound to another moiety, the other monomer bearing a nonaromatic group in the C2 position. The inclusion of these compounds in targeted conjugates is also disclosed. Co-pending International application PCT/EP2012/070233,</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695 filed 12 October 2012, discloses further unsymmetrical dimeric PBD compound bearing an propylenyl group in the C2 position of one monomer bearing a substituent designed to provide an anchor for linking the compound to another moiety, the other monomer bearing an aromatic or non-aromatic group in the C2 position.</div>
    <div class="description-paragraph style-scope patent-text">In 2002, Kamal described the synthesis and evaluation of PBD dimers having an imine bond in one PBD and an amide group in the other PBD (Kamal, A, et al., J. Med. Chem., 2002, 4679-4688), such as:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/01/04/78/e1151b8ed18b37/AU2013366490B9_D0005.png" class="style-scope patent-text"><img file="AU2013366490B9_D0005.tif" img-format="tif" alt="Figure AU2013366490B9_D0005" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/01/04/78/e1151b8ed18b37/AU2013366490B9_D0005.png"></a></div>
    <div class="description-paragraph style-scope patent-text">In 2004, he described the synthesis and evaluation of PBD dimers having an imine bond in one PBD and an amine bond in the other PBD (Kamal, A, et al., Bioorg. Med. Chem., 12 (2004) 5427-5436), such as:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/58/e5/59/8e4fb2c1287694/AU2013366490B9_D0006.png" class="style-scope patent-text"><img file="AU2013366490B9_D0006.tif" img-format="tif" alt="Figure AU2013366490B9_D0006" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/58/e5/59/8e4fb2c1287694/AU2013366490B9_D0006.png"></a></div>
    <div class="description-paragraph style-scope patent-text">These compounds are unable to cross-link DNA but were shown to possess some cytotoxicity.</div>
    <div class="description-paragraph style-scope patent-text">Disclosure of the invention</div>
    <div class="description-paragraph style-scope patent-text">A first aspect of the present invention comprises a compound with the formula I:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/df/65/9c/bde4c93a562c58/AU2013366490B9_D0007.png" class="style-scope patent-text"><img file="AU2013366490B9_D0007.tif" img-format="tif" alt="Figure AU2013366490B9_D0007" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/df/65/9c/bde4c93a562c58/AU2013366490B9_D0007.png"></a></div>
    <div class="description-paragraph style-scope patent-text">or a pharmaceutically acceptable salt or solvate thereof, wherein:</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">2</sup> is of formula Ila, formula lib or formula lie:</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/65/8c/05/493a0beddec37d/AU2013366490B9_D0008.png" class="style-scope patent-text"><img file="AU2013366490B9_D0008.tif" img-format="tif" alt="Figure AU2013366490B9_D0008" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/65/8c/05/493a0beddec37d/AU2013366490B9_D0008.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where A is a C5-7 aryl group, and either (i) Q<sup class="style-scope patent-text">1</sup> is a single bond, and Q<sup class="style-scope patent-text">2</sup> is selected from a single bond and -Z-(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>-, where Z is selected from a single bond, O, S and NH and n is from 1 to 3; or (ii) Q<sup class="style-scope patent-text">1</sup> is -CH=CH-, and Q<sup class="style-scope patent-text">2</sup> is a single bond;</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/65/a5/4d/db3bdf15b64748/AU2013366490B9_D0009.png" class="style-scope patent-text"><img file="AU2013366490B9_D0009.tif" img-format="tif" alt="Figure AU2013366490B9_D0009" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/65/a5/4d/db3bdf15b64748/AU2013366490B9_D0009.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where;</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">C1</sup>, R<sup class="style-scope patent-text">C2</sup> and R<sup class="style-scope patent-text">C3</sup> are independently selected from H and unsubstituted C-i_<sub class="style-scope patent-text">2</sub> alkyl;</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a8/79/ef/a7294bbbe5fb14/AU2013366490B9_D0010.png" class="style-scope patent-text"><img file="AU2013366490B9_D0010.tif" img-format="tif" alt="Figure AU2013366490B9_D0010" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a8/79/ef/a7294bbbe5fb14/AU2013366490B9_D0010.png"></a></div>
    <div class="description-paragraph style-scope patent-text">(c) where Q is selected from OH, SH and NR<sup class="style-scope patent-text">n</sup>, and R<sup class="style-scope patent-text">N</sup> is selected from H, methyl and ethyl X is selected from the group comprising: OH, SH, CO<sub class="style-scope patent-text">2</sub>H, COH, N=C=O, NHNH<sub class="style-scope patent-text">2</sub>, *' conhnh<sub class="style-scope patent-text">2</sub>,</div>
    <div class="description-paragraph style-scope patent-text">NH</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a0/87/91/41343c60d7f38f/AU2013366490B9_D0011.png" class="style-scope patent-text"><img file="AU2013366490B9_D0011.tif" img-format="tif" alt="Figure AU2013366490B9_D0011" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a0/87/91/41343c60d7f38f/AU2013366490B9_D0011.png"></a></div>
    <div class="description-paragraph style-scope patent-text">NHR<sup class="style-scope patent-text">n</sup>, wherein R<sup class="style-scope patent-text">N</sup> is selected from the group comprising H and C1.4 alkyl;</div>
    <div class="description-paragraph style-scope patent-text">and either:</div>
    <div class="description-paragraph style-scope patent-text">when there is a double bond present between C2’ and C3’, R<sup class="style-scope patent-text">12</sup> is selected from the group consisting of:</div>
    <div class="description-paragraph style-scope patent-text">(ia) C5-10 aryl group, optionally substituted by one or more substituents selected from the group comprising: halo, nitro, cyano, ether, carboxy, ester, Ci_<sub class="style-scope patent-text">7</sub> alkyl, C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">7</sub> heterocyclyl and bis-oxy-Ci_<sub class="style-scope patent-text">3</sub> alkylene;</div>
    <div class="description-paragraph style-scope patent-text">(ib) C1.5 saturated aliphatic alkyl;</div>
    <div class="description-paragraph style-scope patent-text">(ic) C<sub class="style-scope patent-text">3</sub>-<sub class="style-scope patent-text">6</sub> saturated cycloalkyl;</div>
    <div class="description-paragraph style-scope patent-text">(id)</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/9f/8c/52/43b52b8fed627f/AU2013366490B9_D0012.png" class="style-scope patent-text"><img file="AU2013366490B9_D0012.tif" img-format="tif" alt="Figure AU2013366490B9_D0012" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/9f/8c/52/43b52b8fed627f/AU2013366490B9_D0012.png"></a></div>
    <div class="description-paragraph style-scope patent-text">, wherein each of R<sup class="style-scope patent-text">21</sup>, R<sup class="style-scope patent-text">22</sup> and R<sup class="style-scope patent-text">23</sup> are independently selected from H, C-|.<sub class="style-scope patent-text">3</sub> saturated alkyl, C<sub class="style-scope patent-text">2</sub>.<sub class="style-scope patent-text">3</sub> alkenyl, C<sub class="style-scope patent-text">2</sub>.<sub class="style-scope patent-text">3</sub> alkynyl and cyclopropyl, where the total number of carbon atoms in the R<sup class="style-scope patent-text">12</sup> group is no more than 5;</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695 (ie)</div>
    <div class="description-paragraph style-scope patent-text">R' ,25b *</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/d6/ae/5d/b41331f76a4de5/AU2013366490B9_D0013.png" class="style-scope patent-text"><img file="AU2013366490B9_D0013.tif" img-format="tif" alt="Figure AU2013366490B9_D0013" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/d6/ae/5d/b41331f76a4de5/AU2013366490B9_D0013.png"></a></div>
    <div class="description-paragraph style-scope patent-text">, wherein one of R<sup class="style-scope patent-text">25a</sup> and R<sup class="style-scope patent-text">25b</sup> is H and the other is selected from:</div>
    <div class="description-paragraph style-scope patent-text">phenyl, which phenyl is optionally substituted by a group selected from halo, methyl, methoxy; pyridyl; and thiophenyl; and (if) <sup class="style-scope patent-text">R</sup> , where R<sup class="style-scope patent-text">24</sup> is selected from: H; C^ saturated alkyl; C<sub class="style-scope patent-text">2</sub>-3 alkenyl; C<sub class="style-scope patent-text">2</sub>.<sub class="style-scope patent-text">3</sub> alkynyl; cyclopropyl; phenyl, which phenyl is optionally substituted by a group selected from halo, methyl, methoxy; pyridyl; and thiophenyl;</div>
    <div class="description-paragraph style-scope patent-text">when there is a single bond present between C2’ and C3’,</div>
    <div class="description-paragraph style-scope patent-text">R' ,26a</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">12</sup> is H or <sup class="style-scope patent-text">R</sup> , where R<sup class="style-scope patent-text">26a</sup> and R<sup class="style-scope patent-text">26b</sup> are independently selected from H, F, Ci_<sub class="style-scope patent-text">4</sub> saturated alkyl, C<sub class="style-scope patent-text">2</sub>.<sub class="style-scope patent-text">3</sub> alkenyl, which alkyl and alkenyl groups are optionally substituted by a group selected from C-m alkyl amido and Cm alkyl ester; or, when one of R<sup class="style-scope patent-text">26a</sup> and R<sup class="style-scope patent-text">26b</sup> is H, the other is selected from nitrile and a Cm alkyl ester;</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">6</sup> and R<sup class="style-scope patent-text">9</sup> are independently selected from H, R, OH, OR, SH, SR, NH<sub class="style-scope patent-text">2</sub>, NHR, NRR’, nitro,</div>
    <div class="description-paragraph style-scope patent-text">Me<sub class="style-scope patent-text">3</sub>Sn and halo;</div>
    <div class="description-paragraph style-scope patent-text">where R and R’ are independently selected from optionally substituted Cm2 alkyl, C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">20 </sub>heterocyclyl and C5-20 aryl groups;</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">7</sup> is selected from H, R, OH, OR, SH, SR, NH<sub class="style-scope patent-text">2</sub>, NHR, NHRR’, nitro, Me<sub class="style-scope patent-text">3</sub>Sn and halo;</div>
    <div class="description-paragraph style-scope patent-text">R is a C<sub class="style-scope patent-text">3</sub>_i<sub class="style-scope patent-text">2</sub> alkylene group, which chain may be interrupted by one or more heteroatoms, e.g. O, S, NR<sup class="style-scope patent-text">N2</sup> (where R<sup class="style-scope patent-text">N2</sup> is H or Cm alkyl), and/or aromatic rings, e.g. benzene or pyridine;</div>
    <div class="description-paragraph style-scope patent-text">Y and Y’ are selected from O, S, or NH;</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">6</sup> , R<sup class="style-scope patent-text">7</sup>, R<sup class="style-scope patent-text">9</sup> are selected from the same groups as R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7</sup> and R<sup class="style-scope patent-text">9</sup> respectively; either:</div>
    <div class="description-paragraph style-scope patent-text">(A) R<sup class="style-scope patent-text">20</sup> is H or Me and R<sup class="style-scope patent-text">21a</sup> and R<sup class="style-scope patent-text">21b</sup> are both H or together form =0 and either:</div>
    <div class="description-paragraph style-scope patent-text">(i) R<sup class="style-scope patent-text">10</sup> is H, R<sup class="style-scope patent-text">11a</sup> is H and R<sup class="style-scope patent-text">11b</sup> is OH or OR<sup class="style-scope patent-text">A</sup>, where R<sup class="style-scope patent-text">A</sup> is Cm alkyl; or (ii) R<sup class="style-scope patent-text">10</sup> and R<sup class="style-scope patent-text">11b</sup> form a nitrogen-carbon double bond between the nitrogen and carbon atoms to which they are bound and R<sup class="style-scope patent-text">11a</sup> is H; or (iii) R<sup class="style-scope patent-text">10</sup> is H, R<sup class="style-scope patent-text">11a</sup> is H and R<sup class="style-scope patent-text">11b</sup> is SO<sub class="style-scope patent-text">Z</sub>M, where z is 2 or 3 and M is a monovalent pharmaceutically acceptable cation; or (B) R<sup class="style-scope patent-text">10</sup> is H or Me and R<sup class="style-scope patent-text">11a</sup> and R<sup class="style-scope patent-text">11b</sup> are both H or together form =0 and either:</div>
    <div class="description-paragraph style-scope patent-text">(i) R<sup class="style-scope patent-text">20</sup> is H, R<sup class="style-scope patent-text">21a</sup> is H and R<sup class="style-scope patent-text">21b</sup> is OH or OR<sup class="style-scope patent-text">A</sup>, where R<sup class="style-scope patent-text">A</sup> is C<sub class="style-scope patent-text">M</sub> alkyl; or</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695 (ii) R<sup class="style-scope patent-text">20</sup> and R<sup class="style-scope patent-text">21b</sup> form a nitrogen-carbon double bond between the nitrogen and carbon atoms to which they are bound and R<sup class="style-scope patent-text">11a</sup> is H; or (iii) R<sup class="style-scope patent-text">20</sup> is H, R<sup class="style-scope patent-text">21a</sup> is H and R<sup class="style-scope patent-text">21b</sup> is SO<sub class="style-scope patent-text">Z</sub>M, where z is 2 or 3 and M is a monovalent pharmaceutically acceptable cation.</div>
    <div class="description-paragraph style-scope patent-text">Thus, the options (A) and (B) above can result in compounds of the following formulae (lA-a, ΙΑ-b, IB-a, IB-b):</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/96/11/b7/b973a0042ae15c/AU2013366490B9_D0014.png" class="style-scope patent-text"><img file="AU2013366490B9_D0014.tif" img-format="tif" alt="Figure AU2013366490B9_D0014" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/96/11/b7/b973a0042ae15c/AU2013366490B9_D0014.png"></a></div>
    <div class="description-paragraph style-scope patent-text">Dimers of the invention therefore have an imine bond in one monomer, that may be 10 present as a carbinolamine, carbinolamine ether or bisulphite form, and either a second/tertiary amine or (methyl)amido functionality in the other monomer.</div>
    <div class="description-paragraph style-scope patent-text">A second aspect of the present invention provides the use of a compound of the first aspect of the invention in the manufacture of a medicament for treating a proliferative</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695 disease. The second aspect also provides a compound of the first aspect of the invention for use in the treatment of a proliferative disease.</div>
    <div class="description-paragraph style-scope patent-text">One of ordinary skill in the art is readily able to determine whether or not a candidate compound treats a proliferative condition for any particular cell type. For example, assays which may conveniently be used to assess the activity offered by a particular compound are described in the examples below.</div>
    <div class="description-paragraph style-scope patent-text">A third aspect of the present invention provides a method of making a compound of the first aspect of the invention, comprising at least one of the method steps set out below.</div>
    <div class="description-paragraph style-scope patent-text">A fourth aspect of the present invention provides compounds of formula III:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/0e/78/eb/864f5193e75cfb/AU2013366490B9_D0015.png" class="style-scope patent-text"><img file="AU2013366490B9_D0015.tif" img-format="tif" alt="Figure AU2013366490B9_D0015" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/0e/78/eb/864f5193e75cfb/AU2013366490B9_D0015.png"></a></div>
    <div class="description-paragraph style-scope patent-text">or a pharmaceutically acceptable salt or solvate thereof, wherein:</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">22</sup> is selected from:</div>
    <div class="description-paragraph style-scope patent-text">(a) formula IVa:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/3e/02/d1/b5948cb8cd35e8/AU2013366490B9_D0016.png" class="style-scope patent-text"><img file="AU2013366490B9_D0016.tif" img-format="tif" alt="Figure AU2013366490B9_D0016" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/3e/02/d1/b5948cb8cd35e8/AU2013366490B9_D0016.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where A, Q<sup class="style-scope patent-text">1</sup>, Q<sup class="style-scope patent-text">2</sup> are as defined in the first aspect of the invention;</div>
    <div class="description-paragraph style-scope patent-text">(b) formula IVb:</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">C2</sup> </div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/b0/fa/aa/1070fd23df9bac/AU2013366490B9_D0017.png" class="style-scope patent-text"><img file="AU2013366490B9_D0017.tif" img-format="tif" alt="Figure AU2013366490B9_D0017" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/b0/fa/aa/1070fd23df9bac/AU2013366490B9_D0017.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where R<sup class="style-scope patent-text">C1</sup>, R<sup class="style-scope patent-text">C2</sup> and R<sup class="style-scope patent-text">C3</sup> are as defined in the first aspect of the invention;</div>
    <div class="description-paragraph style-scope patent-text">(c) formula IVc:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/fb/47/9d/c7f842c1c638e4/AU2013366490B9_D0018.png" class="style-scope patent-text"><img file="AU2013366490B9_D0018.tif" img-format="tif" alt="Figure AU2013366490B9_D0018" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/fb/47/9d/c7f842c1c638e4/AU2013366490B9_D0018.png"></a></div>
    <div class="description-paragraph style-scope patent-text">L<sup class="style-scope patent-text">4</sup> is selected from a single bond and a group of:</div>
    <div class="description-paragraph style-scope patent-text">2013366490 24 Nov 2017 (a):</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ce/33/9d/8e7f2f6f71f76d/AU2013366490B9_D0019.png" class="style-scope patent-text"><img file="AU2013366490B9_D0019.tif" img-format="tif" alt="Figure AU2013366490B9_D0019" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ce/33/9d/8e7f2f6f71f76d/AU2013366490B9_D0019.png"></a></div>
    <div class="description-paragraph style-scope patent-text">o</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e8/70/36/8b8da86ab6c49a/AU2013366490B9_D0020.png" class="style-scope patent-text"><img file="AU2013366490B9_D0020.tif" img-format="tif" alt="Figure AU2013366490B9_D0020" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e8/70/36/8b8da86ab6c49a/AU2013366490B9_D0020.png"></a></div>
    <div class="description-paragraph style-scope patent-text">V wherein n is 0 to 3; (b)</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/0e/ba/a8/9f1aa66074af08/AU2013366490B9_D0021.png" class="style-scope patent-text"><img file="AU2013366490B9_D0021.tif" img-format="tif" alt="Figure AU2013366490B9_D0021" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/0e/ba/a8/9f1aa66074af08/AU2013366490B9_D0021.png"></a></div>
    <div class="description-paragraph style-scope patent-text">, wherein n is as defined above;</div>
    <div class="description-paragraph style-scope patent-text">(c)</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/97/3d/f0/2f0b500f076333/AU2013366490B9_D0022.png" class="style-scope patent-text"><img file="AU2013366490B9_D0022.tif" img-format="tif" alt="Figure AU2013366490B9_D0022" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/97/3d/f0/2f0b500f076333/AU2013366490B9_D0022.png"></a></div>
    <div class="description-paragraph style-scope patent-text">wherein n is as defined above; and (d)</div>
    <div class="description-paragraph style-scope patent-text">NHjV , wherein n is as defined above, E is O, S or NR, D is N, CH, or CR, and F is N, CH, or CR;</div>
    <div class="description-paragraph style-scope patent-text">L<sup class="style-scope patent-text">3</sup> is:</div>
    <div class="description-paragraph style-scope patent-text">Prot <sup class="style-scope patent-text">0</sup> , where X is such that L<sup class="style-scope patent-text">3</sup> is an amino-acid residue, a dipeptide residue or a tripeptide residue;</div>
    <div class="description-paragraph style-scope patent-text">Prot is selected from Fmoc (fluorenylmethyloxycarbonyl), Teoc (2(trimethylsilyl)ethoxycarbonyl), Boc (t-butoxycarbonyl) and Alloc (allyloxycarbonyl); and R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7</sup>, R<sup class="style-scope patent-text">9</sup>, R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7</sup>, R<sup class="style-scope patent-text">9</sup>, R<sup class="style-scope patent-text">12</sup>, RY, Y’, R <sup class="style-scope patent-text">10</sup>, R<sup class="style-scope patent-text">11a</sup>, R<sup class="style-scope patent-text">11b</sup>, R<sup class="style-scope patent-text">20</sup>, R<sup class="style-scope patent-text">21a</sup> and R<sup class="style-scope patent-text">21b</sup> are as defined in the first aspect of the invention.</div>
    <div class="description-paragraph style-scope patent-text">In one aspect, the invention provides a compound of formula III:</div>
    <div class="description-paragraph style-scope patent-text">2013366490 24 Nov 2017</div>
    <div class="description-paragraph style-scope patent-text">8A</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ad/b0/c2/fe91cf6cdc4241/AU2013366490B9_D0023.png" class="style-scope patent-text"><img file="AU2013366490B9_D0023.tif" img-format="tif" alt="Figure AU2013366490B9_D0023" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ad/b0/c2/fe91cf6cdc4241/AU2013366490B9_D0023.png"></a></div>
    <div class="description-paragraph style-scope patent-text">or a pharmaceutically acceptable salt or solvate thereof, wherein:</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">22</sup> is selected from:</div>
    <div class="description-paragraph style-scope patent-text">(a) formula IVa:</div>
    <div class="description-paragraph style-scope patent-text">'Prot</div>
    <div class="description-paragraph style-scope patent-text">IVa wherein A is a C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">7</sub> aryl group, and either (i) Q<sup class="style-scope patent-text">1</sup> is a single bond, and Q<sup class="style-scope patent-text">2</sup> is selected from a single bond and -Z-(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n </sub>, where Z is selected from a single bond, O, S and NH and n is from 1 to 3; or (ii) Q<sup class="style-scope patent-text">1</sup> is -CH=CH-, and Q<sup class="style-scope patent-text">2</sup> is a single bond;</div>
    <div class="description-paragraph style-scope patent-text">(b) formula IVb:</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">C2</sup> </div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/56/e7/6e/61256458a9571a/AU2013366490B9_D0024.png" class="style-scope patent-text"><img file="AU2013366490B9_D0024.tif" img-format="tif" alt="Figure AU2013366490B9_D0024" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/56/e7/6e/61256458a9571a/AU2013366490B9_D0024.png"></a></div>
    <div class="description-paragraph style-scope patent-text">wherein R<sup class="style-scope patent-text">C1</sup>, R<sup class="style-scope patent-text">C2</sup> and R<sup class="style-scope patent-text">C3</sup> are independently selected from Η and unsubstituted C-i_<sub class="style-scope patent-text">2</sub> alkyl; (c) formula IVc:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/67/ef/ee/30a46f971cae7e/AU2013366490B9_D0025.png" class="style-scope patent-text"><img file="AU2013366490B9_D0025.tif" img-format="tif" alt="Figure AU2013366490B9_D0025" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/67/ef/ee/30a46f971cae7e/AU2013366490B9_D0025.png"></a></div>
    <div class="description-paragraph style-scope patent-text">L<sup class="style-scope patent-text">4</sup> is selected from a single bond and a group of: (a):</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/46/39/a2/b1a0f7c13301c3/AU2013366490B9_D0026.png" class="style-scope patent-text"><img file="AU2013366490B9_D0026.tif" img-format="tif" alt="Figure AU2013366490B9_D0026" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/46/39/a2/b1a0f7c13301c3/AU2013366490B9_D0026.png"></a></div>
    <div class="description-paragraph style-scope patent-text">wherein n is 0 to 3; (b)</div>
    <div class="description-paragraph style-scope patent-text">2013366490 24 Nov 2017</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/83/87/50/e9e5df188f4a10/AU2013366490B9_D0027.png" class="style-scope patent-text"><img file="AU2013366490B9_D0027.tif" img-format="tif" alt="Figure AU2013366490B9_D0027" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/83/87/50/e9e5df188f4a10/AU2013366490B9_D0027.png"></a></div>
    <div class="description-paragraph style-scope patent-text">(c)</div>
    <div class="description-paragraph style-scope patent-text">8B , wherein n is as defined above;</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f9/cd/3d/7cd9c37b675f09/AU2013366490B9_D0028.png" class="style-scope patent-text"><img file="AU2013366490B9_D0028.tif" img-format="tif" alt="Figure AU2013366490B9_D0028" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f9/cd/3d/7cd9c37b675f09/AU2013366490B9_D0028.png"></a></div>
    <div class="description-paragraph style-scope patent-text">(d) wherein n is as defined above; and </div>
    <div class="description-paragraph style-scope patent-text">, wherein n is as defined above, E is O, S or NR, D is N, CH, or CR, and F is N, CH, or CR;</div>
    <div class="description-paragraph style-scope patent-text">L<sup class="style-scope patent-text">3</sup> is:</div>
    <div class="description-paragraph style-scope patent-text"> <sup class="style-scope patent-text">L4</sup>r</div>
    <div class="description-paragraph style-scope patent-text">V'!</div>
    <div class="description-paragraph style-scope patent-text"> <sup class="style-scope patent-text">0</sup> , where X is such that L<sup class="style-scope patent-text">3</sup> is an amino-acid residue, a dipeptide residue or a tripeptide residue;</div>
    <div class="description-paragraph style-scope patent-text">Prof is selected from Fmoc (fluorenylmethyloxycarbonyl), Teoc (2(trimethylsilyl)ethoxycarbonyl) and Boc (t-butoxycarbonyl);</div>
    <div class="description-paragraph style-scope patent-text">and either:</div>
    <div class="description-paragraph style-scope patent-text">when there is a double bond present between C2’ andC3’, R<sup class="style-scope patent-text">12</sup> is selected from the group consisting of:</div>
    <div class="description-paragraph style-scope patent-text">(ia) C5-10 aryl group, optionally substituted by one or more substituents selected from the group comprising: halo, nitro, cyano, ether, carboxy, ester, Ci_<sub class="style-scope patent-text">7</sub> alkyl, C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">7</sub> heterocyclyl and bis-oxy-Ci-3 alkylene;</div>
    <div class="description-paragraph style-scope patent-text">(ib) C1.5 saturated aliphatic alkyl;</div>
    <div class="description-paragraph style-scope patent-text">(ic) C3-6 saturated cycloalkyl;</div>
    <div class="description-paragraph style-scope patent-text">R</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/5b/d6/56/7cbf851784b5a4/AU2013366490B9_D0029.png" class="style-scope patent-text"><img file="AU2013366490B9_D0029.tif" img-format="tif" alt="Figure AU2013366490B9_D0029" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/5b/d6/56/7cbf851784b5a4/AU2013366490B9_D0029.png"></a></div>
    <div class="description-paragraph style-scope patent-text">R'</div>
    <div class="description-paragraph style-scope patent-text">R‘</div>
    <div class="description-paragraph style-scope patent-text">A I (id) wherein each of R<sup class="style-scope patent-text">21</sup>, R<sup class="style-scope patent-text">22</sup> and R<sup class="style-scope patent-text">23</sup> are independently selected from H, C1.3 saturated alkyl, C<sub class="style-scope patent-text">2</sub>-3 alkenyl, C<sub class="style-scope patent-text">2</sub>.<sub class="style-scope patent-text">3</sub> alkynyl and cyclopropyl, where the total number of carbon atoms in the R<sup class="style-scope patent-text">12</sup> group is no more than 5;</div>
    <div class="description-paragraph style-scope patent-text">2013366490 24 Nov 2017</div>
    <div class="description-paragraph style-scope patent-text">8C</div>
    <div class="description-paragraph style-scope patent-text">R‘ ,25b</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a5/aa/41/63b874dd1832f5/AU2013366490B9_D0030.png" class="style-scope patent-text"><img file="AU2013366490B9_D0030.tif" img-format="tif" alt="Figure AU2013366490B9_D0030" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a5/aa/41/63b874dd1832f5/AU2013366490B9_D0030.png"></a></div>
    <div class="description-paragraph style-scope patent-text">(ie) , wherein one of R<sup class="style-scope patent-text">25a</sup> and R<sup class="style-scope patent-text">25b</sup> is H and the other is selected from:</div>
    <div class="description-paragraph style-scope patent-text">phenyl, which phenyl is optionally substituted by a group selected from halo, methyl, methoxy; pyridyl; and thiophenyl; and</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/87/a3/2e/645821b5e08b2b/AU2013366490B9_D0031.png" class="style-scope patent-text"><img file="AU2013366490B9_D0031.tif" img-format="tif" alt="Figure AU2013366490B9_D0031" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/87/a3/2e/645821b5e08b2b/AU2013366490B9_D0031.png"></a></div>
    <div class="description-paragraph style-scope patent-text"> <sup class="style-scope patent-text">R</sup> , where R<sup class="style-scope patent-text">24</sup> is selected from: H; Ck saturated alkyl; C<sub class="style-scope patent-text">2</sub>-3 alkenyl; C<sub class="style-scope patent-text">2</sub>.<sub class="style-scope patent-text">3</sub> alkynyl; cyclopropyl; phenyl, which phenyl is optionally substituted by a group selected from halo, methyl, methoxy; pyridyl; and thiophenyl; when there is a single bond present between C2’ andC3’, ,26 a</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">12</sup> is H or <sup class="style-scope patent-text">R</sup> , where R<sup class="style-scope patent-text">26a</sup> and R<sup class="style-scope patent-text">26b</sup> are independently selected from H, F, Ck saturated alkyl, C<sub class="style-scope patent-text">2</sub>.<sub class="style-scope patent-text">3</sub> alkenyl, which alkyl and alkenyl groups are optionally substituted by a 3 group selected from C-m alkyl amido and C-m alkyl ester; or, when one of R<sup class="style-scope patent-text">26a</sup> and R<sup class="style-scope patent-text">26b</sup> is</div>
    <div class="description-paragraph style-scope patent-text">H, the other is selected from nitrile and a C1.4 alkyl ester;</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">6</sup> and R<sup class="style-scope patent-text">9</sup> are independently selected from H, R, OH, OR, SH, SR, NH<sub class="style-scope patent-text">2</sub>, NHR, NRR’, nitro, Me<sub class="style-scope patent-text">3</sub>Sn and halo;</div>
    <div class="description-paragraph style-scope patent-text">where R and R’ are independently selected from optbnally substituted C-i_<sub class="style-scope patent-text">12</sub> alkyl, C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">20 </sub>5 heterocyclyl and C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">20</sub> aryl groups;</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">7</sup> is selected from H, R, OH, OR, SH, SR, NH<sub class="style-scope patent-text">2</sub>, NHR, NHRR’, nitro, M^Sn and halo;</div>
    <div class="description-paragraph style-scope patent-text">Ris a C <sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">12</sub> alkylene group, which chain is interrupted by one or more aromatic rings, e.g. benzene or pyridine;</div>
    <div class="description-paragraph style-scope patent-text">Y and Y’ are selected from O, S, or NH;</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7</sup>, R<sup class="style-scope patent-text">9</sup> are selected from the same groups as R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7</sup> and R<sup class="style-scope patent-text">9</sup> respectively; either:</div>
    <div class="description-paragraph style-scope patent-text">(A) R<sup class="style-scope patent-text">20</sup> is H or Me and R<sup class="style-scope patent-text">21a</sup> and R<sup class="style-scope patent-text">21b</sup> are both H or together form =0 and either:</div>
    <div class="description-paragraph style-scope patent-text">(i) R<sup class="style-scope patent-text">10</sup> is H, R<sup class="style-scope patent-text">11a</sup> is H and R<sup class="style-scope patent-text">11b</sup> is OH or OR<sup class="style-scope patent-text">A</sup>, where R<sup class="style-scope patent-text">A</sup> is Ο<sub class="style-scope patent-text">Ί</sub>.<sub class="style-scope patent-text">4</sub> alkyl; or (ii) R<sup class="style-scope patent-text">10</sup> and R<sup class="style-scope patent-text">11b</sup> form a nitrogen-carbon double bond between the nitrogen and carbon atoms to which they are bound and R<sup class="style-scope patent-text">11a</sup> is H; or (iii) R<sup class="style-scope patent-text">10</sup> is H, R<sup class="style-scope patent-text">11a</sup> is H and R<sup class="style-scope patent-text">11b</sup> is SO<sub class="style-scope patent-text">Z</sub>M, where z is 2 or 3 and M is a monovalent pharmaceutically acceptable cation; or (B) R<sup class="style-scope patent-text">10</sup> is H or Me and R<sup class="style-scope patent-text">11a</sup> and R<sup class="style-scope patent-text">11b</sup> are both H or together form =0 and either:</div>
    <div class="description-paragraph style-scope patent-text">(i) R<sup class="style-scope patent-text">20</sup> is H, R<sup class="style-scope patent-text">21a</sup> is H and R<sup class="style-scope patent-text">21b</sup> is OH or OR<sup class="style-scope patent-text">A</sup>, where R<sup class="style-scope patent-text">A</sup> is alkyl; or (ii) R<sup class="style-scope patent-text">20</sup> and R<sup class="style-scope patent-text">21b</sup> form a nitrogen-carbon double bond between the nitrogen and carbon atoms to which they are bound and R<sup class="style-scope patent-text">11a</sup> is H; or</div>
    <div class="description-paragraph style-scope patent-text">2013366490 24 Nov 2017</div>
    <div class="description-paragraph style-scope patent-text">8D (iii) R<sup class="style-scope patent-text">20</sup> is H, R<sup class="style-scope patent-text">21a</sup> is H and R<sup class="style-scope patent-text">21b</sup> is SO<sub class="style-scope patent-text">Z</sub>M, where z is 2 or 3 and M is a monovalent pharmaceutically acceptable cation.</div>
    <div class="description-paragraph style-scope patent-text">In a fifth aspect, the present invention relates to Conjugates comprising dimers of PBDs 5 linked to a targeting agent, wherein the PBD dimer is of formula I, or a pharmaceutically acceptable salt or solvate thereof (supra).</div>
    <div class="description-paragraph style-scope patent-text">2013366490 24 Nov 2017</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, the Conjugates have the following formula V:</div>
    <div class="description-paragraph style-scope patent-text">L - (LU-D)<sub class="style-scope patent-text">P</sub> (V) or a pharmaceutically acceptable salt or solvate thereof, wherein L is a Ligand unit (i.e., a targeting agent), LU is a Linker unit and D is a Drug unit that is a PBD dimer (see below). The subscript p is an integer of from 1 to 20. Accordingly, the Conjugates comprise a Ligand unit covalently linked to at least one Drug unit by a Linker unit. The Ligand unit, described more fully below, is a targeting agent that binds to a target moiety. The Ligand unit can, for example, specifically bind to a cell component (a Cell Binding Agent) or to other target molecules of interest. Accordingly, the present invention also provides methods for the treatment of, for example, various cancers and autoimmune disease. These methods encompass the use of the Conjugates wherein the Ligand unit is a targeting agent that specifically binds to a target molecule. The Ligand unit can be, for example, a protein, polypeptide or peptide, such as an antibody, an antigen-binding fragment of an antibody, or other binding agent, such as an Fc fusion protein.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, the present invention provides a Conjugate having formula V: L-(LU-D)<sub class="style-scope patent-text">P</sub> (V) wherein L is an antibody or antibody fragment, p is 1 to 20; and</div>
    <div class="description-paragraph style-scope patent-text">D is a Drug unit which is a PBD dimer according to formula I:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/0e/2a/24/6b79a74e1516f7/AU2013366490B9_D0032.png" class="style-scope patent-text"><img file="AU2013366490B9_D0032.tif" img-format="tif" alt="Figure AU2013366490B9_D0032" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/0e/2a/24/6b79a74e1516f7/AU2013366490B9_D0032.png"></a></div>
    <div class="description-paragraph style-scope patent-text">20 j21a wherein R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7</sup>, R<sup class="style-scope patent-text">7</sup>, R<sup class="style-scope patent-text">9</sup>, R<sup class="style-scope patent-text">9</sup>, R<sup class="style-scope patent-text">10</sup>, R<sup class="style-scope patent-text">11a</sup>, R<sup class="style-scope patent-text">11b </sup>defined in any one of claims 1 to 17; and R<sup class="style-scope patent-text">2</sup> is of formula Ila, formula lib or formula lie:</div>
    <div class="description-paragraph style-scope patent-text">,21b</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">12</sup>, R<sup class="style-scope patent-text">zu</sup>, R<sup class="style-scope patent-text">zla</sup>, R<sup class="style-scope patent-text">zw</sup>, Y, Y’ and R’ ’ are as <sub class="style-scope patent-text">(a)</sub>A<sub class="style-scope patent-text">Q</sub>’-%-<sup class="style-scope patent-text">x</sup> fe where A is a C5-7 aryl group, and either (i) Q<sup class="style-scope patent-text">1</sup> is a single bond, and Q<sup class="style-scope patent-text">2</sup> is selected from a single bond and -Z-(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>-, where Z is selected from a single bond, O, S and NH and n is from 1 to 3; or (ii) Q<sup class="style-scope patent-text">1</sup> is -CH=CH-, and Q<sup class="style-scope patent-text">2</sup> is a single bond;</div>
    <div class="description-paragraph style-scope patent-text">2013366490 24 Nov 2017</div>
    <div class="description-paragraph style-scope patent-text">9A</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/66/3e/89/446bfc9e409ea3/AU2013366490B9_D0033.png" class="style-scope patent-text"><img file="AU2013366490B9_D0033.tif" img-format="tif" alt="Figure AU2013366490B9_D0033" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/66/3e/89/446bfc9e409ea3/AU2013366490B9_D0033.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where;</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">C1</sup>, R<sup class="style-scope patent-text">C2</sup> and R<sup class="style-scope patent-text">C3</sup> are independently selected from H and unsubstituted Ci_<sub class="style-scope patent-text">2</sub> alkyl;</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/38/a4/f9/fb1ce499da9748/AU2013366490B9_D0034.png" class="style-scope patent-text"><img file="AU2013366490B9_D0034.tif" img-format="tif" alt="Figure AU2013366490B9_D0034" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/38/a4/f9/fb1ce499da9748/AU2013366490B9_D0034.png"></a></div>
    <div class="description-paragraph style-scope patent-text">(c) where Q is selected from OH, SH and NR<sup class="style-scope patent-text">n</sup>, and R<sup class="style-scope patent-text">N</sup> is selected from H, methyl and ethyl X is selected from the group comprising: OH, SH, CO<sub class="style-scope patent-text">2</sub>H, COH, N=C=O, NHNH<sub class="style-scope patent-text">2</sub>,</div>
    <div class="description-paragraph style-scope patent-text">NH</div>
    <div class="description-paragraph style-scope patent-text">CONHNH<sub class="style-scope patent-text">2</sub>,</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/48/09/ee/f540cd2d28a678/AU2013366490B9_D0035.png" class="style-scope patent-text"><img file="AU2013366490B9_D0035.tif" img-format="tif" alt="Figure AU2013366490B9_D0035" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/48/09/ee/f540cd2d28a678/AU2013366490B9_D0035.png"></a></div>
    <div class="description-paragraph style-scope patent-text">, NHR<sup class="style-scope patent-text">n</sup>, wherein R<sup class="style-scope patent-text">N</sup> is selected from the group comprising H and C<sub class="style-scope patent-text">14</sub> alkyl;</div>
    <div class="description-paragraph style-scope patent-text">wherein LU is connected to D via the X substituent of R<sup class="style-scope patent-text">2</sup>, wherein LU has the formula (Va):</div>
    <div class="description-paragraph style-scope patent-text">-A<sup class="style-scope patent-text">1</sup>a-L<sup class="style-scope patent-text">1</sup>s-L<sup class="style-scope patent-text">2</sup>y-, (Va) wherein:</div>
    <div class="description-paragraph style-scope patent-text">a is 1 or 2, s is an integer ranging from 0 to 12, y is 0, 1 or 2, and p is from 1- 20;</div>
    <div class="description-paragraph style-scope patent-text">L<sup class="style-scope patent-text">1</sup> comprises an amino acid sequence;</div>
    <div class="description-paragraph style-scope patent-text">L<sup class="style-scope patent-text">2</sup> is selected from the groups</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/09/e7/54/e41b7d69175048/AU2013366490B9_D0036.png" class="style-scope patent-text"><img file="AU2013366490B9_D0036.tif" img-format="tif" alt="Figure AU2013366490B9_D0036" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/09/e7/54/e41b7d69175048/AU2013366490B9_D0036.png"></a></div>
    <div class="description-paragraph style-scope patent-text">O</div>
    <div class="description-paragraph style-scope patent-text">O</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f1/1b/cf/562dd1fabd6ef5/AU2013366490B9_D0037.png" class="style-scope patent-text"><img file="AU2013366490B9_D0037.tif" img-format="tif" alt="Figure AU2013366490B9_D0037" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f1/1b/cf/562dd1fabd6ef5/AU2013366490B9_D0037.png"></a></div>
    <div class="description-paragraph style-scope patent-text">2013366490 24 Nov 2017</div>
    <div class="description-paragraph style-scope patent-text">9B</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/9d/d2/cc/05bdcc2832c75e/AU2013366490B9_D0038.png" class="style-scope patent-text"><img file="AU2013366490B9_D0038.tif" img-format="tif" alt="Figure AU2013366490B9_D0038" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/9d/d2/cc/05bdcc2832c75e/AU2013366490B9_D0038.png"></a></div>
    <div class="description-paragraph style-scope patent-text">wherein the asterisk indicates the point of attachment to the Drug unit, and the wavy line indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>,</div>
    <div class="description-paragraph style-scope patent-text">Y is -N(H)-, -0-, -C(=O)N(H)- or -C(=O)O-, n is 0 to 3 EisO, SorNH,</div>
    <div class="description-paragraph style-scope patent-text">D is N orCH,</div>
    <div class="description-paragraph style-scope patent-text">F is N orCH;</div>
    <div class="description-paragraph style-scope patent-text">-A<sup class="style-scope patent-text">1</sup>- is selected from where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, the wavy line indicates the point of attachment to L, and n is 0 to 6;</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bd/42/bb/3b66f761b6658e/AU2013366490B9_D0039.png" class="style-scope patent-text"><img file="AU2013366490B9_D0039.tif" img-format="tif" alt="Figure AU2013366490B9_D0039" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bd/42/bb/3b66f761b6658e/AU2013366490B9_D0039.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, the wavy line indicates the point of attachment to L, and n is 0 to 6;</div>
    <div class="description-paragraph style-scope patent-text">2013366490 24 Nov 2017</div>
    <div class="description-paragraph style-scope patent-text">9C</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/ee/1c/23f2a8149091f5/AU2013366490B9_D0040.png" class="style-scope patent-text"><img file="AU2013366490B9_D0040.tif" img-format="tif" alt="Figure AU2013366490B9_D0040" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/ee/1c/23f2a8149091f5/AU2013366490B9_D0040.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, the wavy line indicates the point of attachment to L, n is 0 or 1, and m is 0 to 30; or</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ab/ef/44/bffa63280bdd6f/AU2013366490B9_D0041.png" class="style-scope patent-text"><img file="AU2013366490B9_D0041.tif" img-format="tif" alt="Figure AU2013366490B9_D0041" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ab/ef/44/bffa63280bdd6f/AU2013366490B9_D0041.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, the wavy line indicates the point of attachment to L, n is 0 or 1, and m is 0 to 30.</div>
    <div class="description-paragraph style-scope patent-text">In conjugates of the present invention, the PBD dimer D is of formula I, or a pharmaceutically acceptable salt or solvate thereof, except that X is selected from the group comprising: *-O-<sup class="style-scope patent-text">+</sup>, *-S-<sup class="style-scope patent-text">+</sup>, *-CO<sub class="style-scope patent-text">2</sub>-<sup class="style-scope patent-text">+</sup>, *-CO-<sup class="style-scope patent-text">+</sup>, *-NH(C=O)-<sup class="style-scope patent-text">+</sup>, *-NHNH-<sup class="style-scope patent-text">+</sup>, *-CONHNH-<sup class="style-scope patent-text">+</sup>,</div>
    <div class="description-paragraph style-scope patent-text">N-£- *-l/ N-£- *—N(R<sup class="style-scope patent-text">n</sup>)1\-/ d , \-/ , -<sup class="style-scope patent-text">3</sup> , wherein R<sup class="style-scope patent-text">N</sup> is selected from the group comprising H and Cm alkyl, and the asterix indicates the point of attachment to the remainder of the Drug unit and the wavy line or<sup class="style-scope patent-text">+</sup> indicates the point of attachment to the Linker Unit.</div>
    <div class="description-paragraph style-scope patent-text">The drug loading is represented by p, the number of drug molecules per Ligand unit (e.g., an antibody). Drug loading may range from 1 to 20 Drug units (D) per Ligand unit (e.g., Ab or mAb). For compositions, p represents the average drug loading of the Conjugates in the composition, and p ranges from 1 to 20.</div>
    <div class="description-paragraph style-scope patent-text">A sixth aspect of the present invention provides the use of a conjugate of the fifth aspect of the invention in the manufacture of a medicament for treating a proliferative disease. The sixth aspect also provides a conjugate of the fifth aspect of the invention for use in the treatment of a proliferative disease.</div>
    <div class="description-paragraph style-scope patent-text">2013366490 24 Nov 2017</div>
    <div class="description-paragraph style-scope patent-text">One of ordinary skill in the art is readily able to determine whether or not a candidate conjugate treats a proliferative condition for any particular cell type. For example, assays which may conveniently be used to assess the activity offered by a particular compound are described in the examples below.</div>
    <div class="description-paragraph style-scope patent-text">In a seventh aspect, the present invention relates to Linker-Drug compounds (i.e., DrugLinkers) comprising dimers of PBDs (see above) linked to a linking unit. These Druglinkers can be used as intermediates for the synthesis of Conjugates comprising dimers of PBDs linked to a targeting agent.</div>
    <div class="description-paragraph style-scope patent-text">These Drug-Linkers have the following formula VI:</div>
    <div class="description-paragraph style-scope patent-text">LU-D (VI) or a pharmaceutically acceptable salt or solvate thereof, wherein LU is a Linker unit and D is a Drug unit that is a PBD dimer.</div>
    <div class="description-paragraph style-scope patent-text">In a further embodiment, the present invention provides a drug linker of formula VI:</div>
    <div class="description-paragraph style-scope patent-text">LU-D (VI) or a pharmaceutically acceptable salt or solvate thereof, wherein D is a Drug unit which is a PBD dimer according to formula I as defined in claim 21, but where X is selected from *-ON✓</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/45/51/ea/a6b61897789f94/AU2013366490B9_D0042.png" class="style-scope patent-text"><img file="AU2013366490B9_D0042.tif" img-format="tif" alt="Figure AU2013366490B9_D0042" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/45/51/ea/a6b61897789f94/AU2013366490B9_D0042.png"></a></div>
    <div class="description-paragraph style-scope patent-text"> <sup class="style-scope patent-text">q</sup>, *-S-<sup class="style-scope patent-text">q</sup>, *-CO<sub class="style-scope patent-text">2</sub>-<sup class="style-scope patent-text">q</sup>, *-CO-<sup class="style-scope patent-text">q</sup>, *-NH(C=O)-<sup class="style-scope patent-text">q</sup>, *-NHNH-<sup class="style-scope patent-text">q</sup>, *-CONHNH-<sup class="style-scope patent-text">q</sup>, *—[/ N-/ *—N(R<sup class="style-scope patent-text">n</sup>)N \-/ , ? , wherein R<sup class="style-scope patent-text">N</sup> is selected from the group comprising H and</div>
    <div class="description-paragraph style-scope patent-text">C-i-4 alkyl, and the asterix indicates the point of attachment to the remainder of the Drug unit and the wavy line or<sup class="style-scope patent-text">q</sup> indicates the point of attachment to LU;</div>
    <div class="description-paragraph style-scope patent-text">wherein LU is selected from:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/69/9b/05/4bb6e2f43b1bf5/AU2013366490B9_D0043.png" class="style-scope patent-text"><img file="AU2013366490B9_D0043.tif" img-format="tif" alt="Figure AU2013366490B9_D0043" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/69/9b/05/4bb6e2f43b1bf5/AU2013366490B9_D0043.png"></a></div>
    <div class="description-paragraph style-scope patent-text">G<sup class="style-scope patent-text">1</sup>-L<sup class="style-scope patent-text">1</sup>-L<sup class="style-scope patent-text">2</sup>- and wherein L<sup class="style-scope patent-text">1</sup> and L<sup class="style-scope patent-text">2</sup> are as defined in claim 21;</div>
    <div class="description-paragraph style-scope patent-text">and -G<sup class="style-scope patent-text">1</sup>- is selected from</div>
    <div class="description-paragraph style-scope patent-text">2013366490 24 Nov 2017</div>
    <div class="description-paragraph style-scope patent-text">10A</div>
    <div class="description-paragraph style-scope patent-text">Ο</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e9/a8/de/abce123d3abdf1/AU2013366490B9_D0044.png" class="style-scope patent-text"><img file="AU2013366490B9_D0044.tif" img-format="tif" alt="Figure AU2013366490B9_D0044" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e9/a8/de/abce123d3abdf1/AU2013366490B9_D0044.png"></a></div>
    <div class="description-paragraph style-scope patent-text">N η '0 where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup> and n is 0 to 6; O</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/30/10/f4/769a781093835b/AU2013366490B9_D0045.png" class="style-scope patent-text"><img file="AU2013366490B9_D0045.tif" img-format="tif" alt="Figure AU2013366490B9_D0045" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/30/10/f4/769a781093835b/AU2013366490B9_D0045.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a3/c2/c0/fc05893dde3f0e/AU2013366490B9_D0046.png" class="style-scope patent-text"><img file="AU2013366490B9_D0046.tif" img-format="tif" alt="Figure AU2013366490B9_D0046" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a3/c2/c0/fc05893dde3f0e/AU2013366490B9_D0046.png"></a></div>
    <div class="description-paragraph style-scope patent-text">O</div>
    <div class="description-paragraph style-scope patent-text">O where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup> and n is 0 to 6;</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/dd/96/8d/bc215a07225548/AU2013366490B9_D0047.png" class="style-scope patent-text"><img file="AU2013366490B9_D0047.tif" img-format="tif" alt="Figure AU2013366490B9_D0047" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/dd/96/8d/bc215a07225548/AU2013366490B9_D0047.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, n is 0 or 1, and m is 0 to</div>
    <div class="description-paragraph style-scope patent-text">30; or</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/54/f3/65/9c10aa9e03ceaf/AU2013366490B9_D0048.png" class="style-scope patent-text"><img file="AU2013366490B9_D0048.tif" img-format="tif" alt="Figure AU2013366490B9_D0048" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/54/f3/65/9c10aa9e03ceaf/AU2013366490B9_D0048.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, n is 0 or 1, and m is 0 to 30.</div>
    <div class="description-paragraph style-scope patent-text">In the Drug-Linkers of the present invention, the PBD dimer D is of formula I, or a pharmaceutically acceptable salt or solvate thereof, except that X is selected from the group comprising: *-O-<sup class="style-scope patent-text">q</sup>, *-S-<sup class="style-scope patent-text">q</sup>, *-CO<sub class="style-scope patent-text">2</sub>-<sup class="style-scope patent-text">q</sup>, *-CO-<sup class="style-scope patent-text">q</sup>, *-NH(C=O)-<sup class="style-scope patent-text">q</sup>, *-NHNH-<sup class="style-scope patent-text">q</sup>, *-CONHNH-<sup class="style-scope patent-text">q</sup>, / N-£- *-l/ N-£- *—N(R<sup class="style-scope patent-text">n</sup>)N \? , \-/ , , wherein R<sup class="style-scope patent-text">N</sup> is selected from the group comprising H and Cm alkyl, and the asterix indicates the point of attachment to the remainder of the Drug unit and the wavy line or<sup class="style-scope patent-text">q</sup> indicates the point of attachment to the Linker Unit.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, the drug linkers are of formula III as defined above.</div>
    <div class="description-paragraph style-scope patent-text">2013366490 24 Nov 2017</div>
    <div class="description-paragraph style-scope patent-text">10B</div>
    <div class="description-paragraph style-scope patent-text">Definitions</div>
    <div class="description-paragraph style-scope patent-text">Pharmaceutically acceptable cations</div>
    <div class="description-paragraph style-scope patent-text">Examples of pharmaceutically acceptable monovalent and divalent cations are discussed in Berge, etal., J. Pharm. Sci., 66, 1-19 (1977), which is incorporated herein by reference</div>
    <div class="description-paragraph style-scope patent-text">The pharmaceutically acceptable cation may be inorganic or organic.</div>
    <div class="description-paragraph style-scope patent-text">Examples of pharmaceutically acceptable monovalent inorganic cations include, but are not limited to, alkali metal ions such as Na<sup class="style-scope patent-text">+</sup> and K<sup class="style-scope patent-text">+</sup>. Examples of pharmaceutically</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695 acceptable divalent inorganic cations include, but are not limited to, alkaline earth cations such as Ca<sup class="style-scope patent-text">2+</sup> and Mg<sup class="style-scope patent-text">2+</sup>. Examples of pharmaceutically acceptable organic cations include, but are not limited to, ammonium ion (i.e. NH4<sup class="style-scope patent-text">+</sup>) and substituted ammonium ions (e.g. NH3R<sup class="style-scope patent-text">+</sup>, NH2R2<sup class="style-scope patent-text">+</sup>, NHR3<sup class="style-scope patent-text">+</sup>, NR4<sup class="style-scope patent-text">+</sup>). Examples of some suitable substituted ammonium ions are those derived from: ethylamine, diethylamine, dicyclohexylamine, triethylamine, butylamine, ethylenediamine, ethanolamine, diethanolamine, piperazine, benzylamine, phenylbenzylamine, choline, meglumine, and tromethamine, as well as amino acids, such as lysine and arginine. An example of a common quaternary ammonium ion is N(CH3)<sub class="style-scope patent-text">4</sub> <sup class="style-scope patent-text">+</sup>.</div>
    <div class="description-paragraph style-scope patent-text">Substituents</div>
    <div class="description-paragraph style-scope patent-text">The phrase “optionally substituted” as used herein, pertains to a parent group which may be unsubstituted or which may be substituted.</div>
    <div class="description-paragraph style-scope patent-text">Unless otherwise specified, the term “substituted” as used herein, pertains to a parent group which bears one or more substituents. The term “substituent” is used herein in the conventional sense and refers to a chemical moiety which is covalently attached to, or if appropriate, fused to, a parent group. A wide variety of substituents are well known, and methods for their formation and introduction into a variety of parent groups are also well known.</div>
    <div class="description-paragraph style-scope patent-text">Examples of substituents are described in more detail below.</div>
    <div class="description-paragraph style-scope patent-text">Ci_i<sub class="style-scope patent-text">2</sub> alkyl: The term “Ci_i<sub class="style-scope patent-text">2</sub> alkyl” as used herein, pertains to a monovalent moiety obtained by removing a hydrogen atom from a carbon atom of a hydrocarbon compound having from 1 to 12 carbon atoms, which may be aliphatic or alicyclic, and which may be saturated or unsaturated (e.g. partially unsaturated, fully unsaturated). The term “C<sub class="style-scope patent-text">14</sub> alkyl” as used herein, pertains to a monovalent moiety obtained by removing a hydrogen atom from a carbon atom of a hydrocarbon compound having from 1 to 4 carbon atoms, which may be aliphatic or alicyclic, and which may be saturated or unsaturated (e.g. partially unsaturated, fully unsaturated). Thus, the term “alkyl” includes the sub-classes alkenyl, alkynyl, cycloalkyl, etc., discussed below.</div>
    <div class="description-paragraph style-scope patent-text">Examples of saturated alkyl groups include, but are not limited to, methyl (Ci), ethyl (C<sub class="style-scope patent-text">2</sub>), propyl (C<sub class="style-scope patent-text">3</sub>), butyl (C<sub class="style-scope patent-text">4</sub>), pentyl (C<sub class="style-scope patent-text">5</sub>), hexyl (C<sub class="style-scope patent-text">6</sub>) and heptyl (C<sub class="style-scope patent-text">7</sub>).</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Examples of saturated linear alkyl groups include, but are not limited to, methyl (Ci), ethyl (C<sub class="style-scope patent-text">2</sub>), n-propyl (C<sub class="style-scope patent-text">3</sub>), n-butyl (C<sub class="style-scope patent-text">4</sub>), n-pentyl (amyl) (C<sub class="style-scope patent-text">5</sub>), n-hexyl (C<sub class="style-scope patent-text">6</sub>) and n-heptyl (C<sub class="style-scope patent-text">7</sub>).</div>
    <div class="description-paragraph style-scope patent-text">Examples of saturated branched alkyl groups include iso-propyl (C<sub class="style-scope patent-text">3</sub>), iso-butyl (C<sub class="style-scope patent-text">4</sub>), sec-butyl (C<sub class="style-scope patent-text">4</sub>), tert-butyl (C<sub class="style-scope patent-text">4</sub>), iso-pentyl (C<sub class="style-scope patent-text">5</sub>), and neo-pentyl (C<sub class="style-scope patent-text">5</sub>).</div>
    <div class="description-paragraph style-scope patent-text">C<sub class="style-scope patent-text">2</sub>.<sub class="style-scope patent-text">12</sub> Alkenyl: The term “C<sub class="style-scope patent-text">2</sub>.<sub class="style-scope patent-text">12</sub> alkenyl” as used herein, pertains to an alkyl group having one or more carbon-carbon double bonds.</div>
    <div class="description-paragraph style-scope patent-text">Examples of unsaturated alkenyl groups include, but are not limited to, ethenyl (vinyl, CH=CH<sub class="style-scope patent-text">2</sub>), 1-propenyl (-CH=CH-CH<sub class="style-scope patent-text">3</sub>), 2-propenyl (allyl, -CH-CH=CH<sub class="style-scope patent-text">2</sub>), isopropenyl (1methylvinyl, -C(CH<sub class="style-scope patent-text">3</sub>)=CH<sub class="style-scope patent-text">2</sub>), butenyl (C<sub class="style-scope patent-text">4</sub>), pentenyl (C<sub class="style-scope patent-text">5</sub>), and hexenyl (C<sub class="style-scope patent-text">6</sub>).</div>
    <div class="description-paragraph style-scope patent-text">C<sub class="style-scope patent-text">2</sub>_i<sub class="style-scope patent-text">2</sub> alkynyl: The term “C<sub class="style-scope patent-text">2</sub>.-|<sub class="style-scope patent-text">2</sub> alkynyl” as used herein, pertains to an alkyl group having one or more carbon-carbon triple bonds.</div>
    <div class="description-paragraph style-scope patent-text">Examples of unsaturated alkynyl groups include, but are not limited to, ethynyl (-ΟξΟΗ) and 2-propynyl (propargyl, -ΟΗ<sub class="style-scope patent-text">2</sub>-ΟξΟΗ).</div>
    <div class="description-paragraph style-scope patent-text">C<sub class="style-scope patent-text">3</sub>_i<sub class="style-scope patent-text">2</sub> cycloalkyl: The term “C<sub class="style-scope patent-text">3</sub>_i<sub class="style-scope patent-text">2</sub> cycloalkyl” as used herein, pertains to an alkyl group which is also a cyclyl group; that is, a monovalent moiety obtained by removing a hydrogen atom from an alicyclic ring atom of a cyclic hydrocarbon (carbocyclic) compound, which moiety has from 3 to 7 carbon atoms, including from 3 to 7 ring atoms.</div>
    <div class="description-paragraph style-scope patent-text">Examples of cycloalkyl groups include, but are not limited to, those derived from: saturated monocyclic hydrocarbon compounds:</div>
    <div class="description-paragraph style-scope patent-text">cyclopropane (C<sub class="style-scope patent-text">3</sub>), cyclobutane (C<sub class="style-scope patent-text">4</sub>), cyclopentane (C<sub class="style-scope patent-text">5</sub>), cyclohexane (C<sub class="style-scope patent-text">6</sub>), cycloheptane (C<sub class="style-scope patent-text">7</sub>), methylcyclopropane (C<sub class="style-scope patent-text">4</sub>), dimethylcyclopropane (C<sub class="style-scope patent-text">5</sub>), methylcyclobutane (C<sub class="style-scope patent-text">5</sub>), dimethylcyclobutane (C<sub class="style-scope patent-text">6</sub>), methylcyclopentane (C<sub class="style-scope patent-text">6</sub>), dimethylcyclopentane (C<sub class="style-scope patent-text">7</sub>) and methylcyclohexane (C<sub class="style-scope patent-text">7</sub>);</div>
    <div class="description-paragraph style-scope patent-text">unsaturated monocyclic hydrocarbon compounds: cyclopropene (C<sub class="style-scope patent-text">3</sub>), cyclobutene (C<sub class="style-scope patent-text">4</sub>), cyclopentene (C<sub class="style-scope patent-text">5</sub>), cyclohexene (C<sub class="style-scope patent-text">6</sub>), methylcyclopropene (C<sub class="style-scope patent-text">4</sub>), dimethylcyclopropene (C<sub class="style-scope patent-text">5</sub>), methylcyclobutene (C<sub class="style-scope patent-text">5</sub>), dimethylcyclobutene (C<sub class="style-scope patent-text">6</sub>), methylcyclopentene (C<sub class="style-scope patent-text">6</sub>), dimethylcyclopentene (C<sub class="style-scope patent-text">7</sub>) and methylcyclohexene (C<sub class="style-scope patent-text">7</sub>); and</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695 saturated polycyclic hydrocarbon compounds: norcarane (C<sub class="style-scope patent-text">7</sub>), norpinane (C<sub class="style-scope patent-text">7</sub>), norbornane (C<sub class="style-scope patent-text">7</sub>).</div>
    <div class="description-paragraph style-scope patent-text">C3-20 heterocyclyl: The term “C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">2</sub>o heterocyclyl” as used herein, pertains to a monovalent moiety obtained by removing a hydrogen atom from a ring atom of a heterocyclic compound, which moiety has from 3 to 20 ring atoms, of which from 1 to 10 are ring heteroatoms. Preferably, each ring has from 3 to 7 ring atoms, of which from 1 to 4 are ring heteroatoms.</div>
    <div class="description-paragraph style-scope patent-text">In this context, the prefixes (e.g. C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">20</sub>, C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">7</sub>, C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">6</sub>, etc.) denote the number of ring atoms, or range of number of ring atoms, whether carbon atoms or heteroatoms. For example, the term “C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">6</sub>heterocyclyl”, as used herein, pertains to a heterocyclyl group having 5 or 6 ring atoms.</div>
    <div class="description-paragraph style-scope patent-text">Examples of monocyclic heterocyclyl groups include, but are not limited to, those derived from:</div>
    <div class="description-paragraph style-scope patent-text">N&lt; aziridine (C<sub class="style-scope patent-text">3</sub>), azetidine (C<sub class="style-scope patent-text">4</sub>), pyrrolidine (tetrahydropyrrole) (C<sub class="style-scope patent-text">5</sub>), pyrroline (e.g., 3-pyrroline, 2,5-dihydropyrrole) (C<sub class="style-scope patent-text">5</sub>), 2H-pyrrole or 3H-pyrrole (isopyrrole, isoazole) (C<sub class="style-scope patent-text">5</sub>), piperidine (C<sub class="style-scope patent-text">6</sub>), dihydropyridine (C<sub class="style-scope patent-text">6</sub>), tetrahydropyridine (C<sub class="style-scope patent-text">6</sub>), azepine (C<sub class="style-scope patent-text">7</sub>);</div>
    <div class="description-paragraph style-scope patent-text">O&lt; oxirane (C<sub class="style-scope patent-text">3</sub>), oxetane (C<sub class="style-scope patent-text">4</sub>), oxolane (tetrahydrofuran) (C<sub class="style-scope patent-text">5</sub>), oxole (dihydrofuran) (C<sub class="style-scope patent-text">5</sub>), oxane (tetrahydropyran) (C<sub class="style-scope patent-text">6</sub>), dihydropyran (C<sub class="style-scope patent-text">6</sub>), pyran (C<sub class="style-scope patent-text">6</sub>), oxepin (C<sub class="style-scope patent-text">7</sub>);</div>
    <div class="description-paragraph style-scope patent-text">Su thiirane (C<sub class="style-scope patent-text">3</sub>), thietane (C<sub class="style-scope patent-text">4</sub>), thiolane (tetrahydrothiophene) (C<sub class="style-scope patent-text">5</sub>), thiane (tetrahydrothiopyran) (C<sub class="style-scope patent-text">6</sub>), thiepane (C<sub class="style-scope patent-text">7</sub>);</div>
    <div class="description-paragraph style-scope patent-text">O<sub class="style-scope patent-text">2</sub>: dioxolane (C<sub class="style-scope patent-text">5</sub>), dioxane (C<sub class="style-scope patent-text">6</sub>), and dioxepane (C<sub class="style-scope patent-text">7</sub>);</div>
    <div class="description-paragraph style-scope patent-text">O<sub class="style-scope patent-text">3</sub>: trioxane (C<sub class="style-scope patent-text">6</sub>);</div>
    <div class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">2</sub>: imidazolidine (C<sub class="style-scope patent-text">5</sub>), pyrazolidine (diazolidine) (C<sub class="style-scope patent-text">5</sub>), imidazoline (C<sub class="style-scope patent-text">5</sub>), pyrazoline (dihydropyrazole) (C<sub class="style-scope patent-text">5</sub>), piperazine (C<sub class="style-scope patent-text">6</sub>);</div>
    <div class="description-paragraph style-scope patent-text">tetrahydrooxazole (C<sub class="style-scope patent-text">5</sub>), dihydrooxazole (C<sub class="style-scope patent-text">5</sub>), tetrahydroisoxazole (C<sub class="style-scope patent-text">5</sub>), dihydroisoxazole (C<sub class="style-scope patent-text">5</sub>), morpholine (C<sub class="style-scope patent-text">6</sub>), tetrahydrooxazine (C<sub class="style-scope patent-text">6</sub>), di hydrooxazine (C<sub class="style-scope patent-text">6</sub>), oxazine (C<sub class="style-scope patent-text">6</sub>);</div>
    <div class="description-paragraph style-scope patent-text">NhSi: thiazoline (C<sub class="style-scope patent-text">5</sub>), thiazolidine (C<sub class="style-scope patent-text">5</sub>), thiomorpholine (C<sub class="style-scope patent-text">6</sub>);</div>
    <div class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">2</sub>Oi: oxadiazine (C<sub class="style-scope patent-text">6</sub>);</div>
    <div class="description-paragraph style-scope patent-text">O1S1: oxathiole (C<sub class="style-scope patent-text">5</sub>) and oxathiane (thioxane) (C<sub class="style-scope patent-text">6</sub>); and,</div>
    <div class="description-paragraph style-scope patent-text">NhOiSi: oxathiazine (C<sub class="style-scope patent-text">6</sub>).</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Examples of substituted monocyclic heterocyclyl groups include those derived from saccharides, in cyclic form, for example, furanoses (C<sub class="style-scope patent-text">5</sub>), such as arabinofuranose, lyxofuranose, ribofuranose, and xylofuranse, and pyranoses (C<sub class="style-scope patent-text">6</sub>), such as allopyranose, altropyranose, glucopyranose, mannopyranose, gulopyranose, idopyranose, galactopyranose, and talopyranose.</div>
    <div class="description-paragraph style-scope patent-text">C5-20 aryb The term “C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">2</sub>o aryl”, as used herein, pertains to a monovalent moiety obtained by removing a hydrogen atom from an aromatic ring atom of an aromatic compound, which moiety has from 3 to 20 ring atoms. The term “C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">7</sub> aryl”, as used herein, pertains to a monovalent moiety obtained by removing a hydrogen atom from an aromatic ring atom of an aromatic compound, which moiety has from 5 to 7 ring atoms and the term “C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">10</sub> aryl”, as used herein, pertains to a monovalent moiety obtained by removing a hydrogen atom from an aromatic ring atom of an aromatic compound, which moiety has from 5 to 10 ring atoms. Preferably, each ring has from 5 to 7 ring atoms.</div>
    <div class="description-paragraph style-scope patent-text">In this context, the prefixes (e.g. C3-20, C5-7, C<sub class="style-scope patent-text">5</sub>-6, C5-10, etc.) denote the number of ring atoms, or range of number of ring atoms, whether carbon atoms or heteroatoms. For example, the term “C<sub class="style-scope patent-text">5</sub>-<sub class="style-scope patent-text">6</sub>aryl” as used herein, pertains to an aryl group having 5 or 6 ring atoms.</div>
    <div class="description-paragraph style-scope patent-text">The ring atoms may be all carbon atoms, as in “carboaryl groups”.</div>
    <div class="description-paragraph style-scope patent-text">Examples of carboaryl groups include, but are not limited to, those derived from benzene (i.e. phenyl) (C<sub class="style-scope patent-text">6</sub>), naphthalene (C10), azulene (Cw), anthracene (C14), phenanthrene (C14), naphthacene (Cw), and pyrene (Ci<sub class="style-scope patent-text">6</sub>).</div>
    <div class="description-paragraph style-scope patent-text">Examples of aryl groups which comprise fused rings, at least one of which is an aromatic ring, include, but are not limited to, groups derived from indane (e.g. 2,3-dihydro-1 Hlindene) (C<sub class="style-scope patent-text">9</sub>), indene (C<sub class="style-scope patent-text">9</sub>), isoindene (C<sub class="style-scope patent-text">9</sub>), tetraline (1,2,3,4-tetrahydronaphthalene (C<sub class="style-scope patent-text">10</sub>), acenaphthene (C<sub class="style-scope patent-text">12</sub>), fluorene (C<sub class="style-scope patent-text">13</sub>), phenalene (C<sub class="style-scope patent-text">13</sub>), acephenanthrene (C<sub class="style-scope patent-text">15</sub>), and aceanthrene (Ci<sub class="style-scope patent-text">6</sub>).</div>
    <div class="description-paragraph style-scope patent-text">Alternatively, the ring atoms may include one or more heteroatoms, as in “heteroaryl groups”. Examples of monocyclic heteroaryl groups include, but are not limited to, those derived from:</div>
    <div class="description-paragraph style-scope patent-text">N&lt; pyrrole (azole) (C<sub class="style-scope patent-text">5</sub>), pyridine (azine) (C<sub class="style-scope patent-text">6</sub>);</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">O&lt; furan (oxole) (C<sub class="style-scope patent-text">5</sub>);</div>
    <div class="description-paragraph style-scope patent-text">Su thiophene (thiole) (C<sub class="style-scope patent-text">5</sub>);</div>
    <div class="description-paragraph style-scope patent-text">NhOi: oxazole (C<sub class="style-scope patent-text">5</sub>), isoxazole (C<sub class="style-scope patent-text">5</sub>), isoxazine (C<sub class="style-scope patent-text">6</sub>);</div>
    <div class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">2</sub>Oi: oxadiazole (furazan) (C<sub class="style-scope patent-text">5</sub>);</div>
    <div class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">3</sub>Oi: oxatriazole (C<sub class="style-scope patent-text">5</sub>);</div>
    <div class="description-paragraph style-scope patent-text">NhSi: thiazole (C<sub class="style-scope patent-text">5</sub>), isothiazole (C<sub class="style-scope patent-text">5</sub>);</div>
    <div class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">2</sub>: imidazole (1,3-diazole) (C<sub class="style-scope patent-text">5</sub>), pyrazole (1,2-diazole) (C<sub class="style-scope patent-text">5</sub>), pyridazine (1,2-diazine) (C<sub class="style-scope patent-text">6</sub>), pyrimidine (1,3-diazine) (C<sub class="style-scope patent-text">6</sub>) (e.g., cytosine, thymine, uracil), pyrazine (1,4-diazine) (C<sub class="style-scope patent-text">6</sub>);</div>
    <div class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">3</sub>: triazole (C<sub class="style-scope patent-text">5</sub>), triazine (C<sub class="style-scope patent-text">6</sub>); and,</div>
    <div class="description-paragraph style-scope patent-text">N<sub class="style-scope patent-text">4</sub>: tetrazole (C<sub class="style-scope patent-text">5</sub>).</div>
    <div class="description-paragraph style-scope patent-text">Examples of heteroaryl which comprise fused rings, include, but are not limited to:</div>
    <div class="description-paragraph style-scope patent-text">Cg(with 2 fused rings) derived from benzofuran (O-ι), isobenzofuran (O-ι), indole (I'D, isoindole (NY indolizine (NY indoline (NY isoindoline (NY purine (N<sub class="style-scope patent-text">4</sub>) (e.g., adenine, guanine), benzimidazole (N<sub class="style-scope patent-text">2</sub>), indazole (N<sub class="style-scope patent-text">2</sub>), benzoxazole (N^Y benzisoxazole (N^Y benzodioxole (O<sub class="style-scope patent-text">2</sub>), benzofurazan (N<sub class="style-scope patent-text">2</sub>OY benzotriazole (N<sub class="style-scope patent-text">3</sub>), benzothiofuran (SY benzothiazole (N<sub class="style-scope patent-text">4</sub>Si), benzothiadiazole (N<sub class="style-scope patent-text">2</sub>S);</div>
    <div class="description-paragraph style-scope patent-text">Cw(with 2 fused rings) derived from chromene (OY isochromene (OY chroman (OY isochroman (OY benzodioxan (O<sub class="style-scope patent-text">2</sub>), quinoline (NY isoquinoline (NY quinolizine (NY benzoxazine (N^Y benzodiazine (N<sub class="style-scope patent-text">2</sub>), pyridopyridine (N<sub class="style-scope patent-text">2</sub>), quinoxaline (N<sub class="style-scope patent-text">2</sub>), quinazoline (N<sub class="style-scope patent-text">2</sub>), cinnoline (N<sub class="style-scope patent-text">2</sub>), phthalazine (N<sub class="style-scope patent-text">2</sub>), naphthyridine (N<sub class="style-scope patent-text">2</sub>), pteridine (N<sub class="style-scope patent-text">4</sub>);</div>
    <div class="description-paragraph style-scope patent-text">Cn (with 2 fused rings) derived from benzodiazepine (N<sub class="style-scope patent-text">2</sub>);</div>
    <div class="description-paragraph style-scope patent-text">Ci<sub class="style-scope patent-text">3</sub>(with 3 fused rings) derived from carbazole (NY dibenzofuran (OY dibenzothiophene (SY carboline (N<sub class="style-scope patent-text">2</sub>), perimidine (N<sub class="style-scope patent-text">2</sub>), pyridoindole (N<sub class="style-scope patent-text">2</sub>); and,</div>
    <div class="description-paragraph style-scope patent-text">C<sub class="style-scope patent-text">14</sub>(with 3 fused rings) derived from acridine (NY xanthene (OY thioxanthene (SY oxanthrene (O<sub class="style-scope patent-text">2</sub>), phenoxathiin (OiSY phenazine (N<sub class="style-scope patent-text">2</sub>), phenoxazine (N-ιθγ phenothiazine (N-iS-ι), thianthrene (S<sub class="style-scope patent-text">2</sub>), phenanthridine (NY phenanthroline (N<sub class="style-scope patent-text">2</sub>), phenazine (N<sub class="style-scope patent-text">2</sub>).</div>
    <div class="description-paragraph style-scope patent-text">The above groups, whether alone or part of another substituent, may themselves optionally be substituted with one or more groups selected from themselves and the additional substituents listed below.</div>
    <div class="description-paragraph style-scope patent-text">Halo: -F, -Cl, -Br, and -I.</div>
    <div class="description-paragraph style-scope patent-text">Hydroxy: -OH.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Ether: -OR, wherein R is an ether substituent, for example, a C-i_<sub class="style-scope patent-text">7</sub> alkyl group (also referred to as a Ci_<sub class="style-scope patent-text">7</sub> alkoxy group, discussed below), a C3-20 heterocyclyl group (also referred to as a C3-20 heterocyclyloxy group), or a C<sub class="style-scope patent-text">5</sub>-2oaryl group (also referred to as a C<sub class="style-scope patent-text">5</sub>-2oaryloxy group), preferably a Ci_<sub class="style-scope patent-text">7</sub>alkyl group.</div>
    <div class="description-paragraph style-scope patent-text">Alkoxy: -OR, wherein R is an alkyl group, for example, a C-i_<sub class="style-scope patent-text">7</sub> alkyl group. Examples of C-i_<sub class="style-scope patent-text">7 </sub>alkoxy groups include, but are not limited to, -OMe (methoxy), -OEt (ethoxy), -O(nPr) (npropoxy), -O(iPr) (isopropoxy), -O(nBu) (n-butoxy), -O(sBu) (sec-butoxy), -O(iBu) (isobutoxy), and -O(tBu) (tert-butoxy).</div>
    <div class="description-paragraph style-scope patent-text">Acetal: -CH(OR<sup class="style-scope patent-text">1</sup>)(OR<sup class="style-scope patent-text">2</sup>), wherein R<sup class="style-scope patent-text">1</sup> and R<sup class="style-scope patent-text">2</sup> are independently acetal substituents, for example, a Ci_7alkyl group, a C3-20heterocyclyl group, ora C5-2oaryl group, preferably a Ci_7 alkyl group, or, in the case of a “cyclic” acetal group, R<sup class="style-scope patent-text">1</sup> and R<sup class="style-scope patent-text">2</sup>, taken together with the two oxygen atoms to which they are attached, and the carbon atoms to which they are attached, form a heterocyclic ring having from 4 to 8 ring atoms. Examples of acetal groups include, but are not limited to, -CH(OMe)2, -CH(OEt)<sub class="style-scope patent-text">2</sub>, and -CH(OMe)(OEt).</div>
    <div class="description-paragraph style-scope patent-text">Hemiacetal: -CH(OH)(OR<sup class="style-scope patent-text">1</sup>), wherein R<sup class="style-scope patent-text">1</sup> is a hemiacetal substituent, for example, a C-i_<sub class="style-scope patent-text">7 </sub>alkyl group, a C3-20heterocyclyl group, ora C<sub class="style-scope patent-text">5</sub>-2oaryl group, preferably a Ci_<sub class="style-scope patent-text">7</sub>alkyl group. Examples of hemiacetal groups include, but are not limited to, -CH(OH)(OMe) and CH(OH)(OEt).</div>
    <div class="description-paragraph style-scope patent-text">Ketal: -CR(OR<sup class="style-scope patent-text">1</sup>)(OR<sup class="style-scope patent-text">2</sup>), where R<sup class="style-scope patent-text">1</sup> and R<sup class="style-scope patent-text">2</sup> are as defined for acetals, and R is a ketal substituent other than hydrogen, for example, a C1.7 alkyl group, a C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">20</sub> heterocyclyl group, or a C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">20</sub>aryl group, preferably a C1.7 alkyl group. Examples ketal groups include, but are not limited to, -C(Me)(OMe)<sub class="style-scope patent-text">2</sub>, -C(Me)(OEt)<sub class="style-scope patent-text">2</sub>, -C(Me)(OMe)(OEt), -C(Et)(OMe)<sub class="style-scope patent-text">2</sub>, C(Et)(OEt)<sub class="style-scope patent-text">2</sub>, and -C(Et)(OMe)(OEt).</div>
    <div class="description-paragraph style-scope patent-text">Hemiketal: -CR(OH)(OR<sup class="style-scope patent-text">1</sup>), where R<sup class="style-scope patent-text">1</sup> is as defined for hemiacetals, and R is a hemiketal substituent other than hydrogen, for example, a Ci_<sub class="style-scope patent-text">7</sub> alkyl group, a C3-20 heterocyclyl group, or a C<sub class="style-scope patent-text">5</sub>-2oaryl group, preferably a Ci_<sub class="style-scope patent-text">7</sub> alkyl group. Examples of hemiacetal groups include, but are not limited to, -C(Me)(OH)(OMe), -C(Et)(OH)(OMe), -C(Me)(OH)(OEt), and -C(Et)(OH)(OEt).</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Oxo (keto, -one): =0.</div>
    <div class="description-paragraph style-scope patent-text">Thione (thioketone): =S.</div>
    <div class="description-paragraph style-scope patent-text">Imino (imine): =NR, wherein R is an imino substituent, for example, hydrogen, C-i_<sub class="style-scope patent-text">7</sub> alkyl group, a C3-20 heterocyclyl group, or a C<sub class="style-scope patent-text">5</sub>-2oaryl group, preferably hydrogen or a Ci_<sub class="style-scope patent-text">7</sub> alkyl group. Examples of ester groups include, but are not limited to, =NH, =NMe, =NEt, and =NPh.</div>
    <div class="description-paragraph style-scope patent-text">Formyl (carbaldehyde, carboxaldehyde): -C(=O)H.</div>
    <div class="description-paragraph style-scope patent-text">Acyl (keto): -C(=O)R, wherein R is an acyl substituent, for example, a C-i_<sub class="style-scope patent-text">7</sub> alkyl group (also referred to as Ci_<sub class="style-scope patent-text">7</sub> alkylacyl or Ci_<sub class="style-scope patent-text">7</sub>alkanoyl), a C3-20 heterocyclyl group (also referred to as C<sub class="style-scope patent-text">3</sub>-2oheterocyclylacyl), or a C<sub class="style-scope patent-text">5</sub>-2oaryl group (also referred to as C<sub class="style-scope patent-text">5</sub>-2oarylacyl), preferably a Ci_<sub class="style-scope patent-text">7</sub> alkyl group. Examples of acyl groups include, but are not limited to, -C(=O)CH<sub class="style-scope patent-text">3 </sub>(acetyl), -C(=O)CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub> (propionyl), -C(=O)C(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">3</sub> (t-butyryl), and -C(=O)Ph (benzoyl, phenone).</div>
    <div class="description-paragraph style-scope patent-text">Carboxy (carboxylic acid): -C(=O)OH.</div>
    <div class="description-paragraph style-scope patent-text">Thiocarboxy (thiocarboxylic acid): -C(=S)SH.</div>
    <div class="description-paragraph style-scope patent-text">Thiolocarboxy (thiolocarboxylic acid): -C(=O)SH.</div>
    <div class="description-paragraph style-scope patent-text">Thionocarboxy (thionocarboxylic acid): -C(=S)OH.</div>
    <div class="description-paragraph style-scope patent-text">Imidic acid:-C(=NH)OH.</div>
    <div class="description-paragraph style-scope patent-text">Hydroxamic acid: -C(=NOH)OH.</div>
    <div class="description-paragraph style-scope patent-text">Ester (carboxylate, carboxylic acid ester, oxycarbonyl): -C(=O)OR, wherein R is an ester substituent, for example, a Ci_<sub class="style-scope patent-text">7</sub> alkyl group, a C3-20 heterocyclyl group, ora C<sub class="style-scope patent-text">5</sub>-2oaryl group, preferably a Ci_<sub class="style-scope patent-text">7</sub> alkyl group. Examples of ester groups include, but are not limited to, -C(=O)OCH<sub class="style-scope patent-text">3</sub>, -C(=O)OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>, -C(=O)OC(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">3</sub>, and -C(=O)OPh.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Acyloxy (reverse ester): -OC(=O)R, wherein R is an acyloxy substituent, for example, a Ci_<sub class="style-scope patent-text">7 </sub>alkyl group, a C3-20heterocyclyl group, ora C<sub class="style-scope patent-text">5</sub>-2oaryl group, preferably a Ci_<sub class="style-scope patent-text">7</sub>alkyl group. Examples of acyloxy groups include, but are not limited to, -OC(=O)CH<sub class="style-scope patent-text">3</sub> (acetoxy), -OC(=O)CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>, -OC(=O)C(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">3</sub>, -OC(=O)Ph, and -OC(=O)CH<sub class="style-scope patent-text">2</sub>Ph.</div>
    <div class="description-paragraph style-scope patent-text">Oxycarboyloxy: -OC(=O)OR, wherein R is an ester substituent, for example, a C-i_<sub class="style-scope patent-text">7</sub> alkyl group, a C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">20</sub> heterocyclyl group, or a C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">20</sub>aryl group, preferably a Ci.<sub class="style-scope patent-text">7</sub> alkyl group. Examples of ester groups include, but are not limited to, -OC(=O)OCH<sub class="style-scope patent-text">3</sub>,</div>
    <div class="description-paragraph style-scope patent-text">-OC(=O)OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>, -OC(=O)OC(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">3</sub>, and -OC(=O)OPh.</div>
    <div class="description-paragraph style-scope patent-text">Amino: -NR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>, wherein R<sup class="style-scope patent-text">1</sup> and R<sup class="style-scope patent-text">2</sup> are independently amino substituents, for example, hydrogen, a Ci_7 alkyl group (also referred to as Ci.7alkylamino or di-Ci.7alkylamino), a C3-20 heterocyclyl group, or a C5-2oaryl group, preferably H or a Ci_7 alkyl group, or, in the case of a “cyclic” amino group, R<sup class="style-scope patent-text">1</sup> and R<sup class="style-scope patent-text">2</sup>, taken together with the nitrogen atom to which they are attached, form a heterocyclic ring having from 4 to 8 ring atoms. Amino groups may be primary (-NH2), secondary (-NHR<sup class="style-scope patent-text">1</sup>), or tertiary (-NHR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>), and in cationic form, may be quaternary (-<sup class="style-scope patent-text">+</sup>NR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>R<sup class="style-scope patent-text">3</sup>). Examples of amino groups include, but are not limited to,</div>
    <div class="description-paragraph style-scope patent-text">-NH<sub class="style-scope patent-text">2</sub>, -NHCH<sub class="style-scope patent-text">3</sub>, -NHC(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, -N(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, -N(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, and -NHPh. Examples of cyclic amino groups include, but are not limited to, aziridino, azetidino, pyrrolidino, piperidino, piperazino, morpholino, and thiomorpholino.</div>
    <div class="description-paragraph style-scope patent-text">Amido (carbamoyl, carbamyl, aminocarbonyl, carboxamide): -C(=O)NR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>, wherein R<sup class="style-scope patent-text">1</sup> and R<sup class="style-scope patent-text">2</sup> are independently amino substituents, as defined for amino groups. Examples of amido groups include, but are not limited to, -C(=O)NH<sub class="style-scope patent-text">2</sub>, -C(=O)NHCH<sub class="style-scope patent-text">3</sub>, -C(=O)N(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, -C(=O)NHCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>, and -C(=O)N(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, as well as amido groups in which R<sup class="style-scope patent-text">1</sup> and R<sup class="style-scope patent-text">2</sup>, together with the nitrogen atom to which they are attached, form a heterocyclic structure as in, for example, piperidinocarbonyl, morpholinocarbonyl, thiomorpholinocarbonyl, and piperazinocarbonyl.</div>
    <div class="description-paragraph style-scope patent-text">Thioamido (thiocarbamyl): -C(=S)NR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>, wherein R<sup class="style-scope patent-text">1</sup> and R<sup class="style-scope patent-text">2</sup> are independently amino substituents, as defined for amino groups. Examples of amido groups include, but are not limited to, -C(=S)NH<sub class="style-scope patent-text">2</sub>, -C(=S)NHCH<sub class="style-scope patent-text">3</sub>, -C(=S)N(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, and -C(=S)NHCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>.</div>
    <div class="description-paragraph style-scope patent-text">Acylamido (acylamino): -NR<sup class="style-scope patent-text">1</sup>C(=O)R<sup class="style-scope patent-text">2</sup>, wherein R<sup class="style-scope patent-text">1</sup> is an amide substituent, for example, hydrogen, a Ci_<sub class="style-scope patent-text">7</sub>alkyl group, a C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">20</sub>heterocyclyl group, ora C<sub class="style-scope patent-text">5</sub>-2oaryl group, preferably</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695 hydrogen or a Ci_<sub class="style-scope patent-text">7</sub> alkyl group, and R<sup class="style-scope patent-text">2</sup> is an acyl substituent, for example, a Ci_<sub class="style-scope patent-text">7</sub> alkyl group, a C3-20 heterocyclyl group, or a C<sub class="style-scope patent-text">5</sub>-2oaryl group, preferably hydrogen or a Ci_<sub class="style-scope patent-text">7</sub> alkyl group. Examples of acylamide groups include, but are not limited to, -NHC(=O)CH<sub class="style-scope patent-text">3</sub>, -NHC(=O)CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>, and -NHC(=O)Ph. R<sup class="style-scope patent-text">1</sup> and R<sup class="style-scope patent-text">2</sup> may together form a cyclic structure, as in, for example, succinimidyl, maleimidyl, and phthalimidyl:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/10/61/17/0e99a95a2d0954/AU2013366490B9_D0049.png" class="style-scope patent-text"><img file="AU2013366490B9_D0049.tif" img-format="tif" alt="Figure AU2013366490B9_D0049" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/10/61/17/0e99a95a2d0954/AU2013366490B9_D0049.png"></a></div>
    <div class="description-paragraph style-scope patent-text">succinimidyl maleimidyl phthalimidyl</div>
    <div class="description-paragraph style-scope patent-text">Aminocarbonyloxy: -OC(=O)NR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>, wherein R<sup class="style-scope patent-text">1</sup> and R<sup class="style-scope patent-text">2</sup> are independently amino substituents, as defined for amino groups. Examples of aminocarbonyloxy groups include, but are not limited to, -OC(=O)NH<sub class="style-scope patent-text">2</sub>, -OC(=O)NHMe, -OC(=O)NMe<sub class="style-scope patent-text">2</sub>, and -OC(=O)NEt<sub class="style-scope patent-text">2</sub>.</div>
    <div class="description-paragraph style-scope patent-text">Ureido: -N(R<sup class="style-scope patent-text">1</sup>)CONR<sup class="style-scope patent-text">2</sup>R<sup class="style-scope patent-text">3</sup> wherein R<sup class="style-scope patent-text">2</sup> and R<sup class="style-scope patent-text">3</sup> are independently amino substituents, as defined for amino groups, and R<sup class="style-scope patent-text">1</sup> is a ureido substituent, for example, hydrogen, a C-i_<sub class="style-scope patent-text">7</sub> alkyl group, a C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">20</sub> heterocyclyl group, or a C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">20</sub>aryl group, preferably hydrogen or a C<sub class="style-scope patent-text">v7</sub> alkyl group. Examples of ureido groups include, but are not limited to, -NHCONH<sub class="style-scope patent-text">2</sub>, NHCONHMe, -NHCONHEt, -NHCONMe<sub class="style-scope patent-text">2</sub>, -NHCONEt<sub class="style-scope patent-text">2</sub>, -NMeCONH<sub class="style-scope patent-text">2</sub>, -NMeCONHMe, -NMeCONHEt, -NMeCONMe<sub class="style-scope patent-text">2</sub>, and -NMeCONEt<sub class="style-scope patent-text">2</sub>.</div>
    <div class="description-paragraph style-scope patent-text">Guanidino: -NH-C(=NH)NH<sub class="style-scope patent-text">2</sub>.</div>
    <div class="description-paragraph style-scope patent-text">Tetrazolyl: a five membered aromatic ring having four nitrogen atoms and one carbon atom,</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/68/d6/77/dcdb279d80b94e/AU2013366490B9_D0050.png" class="style-scope patent-text"><img file="AU2013366490B9_D0050.tif" img-format="tif" alt="Figure AU2013366490B9_D0050" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/68/d6/77/dcdb279d80b94e/AU2013366490B9_D0050.png"></a></div>
    <div class="description-paragraph style-scope patent-text">Imino: =NR, wherein R is an imino substituent, for example, for example, hydrogen, a C-i_<sub class="style-scope patent-text">7 </sub>alkyl group, a C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">20</sub> heterocyclyl group, or a C<sub class="style-scope patent-text">5</sub>-2oaryl group, preferably H or a Ci_<sub class="style-scope patent-text">7</sub>alkyl group. Examples of imino groups include, but are not limited to, =NH, =NMe, and =NEt.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Amidine (amidino): -C(=NR)NR<sub class="style-scope patent-text">2</sub>, wherein each R is an amidine substituent, for example, hydrogen, a Ci_<sub class="style-scope patent-text">7</sub>alkyl group, a C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">2</sub>oheterocyclyl group, ora C<sub class="style-scope patent-text">5</sub>-2oaryl group, preferably H or a Ci_7 alkyl group. Examples of amidine groups include, but are not limited to,</div>
    <div class="description-paragraph style-scope patent-text">-C(=NH)NH<sub class="style-scope patent-text">2</sub>, -C(=NH)NMe<sub class="style-scope patent-text">2</sub>, and -C(=NMe)NMe<sub class="style-scope patent-text">2</sub>.</div>
    <div class="description-paragraph style-scope patent-text">Nitro: -NO<sub class="style-scope patent-text">2</sub>.</div>
    <div class="description-paragraph style-scope patent-text">Nitroso: -NO.</div>
    <div class="description-paragraph style-scope patent-text">Azido: -N<sub class="style-scope patent-text">3</sub>.</div>
    <div class="description-paragraph style-scope patent-text">Cyano (nitrile, carbonitrile): -CN.</div>
    <div class="description-paragraph style-scope patent-text">Isocyano: -NC.</div>
    <div class="description-paragraph style-scope patent-text">Cyanato: -OCN.</div>
    <div class="description-paragraph style-scope patent-text">Isocyanato: -NCO.</div>
    <div class="description-paragraph style-scope patent-text">Thiocyano (thiocyanato): -SCN.</div>
    <div class="description-paragraph style-scope patent-text">Isothiocyano (isothiocyanato): -NCS.</div>
    <div class="description-paragraph style-scope patent-text">Sulfhydryl (thiol, mercapto): -SH.</div>
    <div class="description-paragraph style-scope patent-text">Thioether (sulfide): -SR, wherein R is a thioether substituent, for example, a C^y alkyl group (also referred to as a Cwalkylthio group), a C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">20</sub> heterocyclyl group, or a C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">20</sub>aryl group, preferably a C-i_<sub class="style-scope patent-text">7</sub> alkyl group. Examples of C-i_<sub class="style-scope patent-text">7</sub> alkylthio groups include, but are not limited to, -SCH<sub class="style-scope patent-text">3</sub> and -SCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>.</div>
    <div class="description-paragraph style-scope patent-text">Disulfide: -SS-R, wherein R is a disulfide substituent, for example, a C-|.<sub class="style-scope patent-text">7</sub> alkyl group, a C<sub class="style-scope patent-text">3</sub>. <sub class="style-scope patent-text">20</sub> heterocyclyl group, or a C<sub class="style-scope patent-text">5</sub>-2oaryl group, preferably a Ci_<sub class="style-scope patent-text">7</sub> alkyl group (also referred to herein as C-|.<sub class="style-scope patent-text">7</sub> alkyl disulfide). Examples of C-|.<sub class="style-scope patent-text">7</sub> alkyl disulfide groups include, but are not limited to, -SSCH<sub class="style-scope patent-text">3</sub> and -SSCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Sulfine (sulfinyl, sulfoxide): -S(=O)R, wherein R is a sulfine substituent, for example, a Ci_<sub class="style-scope patent-text">7 </sub>alkyl group, a C3-20heterocyciyl group, ora C<sub class="style-scope patent-text">5</sub>-2oaryl group, preferably a Ci_<sub class="style-scope patent-text">7</sub>alkyl group. Examples of sulfine groups include, but are not limited to, -S(=O)CH<sub class="style-scope patent-text">3</sub> and -S(=O)CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>.</div>
    <div class="description-paragraph style-scope patent-text">Sulfone (sulfonyl): -S(=O)<sub class="style-scope patent-text">2</sub>R, wherein R is a sulfone substituent, for example, a C-i_<sub class="style-scope patent-text">7</sub> alkyl group, a C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">20</sub> heterocyciyl group, or a C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">2</sub>oaryl group, preferably a Ci_<sub class="style-scope patent-text">7</sub> alkyl group, including, for example, a fluorinated or perfluorinated C-i_<sub class="style-scope patent-text">7</sub> alkyl group. Examples of sulfone groups include, but are not limited to, -S(=O)<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub> (methanesulfonyl, mesyl), -S(=O)<sub class="style-scope patent-text">2</sub>CF<sub class="style-scope patent-text">3 </sub>(triflyl), -S(=O)<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub> (esyl), -S(=O)<sub class="style-scope patent-text">2</sub>C<sub class="style-scope patent-text">4</sub>F<sub class="style-scope patent-text">9</sub> (nonaflyl), -S(=O)<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CF<sub class="style-scope patent-text">3</sub> (tresyl), -S(=O)<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>NH<sub class="style-scope patent-text">2</sub> (tauryl), -S(=O)<sub class="style-scope patent-text">2</sub>Ph (phenylsulfonyl, besyl), 4-methylphenylsulfonyl (tosyl), 4-chlorophenylsulfonyl (closyl), 4-bromophenylsulfonyl (brosyl), 4-nitrophenyl (nosyl), 2-naphthalenesulfonate (napsyl), and 5-dimethylamino-naphthalen-1-ylsulfonate (dansyl).</div>
    <div class="description-paragraph style-scope patent-text">Sulfinic acid (sulfino): -S(=O)OH, -SO<sub class="style-scope patent-text">2</sub>H.</div>
    <div class="description-paragraph style-scope patent-text">Sulfonic acid (sulfo): -S(=O)<sub class="style-scope patent-text">2</sub>OH, -SO<sub class="style-scope patent-text">3</sub>H.</div>
    <div class="description-paragraph style-scope patent-text">Sulfinate (sulfinic acid ester): -S(=O)OR; wherein R is a sulfinate substituent, for example, a Ci_<sub class="style-scope patent-text">7</sub> alkyl group, a C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">20</sub> heterocyciyl group, or a C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">2</sub>oaryl group, preferably a Ci_<sub class="style-scope patent-text">7</sub> alkyl group. Examples of sulfinate groups include, but are not limited to, -S(=O)OCH<sub class="style-scope patent-text">3 </sub>(methoxysulfinyl; methyl sulfinate) and -S(=O)OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub> (ethoxysulfinyl; ethyl sulfinate).</div>
    <div class="description-paragraph style-scope patent-text">Sulfonate (sulfonic acid ester): -S(=O)<sub class="style-scope patent-text">2</sub>OR, wherein R is a sulfonate substituent, for example, a C<sub class="style-scope patent-text">4</sub>_<sub class="style-scope patent-text">7</sub>alkyl group, a C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">20</sub>heterocyciyl group, ora C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">20</sub>aryl group, preferably a C<sub class="style-scope patent-text">4</sub>_<sub class="style-scope patent-text">7</sub> alkyl group. Examples of sulfonate groups include, but are not limited to, -S(=O)<sub class="style-scope patent-text">2</sub>OCH<sub class="style-scope patent-text">3 </sub>(methoxysulfonyl; methyl sulfonate) and -S(=O)<sub class="style-scope patent-text">2</sub>OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub> (ethoxysulfonyl; ethyl sulfonate).</div>
    <div class="description-paragraph style-scope patent-text">Sulfinyloxy: -OS(=O)R, wherein R is a sulfinyloxy substituent, for example, a C-i_<sub class="style-scope patent-text">7</sub> alkyl group, a C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">20</sub> heterocyciyl group, or a C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">2</sub>oaryl group, preferably a Ci_<sub class="style-scope patent-text">7</sub> alkyl group. Examples of sulfinyloxy groups include, but are not limited to, -OS(=O)CH<sub class="style-scope patent-text">3</sub> and -OS(=O)CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>.</div>
    <div class="description-paragraph style-scope patent-text">Sulfonyloxy: -OS(=O)<sub class="style-scope patent-text">2</sub>R, wherein R is a sulfonyloxy substituent, for example, a C-i_<sub class="style-scope patent-text">7</sub> alkyl group, a C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">20</sub> heterocyciyl group, or a C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">2</sub>oaryl group, preferably a Ci_<sub class="style-scope patent-text">7</sub> alkyl group.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Examples of sulfonyloxy groups include, but are not limited to, -OS(=O)<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub> (mesylate) and -OS(=O)<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub> (esylate).</div>
    <div class="description-paragraph style-scope patent-text">Sulfate: -OS(=O)<sub class="style-scope patent-text">2</sub>OR; wherein R is a sulfate substituent, for example, a Ci_<sub class="style-scope patent-text">7</sub> alkyl group, a C<sub class="style-scope patent-text">3</sub>-<sub class="style-scope patent-text">20</sub> heterocyclyl group, or a C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">2</sub>oaryl group, preferably a Ci_<sub class="style-scope patent-text">7</sub> alkyl group. Examples of sulfate groups include, but are not limited to, -OS(=O)<sub class="style-scope patent-text">2</sub>OCH<sub class="style-scope patent-text">3</sub> and -SO(=O)<sub class="style-scope patent-text">2</sub>OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>.</div>
    <div class="description-paragraph style-scope patent-text">Sulfamyl (sulfamoyl; sulfinic acid amide; sulfinamide): -S(=O)NR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>, wherein R<sup class="style-scope patent-text">1</sup> and R<sup class="style-scope patent-text">2</sup> are independently amino substituents, as defined for amino groups. Examples of sulfamyl groups include, but are not limited to, -S(=O)NH<sub class="style-scope patent-text">2</sub>, -S(=O)NH(CH<sub class="style-scope patent-text">3</sub>), -S(=O)N(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, -S(=O)NH(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>), -S(=O)N(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, and -S(=O)NHPh.</div>
    <div class="description-paragraph style-scope patent-text">Sulfonamido (sulfinamoyl; sulfonic acid amide; sulfonamide): -S(=O)<sub class="style-scope patent-text">2</sub>NR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>, wherein R<sup class="style-scope patent-text">1 </sup>and R<sup class="style-scope patent-text">2</sup> are independently amino substituents, as defined for amino groups. Examples of sulfonamido groups include, but are not limited to, -S(=O)<sub class="style-scope patent-text">2</sub>NH<sub class="style-scope patent-text">2</sub>, -S(=O)<sub class="style-scope patent-text">2</sub>NH(CH<sub class="style-scope patent-text">3</sub>), -S(=O)<sub class="style-scope patent-text">2</sub>N(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, -S(=O)<sub class="style-scope patent-text">2</sub>NH(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>), -S(=O)<sub class="style-scope patent-text">2</sub>N(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, and -S(=O)<sub class="style-scope patent-text">2</sub>NHPh.</div>
    <div class="description-paragraph style-scope patent-text">Sulfamino: -NR<sup class="style-scope patent-text">1</sup>S(=O)2OH, wherein R<sup class="style-scope patent-text">1</sup> is an amino substituent, as defined for amino groups. Examples of sulfamino groups include, but are not limited to, -NHS(=O)2OH and -N(CH<sub class="style-scope patent-text">3</sub>)S(=O)<sub class="style-scope patent-text">2</sub>OH.</div>
    <div class="description-paragraph style-scope patent-text">Sulfonamino: -NR<sup class="style-scope patent-text">1</sup>S(=O)2R, wherein R<sup class="style-scope patent-text">1</sup> is an amino substituent, as defined for amino groups, and R is a sulfonamino substituent, for example, a Ci_7 alkyl group, a C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">2</sub>oaryl group, preferably a Ci_<sub class="style-scope patent-text">7</sub> alkyl group. Examples of sulfonamino groups include, but are not limited to, -NHS(=O)<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub> and -N(CH<sub class="style-scope patent-text">3</sub>)S(=O)<sub class="style-scope patent-text">2</sub>C<sub class="style-scope patent-text">6</sub>H<sub class="style-scope patent-text">5</sub>.</div>
    <div class="description-paragraph style-scope patent-text">Sulfinamino: -NR<sup class="style-scope patent-text">1</sup>S(=O)R, wherein R<sup class="style-scope patent-text">1</sup> is an amino substituent, as defined for amino groups, and R is a sulfinamino substituent, for example, a C1.7 alkyl group, a C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">20 </sub>heterocyclyl group, or a C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">20</sub>aryl group, preferably a C1.7 alkyl group. Examples of sulfinamino groups include, but are not limited to, -NHS(=O)CH<sub class="style-scope patent-text">3</sub> and -N(CH<sub class="style-scope patent-text">3</sub>)S(=O)C<sub class="style-scope patent-text">6</sub>H<sub class="style-scope patent-text">5</sub>.</div>
    <div class="description-paragraph style-scope patent-text">Phosphino (phosphine): -PR<sub class="style-scope patent-text">2</sub>, wherein R is a phosphino substituent, for example, -H, a Ci_<sub class="style-scope patent-text">7 </sub>alkyl group, a C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">20</sub>heterocyclyl group, ora C<sub class="style-scope patent-text">5</sub>-2oaryl group, preferably-H, a Ci_<sub class="style-scope patent-text">7</sub>alkyl group, or a C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">2</sub>oaryl group. Examples of phosphino groups include, but are not limited to, -PH<sub class="style-scope patent-text">2</sub>, -P(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, -P(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, -P(t-Bu)<sub class="style-scope patent-text">2</sub>, and -P(Ph)<sub class="style-scope patent-text">2</sub>.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Phospho: -P(=O)<sub class="style-scope patent-text">2</sub>.</div>
    <div class="description-paragraph style-scope patent-text">Phosphinyl (phosphine oxide): -P(=O)R<sub class="style-scope patent-text">2</sub>, wherein R is a phosphinyl substituent, for example, a Cwalkyl group, a C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">2</sub>oheterocyclyl group, ora C<sub class="style-scope patent-text">5</sub>-2oaryl group, preferably a Ci-<sub class="style-scope patent-text">7</sub> alkyl group or a C5-20 aryl group. Examples of phosphinyl groups include, but are not limited to, -P(=O)(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, -P(=O)(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, -P(=O)(t-Bu)<sub class="style-scope patent-text">2</sub>, and -P(=O)(Ph)<sub class="style-scope patent-text">2</sub>.</div>
    <div class="description-paragraph style-scope patent-text">Phosphonic acid (phosphono): -P(=O)(OH)<sub class="style-scope patent-text">2</sub>.</div>
    <div class="description-paragraph style-scope patent-text">Phosphonate (phosphono ester): -P(=O)(OR)<sub class="style-scope patent-text">2</sub>, where R is a phosphonate substituent, for example, -H, a C1-7alkyl group, a C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">2</sub>oheterocyclyl group, ora C<sub class="style-scope patent-text">5</sub>-2oaryl group, preferably -H, a C1-7 alkyl group, or a C<sub class="style-scope patent-text">5</sub>-2oaryl group. Examples of phosphonate groups include, but are not limited to, -P(=O)(OCH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, -P(=O)(OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, -P(=O)(O-t-Bu)<sub class="style-scope patent-text">2</sub>, and -P(=O)(OPh)<sub class="style-scope patent-text">2</sub>.</div>
    <div class="description-paragraph style-scope patent-text">Phosphoric acid (phosphonooxy): -OP(=O)(OH)<sub class="style-scope patent-text">2</sub>.</div>
    <div class="description-paragraph style-scope patent-text">Phosphate (phosphonooxy ester): -OP(=O)(OR)<sub class="style-scope patent-text">2</sub>, where R is a phosphate substituent, for example, -H, a C1-7 alkyl group, a C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">2</sub>o heterocyclyl group, ora C<sub class="style-scope patent-text">5</sub>-2oaryl group, preferablyH, a C1-7 alkyl group, or a C<sub class="style-scope patent-text">5</sub>-2oaryl group. Examples of phosphate groups include, but are not limited to, -OP(=O)(OCH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, -OP(=O)(OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, -OP(=O)(O-t-Bu)<sub class="style-scope patent-text">2</sub>, and -OP(=O)(OPh)<sub class="style-scope patent-text">2</sub>.</div>
    <div class="description-paragraph style-scope patent-text">Phosphorous acid: -OP(OH)<sub class="style-scope patent-text">2</sub>.</div>
    <div class="description-paragraph style-scope patent-text">Phosphite: -OP(OR)<sub class="style-scope patent-text">2</sub>, where R is a phosphite substituent, for example, -H, a (fy alkyl group, a C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">20</sub> heterocyclyl group, or a C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">20</sub>aryl group, preferably -H, a C1.7 alkyl group, or a C<sub class="style-scope patent-text">5</sub>_<sub class="style-scope patent-text">20</sub>aryl group. Examples of phosphite groups include, but are not limited to, -OP(OCH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, -OP(OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, -OP(O-t-Bu)<sub class="style-scope patent-text">2</sub>, and -OP(OPh)<sub class="style-scope patent-text">2</sub>.</div>
    <div class="description-paragraph style-scope patent-text">Phosphoramidite: -OP(OR<sup class="style-scope patent-text">1</sup>)-NR<sup class="style-scope patent-text">2</sup>2, where R<sup class="style-scope patent-text">1</sup> and R<sup class="style-scope patent-text">2</sup> are phosphoramidite substituents, for example, -H, a (optionally substituted) C1-7alkyl group, a C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">2</sub>oheterocyclyl group, ora C5-20 aryl group, preferably -H, a C1-7 alkyl group, or a C<sub class="style-scope patent-text">5</sub>-2oaryl group. Examples of phosphoramidite groups include, but are not limited to, -OP(OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)-N(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, -OP(OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)-N(i-Pr)<sub class="style-scope patent-text">2</sub>, and -OP(OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CN)-N(i-Pr)<sub class="style-scope patent-text">2</sub>.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Phosphoramidate: -OP(=O)(OR<sup class="style-scope patent-text">1</sup>)-NR<sup class="style-scope patent-text">2</sup>2, where R<sup class="style-scope patent-text">1</sup> and R<sup class="style-scope patent-text">2</sup> are phosphoramidate substituents, for example, -H, a (optionally substituted) Ci_<sub class="style-scope patent-text">7</sub> alkyl group, a C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">2</sub>o heterocyclyl group, or a C<sub class="style-scope patent-text">5</sub>-2oaryl group, preferably -H, a Cw alkyl group, or a C<sub class="style-scope patent-text">5</sub>-2oaryl group.</div>
    <div class="description-paragraph style-scope patent-text">Examples of phosphoramidate groups include, but are not limited to, -OP(=O)(OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)N(CH<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">2</sub>, -OP(=O)(OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)-N(i-Pr)<sub class="style-scope patent-text">2</sub>, and -OP(=O)(OCH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CN)-N(i-Pr)<sub class="style-scope patent-text">2</sub>.</div>
    <div class="description-paragraph style-scope patent-text">Alkylene</div>
    <div class="description-paragraph style-scope patent-text">C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">12</sub> alkylene: The term “C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">12</sub> alkylene”, as used herein, pertains to a bidentate moiety obtained by removing two hydrogen atoms, either both from the same carbon atom, or one from each of two different carbon atoms, of a hydrocarbon compound having from 3 to 12 carbon atoms (unless otherwise specified), which may be aliphatic or alicyclic, and which may be saturated, partially unsaturated, or fully unsaturated. Thus, the term “alkylene” includes the sub-classes alkenylene, alkynylene, cycloalkylene, etc., discussed below.</div>
    <div class="description-paragraph style-scope patent-text">Examples of linear saturated C<sub class="style-scope patent-text">3</sub>.-|<sub class="style-scope patent-text">2</sub> alkylene groups include, but are not limited to, -(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>where n is an integer from 3 to 12, for example, -CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>- (propylene), -CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>- (butylene), -CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>- (pentylene) and -CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH-<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>- (heptylene).</div>
    <div class="description-paragraph style-scope patent-text">Examples of branched saturated C<sub class="style-scope patent-text">3</sub>.-|<sub class="style-scope patent-text">2</sub> alkylene groups include, but are not limited to, -CH(CH<sub class="style-scope patent-text">3</sub>)CH<sub class="style-scope patent-text">2</sub>-, -CH(CH<sub class="style-scope patent-text">3</sub>)CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>-, -CH(CH<sub class="style-scope patent-text">3</sub>)CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>-, -CH<sub class="style-scope patent-text">2</sub>CH(CH<sub class="style-scope patent-text">3</sub>)CH<sub class="style-scope patent-text">2</sub>-, -CH<sub class="style-scope patent-text">2</sub>CH(CH<sub class="style-scope patent-text">3</sub>)CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">2</sub>-, -CH(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)-, -CH(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)CH<sub class="style-scope patent-text">2</sub>-, and -CH<sub class="style-scope patent-text">2</sub>CH(CH<sub class="style-scope patent-text">2</sub>CH<sub class="style-scope patent-text">3</sub>)CH<sub class="style-scope patent-text">2</sub>-.</div>
    <div class="description-paragraph style-scope patent-text">Examples of linear partially unsaturated C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">12</sub> alkylene groups (C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">12</sub> alkenylene, and alkynylene groups) include, but are not limited to, -CH=CH-CH<sub class="style-scope patent-text">2</sub>-, -CH<sub class="style-scope patent-text">2</sub>-CH=CH<sub class="style-scope patent-text">2</sub>-, -CH=CH-CH<sub class="style-scope patent-text">2</sub>-CH<sub class="style-scope patent-text">2</sub>-, -CH=CH-CH<sub class="style-scope patent-text">2</sub>-CH<sub class="style-scope patent-text">2</sub>-CH<sub class="style-scope patent-text">2</sub>-, -CH=CH-CH=CH-, -CH=CH-CH=CH-CH<sub class="style-scope patent-text">2</sub>-, CH=CH-CH=CH-CH<sub class="style-scope patent-text">2</sub>-CH<sub class="style-scope patent-text">2</sub>-, -CH=CH-CH<sub class="style-scope patent-text">2</sub>-CH=CH-, -CH=CH-CH<sub class="style-scope patent-text">2</sub>-CH<sub class="style-scope patent-text">2</sub>-CH=CH-, and -CH<sub class="style-scope patent-text">2</sub>CeC-CH<sub class="style-scope patent-text">2</sub>-.</div>
    <div class="description-paragraph style-scope patent-text">Examples of branched partially unsaturated C<sub class="style-scope patent-text">3</sub>.-|<sub class="style-scope patent-text">2</sub> alkylene groups (C<sub class="style-scope patent-text">3</sub>.-|<sub class="style-scope patent-text">2</sub> alkenylene and alkynylene groups) include, but are not limited to, -C(CH<sub class="style-scope patent-text">3</sub>)=CH-, -C(CH<sub class="style-scope patent-text">3</sub>)=CH-CH<sub class="style-scope patent-text">2</sub>-, -CH=CH-CH(CH<sub class="style-scope patent-text">3</sub>)- and -CeC-CH(CH<sub class="style-scope patent-text">3</sub>)-.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Examples of alicyclic saturated C3-12 alkylene groups (C3-12 cycloalkylenes) include, but are not limited to, cyclopentylene (e.g. cyclopent-1,3-ylene), and cyclohexylene (e.g. cyclohex-1,4-ylene).</div>
    <div class="description-paragraph style-scope patent-text">Examples of alicyclic partially unsaturated C3-12 alkylene groups (C3-12 cycloalkylenes) include, but are not limited to, cyclopentenylene (e.g. 4-cyclopenten-1,3-ylene), cyclohexenylene (e.g. 2-cyclohexen-1,4-ylene; 3-cyclohexen-1,2-ylene; 2,5-cyclohexadien1,4-ylene).</div>
    <div class="description-paragraph style-scope patent-text">Oxygen protecting group: the term “oxygen protecting group” refers to a moiety which masks a hydroxy group, and these are well known in the art. A large number of suitable groups are described on pages 23 to 200 of Greene, T.W. and Wuts, G.M., Protective Groups in Organic Synthesis, 3<sup class="style-scope patent-text">rd</sup> Edition, John Wiley &amp; Sons, Inc., 1999, which is incorporated herein by reference. Classes of particular interest include silyl ethers (e.g. TMS, TBDMS), substituted methyl ethers (e.g. THP) and esters (e.g. acetate).</div>
    <div class="description-paragraph style-scope patent-text">Carbamate nitrogen protecting group: the term “carbamate nitrogen protecting group” pertains to a moiety which masks the nitrogen in the imine bond, and these are well known in the art. These groups have the following structure:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/30/a4/5b/3bc77e334bc687/AU2013366490B9_D0051.png" class="style-scope patent-text"><img file="AU2013366490B9_D0051.tif" img-format="tif" alt="Figure AU2013366490B9_D0051" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/30/a4/5b/3bc77e334bc687/AU2013366490B9_D0051.png"></a></div>
    <div class="description-paragraph style-scope patent-text">wherein R’<sup class="style-scope patent-text">10</sup> is R as defined above. A large number of suitable groups are described on pages 503 to 549 of Greene, T.W. and Wuts, G.M., Protective Groups in Organic Synthesis, 3<sup class="style-scope patent-text">rd</sup> Edition, John Wiley &amp; Sons, Inc., 1999, which is incorporated herein by reference.</div>
    <div class="description-paragraph style-scope patent-text">Hemi-aminal nitrogen protecting group: the term “hemi-aminal nitrogen protecting group” pertains to a group having the following structure:</div>
    <div class="description-paragraph style-scope patent-text">wherein R’<sup class="style-scope patent-text">10</sup> is R as defined above. A large number of suitable groups are described on pages 633 to 647 as amide protecting groups of Greene, T.W. and Wuts, G.M., Protective Groups in Organic Synthesis, 3<sup class="style-scope patent-text">rd</sup> Edition, John Wiley &amp; Sons, Inc., 1999, which is incorporated herein by reference.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Conjugates</div>
    <div class="description-paragraph style-scope patent-text">The present invention provides Conjugates comprising a PBD dimer connected to a Ligand unit via a Linker unit. In one embodiment, the Linker unit includes a Stretcher unit (A), a Specificity unit (L<sup class="style-scope patent-text">1</sup>), and a Spacer unit (L<sup class="style-scope patent-text">2</sup>). The Linker unit is connected at one end to the Ligand unit (L) and at the other end to the PBD dimer compound (D).</div>
    <div class="description-paragraph style-scope patent-text">In one aspect, such a Conjugate is shown below in formula Va:</div>
    <div class="description-paragraph style-scope patent-text">L- (A<sup class="style-scope patent-text">1</sup>a-L<sup class="style-scope patent-text">1</sup>s-L<sup class="style-scope patent-text">2</sup>y-D)<sub class="style-scope patent-text">p</sub> (Va) or a pharmaceutically acceptable salt or solvate thereof, wherein:</div>
    <div class="description-paragraph style-scope patent-text">L is the Ligand unit; and</div>
    <div class="description-paragraph style-scope patent-text">-A<sup class="style-scope patent-text">1</sup>a-L<sup class="style-scope patent-text">1</sup>s-L<sup class="style-scope patent-text">2</sup>y- is a Linker unit (LU), wherein:</div>
    <div class="description-paragraph style-scope patent-text">-A<sup class="style-scope patent-text">1</sup>- is a Stretcher unit, a is 1 or 2,</div>
    <div class="description-paragraph style-scope patent-text">-L<sup class="style-scope patent-text">1</sup>- is a Specificity unit, s is an integer ranging from 0 to 12,</div>
    <div class="description-paragraph style-scope patent-text">-L<sup class="style-scope patent-text">2</sup>- is a Spacer unit, y is 0, 1 or 2;</div>
    <div class="description-paragraph style-scope patent-text">-D is a PBD dimer; and p is from 1 to 20.</div>
    <div class="description-paragraph style-scope patent-text">In another aspect, such a Conjugate is shown below in formula Vb:</div>
    <div class="description-paragraph style-scope patent-text">L<sup class="style-scope patent-text">1</sup>S</div>
    <div class="description-paragraph style-scope patent-text">I</div>
    <div class="description-paragraph style-scope patent-text">L - (A<sup class="style-scope patent-text">1</sup>a-L<sup class="style-scope patent-text">2</sup>y-D)<sub class="style-scope patent-text">p</sub> (Vb)</div>
    <div class="description-paragraph style-scope patent-text">Also illustrated as:</div>
    <div class="description-paragraph style-scope patent-text">L - (A<sup class="style-scope patent-text">1</sup>a- L<sup class="style-scope patent-text">2</sup>y (- L<sup class="style-scope patent-text">1</sup>s) -D)<sub class="style-scope patent-text">p</sub> (Vb) or a pharmaceutically acceptable salt or solvate thereof, wherein:</div>
    <div class="description-paragraph style-scope patent-text">L is the Ligand unit; and</div>
    <div class="description-paragraph style-scope patent-text">-A<sup class="style-scope patent-text">1</sup>a-L<sup class="style-scope patent-text">1</sup>s(L<sup class="style-scope patent-text">2</sup>y)- is a Linker unit (LU), wherein:</div>
    <div class="description-paragraph style-scope patent-text">-A<sup class="style-scope patent-text">1</sup>- is a Stretcher unit linked to a Spacer unit (L<sup class="style-scope patent-text">2</sup>), a is 1 or 2,</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">-L<sup class="style-scope patent-text">1</sup>- is a Specificity unit linked to a Spacer unit (L<sup class="style-scope patent-text">2</sup>), s is an integer ranging from 0 to 12,</div>
    <div class="description-paragraph style-scope patent-text">-L<sup class="style-scope patent-text">2</sup>- is a Spacer unit, y is 0, 1 or 2;</div>
    <div class="description-paragraph style-scope patent-text">-D is a PBD dimer; and p is from 1 to 20.</div>
    <div class="description-paragraph style-scope patent-text">Preferences</div>
    <div class="description-paragraph style-scope patent-text">The following preferences may apply to all aspects of the invention as described above, or may relate to a single aspect. The preferences may be combined together in any combination.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the Conjugate has the formula:</div>
    <div class="description-paragraph style-scope patent-text">L- (A<sup class="style-scope patent-text">1</sup>a-L<sup class="style-scope patent-text">1</sup>s-L<sup class="style-scope patent-text">2</sup>y-D)<sub class="style-scope patent-text">p</sub> </div>
    <div class="description-paragraph style-scope patent-text">L- (A<sup class="style-scope patent-text">1</sup>a-L<sub class="style-scope patent-text">s</sub> <sup class="style-scope patent-text">1</sup>-D)<sub class="style-scope patent-text">p</sub>,</div>
    <div class="description-paragraph style-scope patent-text">L-(A<sup class="style-scope patent-text">1</sup>-L<sup class="style-scope patent-text">1</sup>-D)<sub class="style-scope patent-text">p</sub> or</div>
    <div class="description-paragraph style-scope patent-text">L- (A<sup class="style-scope patent-text">1</sup>-D)<sub class="style-scope patent-text">p</sub> or a pharmaceutically acceptable salt or solvate thereof, wherein L, A<sup class="style-scope patent-text">1</sup>, a, L<sup class="style-scope patent-text">1</sup>, s, L<sup class="style-scope patent-text">2</sup>,</div>
    <div class="description-paragraph style-scope patent-text">D, y and p are as described above.</div>
    <div class="description-paragraph style-scope patent-text">The present invention is suitable for use in providing a PBD compound to a preferred site in a subject. In the preferred embodiments, the conjugate allows the release of an active PBD compound that does not retain any part of the linker. There is no stub present that could affect the reactivity of the PBD compound.</div>
    <div class="description-paragraph style-scope patent-text">In certain embodiments, the invention provides conjugates comprising a PBD dimer group having a linker connected to a cell binding agent. The present inventors describe herein methods of synthesis that enable such dimer conjugates to be prepared.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">The linker attaches the Ligand Unit (L), e.g. antibody, to the PBD drug moiety D through covalent bond(s). The linker is a bifunctional or multifunctional moiety which can be used to link one or more drug moiety (D) and an antibody unit (Ab) to form antibody-drug conjugates (ADC). The linker may be stable outside a cell, i.e. extracellular, or it may be cleavable by enzymatic activity, hydrolysis, or other metabolic conditions. Antibody-drug conjugates (ADC) can be conveniently prepared using a linker having reactive functionality for binding to the drug moiety and to the antibody. A cysteine thiol, or an amine, e.g. Nterminus or amino acid side chain such as lysine, of the antibody (Ab) can form a bond with a functional group of a linker or spacer reagent, PBD drug moiety (D) or drug-linker reagent (D-R<sup class="style-scope patent-text">l</sup>).</div>
    <div class="description-paragraph style-scope patent-text">The linkers of the ADC preferably prevent aggregation of ADC molecules and keep the ADC freely soluble in aqueous media and in a monomeric state.</div>
    <div class="description-paragraph style-scope patent-text">The linkers of the ADC are preferably stable extracellularly. Before transport or delivery into a cell, the antibody-drug conjugate (ADC) is preferably stable and remains intact, i.e. the antibody remains linked to the drug moiety. The linkers are stable outside the target cell and may be cleaved at some efficacious rate inside the cell. An effective linker will: (i) maintain the specific binding properties of the antibody; (ii) allow intracellular delivery of the conjugate or drug moiety; (iii) remain stable and intact, i.e. not cleaved, until the conjugate has been delivered or transported to its targetted site; and (iv) maintain a cytotoxic, cellkilling effect or a cytostatic effect of the PBD drug moiety. Stability of the ADC may be measured by standard analytical techniques such as mass spectroscopy, HPLC, and the separation/analysis technique LC/MS.</div>
    <div class="description-paragraph style-scope patent-text">Covalent attachment of the antibody and the drug moiety requires the linker to have two reactive functional groups, i.e. bivalency in a reactive sense. Bivalent linker reagents which are useful to attach two or more functional or biologically active moieties, such as peptides, nucleic acids, drugs, toxins, antibodies, haptens, and reporter groups are known, and methods have been described their resulting conjugates (Hermanson, G.T. (1996) Bioconjugate Techniques; Academic Press: New York, p 234-242).</div>
    <div class="description-paragraph style-scope patent-text">In another embodiment, the linker may be substituted with groups which modulate aggregation, solubility or reactivity. For example, a sulfonate substituent may increase</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695 water solubility of the reagent and facilitate the coupling reaction of the linker reagent with the antibody or the drug moiety, or facilitate the coupling reaction of Ab-L with D, or D-L with Ab, depending on the synthetic route employed to prepare the ADC.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the Ligand unit (L) is a Cell Binding Agent (CBA) that specifically binds to a target molecule on the surface of a target cell. An exemplary formula is illustrated below:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/b2/4e/8a/a80271904b3d03/AU2013366490B9_D0052.png" class="style-scope patent-text"><img file="AU2013366490B9_D0052.tif" img-format="tif" alt="Figure AU2013366490B9_D0052" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/b2/4e/8a/a80271904b3d03/AU2013366490B9_D0052.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/94/f5/6e/93c908a3a0970e/AU2013366490B9_D0053.png" class="style-scope patent-text"><img file="AU2013366490B9_D0053.tif" img-format="tif" alt="Figure AU2013366490B9_D0053" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/94/f5/6e/93c908a3a0970e/AU2013366490B9_D0053.png"></a></div>
    <div class="description-paragraph style-scope patent-text">o where the asterisk indicates the point of attachment to the Drug unit (D), CBA is the Cell Binding Agent, L<sup class="style-scope patent-text">1</sup> is a Specificity unit, A<sup class="style-scope patent-text">1</sup> is a Stretcher unit connecting L<sup class="style-scope patent-text">1</sup> to the Cell Binding Agent, L<sup class="style-scope patent-text">2</sup> is a Spacer unit, which is a covalent bond, a self-immolative group or together with -OC(=O)- forms a self-immolative group, and L<sup class="style-scope patent-text">2</sup> is optional. -OC(=O)- may be considered as being part of L<sup class="style-scope patent-text">1</sup> or L<sup class="style-scope patent-text">2</sup>, as appropriate.</div>
    <div class="description-paragraph style-scope patent-text">In another embodiment, the Ligand unit (L) is a Cell Binding Agent (CBA) that specifically binds to a target molecule on the surface of a target cell. An exemplary formula is illustrated below:</div>
    <div class="description-paragraph style-scope patent-text">CBA - A<sup class="style-scope patent-text">1</sup>a- L<sup class="style-scope patent-text">1</sup>S - L<sup class="style-scope patent-text">2</sup>y - * where the asterisk indicates the point of attachment to the Drug unit (D), CBA is the Cell Binding Agent, L<sup class="style-scope patent-text">1</sup> is a Specificity unit, A<sup class="style-scope patent-text">1</sup> is a Stretcher unit connecting L<sup class="style-scope patent-text">1</sup> to the Cell Binding Agent, L<sup class="style-scope patent-text">2</sup> is a Spacer unit which is a covalent bond or a self-immolative group, and a is 1 or 2, s is 0, 1 or 2, and y is 0 or 1 or 2.</div>
    <div class="description-paragraph style-scope patent-text">In the embodiments illustrated above, L<sup class="style-scope patent-text">1</sup> can be a cleavable Specificity unit, and may be referred to as a “trigger” that when cleaved activates a self-immolative group (or selfimmolative groups) L<sup class="style-scope patent-text">2</sup>, when a self-immolative group(s) is present. When the Specificity unit L<sup class="style-scope patent-text">1</sup> is cleaved, or the linkage (i.e., the covalent bond) between L<sup class="style-scope patent-text">1</sup> and L<sup class="style-scope patent-text">2</sup> is cleaved, the self-immolative group releases the Drug unit (D).</div>
    <div class="description-paragraph style-scope patent-text">In another embodiment, the Ligand unit (L) is a Cell Binding Agent (CBA) that specifically binds to a target molecule on the surface of a target cell. An exemplary formula is illustrated below:</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">L<sup class="style-scope patent-text">1</sup>S</div>
    <div class="description-paragraph style-scope patent-text">I</div>
    <div class="description-paragraph style-scope patent-text">CBA-A<sup class="style-scope patent-text">1</sup>a-L<sup class="style-scope patent-text">2</sup>y-* where the asterisk indicates the point of attachment to the Drug (D), CBA is the Cell Binding Agent, L<sup class="style-scope patent-text">1</sup> is a Specificity unit connected to L<sup class="style-scope patent-text">2</sup>, A<sup class="style-scope patent-text">1</sup> is a Stretcher unit connecting L<sup class="style-scope patent-text">2 </sup>to the Cell Binding Agent, L<sup class="style-scope patent-text">2</sup> is a self-immolative group, and a is 1 or 2, s is 1 or 2, and y is 1 or 2.</div>
    <div class="description-paragraph style-scope patent-text">In the various embodiments discussed herein, the nature of L<sup class="style-scope patent-text">1</sup> and L<sup class="style-scope patent-text">2</sup> can vary widely. These groups are chosen on the basis of their characteristics, which may be dictated in part, by the conditions at the site to which the conjugate is delivered. Where the Specificity unit L<sup class="style-scope patent-text">1</sup> is cleavable, the structure and/or sequence of L<sup class="style-scope patent-text">1</sup> is selected such that it is cleaved by the action of enzymes present at the target site (e.g., the target cell). L<sup class="style-scope patent-text">1</sup> units that are cleavable by changes in pH (e.g. acid or base labile), temperature or upon irradiation (e.g. photolabile) may also be used. L<sup class="style-scope patent-text">1</sup> units that are cleavable under reducing or oxidising conditions may also find use in the Conjugates.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, L<sup class="style-scope patent-text">1</sup> may comprise one amino acid or a contiguous sequence of amino acids. The amino acid sequence may be the target substrate for an enzyme.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, L<sup class="style-scope patent-text">1</sup> is cleavable by the action of an enzyme. In one embodiment, the enzyme is an esterase or a peptidase. For example, L<sup class="style-scope patent-text">1</sup> may be cleaved by a lysosomal protease, such as a cathepsin.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, L<sup class="style-scope patent-text">2</sup> is present and together with -C(=O)O- forms a self-immolative group or self-immolative groups. In some embodiments, -C(=O)O- also is a self-immolative group.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, where L<sup class="style-scope patent-text">1</sup> is cleavable by the action of an enzyme and L<sup class="style-scope patent-text">2</sup> is present, the enzyme cleaves the bond between L<sup class="style-scope patent-text">1</sup> and L<sup class="style-scope patent-text">2</sup>, whereby the self-immolative group(s) release the Drug unit.</div>
    <div class="description-paragraph style-scope patent-text">L<sup class="style-scope patent-text">1</sup> and L<sup class="style-scope patent-text">2</sup>, where present, may be connected by a bond selected from:</div>
    <div class="description-paragraph style-scope patent-text">-C(=O)NH-,</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">-C(=O)O-,</div>
    <div class="description-paragraph style-scope patent-text">-NHC(=O)-,</div>
    <div class="description-paragraph style-scope patent-text">-00(=0)-,</div>
    <div class="description-paragraph style-scope patent-text">-00(=0)0-,</div>
    <div class="description-paragraph style-scope patent-text">-NHC(=O)O-,</div>
    <div class="description-paragraph style-scope patent-text">-OC(=O)NH-,</div>
    <div class="description-paragraph style-scope patent-text">-NHC(=O)NH, and -0- (a glycosidic bond).</div>
    <div class="description-paragraph style-scope patent-text">An amino group of L<sup class="style-scope patent-text">1</sup> that connects to L<sup class="style-scope patent-text">2</sup> may be the N-terminus of an amino acid or may be derived from an amino group of an amino acid side chain, for example a lysine amino acid side chain.</div>
    <div class="description-paragraph style-scope patent-text">A carboxyl group of L<sup class="style-scope patent-text">1</sup> that connects to L<sup class="style-scope patent-text">2</sup> may be the C-terminus of an amino acid or may be derived from a carboxyl group of an amino acid side chain, for example a glutamic acid amino acid side chain.</div>
    <div class="description-paragraph style-scope patent-text">A hydroxy group of L<sup class="style-scope patent-text">1</sup> that connects to L<sup class="style-scope patent-text">2</sup> may be derived from a hydroxy group of an amino acid side chain, for example a serine amino acid side chain.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, -C(=O)O- and L<sup class="style-scope patent-text">2</sup> together form the group:</div>
    <div class="description-paragraph style-scope patent-text">Y.</div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to the Drug unit, the wavy line indicates the point of attachment to the L<sup class="style-scope patent-text">1</sup>, Y is -N(H)-, -0-, -C(=O)N(H)- or -0(=0)0-, and n is 0 to 3. The phenylene ring is optionally substituted with one, two or three substituents as described herein.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, Y is NH.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, n is 0 or 1. Preferably, n is 0.</div>
    <div class="description-paragraph style-scope patent-text">Where Y is NH and n is 0, the self-immolative group may be referred to as a p-aminobenzylcarbonyl linker (PABC).</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">The self-immolative group will allow for release of the Drug unit (i.e., the asymmetric PBD) when a remote site in the linker is activated, proceeding along the lines shown below (for n=0):</div>
    <div class="description-paragraph style-scope patent-text">Y</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/fb/cd/c2/16d66a87e39570/AU2013366490B9_D0054.png" class="style-scope patent-text"><img file="AU2013366490B9_D0054.tif" img-format="tif" alt="Figure AU2013366490B9_D0054" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/fb/cd/c2/16d66a87e39570/AU2013366490B9_D0054.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the attachment to the Drug, L* is the activated form of the remaining portion of the linker and the released Drug unit is not shown. These groups have the advantage of separating the site of activation from the Drug.</div>
    <div class="description-paragraph style-scope patent-text">In another embodiment, -C(=O)O- and L<sup class="style-scope patent-text">2</sup> together form a group selected from:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/18/50/b4/ddd44e2f0733ec/AU2013366490B9_D0055.png" class="style-scope patent-text"><img file="AU2013366490B9_D0055.tif" img-format="tif" alt="Figure AU2013366490B9_D0055" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/18/50/b4/ddd44e2f0733ec/AU2013366490B9_D0055.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk, the wavy line, Y, and n are as defined above. Each phenylene ring is optionally substituted with one, two or three substituents as described herein. In one embodiment, the phenylene ring having the Y substituent is optionally substituted and the phenylene ring not having the Y substituent is unsubstituted.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">In another embodiment, -C(=O)O- and L<sup class="style-scope patent-text">2</sup> together form a group selected from:</div>
    <div class="description-paragraph style-scope patent-text">where the asterisk, the wavy line, Y, and n are as defined above, E is O, S or NR, D is N, CH, or CR, and F is N, CH, or CR.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, D is N.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, D is CH.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, E is O or S.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, F is CH.</div>
    <div class="description-paragraph style-scope patent-text">In a preferred embodiment, the covalent bond between L<sup class="style-scope patent-text">1</sup> and L<sup class="style-scope patent-text">2</sup> is a cathepsin labile (e.g., cleavable) bond.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, L<sup class="style-scope patent-text">1</sup> comprises a dipeptide. The amino acids in the dipeptide may be any combination of natural amino acids and non-natural amino acids. In some embodiments, the dipeptide comprises natural amino acids. Where the linker is a cathepsin labile linker, the dipeptide is the site of action for cathepsin-mediated cleavage. The dipeptide then is a recognition site for cathepsin.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the group -Xi-X<sub class="style-scope patent-text">2</sub>- in dipeptide, -NH-X<sub class="style-scope patent-text">1</sub>-X<sub class="style-scope patent-text">2</sub>-CO-, is selected from:</div>
    <div class="description-paragraph style-scope patent-text">-Phe-Lys-,</div>
    <div class="description-paragraph style-scope patent-text">-Val-Ala-,</div>
    <div class="description-paragraph style-scope patent-text">-Val-Lys-,</div>
    <div class="description-paragraph style-scope patent-text">-Ala-Lys-,</div>
    <div class="description-paragraph style-scope patent-text">-Val-Cit-,</div>
    <div class="description-paragraph style-scope patent-text">-Phe-Cit-,</div>
    <div class="description-paragraph style-scope patent-text">-Leu-Cit-,</div>
    <div class="description-paragraph style-scope patent-text">-lle-Cit-,</div>
    <div class="description-paragraph style-scope patent-text">-Phe-Arg-, and -T rp-C it-;</div>
    <div class="description-paragraph style-scope patent-text">where Cit is citrulline. In such a dipeptide, -NH- is the amino group of Xi, and CO is the carbonyl group of X<sub class="style-scope patent-text">2</sub>.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Preferably, the group -Xi-X<sub class="style-scope patent-text">2</sub>- in dipeptide, -NH-X1-X2-CO-, is selected from:</div>
    <div class="description-paragraph style-scope patent-text">-Phe-Lys-,</div>
    <div class="description-paragraph style-scope patent-text">-Val-Ala-,</div>
    <div class="description-paragraph style-scope patent-text">-Val-Lys-,</div>
    <div class="description-paragraph style-scope patent-text">-Ala-Lys-, and -Val-Cit-.</div>
    <div class="description-paragraph style-scope patent-text">Most preferably, the group -X-|-X<sub class="style-scope patent-text">2</sub>- in dipeptide, -NH^^-CO-, is -Phe-Lys-, Val-Cit or -Val-Ala-.</div>
    <div class="description-paragraph style-scope patent-text">Other dipeptide combinations of interest include: -Gly-Gly-,</div>
    <div class="description-paragraph style-scope patent-text">-Pro-Pro-, and -Val-Glu-.</div>
    <div class="description-paragraph style-scope patent-text">Other dipeptide combinations may be used, including those described by Dubowchik et al., which is incorporated herein by reference.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the amino acid side chain is chemically protected, where appropriate. The side chain protecting group may be a group as discussed below. Protected amino acid sequences are cleavable by enzymes. For example, a dipeptide sequence comprising a Boc side chain-protected Lys residue is cleavable by cathepsin.</div>
    <div class="description-paragraph style-scope patent-text">Protecting groups for the side chains of amino acids are well known in the art and are described in the Novabiochem Catalog. Additional protecting group strategies are set out in Protective groups in Organic Synthesis, Greene and Wuts.</div>
    <div class="description-paragraph style-scope patent-text">Possible side chain protecting groups are shown below for those amino acids having reactive side chain functionality:</div>
    <div class="description-paragraph style-scope patent-text">Arg: Z, Mtr, Tos;</div>
    <div class="description-paragraph style-scope patent-text">Asn: Trt, Xan;</div>
    <div class="description-paragraph style-scope patent-text">Asp: Bzl, t-Bu;</div>
    <div class="description-paragraph style-scope patent-text">Cys: Acm, Bzl, Bzl-OMe, Bzl-Me, Trt;</div>
    <div class="description-paragraph style-scope patent-text">Glu: Bzl, t-Bu;</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Gin: Trt, Xan;</div>
    <div class="description-paragraph style-scope patent-text">His: Boc, Dnp, Tos, Trt;</div>
    <div class="description-paragraph style-scope patent-text">Lys: Boc, Z-CI, Fmoc, Z;</div>
    <div class="description-paragraph style-scope patent-text">Ser: Bzl, TBDMS, TBDPS;</div>
    <div class="description-paragraph style-scope patent-text">Thr: Bz;</div>
    <div class="description-paragraph style-scope patent-text">Trp: Boc;</div>
    <div class="description-paragraph style-scope patent-text">Tyr: Bzl, Z, Z-Br.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, -X<sub class="style-scope patent-text">2</sub>- is connected indirectly to the Drug unit. In such an embodiment, the Spacer unit L<sup class="style-scope patent-text">2</sup> is present.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the dipeptide is used in combination with a self-immolative group(s) (the Spacer unit). The self-immolative group(s) may be connected to -X<sub class="style-scope patent-text">2</sub>-.</div>
    <div class="description-paragraph style-scope patent-text">Where a self-immolative group is present, -X<sub class="style-scope patent-text">2</sub>- is connected directly to the self-immolative group. In one embodiment, -X<sub class="style-scope patent-text">2</sub>- is connected to the group Y of the self-immolative group. Preferably the group -X<sub class="style-scope patent-text">2</sub>-CO- is connected to Y, where Y is NH.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, -X<sub class="style-scope patent-text">r</sub> is connected directly to A<sup class="style-scope patent-text">1</sup>. Preferably the group NH-X<sub class="style-scope patent-text">r</sub> (the amino terminus of X-i) is connected to A<sup class="style-scope patent-text">1</sup>. A<sup class="style-scope patent-text">1</sup> may comprise the functionality -CO- thereby to form an amide link with -X-i-.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, L<sup class="style-scope patent-text">1</sup> and L<sup class="style-scope patent-text">2</sup> together with -OC(=O)- comprise the group -X1-X2-PABC-. The PABC group is connected directly to the Drug unit. In one example, the selfimmolative group and the dipeptide together form the group -Phe-Lys-PABC-, which is illustrated below:</div>
    <div class="description-paragraph style-scope patent-text">NH</div>
    <div class="description-paragraph style-scope patent-text">N</div>
    <div class="description-paragraph style-scope patent-text">H</div>
    <div class="description-paragraph style-scope patent-text">O</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695 where the asterisk indicates the point of attachment to the Drug unit, and the wavy line indicates the point of attachment to the remaining portion of L<sup class="style-scope patent-text">1</sup> or the point of attachment to A<sup class="style-scope patent-text">1</sup>. Preferably, the wavy line indicates the point of attachment to A<sup class="style-scope patent-text">1</sup>.</div>
    <div class="description-paragraph style-scope patent-text">Alternatively, the self-immolative group and the dipeptide together form the group -Val-AlaPABC-, which is illustrated below:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/92/27/00/6443bd903c4ed1/AU2013366490B9_D0056.png" class="style-scope patent-text"><img file="AU2013366490B9_D0056.tif" img-format="tif" alt="Figure AU2013366490B9_D0056" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/92/27/00/6443bd903c4ed1/AU2013366490B9_D0056.png"></a></div>
    <div class="description-paragraph style-scope patent-text">O where the asterisk and the wavy line are as defined above.</div>
    <div class="description-paragraph style-scope patent-text">In another embodiment, L<sup class="style-scope patent-text">1</sup> and L<sup class="style-scope patent-text">2</sup> together with -OC(=O)- represent:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/54/72/c8/eea8be9eeb0dc4/AU2013366490B9_D0057.png" class="style-scope patent-text"><img file="AU2013366490B9_D0057.tif" img-format="tif" alt="Figure AU2013366490B9_D0057" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/54/72/c8/eea8be9eeb0dc4/AU2013366490B9_D0057.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to the Drug unit, the wavy line indicates the point of attachment to A<sup class="style-scope patent-text">1</sup>, Y is a covalent bond or a functional group, and E is a group that is susceptible to cleavage thereby to activate a self-immolative group.</div>
    <div class="description-paragraph style-scope patent-text">E is selected such that the group is susceptible to cleavage, e.g., by light or by the action of an enzyme. E may be -NO<sub class="style-scope patent-text">2</sub> or glucuronic acid (e.g., β-glucuronic acid). The former may be susceptible to the action of a nitroreductase, the latter to the action of a β-glucuronidase.</div>
    <div class="description-paragraph style-scope patent-text">The group Y may be a covalent bond.</div>
    <div class="description-paragraph style-scope patent-text">The group Y may be a functional group selected from:</div>
    <div class="description-paragraph style-scope patent-text">-0(=0)-NH-O-C(=O)NH-,</div>
    <div class="description-paragraph style-scope patent-text">-C(=O)O-,</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">-NHC(=O)-,</div>
    <div class="description-paragraph style-scope patent-text">-OC(=O)-,</div>
    <div class="description-paragraph style-scope patent-text">-OC(=O)O-,</div>
    <div class="description-paragraph style-scope patent-text">-NHC(=O)O-,</div>
    <div class="description-paragraph style-scope patent-text">-OC(=O)NH-,</div>
    <div class="description-paragraph style-scope patent-text">-NHC(=O)NH-, -NHC(=O)NH, -C(=O)NHC(=O)-, SO<sub class="style-scope patent-text">2</sub>, and</div>
    <div class="description-paragraph style-scope patent-text">-S-.</div>
    <div class="description-paragraph style-scope patent-text">The group Y is preferably -NH-, -CH<sub class="style-scope patent-text">2</sub>-, -0-, and -S-.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, L<sup class="style-scope patent-text">1</sup> and L<sup class="style-scope patent-text">2</sup> together with -00(=0)- represent:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/4b/15/e3/aaa34822d263a4/AU2013366490B9_D0058.png" class="style-scope patent-text"><img file="AU2013366490B9_D0058.tif" img-format="tif" alt="Figure AU2013366490B9_D0058" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/4b/15/e3/aaa34822d263a4/AU2013366490B9_D0058.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/fc/98/91/eb74c399b9d421/AU2013366490B9_D0059.png" class="style-scope patent-text"><img file="AU2013366490B9_D0059.tif" img-format="tif" alt="Figure AU2013366490B9_D0059" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/fc/98/91/eb74c399b9d421/AU2013366490B9_D0059.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/9f/07/65/cac4759177eb2d/AU2013366490B9_D0060.png" class="style-scope patent-text"><img file="AU2013366490B9_D0060.tif" img-format="tif" alt="Figure AU2013366490B9_D0060" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/9f/07/65/cac4759177eb2d/AU2013366490B9_D0060.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ca/10/66/a8234b56f5051e/AU2013366490B9_D0061.png" class="style-scope patent-text"><img file="AU2013366490B9_D0061.tif" img-format="tif" alt="Figure AU2013366490B9_D0061" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ca/10/66/a8234b56f5051e/AU2013366490B9_D0061.png"></a></div>
    <div class="description-paragraph style-scope patent-text">or where the asterisk indicates the point of attachment to the Drug unit, the wavy line indicates the point of attachment to A, Y is a covalent bond or a functional group and E is glucuronic acid (e.g., β-glucuronic acid). Y is preferably a functional group selected from -NH-.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, L<sup class="style-scope patent-text">1</sup> and L<sup class="style-scope patent-text">2</sup> together represent:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/9e/f9/30/16d41eed620115/AU2013366490B9_D0062.png" class="style-scope patent-text"><img file="AU2013366490B9_D0062.tif" img-format="tif" alt="Figure AU2013366490B9_D0062" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/9e/f9/30/16d41eed620115/AU2013366490B9_D0062.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cb/8d/47/8eef814ecf1662/AU2013366490B9_D0063.png" class="style-scope patent-text"><img file="AU2013366490B9_D0063.tif" img-format="tif" alt="Figure AU2013366490B9_D0063" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cb/8d/47/8eef814ecf1662/AU2013366490B9_D0063.png"></a></div>
    <div class="description-paragraph style-scope patent-text">or where the asterisk indicates the point of attachment to the remainder of L<sup class="style-scope patent-text">2</sup> or the Drug unit, the wavy line indicates the point of attachment to A<sup class="style-scope patent-text">1</sup>, Y is a covalent bond or a functional group and E is glucuronic acid (e.g., β-glucuronic acid). Y is preferably a functional group selected from -NH-, -CH<sub class="style-scope patent-text">2</sub>-, -0-, and -S-.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">In some further embodiments, Y is a functional group as set forth above, the functional group is linked to an amino acid, and the amino acid is linked to the Stretcher unit A<sup class="style-scope patent-text">1</sup>. In some embodiments, amino acid is β-alanine. In such an embodiment, the amino acid is equivalently considered part of the Stretcher unit.</div>
    <div class="description-paragraph style-scope patent-text">The Specificity unit L<sup class="style-scope patent-text">1</sup> and the Ligand unit are indirectly connected via the Stretcher unit.</div>
    <div class="description-paragraph style-scope patent-text">L<sup class="style-scope patent-text">1</sup> and A<sup class="style-scope patent-text">1</sup> may be connected by a bond selected from:</div>
    <div class="description-paragraph style-scope patent-text">-C(=O)NH-,</div>
    <div class="description-paragraph style-scope patent-text">-C(=O)O-,</div>
    <div class="description-paragraph style-scope patent-text">-NHC(=O)-,</div>
    <div class="description-paragraph style-scope patent-text">-00(=0)-,</div>
    <div class="description-paragraph style-scope patent-text">-00(=0)0-,</div>
    <div class="description-paragraph style-scope patent-text">-NHC(=O)O-,</div>
    <div class="description-paragraph style-scope patent-text">-OC(=O)NH-, and</div>
    <div class="description-paragraph style-scope patent-text">-NHC(=O)NH-.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the group A<sup class="style-scope patent-text">1</sup> is:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/26/59/90/b0c9aa1d506fbb/AU2013366490B9_D0064.png" class="style-scope patent-text"><img file="AU2013366490B9_D0064.tif" img-format="tif" alt="Figure AU2013366490B9_D0064" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/26/59/90/b0c9aa1d506fbb/AU2013366490B9_D0064.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, the wavy line indicates the point of attachment to the Ligand unit, and n is 0 to 6. In one embodiment, n is 5.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the group A<sup class="style-scope patent-text">1</sup> is:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/50/e4/23/125829a74cadd5/AU2013366490B9_D0065.png" class="style-scope patent-text"><img file="AU2013366490B9_D0065.tif" img-format="tif" alt="Figure AU2013366490B9_D0065" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/50/e4/23/125829a74cadd5/AU2013366490B9_D0065.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, the wavy line indicates the point of attachment to the Ligand unit, and n is 0 to 6. In one embodiment, n is 5.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the group A<sup class="style-scope patent-text">1</sup> is:</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/90/ff/30/96f4881411ad4c/AU2013366490B9_D0066.png" class="style-scope patent-text"><img file="AU2013366490B9_D0066.tif" img-format="tif" alt="Figure AU2013366490B9_D0066" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/90/ff/30/96f4881411ad4c/AU2013366490B9_D0066.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, the wavy line indicates the point of attachment to the Ligand unit, n is 0 or 1, and m is 0 to 30. Ina preferred embodiment, n is 1 and m is 0 to 10, 1 to 8, preferably 4 to 8, most preferably 4 or 8.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the group A<sup class="style-scope patent-text">1</sup> is:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f4/9c/ca/4d1993ad96c34b/AU2013366490B9_D0067.png" class="style-scope patent-text"><img file="AU2013366490B9_D0067.tif" img-format="tif" alt="Figure AU2013366490B9_D0067" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f4/9c/ca/4d1993ad96c34b/AU2013366490B9_D0067.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, the wavy line indicates the point of attachment to the Ligand unit, n is 0 or 1, and m is 0 to 30. Ina preferred embodiment, n is 1 and m is 0 to 10, 1 to 8, preferably 4 to 8, most preferably 4 or 8.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the group A<sup class="style-scope patent-text">1</sup> is:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/6c/b1/4e/d5e6ee69f41c5e/AU2013366490B9_D0068.png" class="style-scope patent-text"><img file="AU2013366490B9_D0068.tif" img-format="tif" alt="Figure AU2013366490B9_D0068" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/6c/b1/4e/d5e6ee69f41c5e/AU2013366490B9_D0068.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, the wavy line indicates the point of attachment to the Ligand unit, and n is 0 to 6. In one embodiment, n is 5.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the group A<sup class="style-scope patent-text">1</sup> is:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/5b/4f/6c/6c12a6fb3d21bc/AU2013366490B9_D0069.png" class="style-scope patent-text"><img file="AU2013366490B9_D0069.tif" img-format="tif" alt="Figure AU2013366490B9_D0069" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/5b/4f/6c/6c12a6fb3d21bc/AU2013366490B9_D0069.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, the wavy line indicates 20 the point of attachment to the Ligand unit, and n is 0 to 6. In one embodiment, n is 5.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the group A<sup class="style-scope patent-text">1</sup> is:</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/d0/03/e1/fb9159b9359449/AU2013366490B9_D0070.png" class="style-scope patent-text"><img file="AU2013366490B9_D0070.tif" img-format="tif" alt="Figure AU2013366490B9_D0070" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/d0/03/e1/fb9159b9359449/AU2013366490B9_D0070.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, the wavy line indicates the point of attachment to the Ligand unit, n is 0 or 1, and m is 0 to 30. Ina preferred embodiment, n is 1 and m is 0 to 10, 1 to 8, preferably 4 to 8, most preferably 4 or 8.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the group A<sup class="style-scope patent-text">1</sup> is:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/62/0c/f0/30c0d687a642d7/AU2013366490B9_D0071.png" class="style-scope patent-text"><img file="AU2013366490B9_D0071.tif" img-format="tif" alt="Figure AU2013366490B9_D0071" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/62/0c/f0/30c0d687a642d7/AU2013366490B9_D0071.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, the wavy line indicates the point of attachment to the Ligand unit, n is 0 or 1, and m is 0 to 30. Ina preferred embodiment, n is 1 and m is 0 to 10, 1 to 8, preferably 4 to 8, most preferably 4 or 8.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the connection between the Ligand unit and A<sup class="style-scope patent-text">1</sup> is through a thiol residue of the Ligand unit and a maleimide group of A<sup class="style-scope patent-text">1</sup>.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the connection between the Ligand unit and A<sup class="style-scope patent-text">1</sup> is:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/77/37/c6/1cf48c68e8c30c/AU2013366490B9_D0072.png" class="style-scope patent-text"><img file="AU2013366490B9_D0072.tif" img-format="tif" alt="Figure AU2013366490B9_D0072" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/77/37/c6/1cf48c68e8c30c/AU2013366490B9_D0072.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to the remaining portion of A<sup class="style-scope patent-text">1</sup>, L<sup class="style-scope patent-text">1</sup>, L<sup class="style-scope patent-text">2</sup> or D, and the wavy line indicates the point of attachment to the remaining portion of the Ligand unit. In this embodiment, the S atom is typically derived from the Ligand unit.</div>
    <div class="description-paragraph style-scope patent-text">In each of the embodiments above, an alternative functionality may be used in place of the malemide-derived group shown below:</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/c0/2d/62/005a64fa809fb0/AU2013366490B9_D0073.png" class="style-scope patent-text"><img file="AU2013366490B9_D0073.tif" img-format="tif" alt="Figure AU2013366490B9_D0073" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/c0/2d/62/005a64fa809fb0/AU2013366490B9_D0073.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the wavy line indicates the point of attachment to the Ligand unit as before, and the asterisk indicates the bond to the remaining portion of the A<sup class="style-scope patent-text">1</sup> group, or to L<sup class="style-scope patent-text">1</sup>, L<sup class="style-scope patent-text">2</sup> or D.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the maleimide-derived group is replaced with the group:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/9c/fb/1d/547d20ef52d6d9/AU2013366490B9_D0074.png" class="style-scope patent-text"><img file="AU2013366490B9_D0074.tif" img-format="tif" alt="Figure AU2013366490B9_D0074" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/9c/fb/1d/547d20ef52d6d9/AU2013366490B9_D0074.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the wavy line indicates point of attachment to the Ligand unit, and the asterisk indicates the bond to the remaining portion of the A<sup class="style-scope patent-text">1</sup> group , or to L<sup class="style-scope patent-text">1</sup>, L<sup class="style-scope patent-text">2</sup> or D.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the maleimide-derived group is replaced with a group, which optionally together with a Ligand unit (e.g., a Cell Binding Agent), is selected from:</div>
    <div class="description-paragraph style-scope patent-text">-C(=O)NH-,</div>
    <div class="description-paragraph style-scope patent-text">-C(=O)O-,</div>
    <div class="description-paragraph style-scope patent-text">-NHC(=O)-,</div>
    <div class="description-paragraph style-scope patent-text">-OC(=O)-,</div>
    <div class="description-paragraph style-scope patent-text">-OC(=O)O-,</div>
    <div class="description-paragraph style-scope patent-text">-NHC(=O)O-,</div>
    <div class="description-paragraph style-scope patent-text">-OC(=O)NH-,</div>
    <div class="description-paragraph style-scope patent-text">-NHC(=O)NH-,</div>
    <div class="description-paragraph style-scope patent-text">-NHC(=O)NH,</div>
    <div class="description-paragraph style-scope patent-text">-C(=O)NHC(=O)-,</div>
    <div class="description-paragraph style-scope patent-text">-S-,</div>
    <div class="description-paragraph style-scope patent-text">-S-S-,</div>
    <div class="description-paragraph style-scope patent-text">-CH<sub class="style-scope patent-text">2</sub>C(=O)-C(=O)CH<sub class="style-scope patent-text">2</sub>-, =N-NH-, and -NH-N=.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Of these -C(=O)CH<sub class="style-scope patent-text">2</sub>- may be preferred especially when the carbonyl group is bound to NH-.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the maleimide-derived group is replaced with a group, which optionally together with the Ligand unit, is selected from:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/98/83/09/8a86874417b551/AU2013366490B9_D0075.png" class="style-scope patent-text"><img file="AU2013366490B9_D0075.tif" img-format="tif" alt="Figure AU2013366490B9_D0075" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/98/83/09/8a86874417b551/AU2013366490B9_D0075.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the wavy line indicates either the point of attachment to the Ligand unit or the bond to the remaining portion of the A<sup class="style-scope patent-text">1</sup> group, and the asterisk indicates the other of the point of attachment to the Ligand unit or the bond to the remaining portion of the A<sup class="style-scope patent-text">1</sup> group.</div>
    <div class="description-paragraph style-scope patent-text">Other groups suitable for connecting L<sup class="style-scope patent-text">1</sup> to the Cell Binding Agent are described in WO 2005/082023.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the Stretcher unit A<sup class="style-scope patent-text">1</sup> is present, the Specificity unit L<sup class="style-scope patent-text">1</sup> is present and Spacer unit L<sup class="style-scope patent-text">2</sup> is absent. Thus, L<sup class="style-scope patent-text">1</sup> and the Drug unit are directly connected via a bond. Equivalently in this embodiment, L<sup class="style-scope patent-text">2</sup> is a bond.</div>
    <div class="description-paragraph style-scope patent-text">L<sup class="style-scope patent-text">1</sup> and D may be connected by a bond selected from:</div>
    <div class="description-paragraph style-scope patent-text">-C(=O)N&lt;,</div>
    <div class="description-paragraph style-scope patent-text">-C(=O)O-,</div>
    <div class="description-paragraph style-scope patent-text">-NHC(=O)-,</div>
    <div class="description-paragraph style-scope patent-text">-OC(=O)-,</div>
    <div class="description-paragraph style-scope patent-text">-OC(=O)O-,</div>
    <div class="description-paragraph style-scope patent-text">-NHC(=O)O-,</div>
    <div class="description-paragraph style-scope patent-text">-OC(=O)N&lt;, and</div>
    <div class="description-paragraph style-scope patent-text">-NHC(=O)N&lt;, where N&lt; or O- are part of D.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, L<sup class="style-scope patent-text">1</sup> and D are preferably connected by a bond selected from:</div>
    <div class="description-paragraph style-scope patent-text">-C(=O)N&lt;, and</div>
    <div class="description-paragraph style-scope patent-text">-NHC(=O)-.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, L<sup class="style-scope patent-text">1</sup> comprises a dipeptide and one end of the dipeptide is linked to D.</div>
    <div class="description-paragraph style-scope patent-text">As described above, the amino acids in the dipeptide may be any combination of natural amino acids and non-natural amino acids. In some embodiments, the dipeptide comprises natural amino acids. Where the linker is a cathepsin labile linker, the dipeptide is the site of action for cathepsin-mediated cleavage. The dipeptide then is a recognition site for cathepsin.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the group -X-|-X<sub class="style-scope patent-text">2</sub>- in dipeptide, -ΝΗ-X^X^CO-, is selected from: -Phe-Lys-,</div>
    <div class="description-paragraph style-scope patent-text">-Val-Ala-,</div>
    <div class="description-paragraph style-scope patent-text">-Val-Lys-,</div>
    <div class="description-paragraph style-scope patent-text">-Ala-Lys-,</div>
    <div class="description-paragraph style-scope patent-text">-Val-Cit-,</div>
    <div class="description-paragraph style-scope patent-text">-Phe-Cit-,</div>
    <div class="description-paragraph style-scope patent-text">-Leu-Cit-,</div>
    <div class="description-paragraph style-scope patent-text">-lle-Cit-,</div>
    <div class="description-paragraph style-scope patent-text">-Phe-Arg-, and -T rp-C it-;</div>
    <div class="description-paragraph style-scope patent-text">where Cit is citrulline. In such a dipeptide, -NH- is the amino group of Χ<sub class="style-scope patent-text">Ί</sub>, and CO is the carbonyl group of X<sub class="style-scope patent-text">2</sub>.</div>
    <div class="description-paragraph style-scope patent-text">Preferably, the group -Xi-X<sub class="style-scope patent-text">2</sub>- in dipeptide, -NH-X<sub class="style-scope patent-text">1</sub>-X<sub class="style-scope patent-text">2</sub>-CO-, is selected from:</div>
    <div class="description-paragraph style-scope patent-text">-Phe-Lys-,</div>
    <div class="description-paragraph style-scope patent-text">-Val-Ala-,</div>
    <div class="description-paragraph style-scope patent-text">-Val-Lys-,</div>
    <div class="description-paragraph style-scope patent-text">-Ala-Lys-, and -Val-Cit-.</div>
    <div class="description-paragraph style-scope patent-text">Most preferably, the group -X<sub class="style-scope patent-text">r</sub>X<sub class="style-scope patent-text">2</sub>- in dipeptide, -ΝΗ-X^X^CO-, is -Phe-Lys- or-Val-Ala-.</div>
    <div class="description-paragraph style-scope patent-text">Other dipeptide combinations of interest include:</div>
    <div class="description-paragraph style-scope patent-text">-Gly-Gly-,</div>
    <div class="description-paragraph style-scope patent-text">-Pro-Pro-, and -Val-Glu-.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Other dipeptide combinations may be used, including those described above.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, L<sup class="style-scope patent-text">1</sup>-D is:</div>
    <div class="description-paragraph style-scope patent-text">/ -NH-XrXz-CO-N where -NH-X1-X2-CO is the dipeptide, -N&lt; is part of the Drug unit, the asterisk indicates the points of attachment to the remainder of the Drug unit, and the wavy line indicates the point of attachment to the remaining portion of L<sup class="style-scope patent-text">1</sup> or the point of attachment to</div>
    <div class="description-paragraph style-scope patent-text">A<sup class="style-scope patent-text">1</sup>. Preferably, the wavy line indicates the point of attachment to A<sup class="style-scope patent-text">1</sup>.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the dipeptide is valine-alanine and L<sup class="style-scope patent-text">1</sup>-D is:</div>
    <div class="description-paragraph style-scope patent-text">where the asterisks, -N&lt; and the wavy line are as defined above.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the dipeptide is phenylalnine-lysine and L<sup class="style-scope patent-text">1</sup>-D is:</div>
    <div class="description-paragraph style-scope patent-text">NH where the asterisks, -N&lt; and the wavy line are as defined above.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the dipeptide is valine-citruNine.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the groups A<sup class="style-scope patent-text">1</sup>-L<sup class="style-scope patent-text">1</sup> are:</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bf/58/77/cf336ae93e1630/AU2013366490B9_D0076.png" class="style-scope patent-text"><img file="AU2013366490B9_D0076.tif" img-format="tif" alt="Figure AU2013366490B9_D0076" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bf/58/77/cf336ae93e1630/AU2013366490B9_D0076.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">2</sup> or D, the wavy line indicates the point of attachment to the Ligand unit, and n is 0 to 6. In one embodiment, n is 5.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the groups A<sup class="style-scope patent-text">1</sup>-L<sup class="style-scope patent-text">1</sup> are:</div>
    <div class="description-paragraph style-scope patent-text">O</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/8c/18/f7/a453877c4676c2/AU2013366490B9_D0077.png" class="style-scope patent-text"><img file="AU2013366490B9_D0077.tif" img-format="tif" alt="Figure AU2013366490B9_D0077" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/8c/18/f7/a453877c4676c2/AU2013366490B9_D0077.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">2</sup> or D, the wavy line indicates the point of attachment to the Ligand unit, and n is 0 to 6. In one embodiment, n is 5.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the groups A<sup class="style-scope patent-text">1</sup>-L<sup class="style-scope patent-text">1</sup> are:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/b6/2f/47/fd0f50c3a6bdf4/AU2013366490B9_D0078.png" class="style-scope patent-text"><img file="AU2013366490B9_D0078.tif" img-format="tif" alt="Figure AU2013366490B9_D0078" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/b6/2f/47/fd0f50c3a6bdf4/AU2013366490B9_D0078.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">2</sup> or D, the wavy line indicates the point of attachment to the Ligand unit, n is 0 or 1, and m is 0 to 30. In a preferred embodiment, n is 1 and m is 0 to 10, 1 to 8, preferably 4 to 8, most preferably 4 or 8.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the groups A<sup class="style-scope patent-text">1</sup>-L<sup class="style-scope patent-text">1</sup> are:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/b4/bb/2c/8c50f3a5806d04/AU2013366490B9_D0079.png" class="style-scope patent-text"><img file="AU2013366490B9_D0079.tif" img-format="tif" alt="Figure AU2013366490B9_D0079" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/b4/bb/2c/8c50f3a5806d04/AU2013366490B9_D0079.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">2</sup> or D, the wavy line indicates the point of attachment to the Ligand unit, n is 0 or 1, and m is 0 to 30. In a preferred embodiment, n is 1 and m is 0 to 10, 1 to 7, preferably 3 to 7, most preferably 3 or 7.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/51/40/ad/b176e28ae0a5d5/AU2013366490B9_D0080.png" class="style-scope patent-text"><img file="AU2013366490B9_D0080.tif" img-format="tif" alt="Figure AU2013366490B9_D0080" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/51/40/ad/b176e28ae0a5d5/AU2013366490B9_D0080.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">2</sup> or D, the wavy line indicates the point of attachment to the Ligand unit, and n is 0 to 6. In one embodiment, n is 5.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the groups A<sup class="style-scope patent-text">1</sup>-L<sup class="style-scope patent-text">1</sup> are:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/09/c8/d3/4e067751aeea1d/AU2013366490B9_D0081.png" class="style-scope patent-text"><img file="AU2013366490B9_D0081.tif" img-format="tif" alt="Figure AU2013366490B9_D0081" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/09/c8/d3/4e067751aeea1d/AU2013366490B9_D0081.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">2</sup> or D, the wavy line indicates the point of attachment to the Ligand unit, and n is 0 to 6. In one embodiment, n is 5.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the groups A<sup class="style-scope patent-text">1</sup>-L<sup class="style-scope patent-text">1</sup> are:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f1/c5/b0/bb1bc0e77fcc9c/AU2013366490B9_D0082.png" class="style-scope patent-text"><img file="AU2013366490B9_D0082.tif" img-format="tif" alt="Figure AU2013366490B9_D0082" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f1/c5/b0/bb1bc0e77fcc9c/AU2013366490B9_D0082.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">2</sup> or D, the wavy line indicates the point of attachment to the Ligand unit, n is 0 or 1, and m is 0 to 30. In a preferred embodiment, n is 1 and m is 0 to 10, 1 to 8, preferably 4 to 8, most preferably 4 or 8.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the groups A<sup class="style-scope patent-text">1</sup>-L<sup class="style-scope patent-text">1</sup> is:</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f6/01/89/fc988df42de79c/AU2013366490B9_D0083.png" class="style-scope patent-text"><img file="AU2013366490B9_D0083.tif" img-format="tif" alt="Figure AU2013366490B9_D0083" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f6/01/89/fc988df42de79c/AU2013366490B9_D0083.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">2</sup> orD, the wavy line indicates the point of attachment to the Ligand unit, n is 0 or 1, and m is 0 to 30. In a preferred embodiment, n is 1 and m is 0 to 10, 1 to 8, preferably 4 to 8, most preferably 4 or 8.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the groups L- A<sup class="style-scope patent-text">1</sup>-L<sup class="style-scope patent-text">1</sup> are:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/30/7d/21/fcf3714e322768/AU2013366490B9_D0084.png" class="style-scope patent-text"><img file="AU2013366490B9_D0084.tif" img-format="tif" alt="Figure AU2013366490B9_D0084" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/30/7d/21/fcf3714e322768/AU2013366490B9_D0084.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">2</sup> or D, S is a sulfur group of the Ligand unit, the wavy line indicates the point of attachment to the rest of the Ligand unit, and n is 0 to 6. In one embodiment, n is 5.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the group L-A<sup class="style-scope patent-text">1</sup>-L<sup class="style-scope patent-text">1</sup> are:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/71/ec/2b/e745d71a26458c/AU2013366490B9_D0085.png" class="style-scope patent-text"><img file="AU2013366490B9_D0085.tif" img-format="tif" alt="Figure AU2013366490B9_D0085" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/71/ec/2b/e745d71a26458c/AU2013366490B9_D0085.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">2</sup> or D, S is a sulfur group of the Ligand unit, the wavy line indicates the point of attachment to the remainder of the Ligand unit, and n is 0 to 6. In one embodiment, n is 5.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the groups L-A<sup class="style-scope patent-text">1</sup>-L<sup class="style-scope patent-text">1</sup> are:</div>
    <div class="description-paragraph style-scope patent-text">O</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a7/59/a2/9fef5c5af69246/AU2013366490B9_D0086.png" class="style-scope patent-text"><img file="AU2013366490B9_D0086.tif" img-format="tif" alt="Figure AU2013366490B9_D0086" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a7/59/a2/9fef5c5af69246/AU2013366490B9_D0086.png"></a></div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695 where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">2</sup> or D, S is a sulfur group of the Ligand unit, the wavy line indicates the point of attachment to the remainder of the Ligand unit, n is 0 or 1, and m is 0 to 30. In a preferred embodiment, n is 1 and m is 0 to 10, 1 to 8, preferably 4 to 8, most preferably 4 or 8.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the groups L-A<sup class="style-scope patent-text">1</sup>-L<sup class="style-scope patent-text">1</sup> are:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/78/63/f5/df93475b778c56/AU2013366490B9_D0087.png" class="style-scope patent-text"><img file="AU2013366490B9_D0087.tif" img-format="tif" alt="Figure AU2013366490B9_D0087" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/78/63/f5/df93475b778c56/AU2013366490B9_D0087.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">2</sup> or D, the wavy line indicates the point of attachment to the Ligand unit, n is 0 or 1, and m is 0 to 30. In a preferred embodiment, n is 1 and m is 0 to 10, 1 to 7, preferably 4 to 8, most preferably 4 or 8.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the groups L-A<sup class="style-scope patent-text">1</sup>-L<sup class="style-scope patent-text">1</sup> are:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e7/5f/bb/1d8693580d4b7f/AU2013366490B9_D0088.png" class="style-scope patent-text"><img file="AU2013366490B9_D0088.tif" img-format="tif" alt="Figure AU2013366490B9_D0088" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e7/5f/bb/1d8693580d4b7f/AU2013366490B9_D0088.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">2</sup> or D, the wavy line indicates the point of attachment to the remainder of the Ligand unit, and n is 0 to 6. In one embodiment, n is 5.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the groups L-A<sup class="style-scope patent-text">1</sup>-L<sup class="style-scope patent-text">1</sup> are:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/30/1c/a0/5c934bcb97dbe0/AU2013366490B9_D0089.png" class="style-scope patent-text"><img file="AU2013366490B9_D0089.tif" img-format="tif" alt="Figure AU2013366490B9_D0089" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/30/1c/a0/5c934bcb97dbe0/AU2013366490B9_D0089.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">2</sup> or D, the wavy line indicates the point of attachment to the remainder of the Ligand unit, and n is 0 to 6. In one embodiment, n is 5.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the groups L-A<sup class="style-scope patent-text">1</sup>-L<sup class="style-scope patent-text">1</sup> are:</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/8e/89/6f/6c1eb0499713ce/AU2013366490B9_D0090.png" class="style-scope patent-text"><img file="AU2013366490B9_D0090.tif" img-format="tif" alt="Figure AU2013366490B9_D0090" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/8e/89/6f/6c1eb0499713ce/AU2013366490B9_D0090.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">2</sup> or D, the wavy line indicates the point of attachment to the remainder of the Ligand unit, n is 0 or 1, and m is 0 to 30. In a preferred embodiment, n is 1 and m is 0 to 10, 1 to 8, preferably 4 to 8, most preferably 4 or 8.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the groups L-A<sup class="style-scope patent-text">1</sup>-L<sup class="style-scope patent-text">1</sup> are:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f9/30/65/215e0eda3b0071/AU2013366490B9_D0091.png" class="style-scope patent-text"><img file="AU2013366490B9_D0091.tif" img-format="tif" alt="Figure AU2013366490B9_D0091" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f9/30/65/215e0eda3b0071/AU2013366490B9_D0091.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">2</sup> or D, the wavy line indicates the point of attachment to the remainder of the Ligand unit, n is 0 or 1, and m is 0 to 30. In a preferred embodiment, n is 1 and m is 0 to 10, 1 to 8, preferably 4 to 8, most preferably 4 or 8.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the Stretcher unit is an acetamide unit, having the formula:</div>
    <div class="description-paragraph style-scope patent-text">/-CH2-CO-N-* where the asterisk indicates the point of attachment to the remainder of the</div>
    <div class="description-paragraph style-scope patent-text">Stretcher unit, L<sup class="style-scope patent-text">1</sup> or D, and the wavy line indicates the point of attachment to the Ligand unit.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Linker-Drugs</div>
    <div class="description-paragraph style-scope patent-text">In other embodiments, Linker-Drug compounds are provided for conjugation to a Ligand unit. In one embodiment, the Linker-Drug compounds are designed for connection to a Cell Binding Agent.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the Drug Linker compound has the formula:</div>
    <div class="description-paragraph style-scope patent-text"> <sub class="style-scope patent-text">G</sub> <sup class="style-scope patent-text">1/L</sup>Y°Y * o where the asterisk indicates the point of attachment to the Drug unit (D, as defined above), G<sup class="style-scope patent-text">1</sup> is a Stretcher group (A<sup class="style-scope patent-text">1</sup>) to form a connection to a Ligand unit, L<sup class="style-scope patent-text">1</sup> is a Specificity unit, L<sup class="style-scope patent-text">2</sup> (a Spacer unit) is a covalent bond or together with -OC(=O)- forms a selfimmolative group(s).</div>
    <div class="description-paragraph style-scope patent-text">In another embodiment, the Drug Linker compound has the formula:</div>
    <div class="description-paragraph style-scope patent-text">G<sup class="style-scope patent-text">1</sup>-L<sup class="style-scope patent-text">1</sup>-L<sup class="style-scope patent-text">2</sup>where the asterisk indicates the point of attachment to the Drug unit (D), G<sup class="style-scope patent-text">1</sup> is a Stretcher unit (A<sup class="style-scope patent-text">1</sup>) to form a connection to a Ligand unit, L<sup class="style-scope patent-text">1</sup> is a Specificity unit, L<sup class="style-scope patent-text">2</sup> (a Spacer unit) is a covalent bond or a self-immolative group(s).</div>
    <div class="description-paragraph style-scope patent-text">L<sup class="style-scope patent-text">1</sup> and L<sup class="style-scope patent-text">2</sup> are as defined above. References to connection to A<sup class="style-scope patent-text">1</sup> can be construed here as referring to a connection to G<sup class="style-scope patent-text">1</sup>.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, where L<sup class="style-scope patent-text">1</sup> comprises an amino acid, the side chain of that amino acid may be protected. Any suitable protecting group may be used. In one embodiment, the side chain protecting groups are removable with other protecting groups in the compound, where present. In other embodiments, the protecting groups may be orthogonal to other protecting groups in the molecule, where present.</div>
    <div class="description-paragraph style-scope patent-text">Suitable protecting groups for amino acid side chains include those groups described in the Novabiochem Catalog 2006/2007. Protecting groups for use in a cathepsin labile linker are also discussed in Dubowchik et al.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">In certain embodiments of the invention, the group L<sup class="style-scope patent-text">1</sup> includes a Lys amino acid residue. The side chain of this amino acid may be protected with a Boc or Alloc protected group. A Boc protecting group is most preferred.</div>
    <div class="description-paragraph style-scope patent-text">The functional group G<sup class="style-scope patent-text">1</sup> forms a connecting group upon reaction with a Ligand unit (e.g., a cell binding agent.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the functional group G<sup class="style-scope patent-text">1</sup> is or comprises an amino, carboxylic acid, hydroxy, thiol, or maleimide group for reaction with an appropriate group on the Ligand unit. In a preferred embodiment, G<sup class="style-scope patent-text">1</sup> comprises a maleimide group.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the group G<sup class="style-scope patent-text">1</sup> is an alkyl maleimide group. This group is suitable for reaction with thiol groups, particularly cysteine thiol groups, present in the cell binding agent, for example present in an antibody.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the group G<sup class="style-scope patent-text">1</sup> is:</div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, L<sup class="style-scope patent-text">2</sup>or D, and n is 0 to 6. In one embodiment, n is 5.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the group G<sup class="style-scope patent-text">1</sup> is:</div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, L<sup class="style-scope patent-text">2</sup>or D, and n is 0 to 6. In one embodiment, n is 5.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the group G<sup class="style-scope patent-text">1</sup> is:</div>
    <div class="description-paragraph style-scope patent-text">O</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695 where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, n is 0 or 1, and m is 0 to 30. In a preferred embodiment, n is 1 and m is 0 to 10, 1 to 2, preferably 4 to 8, and most preferably 4 or 8.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the group G<sup class="style-scope patent-text">1</sup> is:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/37/16/92/a7c57219ce82fe/AU2013366490B9_D0092.png" class="style-scope patent-text"><img file="AU2013366490B9_D0092.tif" img-format="tif" alt="Figure AU2013366490B9_D0092" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/37/16/92/a7c57219ce82fe/AU2013366490B9_D0092.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, n is 0 or 1, and m is 0 to 30. In a preferred embodiment, n is 1 and m is 0 to 10, 1 to 8, preferably 4 to 8, and most preferably 4 or 8.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the group G<sup class="style-scope patent-text">1</sup> is:</div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, L<sup class="style-scope patent-text">2</sup> or D, and n is 0 to 6. In one embodiment, n is 5.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the group G<sup class="style-scope patent-text">1</sup> is:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/54/94/4c/61459b499ca3fa/AU2013366490B9_D0093.png" class="style-scope patent-text"><img file="AU2013366490B9_D0093.tif" img-format="tif" alt="Figure AU2013366490B9_D0093" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/54/94/4c/61459b499ca3fa/AU2013366490B9_D0093.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, L<sup class="style-scope patent-text">2</sup> or D, and n is 0 to 6. In one embodiment, n is 5.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the group G is io-</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f7/78/22/2edce225ce400f/AU2013366490B9_D0094.png" class="style-scope patent-text"><img file="AU2013366490B9_D0094.tif" img-format="tif" alt="Figure AU2013366490B9_D0094" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f7/78/22/2edce225ce400f/AU2013366490B9_D0094.png"></a></div>
    <div class="description-paragraph style-scope patent-text">O</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695 where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, n is 0 or 1, and m is 0 to 30. In a preferred embodiment, n is 1 and m is 0 to 10, 1 to 2, preferably 4 to 8, and most preferably 4 or 8.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the group G<sup class="style-scope patent-text">1</sup> is:</div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, n is 0 or 1, and m is 0 to 30. In a preferred embodiment, n is 1 and m is 0 to 10, 1 to 8, preferably 4 to 8, and most preferably 4 or 8.</div>
    <div class="description-paragraph style-scope patent-text">In each of the embodiments above, an alternative functionality may be used in place of the malemide group shown below:</div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the bond to the remaining portion of the G group.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the maleimide-derived group is replaced with the group:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/8b/d5/51/1d1a2b1b7e6bdf/AU2013366490B9_D0095.png" class="style-scope patent-text"><img file="AU2013366490B9_D0095.tif" img-format="tif" alt="Figure AU2013366490B9_D0095" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/8b/d5/51/1d1a2b1b7e6bdf/AU2013366490B9_D0095.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the asterisk indicates the bond to the remaining portion of the G group.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the maleimide group is replaced with a group selected from: -C(=O)OH,</div>
    <div class="description-paragraph style-scope patent-text">-OH,</div>
    <div class="description-paragraph style-scope patent-text">-SH,</div>
    <div class="description-paragraph style-scope patent-text">-C(=O)CH<sub class="style-scope patent-text">2</sub>X, where X is Cl, Br or I, -CHO,</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">-NHNH<sub class="style-scope patent-text">2 </sub>-ΟξΟΗ, and -N<sub class="style-scope patent-text">3</sub> (azide).</div>
    <div class="description-paragraph style-scope patent-text">Of these, -C(=O)CH<sub class="style-scope patent-text">2</sub>X may be preferred, especially when the carbonyl group is bound to NH-.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, L<sup class="style-scope patent-text">1</sup> is present, and G<sup class="style-scope patent-text">1</sup> is -NH<sub class="style-scope patent-text">2</sub>, -NHMe, -COOH, -OH or -SH.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, where L<sup class="style-scope patent-text">1</sup> is present, G<sup class="style-scope patent-text">1</sup> is -NH<sub class="style-scope patent-text">2</sub> or -NHMe. Either group may be the N-terminal of an L<sup class="style-scope patent-text">1</sup> amino acid sequence.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, L<sup class="style-scope patent-text">1</sup> is present and G<sup class="style-scope patent-text">1</sup> is -NH2, and L<sup class="style-scope patent-text">1</sup> is an amino acid sequence -XrX2, as defined above.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, L<sup class="style-scope patent-text">1</sup> is present and G<sup class="style-scope patent-text">1</sup> is COOH. This group may be the C-terminal of an L<sup class="style-scope patent-text">1</sup> amino acid sequence.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, L<sup class="style-scope patent-text">1</sup> is present and G<sup class="style-scope patent-text">1</sup> is OH.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, L<sup class="style-scope patent-text">1</sup> is present and G<sup class="style-scope patent-text">1</sup> is SH.</div>
    <div class="description-paragraph style-scope patent-text">The group G<sup class="style-scope patent-text">1</sup> may be convertable from one functional group to another. In one embodiment, L<sup class="style-scope patent-text">1</sup> is present and G<sup class="style-scope patent-text">1</sup> is -NH2. This group is convertable to another group G<sup class="style-scope patent-text">1 </sup>comprising a maleimide group. For example, the group -NH2 may be reacted with an acids or an activated acid (e.g., N-succinimide forms) of those G<sup class="style-scope patent-text">1</sup> groups comprising maleimide shown above.</div>
    <div class="description-paragraph style-scope patent-text">The group G<sup class="style-scope patent-text">1</sup> may therefore be converted to a functional group that is more appropriate for reaction with a Ligand unit.</div>
    <div class="description-paragraph style-scope patent-text">As noted above, in one embodiment, L<sup class="style-scope patent-text">1</sup> is present and G<sup class="style-scope patent-text">1</sup> is -NH<sub class="style-scope patent-text">2</sub>, -NHMe, -COOH, -OH or -SH. In a further embodiment, these groups are provided in a chemically protected form. The chemically protected form is therefore a precursor to the linker that is provided with a functional group.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, G<sup class="style-scope patent-text">1</sup> is -NH<sub class="style-scope patent-text">2</sub> in a chemically protected form. The group may be protected with a carbamate protecting group. The carbamate protecting group may be selected from the group consisting of:</div>
    <div class="description-paragraph style-scope patent-text">Alloc, Fmoc, Boc, Troc, Teoc, Cbz and PNZ.</div>
    <div class="description-paragraph style-scope patent-text">Preferably, where G<sup class="style-scope patent-text">1</sup> is -NH<sub class="style-scope patent-text">2</sub>, it is protected with an Alloc or Fmoc group.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, where G<sup class="style-scope patent-text">1</sup> is -NH<sub class="style-scope patent-text">2</sub>, it is protected with an Fmoc group.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the protecting group is the same as the carbamate protecting group of the capping group.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the protecting group is not the same as the carbamate protecting group of the capping group. In this embodiment, it is preferred that the protecting group is removable under conditions that do not remove the carbamate protecting group of the capping group.</div>
    <div class="description-paragraph style-scope patent-text">The chemical protecting group may be removed to provide a functional group to form a connection to a Ligand unit. Optionally, this functional group may then be converted to another functional group as described above.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the active group is an amine. This amine is preferably the N-terminal amine of a peptide, and may be the N-terminal amine of the preferred dipeptides of the invention.</div>
    <div class="description-paragraph style-scope patent-text">The active group may be reacted to yield the functional group that is intended to form a connection to a Ligand unit.</div>
    <div class="description-paragraph style-scope patent-text">In other embodiments, the Linker unit is a precursor to the Linker uit having an active group. In this embodiment, the Linker unit comprises the active group, which is protected by way of a protecting group. The protecting group may be removed to provide the Linker unit having an active group.</div>
    <div class="description-paragraph style-scope patent-text">Where the active group is an amine, the protecting group may be an amine protecting group, such as those described in Green and Wuts.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">The protecting group is preferably orthogonal to other protecting groups, where present, in the Linker unit.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the protecting group is orthogonal to the capping group. Thus, the 5 active group protecting group is removable whilst retaining the capping group. In other embodiments, the protecting group and the capping group is removable under the same conditions as those used to remove the capping group.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the Linker unit is:</div>
    <div class="description-paragraph style-scope patent-text">NHBoc where the asterisk indicates the point of attachment to the Drug unit, and the wavy line indicates the point of attachment to the remaining portion of the Linker unit, as applicable or the point of attachment to G<sup class="style-scope patent-text">1</sup>. Preferably, the wavy line indicates the point of attachment to G<sup class="style-scope patent-text">1</sup>.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the Linker unit is:</div>
    <div class="description-paragraph style-scope patent-text">where the asterisk and the wavy line are as defined above.</div>
    <div class="description-paragraph style-scope patent-text">Other functional groups suitable for use in forming a connection between L<sup class="style-scope patent-text">1</sup> and the Cell Binding Agent are described in WO 2005/082023.</div>
    <div class="description-paragraph style-scope patent-text">Ligand Unit</div>
    <div class="description-paragraph style-scope patent-text">The Ligand Unit may be of any kind, and include a protein, polypeptide, peptide and a non peptidic agent that specifically binds to a target molecule. In some embodiments, the</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Ligand unit may be a protein, polypeptide or peptide. In some embodiments, the Ligand unit may be a cyclic polypeptide. These Ligand units can include antibodies or a fragment of an antibody that contains at least one target molecule-binding site, lymphokines, hormones, growth factors, or any other cell binding molecule or substance that can specifically bind to a target. The ligand Unit is also referred to herein as a “binding agent” or “targeting agent”.</div>
    <div class="description-paragraph style-scope patent-text">The terms “specifically binds” and “specific binding” refer to the binding of an antibody or other protein, polypeptide or peptide to a predetermined molecule (e.g., an antigen). Typically, the antibody or other molecule binds with an affinity of at least about 1x10<sup class="style-scope patent-text">7</sup> M'<sup class="style-scope patent-text">1</sup>, and binds to the predetermined molecule with an affinity that is at least two-fold greater than its affinity for binding to a non-specific molecule (e.g., BSA, casein) other than the predetermined molecule or a closely-related molecule.</div>
    <div class="description-paragraph style-scope patent-text">Examples of Ligand units include those agents described for use in WO 2007/085930, which is incorporated herein.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, the Ligand unit is a Cell Binding Agent that binds to an extracellular target on a cell. Such a Cell Binding Agent can be a protein, polypeptide, peptide or a nonpeptidic agent. In some embodiments, the Cell Binding Agent may be a protein, polypeptide or peptide. In some embodiments, the Cell Binding Agent may be a cyclic polypeptide. The Cell Binding Agent also may be antibody or an antigen-binding fragment of an antibody. Thus, in one embodiment, the present invention provides an antibody-drug conjugate (ADC).</div>
    <div class="description-paragraph style-scope patent-text">Peptides</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the cell binding agent is a linear or cyclic peptide comprising 4-30, preferably 6-20, contiguous amino acid residues. In this embodiment, it is preferred that one cell binding agent is linked to one monomer or dimer pyrrolobenzodiazepine compound.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment the cell binding agent comprises a peptide that binds integrin α<sub class="style-scope patent-text">ν</sub>β<sub class="style-scope patent-text">6</sub>. The peptide may be selective for α<sub class="style-scope patent-text">ν</sub>β<sub class="style-scope patent-text">6</sub> over XYS.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment the cell binding agent comprises the A20FMDV-Cys polypeptide. The A20FMDV-Cys has the sequence: NAVPNLRGDLQVLAQKVARTC. Alternatively, a variant of the A20FMDV-Cys sequence may be used wherein one, two, three, four, five, six, seven, eight, nine or ten amino acid residues are substituted with another amino acid residue. Furthermore, the polypeptide may have the sequence</div>
    <div class="description-paragraph style-scope patent-text">NAVXXXXXXXXXXXXXXXRTC.</div>
    <div class="description-paragraph style-scope patent-text">Antibodies</div>
    <div class="description-paragraph style-scope patent-text">The term “antibody” herein is used in the broadest sense and specifically covers monoclonal antibodies, polyclonal antibodies, dimers, multimers, multispecific antibodies {e.g., bispecific antibodies), and antibody fragments, so long as they exhibit the desired biological activity (Miller et al (2003) Jour, of Immunology 170:4854-4861). Antibodies may be murine, human, humanized, chimeric, or derived from other species. An antibody is a protein generated by the immune system that is capable of recognizing and binding to a specific antigen. (Janeway, C., Travers, P., Walport, M., Shlomchik (2001) Immuno Biology, 5th Ed., Garland Publishing, New York). A target antigen generally has numerous binding sites, also called epitopes, recognized by CDRs on multiple antibodies. Each antibody that specifically binds to a different epitope has a different structure. Thus, one antigen may have more than one corresponding antibody. An antibody includes a fulllength immunoglobulin molecule or an immunologically active portion of a full-length immunoglobulin molecule, i.e., a molecule that contains an antigen binding site that immunospecifically binds an antigen of a target of interest or part thereof, such targets including but not limited to, cancer cell or cells that produce autoimmune antibodies associated with an autoimmune disease. The immunoglobulin can be of any type (e.g. IgG, IgE, IgM, IgD, and IgA), class (e.g. IgG 1, lgG2, IgG3, lgG4, IgA1 and lgA2) or subclass of immunoglobulin molecule. The immunoglobulins can be derived from any species, including human, murine, or rabbit origin.</div>
    <div class="description-paragraph style-scope patent-text">Antibody fragments comprise a portion of a full length antibody, generally the antigen binding or variable region thereof. Examples of antibody fragments include Fab, Fab', F(ab')<sub class="style-scope patent-text">2</sub>, and scFv fragments; diabodies; linear antibodies; fragments produced by a Fab expression library, anti-idiotypic (anti-id) antibodies, CDR (complementary determining region), and epitope-binding fragments of any of the above which immunospecifically bind to cancer cell antigens, viral antigens or microbial antigens, single-chain antibody molecules; and multispecific antibodies formed from antibody fragments.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">The term “monoclonal antibody” as used herein refers to an antibody obtained from a population of substantially homogeneous antibodies, i.e. the individual antibodies comprising the population are identical except for possible naturally occurring mutations that may be present in minor amounts. Monoclonal antibodies are highly specific, being directed against a single antigenic site. Furthermore, in contrast to polyclonal antibody preparations which include different antibodies directed against different determinants (epitopes), each monoclonal antibody is directed against a single determinant on the antigen. In addition to their specificity, the monoclonal antibodies are advantageous in that they may be synthesized uncontaminated by other antibodies. The modifier “monoclonal” indicates the character of the antibody as being obtained from a substantially homogeneous population of antibodies, and is not to be construed as requiring production of the antibody by any particular method. For example, the monoclonal antibodies to be used in accordance with the present invention may be made by the hybridoma method first described by Kohler etal (1975) Nature 256:495, or may be made by recombinant DNA methods (see, US 4816567). The monoclonal antibodies may also be isolated from phage antibody libraries using the techniques described in Clackson et al (1991) Nature, 352:624628; Marks et al (1991) J. Mol. Biol., 222:581-597 or from transgenic mice carrying a fully human immunoglobulin system (Lonberg (2008) Curr. Opinion 20(4):450-459).</div>
    <div class="description-paragraph style-scope patent-text">The monoclonal antibodies herein specifically include “chimeric” antibodies in which a portion of the heavy and/or light chain is identical with or homologous to corresponding sequences in antibodies derived from a particular species or belonging to a particular antibody class or subclass, while the remainder of the chain(s) is identical with or homologous to corresponding sequences in antibodies derived from another species or belonging to another antibody class or subclass, as well as fragments of such antibodies, so long as they exhibit the desired biological activity (US 4816567; and Morrison et al (1984) Proc. Natl. Acad. Sci. USA, 81:6851-6855). Chimeric antibodies include “primatized” antibodies comprising variable domain antigen-binding sequences derived from a non-human primate (e.g. Old World Monkey or Ape) and human constant region sequences.</div>
    <div class="description-paragraph style-scope patent-text">An “intact antibody” herein is one comprising a VL and VH domains, as well as a light chain constant domain (CL) and heavy chain constant domains, CH1, CH2 and CH3. The constant domains may be native sequence constant domains (e.g. human native sequence</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695 constant domains) or amino acid sequence variant thereof. The intact antibody may have one or more “effector functions” which refer to those biological activities attributable to the Fc region (a native sequence Fc region or amino acid sequence variant Fc region) of an antibody. Examples of antibody effector functions include C1 q binding; complement dependent cytotoxicity; Fc receptor binding; antibody-dependent cell-mediated cytotoxicity (ADCC); phagocytosis; and down regulation of cell surface receptors such as B cell receptor and BCR.</div>
    <div class="description-paragraph style-scope patent-text">Depending on the amino acid sequence of the constant domain of their heavy chains, intact antibodies can be assigned to different “classes.” There are five major classes of intact antibodies: IgA, IgD, IgE, IgG, and IgM, and several of these may be further divided into “subclasses” (isotypes), e.g., lgG1, lgG2, lgG3, lgG4, IgA, and lgA2. The heavy-chain constant domains that correspond to the different classes of antibodies are called α, δ, ε, γ, and μ, respectively. The subunit structures and three-dimensional configurations of different classes of immunoglobulins are well known.</div>
    <div class="description-paragraph style-scope patent-text">Humanisation</div>
    <div class="description-paragraph style-scope patent-text">Techniques to reduce the in vivo immunogenicity of a non-human antibody or antibody fragment include those termed “humanisation”.</div>
    <div class="description-paragraph style-scope patent-text">A humanized antibody refers to a polypeptide comprising at least a portion of a modified variable region of a human antibody wherein a portion of the variable region, preferably a portion substantially less than the intact human variable domain, has been substituted by the corresponding sequence from a non-human species and wherein the modified variable region is linked to at least another part of another protein, preferably the constant region of a human antibody. The expression humanized antibodies includes human antibodies in which one or more complementarity determining region (CDR) amino acid residues and/or one or more framework region (FW or FR) amino acid residues are substituted by amino acid residues from analogous sites in rodent or other non-human antibodies. The expression humanized antibody also includes an immunoglobulin amino acid sequence variant or fragment thereof that comprises an FR having substantially the amino acid sequence of a human immunoglobulin and a CDR having substantially the amino acid sequence of a non-human immunoglobulin.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Humanized forms of non-human (e.g., murine) antibodies are chimeric antibodies that contain minimal sequence derived from non-human immunoglobulin. Or, looked at another way, a humanized antibody is a human antibody that also contains selected sequences from non-human (e.g. murine) antibodies in place of the human sequences. A humanized antibody can include conservative amino acid substitutions or non-natural residues from the same or different species that do not significantly alter its binding and/or biologic activity. Such antibodies are chimeric antibodies that contain minimal sequence derived from non-human immunoglobulins.</div>
    <div class="description-paragraph style-scope patent-text">There are a range of humanisation techniques, including ‘CDR grafting’, ‘guided selection’, ‘deimmunization’, ‘resurfacing’ (also known as ‘veneering’), ‘composite antibodies’, ‘Human String Content Optimisation’ and framework shuffling.</div>
    <div class="description-paragraph style-scope patent-text">CDR grafting</div>
    <div class="description-paragraph style-scope patent-text">In this technique, the humanized antibodies are human immunoglobulins (recipient antibody) in which residues from a complementary-determining region (CDR) of the recipient antibody are replaced by residues from a CDR of a non-human species (donor antibody) such as mouse, rat, camel, bovine, goat, or rabbit having the desired properties (in effect, the non-human CDRs are ‘grafted’ onto the human framework). In some instances, framework region (FR) residues of the human immunoglobulin are replaced by corresponding non-human residues (this may happen when, for example, a particular FR residue has significant effect on antigen binding).</div>
    <div class="description-paragraph style-scope patent-text">Furthermore, humanized antibodies can comprise residues that are found neither in the recipient antibody nor in the imported CDR or framework sequences. These modifications are made to further refine and maximize antibody performance. Thus, in general, a humanized antibody will comprise all of at least one, and in one aspect two, variable domains, in which all or all of the hypervariable loops correspond to those of a non-human immunoglobulin and all or substantially all of the FR regions are those of a human immunoglobulin sequence. The humanized antibody optionally also will comprise at least a portion of an immunoglobulin constant region (Fc), or that of a human immunoglobulin.</div>
    <div class="description-paragraph style-scope patent-text">Guided selection</div>
    <div class="description-paragraph style-scope patent-text">The method consists of combining the V<sub class="style-scope patent-text">H</sub> or V<sub class="style-scope patent-text">L</sub> domain of a given non-human antibody specific for a particular epitope with a human V<sub class="style-scope patent-text">H</sub> or V<sub class="style-scope patent-text">L</sub> library and specific human V</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695 domains are selected against the antigen of interest. This selected human VH is then combined with a VL library to generate a completely human VHxVL combination. The method is described in Nature Biotechnology (N.Y.) 12, (1994) 899-903.</div>
    <div class="description-paragraph style-scope patent-text">Composite antibodies</div>
    <div class="description-paragraph style-scope patent-text">In this method, two or more segments of amino acid sequence from a human antibody are combined within the final antibody molecule. They are constructed by combining multiple human VH and VL sequence segments in combinations which limit or avoid human T cell epitopes in the final composite antibody V regions. Where required, T cell epitopes are limited or avoided by, exchanging V region segments contributing to or encoding a T cell epitope with alternative segments which avoid T cell epitopes. This method is described in US 2008/0206239 A1.</div>
    <div class="description-paragraph style-scope patent-text">Deimmunization</div>
    <div class="description-paragraph style-scope patent-text">This method involves the removal of human (or other second species) T-cell epitopes from the V regions of the therapeutic antibody (or other molecule). The therapeutic antibodies V-region sequence is analysed for the presence of MHC class II- binding motifs by, for example, comparison with databases of MHC-binding motifs (such as the motifs database hosted at www.wehi.edu.au). Alternatively, MHC class II- binding motifs may be identified using computational threading methods such as those devised by Altuvia et al. (J. Mol. Biol. 249 244-250 (1995)); in these methods, consecutive overlapping peptides from the V-region sequences are testing for their binding energies to MHC class II proteins. This data can then be combined with information on other sequence features which relate to successfully presented peptides, such as amphipathicity, Rothbard motifs, and cleavage sites for cathepsin B and other processing enzymes.</div>
    <div class="description-paragraph style-scope patent-text">Once potential second species (e.g. human) T-cell epitopes have been identified, they are eliminated by the alteration of one or more amino acids. The modified amino acids are usually within the T-cell epitope itself, but may also be adjacent to the epitope in terms of the primary or secondary structure of the protein (and therefore, may not be adjacent in the primary structure). Most typically, the alteration is by way of substitution but, in some circumstances amino acid addition or deletion will be more appropriate.</div>
    <div class="description-paragraph style-scope patent-text">All alterations can be accomplished by recombinant DNA technology, so that the final molecule may be prepared by expression from a recombinant host using well established</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695 methods such as Site Directed Mutagenesis. However, the use of protein chemistry or any other means of molecular alteration is also possible.</div>
    <div class="description-paragraph style-scope patent-text">Resurfacing</div>
    <div class="description-paragraph style-scope patent-text">This method involves:</div>
    <div class="description-paragraph style-scope patent-text">(a) determining the conformational structure of the variable region of the nonhuman (e.g. rodent) antibody (or fragment thereof) by constructing a three-dimensional model of the non-human antibody variable region;</div>
    <div class="description-paragraph style-scope patent-text">(b) generating sequence alignments using relative accessibility distributions from x-ray crystallographic structures of a sufficient number of non-human and human antibody variable region heavy and light chains to give a set of heavy and light chain framework positions wherein the alignment positions are identical in 98% of the sufficient number of non-human antibody heavy and light chains;</div>
    <div class="description-paragraph style-scope patent-text">(c) defining for the non-human antibody to be humanized, a set of heavy and light chain surface exposed amino acid residues using the set of framework positions generated in step (b);</div>
    <div class="description-paragraph style-scope patent-text">(d) identifying from human antibody amino acid sequences a set of heavy and light chain surface exposed amino acid residues that is most closely identical to the set of surface exposed amino acid residues defined in step (c), wherein the heavy and light chain from the human antibody are or are not naturally paired;</div>
    <div class="description-paragraph style-scope patent-text">(e) substituting, in the amino acid sequence of the non-human antibody to be humanized, the set of heavy and light chain surface exposed amino acid residues defined in step (c) with the set of heavy and light chain surface exposed amino acid residues identified in step (d);</div>
    <div class="description-paragraph style-scope patent-text">(f) constructing a three-dimensional model of the variable region of the non-human antibody resulting from the substituting specified in step (e);</div>
    <div class="description-paragraph style-scope patent-text">(g) identifying, by comparing the three-dimensional models constructed in steps (a) and (f), any amino acid residues from the sets identified in steps (c) or (d), that are within 5 Angstroms of any atom of any residue of the complementarity determining regions of the non-human antibodt to be humanized; and (h) changing any residues identified in step (g) from the human to the original nonhuman amino acid residue to thereby define a non-human antibody humanizing set of surface exposed amino acid residues; with the proviso that step (a) need not be conducted first, but must be conducted prior to step (g).</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Superhumanization</div>
    <div class="description-paragraph style-scope patent-text">The method compares the non-human sequence with the functional human germline gene repertoire. Those human genes encoding canonical structures identical or closely related to the non-human sequences are selected. Those selected human genes with highest homology within the CDRs are chosen as FR donors. Finally, the non-human CDRs are grafted onto these human FRs. This method is described in patent WO 2005/079479 A2.</div>
    <div class="description-paragraph style-scope patent-text">Human String Content Optimization</div>
    <div class="description-paragraph style-scope patent-text">This method compares the non-human (e.g. mouse) sequence with the repertoire of human germline genes and the differences are scored as Human String Content (HSC) that quantifies a sequence at the level of potential MHC/T-cell epitopes. The target sequence is then humanized by maximizing its HSC rather than using a global identity measure to generate multiple diverse humanized variants (described in Molecular Immunology, 44, (2007) 1986-1998).</div>
    <div class="description-paragraph style-scope patent-text">Framework Shuffling</div>
    <div class="description-paragraph style-scope patent-text">The CDRs of the non-human antibody are fused in-frame to cDNA pools encompassing all known heavy and light chain human germline gene frameworks. Humanised antibodies are then selected by e.g. panning of the phage displayed antibody library. This is described in Methods 36, 43-60 (2005).</div>
    <div class="description-paragraph style-scope patent-text">Examples of cell binding agents include those agents described for use in</div>
    <div class="description-paragraph style-scope patent-text">WO 2007/085930, which is incorporated herein.</div>
    <div class="description-paragraph style-scope patent-text">Tumour-associate antigens and cognate antibodies for use in embodiments of the present invention are listed below.</div>
    <div class="description-paragraph style-scope patent-text">TUMOR-ASSOCIATED ANTIGENS AND COGNATE ANTIBODIES (1) BMPR1B (bone morphogenetic protein receptor-type IB)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM_001203</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_001203.2 GI:169790809</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 23, 2012 02:06 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_001194</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_001194.1 GL4502431</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 23, 2012 02:06 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references ten Dijke,P., et al Science 264 (5155): 101-104 (1994), Oncogene 14 10 (11):1377-1382 (1997)); W02004/063362 (Claim 2); W02003/042661 (Claim 12);</div>
    <div class="description-paragraph style-scope patent-text">US2003/134790-A1 (Page 38-39); W02002/102235 (Claim 13; Page 296); W02003/055443 (Page 91-92); WO2002/99122 (Example 2; Page 528-530); W02003/029421 (Claim 6); W02003/024392 (Claim 2; Fig 112); WO2002/98358 (Claim 1; Page 183); W02002/54940 (Page 100-101); WO2002/59377(Page 349-350); W02002/30268 (Claim 27; Page 376);</div>
    <div class="description-paragraph style-scope patent-text">W02001/48204 (Example; Fig 4); NP_001194 bone morphogenetic protein receptor, type IB /pid=NP_001194.1.; MIM:603248; AY065994 (2) E16 (LAT1, SLC7A5)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM_003486</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_003486.5 GL71979931</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 27, 2012 12:06 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_003477</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_003477.4 GL71979932</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 27, 2012 12:06 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Biochem. Biophys. Res.</div>
    <div class="description-paragraph style-scope patent-text">Commun. 255 (2), 283-288 (1999), Nature 395 (6699):288-291 (1998), Gaugitsch, H.W., et 20 al (1992) J. Biol. Chem. 267 (16):11267-11273); W02004/048938 (Example 2); W02004/032842 (Example IV); W02003/042661 (Claim 12); W02003/016475 (Claim 1); WO2002/78524 (Example 2); W02002/99074 (Claim 19; Page 127-129); WO2002/86443 (Claim 27; Pages 222, 393); W02003/003906 (Claim 10; Page 293); WO2002/64798 (Claim 33; Page 93-95); W02000/14228 (Claim 5; Page 133-136); US2003/224454 (Fig 3);</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">W02003/025138 (Claim 12; Page 150); NP_003477 solute carrier family 7 (cationic amino acid transporter, y+system), member 5 /pid=NP_003477.3 - Homo sapiens; MIM:600182;; NM_015923.</div>
    <div class="description-paragraph style-scope patent-text">(3) STEAP1 (six transmembrane epithelial antigen of prostate)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM_012449</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_012449.2 GI:22027487</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 9, 2012 02:57 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_036581</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_036581.1 Gl:9558759</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 9, 2012 02:57 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Cancer Res. 61 (15), 5857-5860 (2001), Hubert, R.S., et a I (1999) Proc. Natl.</div>
    <div class="description-paragraph style-scope patent-text">Acad. Sci. U.S.A. 96 (25): 14523-14528); W02004/065577 (Claim 6); W02004/027049 (Fig 1L); EP1394274 (Example 11); W02004/016225 (Claim 2); W02003/042661 (Claim 12); US2003/157089 (Example 5); US2003/185830 (Example 5); US2003/064397 (Fig 2); WO2002/89747 (Example 5; Page 618-619); W02003/022995 (Example 9; Fig 13A,</div>
    <div class="description-paragraph style-scope patent-text">Example 53; Page 173, Example 2; Fig 2A); six transmembrane epithelial antigen of the prostate; MIM:604415.</div>
    <div class="description-paragraph style-scope patent-text">(4) 0772P (CA125, MUC16)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AF361486</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AF361486.3 GI:34501466</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 11,2010 07:56 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAK74120</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAK74120.3 GI:34501467</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 11,2010 07:56 AM</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">J. Biol. Chem. 276 (29):27371-27375 (2001)); W02004/045553 (Claim 14);</div>
    <div class="description-paragraph style-scope patent-text">WO2002/92836 (Claim 6; Fig 12); WO2002/83866 (Claim 15; Page 116-121); US2003/124140 (Example 16); GL34501467;</div>
    <div class="description-paragraph style-scope patent-text">(5) MPF (MPF, MSLN, SMR, megakaryocyte potentiating factor, mesothelin)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM_005823</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_005823.5 Gl:293651528</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 2, 2012 01:47 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_005814</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_005814.2 Gl:53988378</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 2, 2012 01:47 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Yamaguchi, N., etal Biol. Chem. 269 (2), 805-808 (1994), Proc. Natl. Acad. Sci. U.S.A. 96 (20):11531-11536 (1999), Proc. Natl. Acad. Sci. U.S.A. 93 10 (1):136-140 (1996), J. Biol. Chem. 270 (37):21984-21990 (1995)); W02003/101283 (Claim 14); (W02002/102235 (Claim 13; Page 287-288); W02002/101075 (Claim 4; Page 308- 309); WO2002/71928 (Page 320-321); WO94/10312 (Page 52-57); IM:601051.</div>
    <div class="description-paragraph style-scope patent-text">(6) Napi3b (NAPI-3B, NPTIIb, SLC34A2, solute carrier family 34 (sodium phosphate), member 2, type II sodium-dependent phosphate transporter 3b)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM_006424</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_006424.2 Gl:110611905</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jul 22, 2012 03:39 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_006415</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_006415.2 Gl:110611906</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jul 22, 2012 03:39 PM</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">J. Biol. Chem. 277 (22):19665-19672 (2002), Genomics 62 (2):281-284 (1999), Feild, J.A., et a/(1999) Biochem. Biophys. Res. Commun. 258 (3):578-582); W02004/022778 (Claim 2); EP1394274 (Example 11); W02002/102235 (Claim 13; Page 20 326); EP0875569 (Claim 1; Page 17-19); W02001/57188 (Claim 20; Page 329); W02004/032842 (Example IV); W02001/75177 (Claim 24; Page 139-140); MIM:604217.</div>
    <div class="description-paragraph style-scope patent-text">(7) Serna 5b (FLJ10372, KIAA1445, Mm.42015, SEMA5B, SEMAG, Semaphorin 5b Hlog, 25 sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AB040878</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AB040878.1 Gl:7959148</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Aug 2, 2006 05:40 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. BAA95969</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. BAA95969.1 Gl:7959149</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Aug 2, 2006 05:40 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Nagase T„ et al (2000) DNA Res. 7 (2):143-150); W02004/000997 (Claim 1); W02003/003984 (Claim 1); W02002/06339 (Claim 1; Page 50); W02001/88133 (Claim 1; Page 41-43, 48-58); W02003/054152 (Claim 20); W02003/101400 (Claim 11); Accession: 30 O9P283; Genew; HGNC:10737 (8) PSCA hlg (2700050C12Rik, C530008016Rik, RIKEN cDNA 2700050C12, RIKEN cDNA</div>
    <div class="description-paragraph style-scope patent-text">2700050C12 gene)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AY358628</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AY358628.1 Gl:37182377</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Dec 1, 2009 04:15 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAQ88991</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAQ88991.1 Gl:37182378</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Dec 1, 2009 04:15 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Ross et a/(2002) Cancer Res. 62:2546-2553; US2003/129192 (Claim 2); US2004/044180 (Claim 12); US2004/044179 35 (Claim 11); US2003/096961 (Claim 11); US2003/232056 (Example 5); W02003/105758 16 (Claim 12); US2003/206918 (Example 5); EP1347046 (Claim 1); W02003/025148 (Claim 20); GL37182378.</div>
    <div class="description-paragraph style-scope patent-text">(9) ETBR (Endothelin type B receptor)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AY275463</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AY275463.1 GI:30526094</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 11,2010 02:26 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAP32295</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAP32295.1 GI:30526095</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 11,2010 02:26 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Nakamuta M., et al Biochem. Biophys. Res. Commun. 177, 34-39, 1991; Ogawa Y., etal Biochem. Biophys. Res. Commun. 178, 248-255, 1991; Arai H., et al Jpn. Circ. J. 56, 13031307, 1992; Arai H., et al J. Biol. Chem. 268, 3463-3470, 1993; Sakamoto A., Yanagisawa M., et al Biochem. Biophys. Res. Commun. 178, 656-663, 1991; Elshourbagy N.A., etal J. Biol. Chem. 268, 3873-3879, 1993; Haendler B., et al J. Cardiovasc. Pharmacol. 20, s1-S4, 1992; Tsutsumi M., et al Gene 228, 43-49, 1999; Strausberg R.L., et al Proc. Natl. Acad. Sci. U.S.A. 99, 16899-16903, 2002; Bourgeois C., et al J. Clin. Endocrinol. Metab. 82, 3116-3123, 1997;</div>
    <div class="description-paragraph style-scope patent-text">Okamoto Y., et al Biol. Chem. 272, 21589-21596, 1997; Verheij J.B., et al Am. J. Med. Genet. 108, 223-225, 2002; Hofstra R.M.W., etal Eur. J. Hum. Genet. 5, 180-185, 1997; Puffenberger E.G., etal Cell 79, 1257-1266, 1994; Attie T., et al, Hum. Mol. Genet. 4,</div>
    <div class="description-paragraph style-scope patent-text">2407WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">2409, 1995; Auricchio A., et al Hum. Mol. Genet. 5:351-354, 1996; Amiel J., et al Hum. Mol.</div>
    <div class="description-paragraph style-scope patent-text">Genet. 5, 355-357, 1996; Hofstra R.M.W., etal Nat. Genet. 12, 445-447, 1996; Svensson P.J., et al Hum. Genet. 103, 145-148, 1998; Fuchs S., et al Mol. Med. 7, 115-124, 2001; Pingault V., et al (2002) Hum. Genet. 111, 198-206; W02004/045516 (Claim 1); W02004/048938 (Example 2); W02004/040000 (Claim 151); W02003/087768 (Claim 1); 20 W02003/016475 (Claim 1); W02003/016475 (Claim 1); W02002/61087 (Fig 1); W02003/016494 (Fig 6); W02003/025138 (Claim 12; Page 144); W02001/98351 (Claim 1;</div>
    <div class="description-paragraph style-scope patent-text">Page 124-125); EP0522868 (Claim 8; Fig 2); W02001/77172 (Claim 1; Page 297-299); US2003/109676; US6518404 (Fig 3); US5773223 (Claim 1a; Col 31-34); W02004/001004.</div>
    <div class="description-paragraph style-scope patent-text">(10) MSG783 (RNF124, hypothetical protein FLJ20315)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM_017763</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_017763.4 GI:167830482</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jul 22, 2012 12:34 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_060233</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_060233.3 Gl:56711322</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jul 22, 2012 12:34 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">W02003/104275 (Claim 1); W02004/046342 (Example 2); W02003/042661 (Claim 12); W02003/083074 (Claim 14; Page 61); W02003/018621 (Claim 1); W02003/024392 (Claim 2; Fig 93); WO2001/66689 (Example 6); LocuslD:54894.</div>
    <div class="description-paragraph style-scope patent-text">(11) STEAP2 (HGNC_8639, IPCA-1, PCANAP1, STAMP1, STEAP2, STMP, prostate cancer associated gene 1, prostate cancer associated protein 1, six transmembrane epithelial antigen of prostate 2, six transmembrane prostate protein)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AF455138</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AF455138.1 Gl:22655487</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 11,2010 01:54 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAN04080</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAN04080.1 Gl:22655488</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 11,2010 01:54 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Lab. Invest. 82 (11):1573-1582 (2002)); W02003/087306; US2003/064397 (Claim 1; Fig 1); WO2002/72596 (Claim 13; Page 54-55); WO2001/72962 (Claim 1; Fig 4B); 35 W02003/104270 (Claim 11); W02003/104270 (Claim 16); US2004/005598 (Claim 22); W02003/042661 (Claim 12); US2003/060612 (Claim 12; Fig 10); WO2002/26822 (Claim 23; Fig 2); WO2002/16429 (Claim 12; Fig 10); GL22655488.</div>
    <div class="description-paragraph style-scope patent-text">(12) TrpM4 (BR22450, FLJ20041, TRPM4, TRPM4B, transient receptor potential cation 5 channel, subfamily M, member 4)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM_017636</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_017636.3 GL304766649</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 29, 2012 11:27 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_060106</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_060106.2 GL21314671</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 29, 2012 11:27 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Xu, X.Z., etal Proc. Natl. Acad. Sci. U.S.A. 98 (19):10692-10697 (2001), Cell 109 (3):397407 (2002), J. Biol. Chem. 278 (33):30813-30820 (2003)); US2003/143557 (Claim 4); W02000/40614 (Claim 14; Page 100-103); W02002/10382 (Claim 1; Fig 9A); W02003/042661 (Claim 12); W02002/30268 (Claim 27; Page 391); US2003/219806 (Claim 4); WO2001/62794 (Claim 10 14; Fig 1A-D); MIM:606936.</div>
    <div class="description-paragraph style-scope patent-text">(13) CRIPTO (CR, CR1, CRGF, CRIPTO, TDGF1, teratocarcinoma-derived growth factor)</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM_003212</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_003212.3 GL292494881</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 23, 2012 02:27 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_003203</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_003203.1 GL4507425</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 23, 2012 02:27 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Ciccodicola, A., et al EMBO J. 8 (7):1987-1991 (1989), Am. J. Hum. Genet. 49 (3):555-565 (1991)); US2003/224411 (Claim 1); W02003/083041 (Example 1); W02003/034984 (Claim 12); W02002/88170 (Claim 2; Page 52-53); W02003/024392 (Claim 2; Fig 58); W02002/16413 (Claim 1; Page 94-95, 105); W02002/22808 (Claim 2; Fig 1); US5854399 (Example 2; Col 17-18); US5792616 (Fig 2); MIM:187395.</div>
    <div class="description-paragraph style-scope patent-text">(14) CD21 (CR2 (Complement receptor 2) or C3DR (C3d/Epstein Barr virus receptor) or Hs.73792)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no M26004</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. M26004.1 GL181939</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:47 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAA35786</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAA35786.1 GL181940</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:47 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Fujisaku ef a/(1989) J. Biol. Chem. 264 (4):2118-2125); Weis J.J., et al J. Exp. Med. 167, 1047-1066, 1988; Moore M., etal Proc. Natl. Acad. Sci. U.S.A. 84, 9194-9198, 1987; Barel M., et al Mol. Immunol. 35, 1025-1031, 1998; Weis J.J., et al Proc. Natl. Acad. Sci. U.S.A. 83, 5639-5643, 1986; Sinha S.K., et al (1993) J. Immunol. 150, 5311-5320;</div>
    <div class="description-paragraph style-scope patent-text">W02004/045520 (Example 4); US2004/005538 (Example 1); W02003/062401 (Claim 9);</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">W02004/045520 (Example 4); WO91/02536 (Fig 9.1-9.9); W02004/020595 (Claim 1); Accession: P20023; Q13866; Q14212; EMBL; M26004; AAA35786.1.</div>
    <div class="description-paragraph style-scope patent-text">(15) CD79b (CD79B, Οϋ79β, IGb (immunoglobulin-associated beta), B29)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no NM_000626</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_000626.2 GL90193589</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 26, 2012 01:53 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_000617</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_000617.1 Gl:11038674</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 26, 2012 01:53 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. (2003) 100 (7):41264131, Blood (2002) 100 (9):3068-3076, Muller et al (1992) Eur. J. Immunol. 22 (6):16211625); W02004/016225 (claim 2, Fig 140); W02003/087768, US2004/101874 (claim 1, page 102); W02003/062401 (claim 9); WO2002/78524 (Example 2); US2002/150573 (claim</div>
    <div class="description-paragraph style-scope patent-text">5, page 15); US5644033; W02003/048202 (claim 1, pages 306 and 309); WO 99/58658,</div>
    <div class="description-paragraph style-scope patent-text">US6534482 (claim 13, Fig 17A/B); W02000/55351 (claim 11, pages 1145-1146); MIM:147245 (16) FcRH2 (IFGP4, IRTA4, SPAP1A (SH2 domain containing phosphatase anchor protein 5 1a), SPAP1B, SPAP1C)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no NM_030764</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_030764.3 GL227430280</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 30, 2012 12:30 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_110391</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_110391.2 GL19923629</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 30, 2012 12:30 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">AY358130); Genome Res. 13 (10):2265-2270 (2003), Immunogenetics 54 (2):87-95 (2002), Blood 99 (8):2662-2669 (2002), Proc. Natl. Acad. Sci. U.S.A. 98 (17):9772-9777 (2001), Xu, M.J., et a/(2001) Biochem. Biophys. Res. Commun. 280 (3):768-775; W02004/016225 (Claim 2); W02003/077836; WO2001/38490 (Claim 5; Fig 18D-1-18D-2); W02003/097803 (Claim 12);</div>
    <div class="description-paragraph style-scope patent-text">W02003/089624 (Claim 25);: MIM:606509.</div>
    <div class="description-paragraph style-scope patent-text">(17) HER2 (ErbB2)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no M11730</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. M11730.1 GL183986</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:47 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAA75493</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAA75493.1 GL306840</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:47 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Coussens L., etal Science (1985) 230(4730):1132-1139); Yamamoto T., et al Nature 319, 230-234, 1986; Semba K., etal Proc. Natl. Acad. Sci. U.S.A. 82, 6497-6501, 1985; Swiercz J.M., etal J. Cell Biol. 165, 869- 15 880, 2004; Kuhns J.J., et al J. Biol. Chem. 274, 3642236427, 1999; Cho H.-S., et al Nature 421, 756-760, 2003; Ehsani A., etal (1993)</div>
    <div class="description-paragraph style-scope patent-text">Genomics 15, 426-429; W02004/048938 (Example 2); W02004/027049 (Fig 11); W02004/009622; W02003/081210;</div>
    <div class="description-paragraph style-scope patent-text">W02003/089904 (Claim 9); W02003/016475 (Claim 1); US2003/118592; W02003/008537 (Claim 1); W02003/055439 (Claim 29; Fig 1A-B); W02003/025228 (Claim 37; Fig 5C);</div>
    <div class="description-paragraph style-scope patent-text">WO2002/22636 (Example 13; Page 95-107); W02002/12341 (Claim 68; Fig 7); WO2002/13847 (Page 71-74); W02002/14503 (Page 114-117); WO2001/53463 (Claim 2; Page 41-46); W02001/41787 (Page 15); W02000/44899 (Claim 52; Fig 7);</div>
    <div class="description-paragraph style-scope patent-text">W02000/20579 (Claim 3; Fig 2); US5869445 (Claim 3; Col 31-38); WO9630514 (Claim 2; Page 56-61);</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">EP1439393 (Claim 7); W02004/043361 (Claim 7); W02004/022709; W02001/00244 25 (Example 3; Fig 4); Accession: P04626; EMBL; M11767; AAA35808.1. EMBL; M11761; AAA35808.1</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">Abbott: US20110177095</div>
    <div class="description-paragraph style-scope patent-text">For example, an antibody comprising CDRs having overall at least 80% sequence identity to CDRs having amino acid sequences of SEQ ID NO:3 (CDR-H1), SEQ ID NO:4 (CDR-H2), SEQ ID NO:5 (CDR-H3), SEQ ID NO:104 and/or SEQ ID NO:6 (CDR-L1), SEQ ID NO:7 (CDR-L2), and SEQ ID NO:8 (CDR-L3), wherein the antiHER2 antibody or anti-HER2 binding fragment has reduced immunogenicity as compared to an antibody having a VH of SEQ ID NO:1 and a VL of SEQ ID NO:2.</div>
    <div class="description-paragraph style-scope patent-text">Biogen: US20100119511</div>
    <div class="description-paragraph style-scope patent-text">For example, ATCC accession numbers: PTA-10355, PTA-10356, PTA-10357, PTA-10358</div>
    <div class="description-paragraph style-scope patent-text">For example, a purified antibody molecule that binds to HER2 comprising a all six CDR's from an antibody selected from the group consisting of BIIB71F10 (SEQ ID NOs:11, 13), BIIB69A09 (SEQ ID NOs:15, 17); BIIB67F10 (SEQ ID NOs:19, 21); BIIB67F11 (SEQ ID NOs:23, 25), BIIB66A12 (SEQ ID NOs:27, 29), BIIB66C01 (SEQ ID NOs:31, 33), BIIB65C10 (SEQ ID NOs:35, 37), BIIB65H09 (SEQ ID NOs:39, 41) and BIIB65B03 (SEQ ID NOs:43, 45), or CDRs which are identical or which have no more than two alterations from said CDRs.</div>
    <div class="description-paragraph style-scope patent-text">Herceptin (Genentech) - US6,054,297; ATCC accession no. CRL-10463 (Genentech)</div>
    <div class="description-paragraph style-scope patent-text">Pertuzumab (Genentech)</div>
    <div class="description-paragraph style-scope patent-text">US20110117097 for example, see SEQ IDs No. 15&amp;16, SEQ IDs No. 17&amp;18, SEQ IDs No. 23&amp;24 &amp; ATCC accession numbers HB-12215, HB-12216, CRL 10463, HB12697.</div>
    <div class="description-paragraph style-scope patent-text">US20090285837</div>
    <div class="description-paragraph style-scope patent-text">US20090202546 for example, ATCC accession numbers: HB-12215, HB-12216, CRL 10463, HB-12698.</div>
    <div class="description-paragraph style-scope patent-text">US20060088523</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">- for example, ATCC accession numbers: HB-12215, HB-12216</div>
    <div class="description-paragraph style-scope patent-text">- for example, an antibody comprising the variable light and variable heavy amino acid sequences in SEQ ID Nos. 3 and 4, respectively.</div>
    <div class="description-paragraph style-scope patent-text">- for example, an antibody comprising a light chain amino acid sequence selected from SEQ ID No. 15 and 23, and a heavy chain amino acid sequence selected from SEQ ID No. 16 and 24</div>
    <div class="description-paragraph style-scope patent-text">US20060018899</div>
    <div class="description-paragraph style-scope patent-text">- for example, ATCC accession numbers: (7C2) HB-12215, (7F3) HB12216, (4D5) CRL-10463, (2C4) ΗΒ-12697.</div>
    <div class="description-paragraph style-scope patent-text">- for example, an antibody comprising the amino acid sequence in SEQ ID No. 23, or a deamidated and/or oxidized variant thereof.</div>
    <div class="description-paragraph style-scope patent-text">US2011/0159014</div>
    <div class="description-paragraph style-scope patent-text">- for example, an antibody having a light chain variable domain comprising the hypervariable regions of SEQ ID NO: 1”.</div>
    <div class="description-paragraph style-scope patent-text">- For example, an antibody having a heavy chain variable domain comprising the hypervariable regions of SEQ ID NO: 2.</div>
    <div class="description-paragraph style-scope patent-text">US20090187007</div>
    <div class="description-paragraph style-scope patent-text">Glycotope: TrasGEX antibody http://www.glycotope.com/pipeline</div>
    <div class="description-paragraph style-scope patent-text">For example, see International Joint Cancer Institute and Changhai Hospital Cancer Cent: HMTI-Fc Ab - Gao J., et al BMB Rep. 2009 Oct 31 ;42(10):636-41.</div>
    <div class="description-paragraph style-scope patent-text">Symphogen: US20110217305</div>
    <div class="description-paragraph style-scope patent-text">Union Stem Cell &amp;Gene Engineering, China - Liu HQ., et al Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2010 May;26(5):456-8.</div>
    <div class="description-paragraph style-scope patent-text">(18) NCA (CEACAM6)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no M18728</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. M18728.1 GI:189084</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:48 AM</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAA59907</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAA59907.1 Gl:189085</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:48 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Barnett T., etal Genomics 3, 59-66, 1988; Tawaragi Y., et al Biochem. Biophys. Res. Commun. 150, 89-96, 1988; Strausberg R.L., et a I Proc. Natl. Acad. Sci. U.S.A. 99:1689916903, 2002; W02004/063709; EP1439393 (Claim 7); W02004/044178 (Example 4); W02004/031238; W02003/042661 (Claim 12); WO2002/78524 (Example 2); WO2002/86443 (Claim 27; Page 427); W02002/60317 (Claim 2); Accession: P40199; Q14920; EMBL; M29541; AAA59915.1.</div>
    <div class="description-paragraph style-scope patent-text">EMBL; M18728.</div>
    <div class="description-paragraph style-scope patent-text">(19) MDP (DPEP1)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no BC017023</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. BC017023.1 Gl:16877538</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 6, 2012 01:00 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAH17023</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAH17023.1 GL16877539</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 6, 2012 01:00 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. 99 (26):16899-16903 (2002)); W02003/016475 (Claim 1); WO2002/64798 (Claim 33; Page 85- 87); JP05003790 (Fig 6-8); WO99/46284 (Fig 9); MIM:179780.</div>
    <div class="description-paragraph style-scope patent-text">(20) IL20R-alpha (IL20Ra, ZCYTOR7)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no AF184971</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AF184971.1 GL6013324</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 10, 2010 10:00 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAF01320</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAF01320.1 GI:6013325</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 10, 2010 10:00 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Clark H.F., etal Genome Res. 13, 2265-2270, 2003; Mungall A.J., et al Nature 425, 805811,2003; Blumberg H., et al Cell 104, 9-19, 2001; Dumoutier L., etal J. Immunol. 167, 3545-3549,</div>
    <div class="description-paragraph style-scope patent-text">2001; Parrish-Novak J., et al J. Biol. Chem. 277, 47517-47523, 2002; Pletnev S., et al (2003)</div>
    <div class="description-paragraph style-scope patent-text">Biochemistry 42:12617-12624; Sheikh F„ et a/(2004) J. Immunol. 172, 2006-2010; EP1394274 (Example 11); US2004/005320 (Example 5); W02003/029262 (Page 74-75); W02003/002717 (Claim 2; Page 63); WO2002/22153 (Page 45-47); US2002/042366 (Page</div>
    <div class="description-paragraph style-scope patent-text">20-21); W02001/46261 (Page 57-59); WO2001/46232 (Page 63-65); WO98/37193 (Claim 1;</div>
    <div class="description-paragraph style-scope patent-text">Page 55-59); Accession: Q9UHF4; Q6UWA9; Q96SH8; EMBL; AF184971; AAF01320.1.</div>
    <div class="description-paragraph style-scope patent-text">(21) Brevican (BCAN, BEHAB)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no AF229053</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AF229053.1 GI:10798902</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 11,2010 12:58 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAG23135</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAG23135.1 GI:10798903</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 11,2010 12:58 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Gary S.C., etal Gene 256, 139-147, 2000; Clark H.F., et al Genome Res. 13, 2265-2270, 2003; Strausberg R.L., et a I Proc. Natl. Acad. Sci. U.S.A. 99, 16899-16903, 2002;</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">US2003/186372 (Claim 11); US2003/186373 (Claim 11); US2003/119131 (Claim 1; Fig 52); US2003/119122 (Claim 1; 20 Fig 52); US2003/119126 (Claim 1); US2003/119121 (Claim 1; Fig 52); US2003/119129 (Claim 1); US2003/119130 (Claim 1); US2003/119128 (Claim 1; Fig 52); US2003/119125 (Claim 1); W02003/016475 (Claim 1); W02002/02634 (Claim 1) (22) EphB2R (DRT, ERK, Hek5, EPHT3, Tyro5)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no NM_004442</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_004442.6 Gl:111118979</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 8, 2012 04:43 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_004433</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_004433.2 GI:21396504</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 8, 2012 04:43 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Chan,J. and Watt, V.M., Oncogene 6 (6), 1057-1061 (1991) Oncogene 10 (5):897-905 (1995), Annu. Rev. Neurosci. 21:309-345 (1998), Int. Rev. Cytol. 196:177-244 (2000)); W02003042661 (Claim 12); W0200053216 (Claim 1; Page 41); W02004065576 (Claim 1); W02004020583 (Claim 9); W02003004529 (Page 128-132); W0200053216 (Claim 1; Page 42); MIM:600997.</div>
    <div class="description-paragraph style-scope patent-text">(23) AS LG 659 (B7h)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AX092328</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AX092328.1 GL13444478</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jan 26, 2011 07:37 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">US2004/0101899 (Claim 2); W02003104399 (Claim 11); W02004000221 (Fig 3); US2003/165504 (Claim 1); US2003/124140 (Example 2); US2003/065143 (Fig 60); W02002/102235 (Claim 13; Page 299); US2003/091580 (Example 2); W02002/10187</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695 (Claim 6; Fig 10); W02001/94641 (Claim 12; Fig 7b); W02002/02624 (Claim 13; Fig 1A1B); US2002/034749 (Claim 54; Page 45-46); W02002/06317 (Example 2; Page 320-321, Claim 34; Page 321-322); WO2002/71928 (Page 468-469); W02002/02587 (Example 1;</div>
    <div class="description-paragraph style-scope patent-text">Fig 1); W02001/40269 (Example 3; Pages 190-192); W02000/36107 (Example 2; Page 205-207); W02004/053079 (Claim 12); W02003/004989 (Claim 1); WO2002/71928 (Page 233-234, 452-453); WO 01/16318.</div>
    <div class="description-paragraph style-scope patent-text">(24) PSCA (Prostate stem cell antigen precursor)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no AJ297436</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AJ297436.1 GL9367211</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Feb 1, 2011 11:25 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. CAB97347</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. CAB97347.1 GL9367212</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Feb 1, 2011 11:25 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Reiter R.E., et al Proc. Natl. Acad. Sci. U.S.A. 95, 1735-1740, 1998; Gu Z., et al Oncogene 19,</div>
    <div class="description-paragraph style-scope patent-text">1288-1296, 2000; Biochem. Biophys. Res. Commun. (2000) 275(3):783-788;</div>
    <div class="description-paragraph style-scope patent-text">W02004/022709; EP1394274 (Example 11); US2004/018553 (Claim 17); W02003/008537 (Claim 1); WO2002/81646 (Claim 1; Page 164); W02003/003906 (Claim 10; Page 288); W02001/40309 (Example 1; Fig 17); US2001/055751 (Example 1; Fig 1b); W02000/32752 (Claim 18; Fig 1); WO98/51805 (Claim 17; Page 97); WO98/51824 (Claim 10; Page 94); W098/40403 (Claim 2; Fig 1B); Accession: 043653; EMBL; AF043498; AAC39607.1 (25) GEDA</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no AY260763</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AY260763.1 GI:30102448</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 11,2010 02:24 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAP14954</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAP14954.1 GI:30102449</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 11,2010 02:24 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">AP14954 lipoma HMGIC fusion-partnerlike protein /pid=AAP14954.1 - Homo sapiens (human); W02003/054152 (Claim 20); W02003/000842 (Claim 1); W02003/023013 (Example 3, Claim 20); US2003/194704 (Claim 45); GL30102449;</div>
    <div class="description-paragraph style-scope patent-text">(26) BAFF-R (B cell -activating factor receptor, BLyS receptor 3, BR3)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no AF116456</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AF116456.1 Gl:4585274</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 10, 2010 09:44 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAD25356</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAD25356.1 Gl:4585275</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 10, 2010 09:44 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">BAFF receptor/pid=NP_443177.1 - Homo sapiens: Thompson, J.S., et al Science 293 (5537), 2108-2111 (2001); W02004/058309; W02004/011611; W02003/045422 (Example; Page 32-33); W02003/014294 (Claim 35; Fig 6B); W02003/035846 (Claim 70; Page 615-616); WO2002/94852 (Col 136-137); WO2002/38766 25 (Claim 3; Page 133); W02002/24909 (Example 3; Fig 3); MIM:606269; NP_443177.1; NM_052945_1;</div>
    <div class="description-paragraph style-scope patent-text">AF132600 (27) CD22 (B-cell receptor CD22-B isoform, BL-CAM, Lyb-8, Lyb8, SIGLEC-2, FLJ22814) Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no AK026467</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AK026467.1 GL10439337</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 11,2006 11:24 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. BAB15489</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. BAB15489.1 GL10439338</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 11,2006 11:24 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Wilson et al (1991) J. Exp. Med. 173:137-146; 30 W02003/072036 (Claim 1; Fig 1); IM:107266; NP_001762.1; NM_001771_1.</div>
    <div class="description-paragraph style-scope patent-text">(27a) CD22 (CD22 molecule)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no X52785</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. X52785.1 Gl:29778</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Feb 2, 2011 10:09 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. CAA36988</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. CAA36988.1 Gl:29779</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Feb 2, 2011 10:09 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Stamenkovic I. et al., Nature 345 (6270), 74-77 (1990)??</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: CD22</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: SIGLEC-2, SIGLEC2</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: B-cell receptor CD22; B-lymphocyte cell adhesion molecule; BLCAM; CD22 antigen; T-cell surface antigen Leu-14; sialic acid binding Ig-like lectin 2; sialic acid-binding Ig-like lectin 2</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">G5/44 (Inotuzumab): DiJoseph JF.,et al Cancer Immunol Immunother. 2005 Jan;54(1 ):1124.</div>
    <div class="description-paragraph style-scope patent-text">Epratuzumab- Goldenberg DM., et al Expert Rev Anticancer Ther. 6(10): 1341-53, 2006.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695 (28) CD79a (CD79A, CD79alpha), immunoglobulin-associated alpha, a B cell-specific protein that covalently interacts with Ig beta (CD79B) and forms a complex on the surface with Ig M molecules, transduces a signal involved in B-cell differentiation), pi: 4.84, MW: 25028 TM: 2 [P] Gene Chromosome: 19q13.2).</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no NM_001783</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_001783.3 GI:90193587</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 26, 2012 01:48 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_001774</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_001774.1 GI:4502685</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 26, 2012 01:48 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">W02003/088808, US2003/0228319; W02003/062401 (claim 9); US2002/150573 (claim 4, pages 13-14); WO99/58658 (claim 13, Fig 16); WO92/07574 (Fig 1); US5644033; Ha etal (1992) J. Immunol. 148(5):1526-1531; Muller et al (1992) Eur. J. Immunol.. 22:1621-1625; Hashimoto etal (1994) Immunogenetics 40(4):287-295; Preud’homme etal (1992) Clin. Exp.</div>
    <div class="description-paragraph style-scope patent-text">Immunol. 90(1 ):141-146; Yu etal (1992) J. Immunol. 148(2) 633-637; Sakaguchi etal (1988)</div>
    <div class="description-paragraph style-scope patent-text">EMBO J. 7(11):3457-3464 (29) CXCR5 (Burkitt's lymphoma receptor 1, a G protein-coupled receptor that is activated by the CXCL13 chemokine, functions in lymphocyte migration and humoral defense, plays a role in HIV-2 infection and perhaps development of AIDS, lymphoma, myeloma, and leukemia); 372 aa, pi: 8.54 MW: 41959 TM: 7 [P] Gene Chromosome: 11q23.3,</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no NM_001716</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_001716.4 GI:342307092</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 30, 2012 01:49 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_001707</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_001707.1 GI:4502415</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 30, 2012 01:49 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">W02004/040000; W02004/015426; US2003/105292 (Example 2); US6555339 (Example 2); W02002/61087 (Fig 1); W02001/57188 (Claim 20, page 269); W02001/72830 (pages 12-13); W02000/22129 (Example 1, pages 152-153, 15 Example 2, pages 254-256); WO99/28468 (claim 1, page 38); US5440021 (Example 2, col 49-52); WO94/28931 (pages 56-58); WO92/17497 (claim 7, Fig 5); Dobner ef a/(1992) Eur. J. Immunol. 22:2795-2799; Barella et a/(1995) Biochem. J. 309:773-779 (30) HLA-DOB (Beta subunit of MHC class II molecule (la antigen) that binds peptides and 20 presents them to CD4+ T lymphocytes); 273 aa, pi: 6.56, MW: 30820. TM: 1 [P] Gene Chromosome: 6p21.3)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no NM_002120</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_002120.3 GI:118402587</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 8, 2012 04:46 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_002111</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_002111.1 GI:4504403</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 8, 2012 04:46 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Tonnelle etal (1985) EMBO J. 4(11):2839-2847; Jonsson et al (1989) Immunogenetics 29(6):411-413; Beck et al (1992) J. Mol. Biol. 228:433-441; Strausberg et al (2002) Proc. Natl. Acad. Sci USA 99:16899- 16903; Servenius et a/(1987) J. Biol. Chem. 262:87598766; Beck et a/(1996) J. Mol. Biol. 25 255:1-13; Naruse et a I (2002) Tissue Antigens 59:512-519; WO99/58658 (claim 13, Fig 15); US6153408 (Col 35-38); US5976551 (col</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">168-170); US6011146 (col 145-146); Kasahara et al (1989) Immunogenetics 30(1):66-68; Larhammar et al (1985) J. Biol. Chem. 260(26):14111-14119 (31) P2X5 (Purinergic receptor P2X ligand-gated ion channel 5, an ion channel gated by extracellular ATP, may be involved in synaptic transmission and neurogenesis, deficiency may contribute to the pathophysiology of idiopathic detrusor instability); 422 aa), pi: 7.63, MW: 47206 TM: 1 [P] Gene Chromosome: 17p13.3).</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no NM_002561</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_002561.3 GL325197202</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 27, 2012 12:41 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_002552</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_002552.2 GL28416933</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 27, 2012 12:41 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Le etal (1997) FEBS Lett. 418(1-2): 195-199; W02004/047749; W02003/072035 (claim 10); Touchman etal (2000) Genome Res. 10:165-173; W02002/22660 (claim 20); W02003/093444 (claim 1); W02003/087768 (claim 1); W02003/029277 (page 82) (32) CD72 (B-cell differentiation antigen CD72, Lyb-2); 359 aa, pi: 8.66, MW: 40225, TM: 1 5 [P] Gene Chromosome: 9p13.3).</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no NM_001782</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_001782.2 GI:194018444</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 26, 2012 01:43 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_001773</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_001773.1 GI:4502683</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 26, 2012 01:43 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">W02004042346 (claim 65); W02003/026493 (pages 51-52, 57-58); W02000/75655 (pages 105-106); Von Hoegen et a/(1990) J. Immunol. 144(12):4870-4877; Strausberg et al (2002) Proc. Natl. Acad. Sci USA 99:16899-16903.</div>
    <div class="description-paragraph style-scope patent-text">(33) LY64 (Lymphocyte antigen 64 (RP105), type I membrane protein of the leucine rich repeat (LRR) family, regulates B-cell activation and apoptosis, loss of function is associated with increased disease activity in patients with systemic lupus erythematosis); 661 aa, pl: 6.20, MW: 74147 TM: 1 [P] Gene Chromosome: 5q12).</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no NM_005582</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_005582.2 Gl:167555126</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 2, 2012 01:50 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_005573</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_005573.2 Gl:167555127</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 2, 2012 01:50 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">US2002/193567; WO97/07198 (claim 11, pages 39-42); Miura et al (1996) 15 Genomics 38(3):299-304; Miura et a I (1998) Blood 92:2815-2822; W02003/083047; WO97/44452 (claim 8, pages 57-61); W02000/12130 (pages 24-26).</div>
    <div class="description-paragraph style-scope patent-text">(34) FcRH1 (Fc receptor-like protein 1, a putative receptor for the immunoglobulin Fc domain that contains C2 type Ig-like and ITAM domains, may have a role in B-lymphocyte differentiation); 429 aa, pl: 5.28, MW: 46925 TM: 1 [P] Gene Chromosome: 1q21-1q22)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no NM_052938</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_052938.4 Gl:226958543</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 2, 2012 01:43 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_443170</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_443170.1 GL16418419</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 2, 2012 01:43 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">W02003/077836; W02001/38490 (claim 6, Fig 18E-1-18-E-2); Davis et a/(2001) Proc. Natl. Acad. Sci USA 98(17):9772-9777; W02003/089624 (claim 8); EP1347046 (claim 1); W02003/089624 (claim 7).</div>
    <div class="description-paragraph style-scope patent-text">(35) IRTA2 (Immunoglobulin superfamily receptor translocation associated 2, a putative immunoreceptor with possible roles in B cell development and lymphomagenesis; deregulation of the gene by translocation occurs in some B cell malignancies); 977 aa, pi: 6.88, MW: 106468, TM: 1 [P] Gene Chromosome: 1q21)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no AF343662</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AF343662.1 GI:13591709</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 11,2010 01:16 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAK31325</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAK31325.1 Gl: 13591710</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 11,2010 01:16 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">AF343663, AF343664, AF343665, AF369794, AF397453, AK090423, AK090475, AL834187, AY358085; Mouse:AK089756, AY158090, AY506558; NP_112571.1; W02003/024392 (claim 2, Fig 97); Nakayama et a/(2000) Biochem. Biophys. Res. Commun. 277(1): 124-127; W02003/077836; W02001/38490 (claim 3, Fig 18B-1-18B-2).</div>
    <div class="description-paragraph style-scope patent-text">(36) TENB2 (TMEFF2, tomoregulin, TPEF, HPP1, TR, putative transmembrane proteoglycan, related to the EGF/heregulin family of growth factors and follistatin); 374 aa)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no AF179274</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AF179274.2 GI:12280939</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 11,2010 01:05 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAD55776</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAD55776.2 GI:12280940 Genbank record update date: Mar 11,2010 01:05 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">NCBI Accession: AAD55776, AAF91397, AAG49451, NCBI RefSeq: NP_057276; NCBI Gene: 23671; OMIM: 605734; SwissProt Q9UIK5; AY358907, CAF85723, CQ782436; W02004/074320; JP2004113151; W02003/042661; W02003/009814; EP1295944 (pages 69-70); W02002/30268 (page 329); WO2001/90304; US2004/249130; US2004/022727; W02004/063355; US2004/197325; US2003/232350; 5 US2004/005563; US2003/124579; Horie et al (2000) Genomics 67:146-152; Uchida et al (1999) Biochem. Biophys. Res. Commun. 266:593-602; Liang et a/(2000) Cancer Res. 60:4907-12; Glynne-Jones etal (2001) Int J Cancer. Oct 15; 94(2):178-84.</div>
    <div class="description-paragraph style-scope patent-text">(37) PSMA - FOLH1 (Folate hydrolase (prostate-specific membrane antigen) 1) Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no M99487</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. M99487.1 GL190663</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:48 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAA60209</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAA60209.1 Gl:190664</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:48 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Israeli R.S., et al Cancer Res. 53 (2), 227-230 (1993)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: FOLH1</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: GIG27, FGCP, FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA, mGCP</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: N-acetylated alpha-linked acidic dipeptidase 1; N-acetylated-alphalinked acidic dipeptidase I; NAALADase I; cell growth-inhibiting gene 27 protein; folylpolygamma-glutamate carboxypeptidase; glutamate carboxylase II; glutamate carboxypeptidase 2; glutamate carboxypeptidase II; membrane glutamate carboxypeptidase; prostate specific membrane antigen variant F; pteroylpoly-gammaglutamate carboxypeptidase</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">US 7,666,425:</div>
    <div class="description-paragraph style-scope patent-text">Antibodies produces by Hybridomas having the following ATCC references:ATCC accession No. HB-12101, ATCC accession No. HB-12109, ATCC accession No. HB-12127 and ATCC accession No. HB-12126.</div>
    <div class="description-paragraph style-scope patent-text">ProScan: a monoclonal antibody selected from the group consisting of 8H12, 3E11, 17G1, 29B4, 30C1 and 20F2 (US 7,811,564; Moffett S., et al Hybridoma (Larchmt). 2007 Dec;26(6):363-72).</div>
    <div class="description-paragraph style-scope patent-text">Cytogen: monoclonal antibodies 7E11-C5 (ATCC accession No. HB 10494) and 9H10-A4 (ATCC accession No. HB11430) - US 5,763,202</div>
    <div class="description-paragraph style-scope patent-text">GlycoMimetics: NUH2 - ATCC accession No. HB 9762 (US 7,135,301)</div>
    <div class="description-paragraph style-scope patent-text">Human Genome Science: HPRAJ70 - ATCC accession No. 97131 (US 6,824,993); Amino acid sequence encoded by the cDNA clone (HPRAJ70) deposited as American Type Culture Collection (ATCC) Deposit No. 97131</div>
    <div class="description-paragraph style-scope patent-text">Medarex: Anti-PSMA antibodies that lack fucosyl residues - US 7,875,278</div>
    <div class="description-paragraph style-scope patent-text">Mouse anti-PSMA antibodies include the 3F5.4G6, 3D7.1.1, 4E10-1.14, 3E11,4D8, 3E6, 3C9, 2C7, 1G3, 3C4, 3C6, 4D4, 1G9, 5C8B9, 3G6, 4C8B9, and monoclonal antibodies. Hybridomas secreting 3F5.4G6, 3D7.1.1,4E10-1.14, 3E11, 4D8, 3E6, 3C9, 2C7, 1G3, 3C4, 3C6, 4D4, 1G9, 5C8B9, 3G6 or 4C8B9 have been publicly deposited and are described in U.S. Pat. No. 6,159,508. Relevant hybridomas have been publicly deposited</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695 and are described in U.S. Pat. No. 6,107,090. Moreover, humanized anti-PSMA antibodies, including a humanized version of J591, are described in further detail in PCT Publication WO 02/098897.</div>
    <div class="description-paragraph style-scope patent-text">Other mouse anti-human PSMA antibodies have been described in the art, such as mAb 107-1A4 (Wang, S. et al. (2001) Int. J. Cancer 92:871-876) and mAb 2C9 (Kato, K. et al. (2003) Int. J. Urol. 10:439-444).</div>
    <div class="description-paragraph style-scope patent-text">Examples of human anti-PSMA monoclonal antibodies include the 4A3, 7F12, 8C12, 8A11, 16F9, 2A10, 2C6, 2F5 and 1C3 antibodies, isolated and structurally characterized as originally described in PCT Publications WO 01/09192 and WO 03/064606 and in U.S. Provisional Application Ser. No. 60/654,125, entitled Human Monoclonal Antibodies to Prostate Specific Membrane Antigen (PSMA), filed on Feb. 18, 2005. The V.sub.H amino acid sequences of 4A3, 7F12, 8C12, 8A11, 16F9, 2A10, 2C6, 2F5 and 1C3 are shown in SEQ ID NOs: 1-9, respectively. The V.sub.L amino acid sequences of 4A3, 7F12, 8C12, 8A11, 16F9, 2A10, 2C6, 2F5 and 1C3 are shown in SEQ ID NOs: 10-18, respectively.</div>
    <div class="description-paragraph style-scope patent-text">Other human anti-PSMA antibodies include the antibodies disclosed in PCT Publication WO 03/034903 and US Application No. 2004/0033229.</div>
    <div class="description-paragraph style-scope patent-text">NW Biotherapeutics: A hybridoma cell line selected from the group consisting of 3F5.4G6 having ATCC accession number ΗΒ12060, 3D7-1.I. having ATCC accession number ΗΒ12309, 4E10-1.14 having ATCC accession number ΗΒ12310, 3E11 (ATCC ΗΒ12488), 4D8 (ATCC ΗΒ12487), 3E6 (ATCC ΗΒ12486), 3C9 (ATCC ΗΒ12484), 2C7 (ATCC ΗΒ12490), 1G3 (ATCC ΗΒ12489), 3C4 (ATCC ΗΒ12494), 3C6 (ATCC ΗΒ12491), 4D4 (ATCC ΗΒ12493), 1G9 (ATCC ΗΒ12495), 5C8B9 (ATCC ΗΒ12492) and 3G6 (ATCC ΗΒ12485) - see US 6,150,508</div>
    <div class="description-paragraph style-scope patent-text">PSMA Development Company / Progenies / Cytogen - Seattle Genetics: mAb 3.9, produced by the hybridoma deposited under ATCC Accession No. PTA-3258 or mAb 10.3, produced by the hybridoma deposited under ATCC Accession No. PTA-3347 - US 7,850,971</div>
    <div class="description-paragraph style-scope patent-text">PSMA Development Company- Compositions of PSMA antibodies (US 20080286284, Table 1)</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">This application is a divisional of U.S. patent application Ser. No. 10/395,894, filed on Mar. 21,2003 (US 7,850,971)</div>
    <div class="description-paragraph style-scope patent-text">University Hospital Freiburg, Germany - mAbs 3/A12, 3/E7, and 3/F11 (Wolf P., et al Prostate. 2010 Apr 1;70(5):562-9).</div>
    <div class="description-paragraph style-scope patent-text">(38) SST (Somatostatin Receptor; note that there are5 subtypes) (38.1) SSTR2 (Somatostatin receptor 2)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no NM_001050</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_001050.2 GI:44890054</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Aug 19, 2012 01:37 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_001041</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_001041.1 Gl:4557859</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Aug 19, 2012 01:37 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Yamada Y., et al Proc. Natl. Acad. Sci. U.S.A. 89 (1), 251-255 (1992); Susini C., et al Ann Oncol. 2006 Dec; 17(12): 1733-42</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: SSTR2</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: SRIF-1; SS2R; somatostatin receptor type 2 (38.2) SSTR5 (Somatostatin receptor 5)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no D16827</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. D16827.1 Gl:487683</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Aug 1, 2006 12:45 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. BAA04107</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. BAA04107.1 Gl:487684</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Aug 1, 2006 12:45 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Yamada,Y., et al Biochem. Biophys. Res. Commun. 195 (2), 844-852 (1993)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: SSTR5</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: SS-5-R</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: Somatostatin receptor subtype 5; somatostatin receptor type 5 (38.3) SSTR1 (38.4) SSTR3 (38.5) SSTR4</div>
    <div class="description-paragraph style-scope patent-text">AvB6 - Both subunits (39+40) (39) ITGAV (Integrin, alpha V;</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no M14648 J02826 M18365</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. M14648.1 GL340306</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:56 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAA36808</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAA36808.1 GL340307</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:56 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Suzuki S„ et al Proc. Natl. Acad. Sci. U.S.A. 83 (22), 8614-8618 (1986)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: ITGAV</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: CD51, MSK8, VNRA, VTNR</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: antigen identified by monoclonal antibody L230; integrin alpha-V; integrin alphaVbeta3; integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51); vitronectin receptor subunit alpha (40) ITGB6 (Integrin, beta 6)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no NM_000888</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_000888.3 Gl:9966771</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 27, 2012 12:46 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_000879</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_000879.2 GI:9625002</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 27, 2012 12:46 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Sheppard D.J., et al Biol. Chem. 265 (20), 11502-11507 (1990)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: ITGB6</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: integrin beta-6</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">Biogen: US 7,943,742 - Hybridoma clones 6.3G9 and 6.8G6 were deposited with the ATCC, accession numbers ATCC PTA-3649 and -3645, respectively.</div>
    <div class="description-paragraph style-scope patent-text">Biogen: US7,465,449 - In some embodiments, the antibody comprises the same heavy and light chain polypeptide sequences as an antibody produced by hybridoma 6.1A8, 6.3G9, 6.8G6, 6.2B1, 6.2B10, 6.2A1, 6.2E5, 7.1G10, 7.7G5, or7.1C5.</div>
    <div class="description-paragraph style-scope patent-text">Centocor (J&amp;J): US7,550,142; US7,163,681</div>
    <div class="description-paragraph style-scope patent-text">For example in US 7,550,142 - an antibody having human heavy chain and human light chain variable regions comprising the amino acid sequences shown in SEQ ID NO: 7 and SEQ ID NO: 8.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Seattle Genetics: 15H3 (Ryan MC., et al Cancer Res April 15, 2012; 72(8 Supplement): 4630) (41) CEACAM5 (Carcinoembryonic antigen-related cell adhesion molecule 5) Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no M17303</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. M17303.1 GL178676</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:47 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAB59513</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAB59513.1 Gl:178677</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:47 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Beauchemin N„ et al Mol. Cell. Biol. 7 (9), 3221-3230 (1987)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: CEACAM5</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: CD66e, CEA</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: meconium antigen 100</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">AstraZeneca-Medlmmune:US 20100330103; US20080057063;</div>
    <div class="description-paragraph style-scope patent-text">US20020142359</div>
    <div class="description-paragraph style-scope patent-text">- for example an antibody having complementarity determining regions (CDRs) with the following sequences: heavy chain; CDR1 - DNYMH, CDR2 - WIDPENGDTE YAPKFRG, CDR3 - LIYAGYLAMD Y; and light chain CDR1 - SASSSVTYMH, CDR2 - STSNLAS, CDR3 QQRSTYPLT.</div>
    <div class="description-paragraph style-scope patent-text">- Hybridoma 806.077 deposited as European Collection of Cell Cultures (ECACC) deposit no. 96022936.</div>
    <div class="description-paragraph style-scope patent-text">Research Corporation Technologies, lnc.:US5,047,507</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Bayer Corporation: US6,013,772</div>
    <div class="description-paragraph style-scope patent-text">BioAlliance: US7,982,017; US7,674,605 • US 7,674,605</div>
    <div class="description-paragraph style-scope patent-text">- an antibody comprising the heavy chain variable region sequence from the amino acid sequence of SEQ ID NO: 1, and the light chain variable region sequence from the amino acid sequence of SEQ ID NO:2.</div>
    <div class="description-paragraph style-scope patent-text">- an antibody comprising the heavy chain variable region sequence from the amino acid sequence of SEQ ID NO:5, and the light chain variable region sequence from the amino acid sequence of SEQ ID NO:6.</div>
    <div class="description-paragraph style-scope patent-text">Celltech Therapeutics Limited: US5,877,293</div>
    <div class="description-paragraph style-scope patent-text">The Dow Chemical Company: US5,472,693; US6,417,337; US6,333,405 US5,472,693 - for example, ATCC No. CRL-11215 US6,417,337 - for example, ATCC CRL-12208 US6,333,405 - for example, ATCC CRL-12208</div>
    <div class="description-paragraph style-scope patent-text">Immunomedics, Inc: US7,534,431; US7,230,084; US7,300,644; US6,730,300;</div>
    <div class="description-paragraph style-scope patent-text">US20110189085</div>
    <div class="description-paragraph style-scope patent-text">- an antibody having CDRs of the light chain variable region comprise: CDR1 comprises KASQDVGTSVA (SEQ ID NO: 20); CDR2 comprises WTSTRHT (SEQ ID NO: 21); and CDR3 comprises QQYSLYRS (SEQ ID NO: 22);</div>
    <div class="description-paragraph style-scope patent-text">and the CDRs of the heavy chain variable region of said anti-CEA antibody comprise: CDR1 comprises TYWMS (SEQ ID NO: 23); CDR2 comprises EIHPDSSTINYAPSLKD (SEQ ID NO: 24); and CDR3 comprises LYFGFPWFAY (SEQ ID NO: 25).</div>
    <div class="description-paragraph style-scope patent-text">US20100221175; US20090092598; US20070202044; US20110064653; US20090185974; US20080069775.</div>
    <div class="description-paragraph style-scope patent-text">(42) MET (met proto-oncogene; hepatocyte growth factor receptor)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no M35073</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. M35073.1 Gl:187553</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 6, 2012 11:12 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAA59589</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAA59589.1 Gl:553531</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 6, 2012 11:12 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Dean M., et al Nature 318 (6044), 385-388 (1985)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: MET</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: AUTS9, HGFR, RCCP2, c-Met</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: HGF receptor; HGF/SF receptor; SF receptor; hepatocyte growth factor receptor; met proto-oncogene tyrosine kinase; proto-oncogene c-Met; scatter factor receptor; tyrosine-protein kinase Met</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">Abgenix/Pfizer: US20100040629 for example, the antibody produced by hybridoma 13.3.2 having American Type Culture Collection (ATCC) accession number PTA-5026; the antibody produced by hybridoma 9.1.2 having ATCC accession number PTA-5027; the antibody produced by hybridoma 8.70.2 having ATCC accession number PTA-5028; or the antibody produced by hybridoma 6.90.3 having ATCC accession number PTA-5029.</div>
    <div class="description-paragraph style-scope patent-text">Amgen/Pfizer: US20050054019 for example, an antibody comprising a heavy chain having the amino acid sequences set forth in SEQ ID NO: 2 where X2 is glutamate and X4 is serine and a light chain having the amino acid sequence set forth in SEQ ID NO: 4 where X8 is alanine, without the signal sequences; an antibody comprising a heavy chain having the amino acid sequences set forth in SEQ ID NO: 6 and a light chain having the amino acid sequence set forth in SEQ ID NO: 8, without the signal sequences; an antibody comprising a heavy chain having the amino acid sequences set forth in SEQ ID NO: 10 and a light chain having the amino acid</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695 sequence set forth in SEQ ID NO: 12, without the signal sequences; or an antibody comprising a heavy chain having the amino acid sequences set forth in SEQ ID NO: 14 and a light chain having the amino acid sequence set forth in SEQ ID NO: 16, without the signal sequences.</div>
    <div class="description-paragraph style-scope patent-text">Agouron Pharmaceuticals (Now Pfizer): US20060035907</div>
    <div class="description-paragraph style-scope patent-text">Eli Lilly: US20100129369</div>
    <div class="description-paragraph style-scope patent-text">Genentech: US5,686,292; US20100028337; US20100016241; US20070129301; US20070098707; US20070092520, US20060270594; US20060134104; US20060035278; US20050233960; US20050037431</div>
    <div class="description-paragraph style-scope patent-text">US 5,686,292 - for example, ATCC HB-11894 and ATCC HB-11895 US 20100016241 - for example, ATCC HB-11894 (hybridoma 1A3.3.13) or HB11895 (hybridoma 5D5.11.6)</div>
    <div class="description-paragraph style-scope patent-text">National Defense Medical Center, Taiwan: Lu RM., et al Biomaterials. 2011</div>
    <div class="description-paragraph style-scope patent-text">Apr;32(12):3265-74.</div>
    <div class="description-paragraph style-scope patent-text">Novartis: US20090175860</div>
    <div class="description-paragraph style-scope patent-text">- for example, an antibody comprising the sequences of CDR1, CDR2 and CDR3 of heavy chain 4687, wherein the sequences of CDR1, CDR2, and CDR3 of heavy chain 4687 are residues 26-35, 50-65, and 98-102, respectively, of SEQ ID NO: 58; and the sequences of CDR1, CDR2, and CDR3 of light chain 5097, wherein the sequences of CDR1, CDR2, and CDR3 oflight chain 5097 are residues 24-39,55-61, and 94-100 of SEQ ID NO: 37.</div>
    <div class="description-paragraph style-scope patent-text">Pharmacia Corporation: US20040166544</div>
    <div class="description-paragraph style-scope patent-text">Pierre Fabre: US20110239316, US20110097262, US20100115639</div>
    <div class="description-paragraph style-scope patent-text">Sumsung: US 20110129481 - for example a monoclonal antibody produced from a hybridoma cell having accession number KCLRF-BP-00219 or accession number of KCLRF-BP-00223.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">Samsung: US 20110104176 - for example an antibody produced by a hybridoma cell having Accession Number: KCLRF-BP-00220.</div>
    <div class="description-paragraph style-scope patent-text">University of Turin Medical School: DN-30 Pacchiana G., etal J Biol Chem. 2010 Nov 12;285(46):36149-57</div>
    <div class="description-paragraph style-scope patent-text">Van Andel Research Institute: Jiao Y., et al Mol Biotechnol. 2005 Sep;31 (1):41-54.</div>
    <div class="description-paragraph style-scope patent-text">(43) MUC1 (Mucin 1, cell surface associated)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no J05581</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. J05581.1 Gl:188869</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:48 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAA59876</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAA59876.1 Gl:188870</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:48 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">GendlerS.J., et al J. Biol. Chem. 265 (25), 15286-15293 (1990)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: MUC1</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: RP11-263K19.2, CD227, EMA, H23AG, KL-6, MAM6, MUC-1, MUC-1/SEC, MUC-1/X, MUC1/ZD, PEM, PEMT, PUM</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: DF3 antigen; H23 antigen; breast carcinoma-associated antigen DF3; carcinoma-associated mucin; episialin; krebs von den Lungen-6; mucin 1, transmembrane; mucin-1; peanut-reactive urinary mucin; polymorphic epithelial mucin; tumor associated epithelial mucin; tumor-associated epithelial membrane antigen; tumor-associated mucin</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">AltaRex- Quest Pharma Tech: US 6,716,966 - for example an Alt-1 antibody produced by the hybridoma ATCC No PTA-975.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">AltaRex- Quest Pharma Tech: US7,147,850</div>
    <div class="description-paragraph style-scope patent-text">CRT: 5E5 - Sorensen AL., et al Glycobiologyvo\. 16 no. 2 pp. 96-107, 2006; HMFG2 Burchell J., et al Cancer Res., 47, 5476-5482 (1987)</div>
    <div class="description-paragraph style-scope patent-text">Glycotope GT-MAB: GT-MAB 2.5-GEX (Website:</div>
    <div class="description-paragraph style-scope patent-text">http://www.glycotope.com/pipeline/pankomab-gex)</div>
    <div class="description-paragraph style-scope patent-text">Immunogen: US7,202,346</div>
    <div class="description-paragraph style-scope patent-text">- for example, antibody MJ-170: hybridoma cell line MJ-170 ATCC accession no. PTA-5286Monoclonal antibody MJ-171: hybridoma cell line MJ-171 ATCC accession no. PTA-5287; monoclonal antibody MJ172: hybridoma cell line MJ-172 ATCC accession no. PTA-5288; or monoclonal antibody MJ-173: hybridoma cell line MJ-173 ATCC accession no. PTA-5302</div>
    <div class="description-paragraph style-scope patent-text">Immunomedics: US 6,653,104</div>
    <div class="description-paragraph style-scope patent-text">Ramot Tel Aviv Uni: US7,897,351</div>
    <div class="description-paragraph style-scope patent-text">Regents Uni. CA: US 7,183,388; US20040005647; US20030077676.</div>
    <div class="description-paragraph style-scope patent-text">Roche GlycArt: US8,021,856</div>
    <div class="description-paragraph style-scope patent-text">Russian National Cancer Research Center: Imuteran- Ivanov PK., et al Biotechnol J. 2007 Jul;2(7):863-70</div>
    <div class="description-paragraph style-scope patent-text">Technische Univ Braunschweig: (IIB6, HT186-B7, HT186-D11, HT186-G2, HT200-3A-C1, HT220-M-D1, HT220-M-G8) - Thie H„ etal PLoS One. 2011 Jan 14;6(1 ):e15921 (44) CA9 (Carbonic anhydrase IX)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no . X66839</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. X66839.1 GI:1000701</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">100</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Feb 2, 2011 10:15 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. CAA47315</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. CAA47315.1 GI:1000702 Genbank record update date: Feb 2, 2011 10:15 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross references</div>
    <div class="description-paragraph style-scope patent-text">Pastorek J., et al Oncogene 9 (10), 2877-2888 (1994)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: CA9</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: CAIX, MN</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: CA-IX; P54/58N; RCC-associated antigen G250; RCC-associated protein G250; carbonate dehydratase IX; carbonic anhydrase 9; carbonic dehydratase; membrane antigen MN; pMW1; renal cell carcinoma-associated antigen G250</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">Abgenix/Amgen: US20040018198</div>
    <div class="description-paragraph style-scope patent-text">Affibody: Anti-CAIX Affibody molecules (http://www.affibody.com/en/Product-Portfolio/Pipeline/)</div>
    <div class="description-paragraph style-scope patent-text">Bayer: US7,462,696</div>
    <div class="description-paragraph style-scope patent-text">Bayer/Morphosys: 3ee9 mAb - Petrul HM., et al Mol Cancer Ther. 2012 Feb; 11 (2):340-9</div>
    <div class="description-paragraph style-scope patent-text">Harvard Medical School: Antibodies G10, G36, G37, G39, G45, G57, G106, G119, G6, G27, G40 and G125. Xu C., et al PLoS One. 2010 Mar 10;5(3):e9625</div>
    <div class="description-paragraph style-scope patent-text">Institute of Virology, Slovak Academy of Sciences (Bayer) - US5,955,075</div>
    <div class="description-paragraph style-scope patent-text">- for example, M75- ATCC Accession No. HB 11128 or MN12 - ATCC</div>
    <div class="description-paragraph style-scope patent-text">Accession No. HB 11647</div>
    <div class="description-paragraph style-scope patent-text">Institute of Virology, Slovak Academy of Sciences: US7,816,493</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">101</div>
    <div class="description-paragraph style-scope patent-text">- for example the M75 monoclonal antibody that is secreted from the hybridoma VU-M75, which was deposited at the American Type Culture Collection under ATCC No. HB 11128; or the V/10 monoclonal antibody secreted from the hybridoma V/10-VU, which was deposited at the International Depository Authority of the Belgian Coordinated Collection of Microorganisms (BCCM) at the Laboratorium voor Moleculaire Bioloqie-Plasmidencollectie (LMBP) at the Universeit Gent in Gent, Belgium, under Accession No. LMBP 6009CB.</div>
    <div class="description-paragraph style-scope patent-text">Institute of Virology, Slovak Academy of Sciences US20080177046; US20080176310; US20080176258; US20050031623</div>
    <div class="description-paragraph style-scope patent-text">Novartis: US20090252738</div>
    <div class="description-paragraph style-scope patent-text">Wilex: US7,691,375 - for example the antibody produced by the hybridoma cell line DSM ASC 2526.</div>
    <div class="description-paragraph style-scope patent-text">Wilex: US20110123537; Rencarex: Kennett RH., et al Curr Opin Mol Ther. 2003 Feb;5(1 ):70-5</div>
    <div class="description-paragraph style-scope patent-text">Xencor: US20090162382 (45) EGFRvlll (Epidermal growth factor receptor (EGFR), transcript variant 3, Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM_201283</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_201283.1 GL41327733</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 30, 2012 01:47 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_958440</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_958440.1 GL41327734</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 30, 2012 01:47 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Batra SK., et al Cell Growth Differ 1995:6:1251 -1259.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">102</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES:</div>
    <div class="description-paragraph style-scope patent-text">US7,628,986 and US7,736,644 (Amgen)</div>
    <div class="description-paragraph style-scope patent-text">For example, a heavy chain variable region amino acid sequence selected from the group consisting of SEQ ID NO: 142 and variants &amp; a light chain variable region amino acid sequence selected from the group consisting of: SEQ ID NO: 144 and variants.</div>
    <div class="description-paragraph style-scope patent-text">US20100111979 (Amgen)</div>
    <div class="description-paragraph style-scope patent-text">For example, an antibody comprising a heavy chain amino acid sequence comprising:</div>
    <div class="description-paragraph style-scope patent-text">CDR1 consisting of a sequence selected from the group consisting of the amino acid sequences for the CDR1 region of antibodies 13.1.2 (SEQ ID NO: 138), 131 (SEQ ID NO: 2), 170 (SEQ ID NO: 4), 150 (SEQ ID NO: 5), 095 (SEQ ID NO: 7), 250 (SEQ ID NO: 9), 139 (SEQ ID NO: 10), 211 (SEQ ID NO: 12), 124 (SEQ ID NO: 13), 318 (SEQ ID NO: 15), 342 (SEQ ID NO: 16), and 333 (SEQ ID NO: 17); CDR2 consisting of a sequence selected from the group consisting of the amino acid sequences for the CDR2 region of antibodies 13.1.2 (SEQ ID NO: 138), 131 (SEQ ID NO: 2), 170 (SEQ ID NO: 4), 150 (SEQ ID NO: 5), 095 (SEQ ID NO: 7), 250 (SEQ ID NO: 9), 139 (SEQ ID NO: 10), 211 (SEQ ID NO: 12), 124 (SEQ ID NO: 13), 318 (SEQ ID NO: 15), 342 (SEQ ID NO: 16), and 333 (SEQ ID NO: 17); and</div>
    <div class="description-paragraph style-scope patent-text">CDR3 consisting of a sequence selected from the group consisting of the amino acid sequences for the CDR3 region of antibodies 13.1.2 (SEQ ID NO: 138), 131 (SEQ ID NO: 2), 170 (SEQ ID NO: 4), 150 (SEQ ID NO: 5), 095 (SEQ ID NO: 7), 250 (SEQ ID NO: 9), 139 (SEQ ID NO: 10), 211 (SEQ ID NO: 12), 124 (SEQ ID NO: 13), 318 (SEQ ID NO: 15), 342 (SEQ ID NO: 16), and 333 (SEQ ID NO: 17).</div>
    <div class="description-paragraph style-scope patent-text">US20090240038 (Amgen)</div>
    <div class="description-paragraph style-scope patent-text">For example, an antibody having at least one of the heavy or light chain polypeptides comprises an amino acid sequence that is at least 90% identical to the amino acid sequence selected from the group consisting of: SEQ ID NO: 2, SEQ ID NO: 19, SEQ ID NO: 142, SEQ ID NO: 144, and any combination thereof.</div>
    <div class="description-paragraph style-scope patent-text">US20090175887 (Amgen)</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">103</div>
    <div class="description-paragraph style-scope patent-text">For example, an antibody having a heavy chain amino acid sequence selected from the group consisting of the heavy chain amino acid sequence of antibody 13.1.2 (SEQ ID NO: 138), 131 (SEQ ID NO: 2), 170 (SEQ ID NO: 4), 150 (SEQ ID NO: 5), 095 (SEQ ID NO: 7), 250 (SEQ ID NO: 9), 139 (SEQ ID NO: 10), 211 (SEQ ID NO: 12), 124 (SEQ ID NO: 13), 318 (SEQ ID NO: 15), 342 (SEQ ID NO: 16), and 333 (SEQ ID NO: 17).</div>
    <div class="description-paragraph style-scope patent-text">US20090156790 (Amgen)</div>
    <div class="description-paragraph style-scope patent-text">For example, antibody having heavy chain polypeptide and a light chain polypeptide, wherein at least one of the heavy or light chain polypeptides comprises an amino acid sequence that is at least 90% identical to the amino acid sequence selected from the group consisting of: SEQ ID NO: 2, SEQ ID NO: 19, SEQ ID NO: 142, SEQ ID NO: 144, and any combination thereof.</div>
    <div class="description-paragraph style-scope patent-text">US20090155282, US20050059087 and US20050053608 (Amgen)</div>
    <div class="description-paragraph style-scope patent-text">For example, an antibody heavy chain amino acid sequence selected from the group consisting of the heavy chain amino acid sequence of antibody 13.1.2 (SEQ ID NO: 138), 131 (SEQ ID NO: 2), 170 (SEQ ID NO: 4), 150 (SEQ ID NO: 5), 095 (SEQ ID NO: 7), 250 (SEQ ID NO: 9), 139 (SEQ ID NO: 10), 211 (SEQ ID NO: 12), 124 (SEQ ID NO: 13), 318 (SEQ ID NO: 15), 342 (SEQ ID NO: 16), and 333 (SEQ ID NO: 17).</div>
    <div class="description-paragraph style-scope patent-text">MR1-1 (US7,129,332; Duke)</div>
    <div class="description-paragraph style-scope patent-text">For example, a variant antibody having the sequence of SEQ ID NO.18 with the substitutions S98P-T99Y in the CDR3 VH, and F92W in CDR3 VL.</div>
    <div class="description-paragraph style-scope patent-text">L8A4, H10, Y10 (Wikstrand CJ„ et al Cancer Res. 1995 Jul 15;55(14):3140-8; Duke)</div>
    <div class="description-paragraph style-scope patent-text">US20090311803 (Harvard University)</div>
    <div class="description-paragraph style-scope patent-text">For example, SEQ ID NO:9 for antibody heavy chain variable region, and SEQ ID NO: 3 for light chain variable region amino acid sequences</div>
    <div class="description-paragraph style-scope patent-text">US20070274991 (EMD72000, also known as matuzumab; Harvard University)</div>
    <div class="description-paragraph style-scope patent-text">For example, SEQ ID NOs: 3 &amp; 9 for light chain and heavy chain respectively</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">104</div>
    <div class="description-paragraph style-scope patent-text">US6,129,915 (Schering)</div>
    <div class="description-paragraph style-scope patent-text">For example, SEQ. ID NOs: 1, 2, 3, 4, 5 and 6.</div>
    <div class="description-paragraph style-scope patent-text">mAb CH12 - Wang H., et al FASEB J. 2012 Jan;26(1 ):73-80 (Shanghai Cancer Institute).</div>
    <div class="description-paragraph style-scope patent-text">RAbDMvill - Gupta P., et al BMC Biotechnol. 2010 Oct 7;10:72 (Stanford University Medical Center).</div>
    <div class="description-paragraph style-scope patent-text">mAb Ua30 - Ohman L., et al Tumour Biol. 2002 Mar-Apr;23(2):61-9 (Uppsala University).</div>
    <div class="description-paragraph style-scope patent-text">Han DG., et al Nan Fang Yi Ke Da Xue Xue Bao. 2010 Jan;30(1 ):25-9 (Xi'an Jiaotong University).</div>
    <div class="description-paragraph style-scope patent-text">(46) CD33 (CD33 molecule)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. M_23197</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_23197.1 GI:180097</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:47 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAA51948</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAA51948.1 Gl:188098</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:47 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Simmons D., et al J. Immunol. 141 (8), 2797-2800 (1988)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: CD33</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: SIGLEC-3, SIGLEC3, p67</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: CD33 antigen (gp67); gp67; myeloid cell surface antigen CD33; sialic acid binding Ig-like lectin 3; sialic acid-binding Ig-like lectin</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">105</div>
    <div class="description-paragraph style-scope patent-text">H195 (Lintuzumab)- Raza A., et al Leuk Lymphoma. 2009 Aug;50(8):1336-44; US6,759,045 (Seattle Genetics/lmmunomedics) mAb OKT9: Sutherland, D.R. etal. Proc Natl Acad Sci US A 78(7): 4515-4519 1981, Schneider,C., et al J Biol Chem 257, 8516-8522 (1982) mAb E6: Hoogenboom,H.R., et al J Immunol 144, 3211-3217 (1990)</div>
    <div class="description-paragraph style-scope patent-text">US6,590,088 (Human Genome Sciences)</div>
    <div class="description-paragraph style-scope patent-text">For example, SEQ ID NOs: 1 and 2 and ATCC accession no. 97521</div>
    <div class="description-paragraph style-scope patent-text">US7,557,189 (Immunogen)</div>
    <div class="description-paragraph style-scope patent-text">For example, an antibody or fragment thereof comprising a heavy chain variable region which comprises three CDRs having the amino acid sequences of SEQ ID NOs:1-3 and a light chain variable region comprising three CDRs having the amino acid sequences of SEQ ID NOs:4-6.</div>
    <div class="description-paragraph style-scope patent-text">(47) CD19 (CD19 molecule)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM_001178098</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_001178098.1 GI:296010920</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 10, 2012 12:43 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_001171569</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_001171569.1 GI:296010921</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 10, 2012 12:43 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Tedder TF., etal J. Immunol. 143 (2): 712-7 (1989)</div>
    <div class="description-paragraph style-scope patent-text">Other information Official Symbol: CD19 Other Aliases: B4, CVID3</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">106</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: B-lymphocyte antigen CD19; B-lymphocyte surface antigen B4; T-cell surface antigen Leu-12; differentiation antigen CD19</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">Immunogen: HuB4 - Al-Katib AM., etal Clin Cancer Res. 2009 Jun 15;15(12):4038-45.</div>
    <div class="description-paragraph style-scope patent-text">4G7: KOgler M., et al Protein Eng Des Sel. 2009 Mar;22(3):135-47</div>
    <div class="description-paragraph style-scope patent-text">For example, sequences in Fig. 3 of of Knappik, A. et al. J Mol Biol 2000</div>
    <div class="description-paragraph style-scope patent-text">Feb;296(1 ):57-86</div>
    <div class="description-paragraph style-scope patent-text">AstraZeneca /Medlmmune: MEDI-551 - Herbst R., et al J Pharmacol Exp Ther. 2010 Oct;335(1 ):213-22</div>
    <div class="description-paragraph style-scope patent-text">Glenmark Pharmaceuticals: GBR-401 - Hou S., etal Mol Cancer Ther November 2011 10 (Meeting Abstract Supplement) C164</div>
    <div class="description-paragraph style-scope patent-text">US7,109,304 (Immunomedics)</div>
    <div class="description-paragraph style-scope patent-text">For example, an antibody comprising the sequence of hA19Vk (SEQ ID NO:7) and the sequence of hA19VH (SEQ ID NO:10)</div>
    <div class="description-paragraph style-scope patent-text">US7,902,338 (Immunomedics)</div>
    <div class="description-paragraph style-scope patent-text">For example, an antibody or antigen-binding fragment thereof that comprises the light chain complementarity determining region CDR sequences CDR1 of SEQ ID NO: 16 (KASQSVDYDGDSYLN); CDR2 of SEQ ID NO: 17 (DASNLVS); and CDR3 of SEQ ID NO: 18 (QQSTEDPWT) and the heavy chain CDR sequences CDR1 of SEQ ID NO: 19 (SYWMN); CDR2 of SEQ ID NO: 20 (QIWPGDGDTNYNGKFKG) and CDR3 of SEQ ID NO: 21 (RETTTVGRYYYAMDY) and also comprises human antibody framework (FR) and constant region sequences with one or more framework region amino acid residues substituted from the corresponding framework region sequences of the parent murine antibody, and wherein said substituted FR residues comprise the substitution of serine for phenylalanine at Kabat residue 91 of the heavy chain variable region.</div>
    <div class="description-paragraph style-scope patent-text">Medarex: MDX-1342 - Cardarelli PM., et al Cancer Immunol Immunother. 2010 Feb;59(2):257-65.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">107</div>
    <div class="description-paragraph style-scope patent-text">MorphoSys /Xencor: MOR-208/XmAb-5574 - Zalevsky J., et al Blood. 2009 Apr 16; 113(16):3735-43</div>
    <div class="description-paragraph style-scope patent-text">US7,968,687 (Seattle Genetics)</div>
    <div class="description-paragraph style-scope patent-text">An antibody or antigen-binding fragment comprising a heavy chain variable domain comprising the amino acid sequence of SEQ ID NO:9 and a light chain variable domain comprising the amino acid sequence of SEQ ID NO: 24.</div>
    <div class="description-paragraph style-scope patent-text">4G7 chim - Lang P., et al Blood. 2004 May 15; 103(10):3982-5 (University of Tubingen)</div>
    <div class="description-paragraph style-scope patent-text">For example, fig. 6 and SEQ ID No: 80 of US20120082664</div>
    <div class="description-paragraph style-scope patent-text">Zhejiang University School of Medicine: 2E8 - Zhang J., et al J Drug Target. 2010 Nov; 18(9):675-8 (48) IL2RA (Interleukin 2 receptor, alpha); NCBI Reference Sequence: NM_000417.2); Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM_000417</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_000417.2 GI:269973860</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 09, 2012 04:59 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_000408</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_000408.1 Gl:4557667</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 09, 2012 04:59 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Kuziel W.A., et al J. Invest. Dermatol. 94 (6 SUPPL), 27S-32S (1990)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: IL2RA</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: RP11-536K7.1, CD25, IDDM10, IL2R, TCGFR</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: FIL-2 receptor subunit alpha; IL-2-RA; IL-2R subunit alpha; IL2-RA; TAC antigen; interleukin-2 receptor subunit alpha; p55</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">108</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">US6,383,487 (Novartis/UCL: Baxilisimab [Simulect])</div>
    <div class="description-paragraph style-scope patent-text">US6,521,230 (Novartis/UCL: Baxilisimab [Simulect])</div>
    <div class="description-paragraph style-scope patent-text">For example, an antibody having an antigen binding site comprises at least one domain which comprises CDR1 having the amino acid sequence in SEQ. ID. NO: 7, CDR2 having the amino acid sequence in SEQ. ID. NO: 8, and CDR3 chaving the amino acid sequence in SEQ. ID. NO: 9; or said CDR1, CDR2 and CDR3 taken in sequence as a whole comprise an amino acid sequence which is at least 90% identical to SEQ. ID. NOs: 7, 8 and 9 taken in sequence as a whole.</div>
    <div class="description-paragraph style-scope patent-text">Daclizumab - Rech AJ., et al Ann N YAcad Sci. 2009 Sep; 1174:99-106 (Roche) (49) AXL (AXL receptor tyrosine kinase)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. M76125</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. M76125.1 GL292869</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:53 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAA61243</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAA61243.1 GL29870</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:53 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">O'Bryan J.P., et al Mol. Cell. Biol. 11 (10), 5016-5031 (1991); Bergsagel P.L., et al J. Immunol. 148 (2), 590-596 (1992)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: AXL</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: JTK11, UFO</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: AXL oncogene; AXL transforming sequence/gene; oncogene AXL; tyrosine-protein kinase receptor UFO</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">109</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">YW327.6S2 - Ye X., et al Oncogene. 2010 Sep 23;29(38):5254-64. (Genentech)</div>
    <div class="description-paragraph style-scope patent-text">BergenBio: BGB324 (http://www.bergenbio.com/BGB324) (50) CD30 - TNFRSF8 (Tumor necrosis factor receptor superfamily, member 8) Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. M83554</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. M83554.1 GI:180095</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:53 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAA51947</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAA51947.1 Gl:180096</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:53 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Durkop H„ etal Cell 68 (3), 421-427 (1992)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: TNFRSF8</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: CD30, D1S166E, Ki-1</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: CD30L receptor; Ki-1 antigen; cytokine receptor CD30; lymphocyte activation antigen CD30; tumor necrosis factor receptor superfamily member 8 (51) BCMA (B-cell maturation antigen) - TNFRSF17 (Tumor necrosis factor receptor superfamily, member 17)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. Z29574</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. Z29574.1 Gl:471244</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Feb 02, 2011 10:40 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. CAA82690</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. CAA82690.1 Gl:471245</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">110</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Feb 02, 2011 10:40 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Laabi Y., et al Nucleic Acids Res. 22 (7), 1147-1154 (1994)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: TNFRSF17</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: BCM, BCMA, CD269</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: B cell maturation antigen; B-cell maturation factor; B-cell maturation protein; tumor necrosis factor receptor superfamily member 17 (52) CT Ags - CTA (Cancer Testis Antigens)</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Fratta E., et al. Mol Oncol. 2011 Apr;5(2): 164-82; Lim SH., at al Am J Blood Res. 2012;2(1):29-35.</div>
    <div class="description-paragraph style-scope patent-text">(53) CD174 (Lewis Y) - FUT3 (fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM000149</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM000149.3 GI:148277008</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 26, 2012 04:49 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_000140</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_000140.1 GI:4503809</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 26, 2012 04:49 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Kukowska-Latallo,J.F., et al Genes Dev. 4 (8), 1288-1303 (1990)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: FUT3</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">111</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: CD174, FT3B, FucT-lll, LE, Les</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: Lewis FT; alpha-(1,3/1,4)-fucosyltransferase; blood group Lewis alpha-4-fucosyltransferase; fucosyltransferase III; galactoside 3(4)-L-fucosyltransferase (54) CLEC14A (C-type lectin domain family 14, member A; Genbank accession no. NM175060)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM175060</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM175060.2 Gl:371123930</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Apr 01, 2012 03:34 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_778230</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_778230.1 GL28269707</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Apr 01, 2012 03:34 PM</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: CLEC14A</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: UNQ236/PRO269, C14orf27, CEG1, EGFR-5</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: C-type lectin domain family 14 member A; CIECT and EGF-like domain containing protein; epidermal growth factor receptor 5 (55) GRP78 - HSPA5 (heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM005347</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM005347.4 GI:305855105</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 30, 2012 01:42 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_005338</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_005338.1 GI:16507237</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 30, 2012 01:42 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Ting J., et al DNA 7 (4), 275-286 (1988)</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">112</div>
    <div class="description-paragraph style-scope patent-text">Other infromation</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: HSPA5</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: BIP, GRP78, MIF2</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: 78 kDa glucose-regulated protein; endoplasmic reticulum lumenal Ca(2+)-binding protein grp78; immunoglobulin heavy chain-binding protein (56) CD70 (CD70 molecule) L08096</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. L08096</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. L08096.1 GL307127</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2012 08:54 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAA36175</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAA36175.1 GL307128</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2012 08:54 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Goodwin R.G., et al Cell 73 (3), 447-456 (1993)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: CD70</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: CD27L, CD27LG, TNFSF7</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: CD27 ligand; CD27-L; CD70 antigen; Ki-24 antigen; surface antigen CD70; tumor necrosis factor (ligand) superfamily, member 7; tumor necrosis factor ligand superfamily member 7</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">MDX-1411 against CD70 (Medarex) h1F6 (Oflazoglu, E., et al, Clin Cancer Res. 2008 Oct 1; 14(19):6171 -80; Seattle Genetics) For example, see US20060083736 SEQ ID NOs: 1, 2, 11 and 12 and Fig. 1.</div>
    <div class="description-paragraph style-scope patent-text">(57) Stem Cell specific antigens. For example:</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">113 • 5T4 (see entry (63) below) • CD25 (see entry (48) above) • CD32 o Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. ABK42161</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. ABK42161.1 Gl:117616286</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jul 25, 2007 03:00 PM • LGR5/GPR49 o Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM_003667</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_003667.2 Gl:24475886</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jul 22, 2012 03:38 PM o Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_003658</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_003658.1 GI:4504379</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jul 22, 2012 03:38 PM • Prominin/CD133 o Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM_006017</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_006017.2 Gl:224994187</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 30, 2012 01:47 PM o Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_006008</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_006008.1 Gl:5174387</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 30, 2012 01:47 PM (58) ASG-5</div>
    <div class="description-paragraph style-scope patent-text">Cross-references (Smith L.M., et.al AACR 2010 Annual Meeting (abstract #2590); Gudas J.M., et.al. AACR 2010 Annual Meeting (abstract #4393)</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">Anti-AGS-5 Antibody: M6.131 (Smith, L.M., et.al AACR 2010 Annual Meeting (abstract #2590)</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">114 (59) ENPP3 (Ectonucleotide pyrophosphatase/phosphodiesterase 3) Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AF005632</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AF005632.2 Gl:4432589</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 10, 2010 09:41 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAC51813</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAC51813.1 GI:2465540</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 10, 2010 09:41 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Jin-Hua P., et al Genomics 45 (2), 412-415 (1997)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: ENPP3</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: RP5-988G15.3, B10, CD203c, NPP3, PD-IBETA, PDNP3</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: E-NPP 3; dJ1005H11.3 (phosphodiesterase l/nucleotide pyrophosphatase 3); dJ914N13.3 (phosphodiesterase l/nucleotide pyrophosphatase 3); ectonucleotide pyrophosphatase/phosphodiesterase family member 3; gp130RB13-6; phosphodiesterase I beta; phosphodiesterase l/nucleotide pyrophosphatase 3; phosphodiesterase-l beta (60) PRR4 (Proline rich 4 (lacrimal))</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM_007244</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_007244.2 Gl:154448885</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 28, 2012 12:39 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_009175</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_009175.2 Gl:154448886</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 28, 2012 12:39 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">115</div>
    <div class="description-paragraph style-scope patent-text">Dickinson D.P., et al Invest. Ophthalmol. Vis. Sci. 36 (10), 2020-2031 (1995)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: PRR4</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: LPRP, PROL4</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: lacrimal proline-rich protein; nasopharyngeal carcinoma-associated proline-rich protein 4; proline-rich polypeptide 4; proline-rich protein 4 (61) GCC - GUCY2C (guanylate cyclase 2C (heat stable enterotoxin receptor) Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM_004963</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_004963.3 GI:222080082</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 02, 2012 01:50 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_004954</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_004954.2 GI:222080083</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 02, 2012 01:50 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">De Sauvage F.J., et al J. Biol. Chem. 266 (27), 17912-17918 (1991); Singh S., etal Biochem. Biophys. Res. Commun. 179 (3), 1455-1463 (1991)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: GUCY2C</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: DIAR6, GUC2C, MUCIL, STAR</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: GC-C; STA receptor; guanylyl cyclase C; hSTAR; heat-stable enterotoxin receptor; intestinal guanylate cyclase (62) Liv-1 - SLC39A6 (Solute carrier family 39 (zinc transporter), member 6) Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. U41060</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. U41060.2 01:12711792</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Nov 30, 2009 04:35 PM</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">116</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAA96258</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAA96258.2 GL12711793</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Nov 30, 2009 04:35 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Taylor KM., et al Biochim Biophys Acta. 2003 Apr 1 ;1611(1-2):16-30</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: SLC39A6</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: LIV-1</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: LIV-1 protein, estrogen regulated; ZIP-6; estrogen-regulated protein LIV-1; solute carrier family 39 (metal ion transporter), member 6; solute carrier family 39 member 6; zinc transporter ZIP6; zrt- and Irt-like protein 6 (63) 5T4, Trophoblast glycoprotein, TPBG - TPBG (trophoblast glycoprotein) Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AJ012159</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AJ012159.1 GL3805946</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Feb 01,2011 10:27 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. CAA09930</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. CAA09930.1 Gl:3805947</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Feb 01,2011 10:27 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">King K.W.,et al Biochim. Biophys. Acta 1445 (3), 257-270 (1999)</div>
    <div class="description-paragraph style-scope patent-text">Other information • Official Symbol: TPBG • Other Aliases: 5T4, 5T4AG, M6P1 • Other Designations: 5T4 oncofetal antigen; 5T4 oncofetal trophoblast glycoprotein; 5T4 oncotrophoblast glycoprotein</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">117 (64) CD56 - NCMA1 (Neural cell adhesion molecule 1) Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM_000615</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_000615.6 Gl:336285433 Genbank record update date: Sep 23, 2012 02:32 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_000606</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_000606.3 GI:94420689 Genbank record update date: Sep 23, 2012 02:32 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Dickson,G„ et al, Cell 50 (7), 1119-1130 (1987)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: NCAM1</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: CD56, MSK39, NCAM</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: antigen recognized by monoclonal antibody 5.1 H11; neural cell adhesion molecule, NCAM</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">Immunogen: HuN901 (Smith SV., et al CurrOpin Mol Ther. 2005 Aug;7(4):394-401)</div>
    <div class="description-paragraph style-scope patent-text">For example, see humanized from murine N901 antibody. See Fig. 1b and 1e of Roguska, M.A., et al. Proc Natl Acad Sci USA Feb 1994;91:969-973.</div>
    <div class="description-paragraph style-scope patent-text">(65) CanAg (Tumor associated antigen CA242)</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Haglund C., etal 6/-J Cancer 60:845-851, 1989;Baeckstrom D., etal J Biol Chem 266:21537-21547, 1991</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES huC242 (Tolcher AW et al., J Clin Oncol. 2003 Jan 15;21(2):211-22; Immunogen)</div>
    <div class="description-paragraph style-scope patent-text">For example, see US20080138898A1 SEQ ID NO: 1 and 2</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">118 (66) F0LR1 (Folate Receptor 1)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. J05013</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. J05013.1 Gl: 182417</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:47 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAA35823</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAA35823.1 Gl: 182418</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:47 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Elwood P.C., et al J. Biol. Chem. 264 (25), 14893-14901 (1989)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: FOLR1</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: FBP, FOLR</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: FR-alpha; KB cells FBP; adult folate-binding protein; folate binding protein; folate receptor alpha; folate receptor, adult; ovarian tumor-associated antigen MOv18</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">M9346A - Whiteman KR., et al Cancer Res April 15, 2012; 72(8 Supplement): 4628 (Immunogen) (67) GPNMB (Glycoprotein (transmembrane) nmb)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. X76534</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. X76534.1 GI:666042</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Feb 02, 2011 10:10 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. CAA54044</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. CAA54044.1 Gl:666043</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Feb 02, 2011 10:10 AM</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">119</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Weterman M.A., et al Int. J. Cancer 60 (1), 73-81 (1995)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: GPNMB</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: UNQ1725/PRO9925, HGFIN, NMB</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: glycoprotein NMB; glycoprotein nmb-like protein; osteoactivin; transmembrane glycoprotein HGFIN; transmembrane glycoprotein NMB</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">Celldex Therapeutics: CR011 (Tse KF., et al Clin Cancer Res. 2006 Feb 15; 12(4): 1373-82) For example, see EP1827492B1 SEQ ID NO: 22, 24, 26, 31, 33 and 35 (68) TIM-1 - HAVCR1 (Hepatitis A virus cellular receptor 1)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AF043724</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AF043724.1 Gl:2827453</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 10, 2010 06:24 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAC39862</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAC39862.1 Gl:2827454</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 10, 2010 06:24 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Feigelstock D„ et al J. Virol. 72 (8), 6621-6628 (1998)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: HAVCR1</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: HAVCR, HAVCR-1, KIM-1, KIM1, TIM, TIM-1, TIM1, TIMD-1, TIMD1 Other Designations: T cell immunoglobin domain and mucin domain protein 1; T-cell membrane protein 1; kidney injury molecule 1 (69) RG-1/Prostate tumor target Mindin - Mindin/RG-1</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">120</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Parry R., et al Cancer Res. 2005 Sep 15;65(18):8397-405 (70) B7-H4 - VTCN1 (V-set domain containing T cell activation inhibitor 1 Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. BX648021</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. BX648021.1 GI:34367180</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Feb 02, 2011 08:40 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Sica GL., et al Immunity. 2003 Jun; 18(6):849-61</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: VTCN1</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: RP11-229A19.4, B7-H4, B7H4, B7S1, B7X, B7h.5, PRO1291, VCTN1 Other Designations: B7 family member, H4; B7 superfamily member 1; T cell costimulatory molecule B7x; T-cell costimulatory molecule B7x; V-set domain-containing T-cell activation inhibitor 1; immune costimulatory protein B7-H4 (71) PTK7 (PTK7 protein tyrosine kinase 7)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AF447176</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AF447176.1 GI:17432420 Genbank record update date: Nov 28, 2008 01:51 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAL39062</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAL39062.1 Gl:17432421 Genbank record update date: Nov 28, 2008 01:51 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Park S.K.,et al J. Biochem. 119 (2), 235-239 (1996)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">121</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: PTK7</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: CCK-4, CCK4</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: colon carcinoma kinase 4; inactive tyrosine-protein kinase 7; pseudo tyrosine kinase receptor 7; tyrosine-protein kinase-like 7 (72) CD37 (CD37 molecule)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM_001040031</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_001040031.1 GI:91807109</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jul 29, 2012 02:08 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_001035120</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_001035120.1 Gl:91807110</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jul 29, 2012 02:08 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Schwartz-Albiez R., et al J. Immunol. 140 (3), 905-914 (1988)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: CD37</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: GP52-40, TSPAN26</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: CD37 antigen; cell differentiation antigen 37; leukocyte antigen CD37; leukocyte surface antigen CD37; tetraspanin-26; tspan-26</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">Boehringer Ingelheim: mAb37.1 (Heider KH., et al Blood. 2011 Oct 13; 118(15):4159-68)</div>
    <div class="description-paragraph style-scope patent-text">Trubion: CD37-SMIP (G28-1 scFv-lg) ((Zhao X., et al Blood. 2007;110: 2569-2577)</div>
    <div class="description-paragraph style-scope patent-text">For example, see US20110171208A1 SEQ ID NO: 253</div>
    <div class="description-paragraph style-scope patent-text">Immunogen: K7153A (Decked J., et al Cancer Res April 15, 2012; 72(8</div>
    <div class="description-paragraph style-scope patent-text">Supplement): 4625) (73) CD138- SDC1 (syndecan 1)</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">122</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AJ551176</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AJ551176.1 GL29243141</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Feb 01,2011 12:09 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. CAD80245</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. CAD80245.1 GL29243142</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Feb 01,2011 12:09 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">O'Connell FP„ et al Am J Clin Pathol. 2004 Feb; 121 (2):254-63</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: SDC1</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: CD138, SDC, SYND1, syndecan</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: CD138 antigen; heparan sulfate proteoglycan fibroblast growth factor receptor; syndecan proteoglycan 1; syndecan-1</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">Biotest: chimerized MAb (nBT062) - (Jagannath S., et al Poster ASH #3060, 2010; WIPO Patent Application WO/2010/128087)</div>
    <div class="description-paragraph style-scope patent-text">For example, see US20090232810 SEQ ID NO: 1 and 2</div>
    <div class="description-paragraph style-scope patent-text">Immunogen: B-B4 (Tassone P., et al Blood 104_3688-3696)</div>
    <div class="description-paragraph style-scope patent-text">For example, see US20090175863A1 SEQ ID NO: 1 and 2 (74) CD74 (CD74 molecule, major histocompatibility complex, class II invariant chain) Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM_004355</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_004355.1 GL343403784</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 23, 2012 02:30 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_004346</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">123</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_004346.1 GI:10835071</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 23, 2012 02:30 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Kudo,J., et al Nucleic Acids Res. 13 (24), 8827-8841 (1985)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: CD74</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: DHLAG, HLADG, II, la-GAMMA</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated); HLA class II histocompatibility antigen gamma chain; HLA-DR antigens-associated invariant chain; HLA-DR-gamma; la-associated invariant chain; MHC HLA-DR gamma chain; gamma chain of class II antigens; p33</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">Immunomedics: hLL1 (Milatuzumab,) - Berkova Z., et al Expert Opin Investig Drugs. 2010 Jan;19(1):141-9)</div>
    <div class="description-paragraph style-scope patent-text">For example, see US20040115193 SEQ ID NOs: 19, 20, 21, 22, 23 and 24</div>
    <div class="description-paragraph style-scope patent-text">Genmab: HuMax-CD74 (see website) (75) Claudius - CLs (Claudius)</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Offner S., et al Cancer Immunol Immunother. 2005 May; 54(5):431-45, Suzuki H., et al Ann N Y Acad Sci. 2012 Jul;1258:65-70)</div>
    <div class="description-paragraph style-scope patent-text">In humans, 24 members of the family have been described - see literature reference.</div>
    <div class="description-paragraph style-scope patent-text">(76) EGFR (Epidermal growth factor receptor)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM_005228</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_005228.3 Gl:41927737</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 30, 2012 01:47 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">124</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_005219</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_005219.2 GI:29725609</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 30, 2012 01:47 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Dhomen NS., etal Crit Rev Oncog. 2012;17(1 ):31-50</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: EGFR</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: ERBB, ERBB1, HER1, PIG61, mENA</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: avian erythroblastic leukemia viral (v-erb-b) oncogene homolog; cell growth inhibiting protein 40; cell proliferation-inducing protein 61; proto-oncogene c-ErbB-1; receptor tyrosine-protein kinase erbB-1</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">BMS: Cetuximab (Erbitux) - Broadbridge VT., et al Expert Rev Anticancer Ther. 2012 May;12(5):555-65.</div>
    <div class="description-paragraph style-scope patent-text">For example, see US6217866 - ATTC deposit No. 9764.</div>
    <div class="description-paragraph style-scope patent-text">Amgen: Panitumumab (Vectibix) - Argiles G., et al Future Oncol. 2012 Apr;8(4):373-89 For example, see US6235883 SEQ ID NOs: 23-38.</div>
    <div class="description-paragraph style-scope patent-text">Genmab: Zalutumumab - Rivera F., et al Expert Opin Biol Ther. 2009 May;9(5):667-74.</div>
    <div class="description-paragraph style-scope patent-text">YM Biosciences: Nimotuzumab - Ramakrishnan MS., et al MAbs. 2009 Jan-Feb;1(1):41-8. For example, see US5891996 SEQ ID NOs: 27-34.</div>
    <div class="description-paragraph style-scope patent-text">(77) Her3 (ErbB3) - ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian))</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. M34309</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. M34309.1 GI:183990</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:47 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">125</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAA35979</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAA35979.1 GI:306841</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:47 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Plowman,G.D., et al., Proc. Natl. Acad. Sci. U.S.A. 87 (13), 4905-4909 (1990)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: ERBB3</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: ErbB-3, HER3, LCCS2, MDA-BF-1, c-erbB-3, c-erbB3, erbB3-S, p180ErbB3, p45-sErbB3, p85-sErbB3</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: proto-oncogene-like protein c-ErbB-3; receptor tyrosine-protein kinase erbB-3; tyrosine kinase-type cell surface receptor HER3</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">Merimack Pharma : MM-121 (Schoeberl B., et al Cancer Res. 2010 Mar 15;70(6):24852494)</div>
    <div class="description-paragraph style-scope patent-text">For example, see US2011028129 SEQ ID NOs: 1, 2, 3, 4, 5, 6, 7 and 8.</div>
    <div class="description-paragraph style-scope patent-text">(78) RON - MST1R (macrophage stimulating 1 receptor (c-met-related tyrosine kinase)) Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. X70040</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. X70040.1 GI:36109</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Feb 02, 2011 10:17 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. CCA49634</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. CCA49634.1 Gl:36110</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Feb 02, 2011 10:17 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Ronsin C., etal Oncogene 8 (5), 1195-1202 (1993)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: MST1R</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">126</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: CD136, CDw136, PTK8, RON</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: MSP receptor; MST1R variant RON30; MST1R variant RON62; PTK8 protein tyrosine kinase 8; RON variant E2E3; c-met-related tyrosine kinase; macrophagestimulating protein receptor; p185-Ron; soluble RON variant 1; soluble RON variant 2; soluble RON variant 3; soluble RONvariant 4 (79) EPHA2 (EPH receptor A2)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. BC037166</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. BC037166.2 GL33879863</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 06, 2012 01:59 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAH37166</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAH37166.1 GL22713539</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 06, 2012 01:59 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Strausberg R.L., et al Proc. Natl. Acad. Sci. U.S.A. 99 (26), 16899-16903 (2002)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: EPHA2</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: ARCC2, CTPA, CTPP1, ECK</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: ephrin type-A receptor 2; epithelial cell receptor protein tyrosine kinase; soluble EPHA2 variant 1; tyrosine-protein kinase receptor ECK</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">Medimmune: 1C1 (Lee JW., et al Clin Cancer Res. 2010 May 1;16(9):2562-2570) For example, see US20090304721A1 Fig. 7 and 8.</div>
    <div class="description-paragraph style-scope patent-text">(80) CD20 - MS4A1 (membrane-spanning 4-domains, subfamily A, member 1) Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. M27394</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. M27394.1 GL179307</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Nov 30, 2009 11:16 AM</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">127</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAA35581</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAA35581.1 Gl:179308</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Nov 30, 2009 11:16 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Tedder T.F., et al Proc. Natl. Acad. Sci. U.S.A. 85 (1), 208-212 (1988)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: MS4A1</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: B-lymphocyte antigen CD20; B-lymphocyte cell-surface antigen B1; CD20 antigen; CD20 receptor; leukocyte surface antigen Leu-16</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">Genentech/Roche: Rituximab - Abdulla NE., et al BioDrugs. 2012 Apr 1;26(2):71-82.</div>
    <div class="description-paragraph style-scope patent-text">For example, see US5736137, ATCC deposit No. HB-69119.</div>
    <div class="description-paragraph style-scope patent-text">GSK/Genmab: Ofatumumab - Nightingale G., et al Ann Pharmacother. 2011 Oct;45(10):1248-55.</div>
    <div class="description-paragraph style-scope patent-text">For example, see US20090169550A1 SEQ ID NOs: 2, 4 and 5.</div>
    <div class="description-paragraph style-scope patent-text">Immunomedics: Veltuzumab - Goldenberg DM., et al Leuk Lymphoma. 2010 May;51 (5):747-55.</div>
    <div class="description-paragraph style-scope patent-text">For example, see US7919273B2 SEQ ID NOs: 1,2,3,4,5 and 6.</div>
    <div class="description-paragraph style-scope patent-text">(81) Tenascin C - TNC (Tenascin C)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM_002160</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_002160.3 GL340745336</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 23, 2012 02:33 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_002151</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">128</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_002151.2 GL153946395</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 23, 2012 02:33 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Nies D.E., et al J. Biol. Chem. 266 (5), 2818-2823 (1991); Siri A., et al Nucleic Acids Res. 19 (3), 525-531 (1991)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: TNC</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: 150-225, GMEM, GP, HXB, JI, TN, TN-C</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: GP 150-225; cytotactin; glioma-associated-extracellular matrix antigen; hexabrachion (tenascin); myotendinous antigen; neuronectin; tenascin; tenascin-C isoform 14/AD1/16</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">Philogen : G11 (von Lukowicz T., et al J Nucl Med. 2007 Apr;48(4):582-7) and F16 (Pedretti M., et al Lung Cancer. 2009 Apr;64(1 ):28-33)</div>
    <div class="description-paragraph style-scope patent-text">For example, see US7968685 SEQ ID NOs: 29, 35, 45 and 47.</div>
    <div class="description-paragraph style-scope patent-text">(82) FAP (Fibroblast activation protein, alpha)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. U09278</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. U09278.1 GL1888315</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 09:22 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAB49652</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAB49652.1 Gl: 1888316</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 09:22 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Scanlan,M.J.,et al Proc. Natl. Acad. Sci. U.S.A. 91 (12), 5657-5661 (1994)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: FAP</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">129</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: DPPIV, FAPA</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: 170 kDa melanoma membrane-bound gelatinase; integral membrane serine protease; seprase (83) DKK-1 (Dickkopf 1 homolog (Xenopus laevis)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM_012242</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_012242.2 Gl:61676924</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 30, 2012 01:48 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_036374</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_036374.1 Gl:7110719</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 30, 2012 01:48 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Fedi P. et al J. Biol. Chem. 274 (27), 19465-19472 (1999)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: DKK1</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: UNQ492/PR01008, DKK-1, SK</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: dickkopf related protein-1; dickkopf-1 like; dickkopf-like protein 1; dickkopf-related protein 1; hDkk-1</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">Novartis: BHQ880 (Fulciniti M„ etal Blood. 2009 Jul 9;114(2):371-379)</div>
    <div class="description-paragraph style-scope patent-text">For example, see US20120052070A1 SEQ ID NOs: 100 and 108.</div>
    <div class="description-paragraph style-scope patent-text">(84) CD52 (CD52 molecule)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM_001803</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_001803.2 GL68342029</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Sep 30, 2012 01:48 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">130</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_001794</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_001794.2 GI:68342030 Genbank record update date: Sep 30, 2012 01:48 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Xia M.Q., et al Eur. J. Immunol. 21 (7), 1677-1684 (1991)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: CD52</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: CDW52</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: CAMPATH-1 antigen; CD52 antigen (CAMPATH-1 antigen); CDW52 antigen (CAMPATH-1 antigen); Cambridge pathology 1 antigen; epididymal secretory protein E5; he5; human epididymis-specific protein 5</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">Alemtuzumab (Campath) - Skoetz N., et al Cochrane Database Syst Rev. 2012 Feb 15;2:CD008078.</div>
    <div class="description-paragraph style-scope patent-text">For example, see Drugbank Acc. No. DB00087 (BIOD00109, BTD00109) (85) CS1 - SLAMF7 (SLAM family member 7)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NM_021181</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NM_021181.3 01:1993571</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 29, 2012 11:24 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. NP_067004</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. NP_067004.3 GL19923572</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 29, 2012 11:24 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Boles K.S., et al Immunogenetics 52 (3-4), 302-307 (2001)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: SLAMF7</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">131</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: UNQ576/PRO1138, 19A, CD319, CRACC, CS1</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: 19A24 protein; CD2 subset 1; CD2-like receptor activating cytotoxic cells; CD2-like receptor-activating cytotoxic cells; membrane protein FOAP-12; novel LY9 (lymphocyte antigen 9) like protein; protein 19A</div>
    <div class="description-paragraph style-scope patent-text">ANTIBODIES</div>
    <div class="description-paragraph style-scope patent-text">BMS: elotuzumab/Hul_uc63 (Benson DM., et al J Clin Oncol. 2012 Jun 1 ;30(16):20132015)</div>
    <div class="description-paragraph style-scope patent-text">For example, see US20110206701 SEQ ID NOs: 9, 10, 11, 12, 13, 14, 15 and 16.</div>
    <div class="description-paragraph style-scope patent-text">(86) Endoglin - ENG (Endoglin)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AF035753</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AF035753.1 GI:3452260</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 10, 2010 06:36 PM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAC32802</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAC32802.1 Gl:3452261</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Mar 10, 2010 06:36 PM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Rius C„ etal Blood 92 (12), 4677-4690 (1998)</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: ENG</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: RP11-228B15.2, CD105, END, HHT1, ORW, 0RW1 Other Designations: CD105 antigen (87) Annexin A1 - ANXA1 (Annexin A1)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. X05908</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. X05908.1 Gl:34387</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Feb 02, 2011 10:02 AM</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">132</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. CCA29338</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. CCA29338.1 GL34388 Genbank record update date: Feb 02, 2011 10:02 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Wallner B.P.,et al Nature 320 (6057), 77-81 (1986)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol: ANXA1</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: RP11-71A24.1, ANX1, LPC1</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: annexin I (lipocortin I); annexin-1; calpactin II; calpactin-2; chromobindin-9; lipocortin I; p35; phospholipase A2 inhibitory protein (88) V-CAM (CD106) - VCAM1 (Vascular cell adhesion molecule 1)</div>
    <div class="description-paragraph style-scope patent-text">Nucleotide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. M60335</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. M60335.1 GL340193</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:56 AM</div>
    <div class="description-paragraph style-scope patent-text">Polypeptide</div>
    <div class="description-paragraph style-scope patent-text">Genbank accession no. AAA61269</div>
    <div class="description-paragraph style-scope patent-text">Genbank version no. AAA61269.1 GL340194</div>
    <div class="description-paragraph style-scope patent-text">Genbank record update date: Jun 23, 2010 08:56 AM</div>
    <div class="description-paragraph style-scope patent-text">Cross-references</div>
    <div class="description-paragraph style-scope patent-text">Hession C„ et al J. Biol. Chem. 266 (11), 6682-6685 (1991)</div>
    <div class="description-paragraph style-scope patent-text">Other information</div>
    <div class="description-paragraph style-scope patent-text">Official Symbol VCAM1</div>
    <div class="description-paragraph style-scope patent-text">Other Aliases: CD106, INCAM-100</div>
    <div class="description-paragraph style-scope patent-text">Other Designations: CD106 antigen; vascular cell adhesion protein 1</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">133</div>
    <div class="description-paragraph style-scope patent-text">Antibody Sequences</div>
    <div class="description-paragraph style-scope patent-text">Anti-lntegrin ανβ6</div>
    <div class="description-paragraph style-scope patent-text">RHAB6.2</div>
    <div class="description-paragraph style-scope patent-text">QVQLVQSGSELKKPGASVKISCKASGFAFTDSYMHWVRQAPGQGLEWMGWIDPENGDT</div>
    <div class="description-paragraph style-scope patent-text">EYAPKFQGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCTRGTPTAVPNLRGDLQVLAQKVA</div>
    <div class="description-paragraph style-scope patent-text">GPYPFDYWGQGTLVTVSS</div>
    <div class="description-paragraph style-scope patent-text">RHCB6.2</div>
    <div class="description-paragraph style-scope patent-text">QVQLVQSGAEVKKPGASVKVSCKASGYTFIDSYMHWVRQAPGQRLEWMGWIDPENGDT</div>
    <div class="description-paragraph style-scope patent-text">EYAPKFQGRVTITTDTSASTAYMELSSLRSEDTAVYYCARGTPTAVPNLRGDLQVLAQKV</div>
    <div class="description-paragraph style-scope patent-text">AGPYPFDYWGQGTLVTVSS</div>
    <div class="description-paragraph style-scope patent-text">RHF</div>
    <div class="description-paragraph style-scope patent-text">QVQLVQSGAEVKKPGASVKVSCKASGFNFIDSYMHWVRQAPGQRLEWMGWIDPENGD</div>
    <div class="description-paragraph style-scope patent-text">TEYAPKFQGRVTFTTDTSASTAYMELSSLRSEDTAVYYCNEGTPTGPYYFDYWGQGTLV</div>
    <div class="description-paragraph style-scope patent-text">TVSS</div>
    <div class="description-paragraph style-scope patent-text">RHFB6</div>
    <div class="description-paragraph style-scope patent-text">QVQLVQSGAEVKKPGASVKVSCKASGFNFIDSYMHWVRQAPGQRLEWMGWIDPENGD</div>
    <div class="description-paragraph style-scope patent-text">TEYAPKFQGRVTFTTDTSASTAYMELSSLRSEDTAVYYCNEGTPTAVPNLRGDLQVLAQK</div>
    <div class="description-paragraph style-scope patent-text">VAGPYYFDYWGQGTLVTVSS</div>
    <div class="description-paragraph style-scope patent-text">RHAYIOObP</div>
    <div class="description-paragraph style-scope patent-text">QVQLVQSGSELKKPGASVKISCKASGFAFTDSYMHWVRQAPGQGLEWMGWIDPENGDT</div>
    <div class="description-paragraph style-scope patent-text">EYAPKFQGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCTRGTPTGPYPFDYWGQGTLVTV</div>
    <div class="description-paragraph style-scope patent-text">SS</div>
    <div class="description-paragraph style-scope patent-text">RKF</div>
    <div class="description-paragraph style-scope patent-text">ENVLTQSPGTLSLSPGERATLSCSASSSVSYMHWFQQKPGQAPRLLIYSTSNLASGIPDR</div>
    <div class="description-paragraph style-scope patent-text">FSGSGSGTDFTLTISRLEPEDFAVYYCQQRSSYPLTFGGGTKVEIK</div>
    <div class="description-paragraph style-scope patent-text">RKFL36L50</div>
    <div class="description-paragraph style-scope patent-text">ENVLTQSPGTLSLSPGERATLSCSASSSVSYMHWLQQKPGQAPRLLIYLTSNLASGIPDR</div>
    <div class="description-paragraph style-scope patent-text">FSGSGSGTDFTLTISRLEPEDFAVYYCQQRSSYPLTFGGGTKVEIK</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">134</div>
    <div class="description-paragraph style-scope patent-text">RKC</div>
    <div class="description-paragraph style-scope patent-text">EIVLTQSPGTLSLSPGERATLSCSASSSVSYMHWFQQKPGQAPRLLIYSTSNLASGIPDRF</div>
    <div class="description-paragraph style-scope patent-text">SGSGSGTDFTLTISRLEPEDFAVYYCQQRSSYPLTFGGGTKVEIK</div>
    <div class="description-paragraph style-scope patent-text">Anti-CD33</div>
    <div class="description-paragraph style-scope patent-text">CD33 Hum195 VH</div>
    <div class="description-paragraph style-scope patent-text">QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDYNMHWVRQAPGQGLEWIGYIYPYNGGT</div>
    <div class="description-paragraph style-scope patent-text">GYNQKFKSKATITADESTNTAYMELSSLRSEDTAVYYCARGRPAMDYWGQGTLVTVSS</div>
    <div class="description-paragraph style-scope patent-text">CD33 Hum195 VK</div>
    <div class="description-paragraph style-scope patent-text">DIQMTQSPSSLSASVGDRVTITCRASESVDNYGISFMNWFQQKPGKAPKLLIYAASNQGS</div>
    <div class="description-paragraph style-scope patent-text">GVPSRFSGSGSGTDFTLTISSLQPDDFATYYCQQSKEVPWTFGQGTKVEIK</div>
    <div class="description-paragraph style-scope patent-text">Anti-CD19</div>
    <div class="description-paragraph style-scope patent-text">CD 19 B4 resurfaced VH</div>
    <div class="description-paragraph style-scope patent-text">QVQLVQPGAEVVKPGASVKLSCKTSGYTFTSNWMHWVKQRPGQGLEWIGEIDPSDSYT</div>
    <div class="description-paragraph style-scope patent-text">NYNQNFKGKAKLTVDKSTSTAYMEVSSLRSDDTAVYYCARGSNPYYYAMDYWGQGTSV</div>
    <div class="description-paragraph style-scope patent-text">TVSS</div>
    <div class="description-paragraph style-scope patent-text">CD 19 B4 resurfaced VK</div>
    <div class="description-paragraph style-scope patent-text">EIVLTQSPAIMSASPGERVTMTCSASSGVNYMHWYQQKPGTSPRRWIYDTSKLASGVPA</div>
    <div class="description-paragraph style-scope patent-text">RFSGSGSGTSYSLTISSMEPEDAATYYCHQRGSYTFGGGTKLEIK</div>
    <div class="description-paragraph style-scope patent-text">Anti-Her2</div>
    <div class="description-paragraph style-scope patent-text">Herceptin VH chain</div>
    <div class="description-paragraph style-scope patent-text">EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTR</div>
    <div class="description-paragraph style-scope patent-text">YADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVT</div>
    <div class="description-paragraph style-scope patent-text">VSS</div>
    <div class="description-paragraph style-scope patent-text">Herceptin VL chain</div>
    <div class="description-paragraph style-scope patent-text">DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPS</div>
    <div class="description-paragraph style-scope patent-text">RFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIK</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">135</div>
    <div class="description-paragraph style-scope patent-text">Anti-CD25</div>
    <div class="description-paragraph style-scope patent-text">Simulect VK (also known as Basiliximab)</div>
    <div class="description-paragraph style-scope patent-text">QIVSTQSPAIMSASPGEKVTMTCSASSSRSYMQWYQQKPGTSPKRWIYDTSKLASGVPA</div>
    <div class="description-paragraph style-scope patent-text">RFSGSGSGTSYSLTISSMEAEDAATYYCHQRSSYTFGGGTKLEIK</div>
    <div class="description-paragraph style-scope patent-text">Simulect VH</div>
    <div class="description-paragraph style-scope patent-text">QLQQSGTVLARPGASVKMSCKASGYSFTRYWMHWIKQRPGQGLEWIGAIYPGNSDTSY</div>
    <div class="description-paragraph style-scope patent-text">NQKFEGKAKLTAVTSASTAYMELSSLTHEDSAVYYCSRDYGYYFDFWGQGTTLTVSS</div>
    <div class="description-paragraph style-scope patent-text">Anti-PSMA</div>
    <div class="description-paragraph style-scope patent-text">Deimmunised VH ‘1</div>
    <div class="description-paragraph style-scope patent-text">EVQLVQSGPEVKKPGATVKISCKTSGYTFTEYTIHWVKQAPGKGLEWIGNINPNNGGTTY</div>
    <div class="description-paragraph style-scope patent-text">NQKFEDKATLTVDKSTDTAYMELSSLRSEDTAVYYCAAGWNFDYWGQGTLLTVSS</div>
    <div class="description-paragraph style-scope patent-text">Deimmunised VK ‘1</div>
    <div class="description-paragraph style-scope patent-text">DIQMTQSPSSLSTSVGDRVTLTCKASQDVGTAVDWYQQKPGPSPKLLIYWASTRHTGIPS</div>
    <div class="description-paragraph style-scope patent-text">RFSGSGSGTDFTLTISSLQPEDFADYYCQQYNSYPLTFGPGTKVDIK</div>
    <div class="description-paragraph style-scope patent-text">Deimmunised VH1 ‘5</div>
    <div class="description-paragraph style-scope patent-text">EVKLVESGGGLVQPGGSMKLSCVASGFTFSNYWMNWVRQAPGKGLEWVAEIRSQSNN</div>
    <div class="description-paragraph style-scope patent-text">FATHYAESVKGRVTISRDDSKSIVYLQMNNLRAEDTGVYYCTRRWNNFWGQGTTVTVSS</div>
    <div class="description-paragraph style-scope patent-text">Deimmunised VH2 ‘5</div>
    <div class="description-paragraph style-scope patent-text">EVKLVESGGGLVQPGGSLKLSCVASGFTFSNYWMNWVRQAPGKGLEWVAEIRSQSNNF</div>
    <div class="description-paragraph style-scope patent-text">ATHYAESVKGRVTISRDDSKSIVYLQMNNLRAEDTAVYYCTRRWNNFWGQGTTVTVSS</div>
    <div class="description-paragraph style-scope patent-text">Deimmunised VH3 ‘5</div>
    <div class="description-paragraph style-scope patent-text">EVQLVESGGGLVQPGGSLKLSCVASGFTFSNYWMNWVRQAPGKGLEWVAEIRSQSNNF</div>
    <div class="description-paragraph style-scope patent-text">ATHYAESVKGRVTISRDDSKSIVYLQMNNLRAEDTAVYYCTRRWNNFWGQGTTVTVSS</div>
    <div class="description-paragraph style-scope patent-text">Deimmunised VH4 ‘5</div>
    <div class="description-paragraph style-scope patent-text">EVQLVESGGGLVQPGGSLKLSCVASGFTFSNYWMNWVRQAPGKGLEWVAEIRSQSNNF</div>
    <div class="description-paragraph style-scope patent-text">ATHYAESVKGRFTISRDDSKSIVYLQMNNLRAEDTAVYYCTRRWNNFWGQGTTVTVSS</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">136</div>
    <div class="description-paragraph style-scope patent-text">Deimmunised VK1 ‘5</div>
    <div class="description-paragraph style-scope patent-text">NIVMTQFPSSMSASVGDRVTITCKASENVGTYVSWYQQKPDQSPKMLIYGASNRFTGVP</div>
    <div class="description-paragraph style-scope patent-text">DRFTGSGSATDFTLTISSLQTEDLADYYCGQSYTFPYTFGQGTKLEMK</div>
    <div class="description-paragraph style-scope patent-text">Deimmunised VK2 ‘5</div>
    <div class="description-paragraph style-scope patent-text">NIVMTQFPSSMSASVGDRVTITCKASENVGTYVSWYQQKPDQSPKMLIYGASNRFTGVP</div>
    <div class="description-paragraph style-scope patent-text">DRFSGSGSGTDFTLTISSLQAEDLADYYCGQSYTFPYTFGQGTKLEIK</div>
    <div class="description-paragraph style-scope patent-text">Deimmunised VK3 ‘5</div>
    <div class="description-paragraph style-scope patent-text">NIQMTQFPSAMSASVGDRVTITCKASENVGTYVSWYQQKPDQSPKMLIYGASNRFTGVP</div>
    <div class="description-paragraph style-scope patent-text">DRFSGSGSGTDFTLTISSLQAEDLADYYCGQSYTFPYTFGQGTKLEIK</div>
    <div class="description-paragraph style-scope patent-text">Deimmunised VK4 ‘5</div>
    <div class="description-paragraph style-scope patent-text">NIQMTQFPSAMSASVGDRVTITCKASENVGTYVSWYQQKPDQSPKMLIYGASNRFTGVP</div>
    <div class="description-paragraph style-scope patent-text">DRFSGSGSGTDFTLTISSLQAEDEADYYCGQSYTFPYTFGQGTKLEIK</div>
    <div class="description-paragraph style-scope patent-text">Deimmunised VK DI ‘5</div>
    <div class="description-paragraph style-scope patent-text">NIVMTQFPKSMSASAGERMTLTCKASENVGTYVSWYQQKPTQSPKMLIYGASNRFTGVP</div>
    <div class="description-paragraph style-scope patent-text">DRFSGSGSGTDFILTISSVQAEDLVDYYCGQSYTFPYTFGGGTKLEMK</div>
    <div class="description-paragraph style-scope patent-text">Deimmunised VH DI ‘5</div>
    <div class="description-paragraph style-scope patent-text">EVKLEESGGGLVQPGGSMKISCVASGFTFSNYWMNWVRQSPEKGLEWVAEIRSQSNNF</div>
    <div class="description-paragraph style-scope patent-text">ATHYAESVKGRVIISRDDSKSSVYLQMNSLRAEDTAVYYCTRRWNNFWGQGTTVTVSS</div>
    <div class="description-paragraph style-scope patent-text">Humanised RHA ‘5</div>
    <div class="description-paragraph style-scope patent-text">EVQLVESGGGLVQPGGSLKLSCAASGFTFSNYWMNWVRQASGKGLEWVGEIRSQSNNF</div>
    <div class="description-paragraph style-scope patent-text">ATHYAESVKGRFTISRDDSKNTAYLQMNSLKTEDTAVYYCTRRWNNFWGQGTTVTVSS</div>
    <div class="description-paragraph style-scope patent-text">Humanised RHB ‘5</div>
    <div class="description-paragraph style-scope patent-text">EVKLVESGGGLVQPGGSLKLSCAASGFTFSNYWMNWVRQASGKGLEWVAEIRSQSNNF</div>
    <div class="description-paragraph style-scope patent-text">ATHYAESVKGRVIISRDDSKNTVYLQMNSLRTEDTAVYYCTRRWNNFWGQGTTVTVSS</div>
    <div class="description-paragraph style-scope patent-text">Humanised RHC ‘5</div>
    <div class="description-paragraph style-scope patent-text">EVQLVESGGGLVQPGGSLKLSCAASGFTFSNYWMNWVRQASGKGLEWVAEIRSQSNNF</div>
    <div class="description-paragraph style-scope patent-text">ATHYAESVKGRVIISRDDSKNTVYLQMNSLRTEDTAVYYCTRRWNNFWGQGTTVTVSS</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">137</div>
    <div class="description-paragraph style-scope patent-text">Humanised RHP ‘5</div>
    <div class="description-paragraph style-scope patent-text">EVKLVESGGGLVQPGGSLKLSCAASGFTFSNYWMNWVRQASGKGLEWVGEIRSQSNNF</div>
    <div class="description-paragraph style-scope patent-text">ATHYAESVKGRVIISRDDSKNTVYLQMNSLRTEDTAVYYCTRRWNNFWGQGTTVTVSS</div>
    <div class="description-paragraph style-scope patent-text">Humanised RHE ‘5</div>
    <div class="description-paragraph style-scope patent-text">EVKLVESGGGLVQPGGSLKLSCAASGFTFSNYWMNWVRQASGKGLEWVAEIRSQSNNF</div>
    <div class="description-paragraph style-scope patent-text">ATHYAESVKGRFTISRDDSKNTVYLQMNSLRTEDTAVYYCTRRWNNFWGQGTTVTVSS</div>
    <div class="description-paragraph style-scope patent-text">Humanised RHF ‘5</div>
    <div class="description-paragraph style-scope patent-text">EVKLVESGGGLVQPGGSLKLSCAASGFTFSNYWMNWVRQASGKGLEWVAEIRSQSNNF</div>
    <div class="description-paragraph style-scope patent-text">ATHYAESVKGRVIISRDDSKNTAYLQMNSLRTEDTAVYYCTRRWNNFWGQGTTVTVSS</div>
    <div class="description-paragraph style-scope patent-text">Humanised RHG ‘5</div>
    <div class="description-paragraph style-scope patent-text">EVKLVESGGGLVQPGGSLKLSCAASGFTFSNYWMNWVRQASGKGLEWVAEIRSQSNNF</div>
    <div class="description-paragraph style-scope patent-text">ATHYAESVKGRVIISRDDSKNTAYLQMNSLRTEDTAVYYCTRRWNNFWGQGTTVTVSS</div>
    <div class="description-paragraph style-scope patent-text">Humanised RKA ‘5</div>
    <div class="description-paragraph style-scope patent-text">DIQMTQSPSSVSASVGDRVTITCKASENVGTYVSWYQQKPGTAPKLLIYGASNRFTGVPS</div>
    <div class="description-paragraph style-scope patent-text">RFSGSGSATDFTLTINNLQPEDFATYYCGQSYTFPYTFGQGTKVEIK</div>
    <div class="description-paragraph style-scope patent-text">Humanised RKB ‘5</div>
    <div class="description-paragraph style-scope patent-text">DIQMTQSPSSVSASVGDRVTITCKASENVGTYVSWYQQKPGTAPKLLIYGASNRFTGVPS</div>
    <div class="description-paragraph style-scope patent-text">RFSGSGSATDFTLTINNLQPEDFATYYCGQSYTFPYTFGQGTKVEIK</div>
    <div class="description-paragraph style-scope patent-text">Humanised RKC ‘5</div>
    <div class="description-paragraph style-scope patent-text">DIQMTQSPSSVSASVGDRVTITCKASENVGTYVSWYQQKPGTAPKMLIYGASNRFTGVPS</div>
    <div class="description-paragraph style-scope patent-text">RFSGSGSATDFTLTINNLQPEDFATYYCGQSYTFPYTFGQGTKVEIK</div>
    <div class="description-paragraph style-scope patent-text">Humanised RKD ‘5</div>
    <div class="description-paragraph style-scope patent-text">DIQMTQSPSSVSASVGDRVTITCKASENVGTYVSWYQQKPGTAPKMLIYGASNRFTGVPS</div>
    <div class="description-paragraph style-scope patent-text">RFSGSGSATDFTLTINNLQPEDFATYYCGQSYTFPYTFGQGTKVEIK</div>
    <div class="description-paragraph style-scope patent-text">Humanised RKE ‘5</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">138</div>
    <div class="description-paragraph style-scope patent-text">NIVMTQSPSSVSASVGDRVTITCKASENVGTYVSWYQQKPGTAPKLLIYGASNRFTGVPD</div>
    <div class="description-paragraph style-scope patent-text">RFTGSGSATDFILTINNLQPEDFATYYCGQSYTFPYTFGQGTKVEIK</div>
    <div class="description-paragraph style-scope patent-text">Humanised RKF ‘5</div>
    <div class="description-paragraph style-scope patent-text">NIVMTQSPSSVSASVGDRVTITCKASENVGTYVSWYQQKPGTAPKMLIYGASNRFTGVPS</div>
    <div class="description-paragraph style-scope patent-text">RFSGSGSATDFILTINNLQPEDFATYYCGQSYTFPYTFGQGTKVEIK</div>
    <div class="description-paragraph style-scope patent-text">Humanised RKG ‘5</div>
    <div class="description-paragraph style-scope patent-text">NIVMTQSPSSVSASVGDRVTITCKASENVGTYVSWYQQKPGTAPKMLIYGASNRFTGVPD</div>
    <div class="description-paragraph style-scope patent-text">RFTGSGSATDFTLTINNLQPEDFATYYCGQSYTFPYTFGQGTKVEIK</div>
    <div class="description-paragraph style-scope patent-text">The parent antibody may also be a fusion protein comprising an albumin-binding peptide (ABP) sequence (Dennis et al. (2002) “Albumin Binding As A General Strategy For Improving The Pharmacokinetics Of Proteins” J Biol Chem. 277:35035-35043; WO 01/45746). Antibodies of the invention include fusion proteins with ABP sequences taught by: (i) Dennis et al (2002) J Biol Chem. 277:35035-35043 at Tables III and IV, page 35038; (ii) US 2004/0001827 at [0076]; and (iii) WO 01/45746 at pages 12-13, and all of which are incorporated herein by reference.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the antibody has been raised to target specific the tumour related antigen α<sub class="style-scope patent-text">ν</sub>β<sub class="style-scope patent-text">6</sub>.</div>
    <div class="description-paragraph style-scope patent-text">The cell binding agent may be labelled, for example to aid detection or purification of the agent either prior to incorporation as a conjugate, or as part of the conjugate. The label may be a biotin label. In another embodiment, the cell binding agent may be labelled with a radioisotope.</div>
    <div class="description-paragraph style-scope patent-text">The cell binding agent is connected to the linker. In one embodiment, the cell binding agent is connected to A, where present, of the linker.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the connection between the cell binding agent and the linker is through a thioether bond.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the connection between the cell binding agent and the linker is through a disulfide bond.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">139</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the connection between the cell binding agent and the linker is through an amide bond.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the connection between the cell binding agent and the linker is through an ester bond.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the connection between the cell binding agent and the linker is formed between a thiol group of a cysteine residue of the cell binding agent and a maleimide group of the linker.</div>
    <div class="description-paragraph style-scope patent-text">The cysteine residues of the cell binding agent may be available for reaction with the functional group of R<sup class="style-scope patent-text">L</sup> to form a connection. In other embodiments, for example where the cell binding agent is an antibody, the thiol groups of the antibody may participate in interchain disulfide bonds. These interchain bonds may be converted to free thiol groups by e.g. treatment of the antibody with DTT prior to reaction with the functional group of R<sup class="style-scope patent-text">L</sup>.</div>
    <div class="description-paragraph style-scope patent-text">The cell binding agent may be labelled, for example to aid detection or purification of the agent either prior to incorporation as a conjugate, or as part of the conjugate. The label may be a biotin label. In another embodiment, the cell binding agent may be labelled with a radioisotope.</div>
    <div class="description-paragraph style-scope patent-text">Drug loading</div>
    <div class="description-paragraph style-scope patent-text">The drug loading is the average number of PBD drugs per cell binding agent, e.g. antibody. Where the compounds of the invention are bound to cysteines, drug loading may range from 1 to 8 drugs (D) per cell binding agent, i.e. where 1,2,3, 4, 5, 6, 7, and 8 drug moieties are covalently attached to the cell binding agent. Compositions of conjgates include collections of cell binding agents, e.g. antibodies, conjugated with a range of drugs, from 1 to 8. Where the compounds of the invention are bound to lysines, drug loading may range from 1 to 80 drugs (D) per cell binding agent, although an upper limit of 40, 20, 10 or 8 may be preferred. Compositions of conjgates include collections of cell binding agents, e.g. antibodies, conjugated with a range of drugs, from 1 to 80, 1 to 40, 1 to 20, 1 to 10 or 1 to 8.</div>
    <div class="description-paragraph style-scope patent-text">The average number of drugs per antibody in preparations of ADC from conjugation reactions may be characterized by conventional means such as UV, reverse phase HPLC, HIC, mass spectroscopy, ELISA assay, and electrophoresis. The quantitative distribution</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">140 of ADC in terms of p may also be determined. By ELISA, the averaged value of p in a particular preparation of ADC may be determined (Hamblett et al (2004) Clin. Cancer Res.</div>
    <div class="description-paragraph style-scope patent-text">10:7063-7070; Sanderson et al (2005) Clin. Cancer Res. 11:843-852). However, the distribution of p (drug) values is not discernible by the antibody-antigen binding and detection limitation of ELISA. Also, ELISA assay for detection of antibody-drug conjugates does not determine where the drug moieties are attached to the antibody, such as the heavy chain or light chain fragments, or the particular amino acid residues. In some instances, separation, purification, and characterization of homogeneous ADC where p is a certain value from ADC with other drug loadings may be achieved by means such as reverse phase HPLC or electrophoresis. Such techniques are also applicable to other types of conjugates.</div>
    <div class="description-paragraph style-scope patent-text">For some antibody-drug conjugates, p may be limited by the number of attachment sites on the antibody. For example, an antibody may have only one or several cysteine thiol groups, or may have only one or several sufficiently reactive thiol groups through which a linker may be attached. Higher drug loading, e.g. p &gt;5, may cause aggregation, insolubility, toxicity, or loss of cellular permeability of certain antibody-drug conjugates.</div>
    <div class="description-paragraph style-scope patent-text">Typically, fewer than the theoretical maximum of drug moieties are conjugated to an antibody during a conjugation reaction. An antibody may contain, for example, many lysine residues that do not react with the drug-linker intermediate (D-L) or linker reagent. Only the most reactive lysine groups may react with an amine-reactive linker reagent. Also, only the most reactive cysteine thiol groups may react with a thiol-reactive linker reagent. Generally, antibodies do not contain many, if any, free and reactive cysteine thiol groups which may be linked to a drug moiety. Most cysteine thiol residues in the antibodies of the compounds exist as disulfide bridges and must be reduced with a reducing agent such as dithiothreitol (DTT) or TCEP, under partial or total reducing conditions. The loading (drug/antibody ratio) of an ADC may be controlled in several different manners, including:</div>
    <div class="description-paragraph style-scope patent-text">(i) limiting the molar excess of drug-linker intermediate (D-L) or linker reagent relative to antibody, (ii) limiting the conjugation reaction time or temperature, and (iii) partial or limiting reductive conditions for cysteine thiol modification.</div>
    <div class="description-paragraph style-scope patent-text">Certain antibodies have reducible interchain disulfides, i.e. cysteine bridges. Antibodies may be made reactive for conjugation with linker reagents by treatment with a reducing agent such as DTT (dithiothreitol). Each cysteine bridge will thus form, theoretically, two</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">141 reactive thiol nucleophiles. Additional nucleophilic groups can be introduced into antibodies through the reaction of lysines with 2-iminothiolane (Traut’s reagent) resulting in conversion of an amine into a thiol. Reactive thiol groups may be introduced into the antibody (or fragment thereof) by engineering one, two, three, four, or more cysteine residues (e.g., preparing mutant antibodies comprising one or more non-native cysteine amino acid residues). US 7521541 teaches engineering antibodies by introduction of reactive cysteine amino acids.</div>
    <div class="description-paragraph style-scope patent-text">Cysteine amino acids may be engineered at reactive sites in an antibody and which do not form intrachain or intermolecular disulfide linkages (Junutula, et al., 2008b Nature Biotech., 26(8):925-932; Dornan et al (2009) Blood 114(13):2721-2729; US 7521541; US 7723485; W02009/052249). The engineered cysteine thiols may react with linker reagents or the drug-linker reagents of the present invention which have thiol-reactive, electrophilic groups such as maleimide or alpha-halo amides to form ADC with cysteine engineered antibodies and the PBD drug moieties. The location of the drug moiety can thus be designed, controlled, and known. The drug loading can be controlled since the engineered cysteine thiol groups typically react with thiol-reactive linker reagents or drug-linker reagents in high yield. Engineering an IgG antibody to introduce a cysteine amino acid by substitution at a single site on the heavy or light chain gives two new cysteines on the symmetrical antibody. A drug loading near 2 can be achieved with near homogeneity of the conjugation product ADC.</div>
    <div class="description-paragraph style-scope patent-text">Where more than one nucleophilic or electrophilic group of the antibody reacts with a druglinker intermediate, or linker reagent followed by drug moiety reagent, then the resulting product is a mixture of ADC compounds with a distribution of drug moieties attached to an antibody, e.g. 1,2, 3, etc. Liquid chromatography methods such as polymeric reverse phase (PLRP) and hydrophobic interaction (HIC) may separate compounds in the mixture by drug loading value. Preparations of ADC with a single drug loading value (p) may be isolated, however, these single loading value ADCs may still be heterogeneous mixtures because the drug moieties may be attached, via the linker, at different sites on the antibody.</div>
    <div class="description-paragraph style-scope patent-text">Thus the antibody-drug conjugate compositions of the invention include mixtures of antibody-drug conjugate compounds where the antibody has one or more PBD drug</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">142 moieties and where the drug moieties may be attached to the antibody at various amino acid residues.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the average number of dimer pyrrolobenzodiazepine groups per cell binding agent is in the range 1 to 20. In some embodiments the range is selected from 1 to 8, 2 to 8, 2 to 6, 2 to 4, and 4 to 8.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, there is one dimer pyrrolobenzodiazepine group per cell binding agent.</div>
    <div class="description-paragraph style-scope patent-text">Use</div>
    <div class="description-paragraph style-scope patent-text">The Compounds and Conjugates can be used to treat proliferative disease and autoimmune disease. The term “proliferative disease” pertains to an unwanted or uncontrolled cellular proliferation of excessive or abnormal cells which is undesired, such as, neoplastic or hyperplastic growth, whether in vitro or in vivo.</div>
    <div class="description-paragraph style-scope patent-text">Examples of proliferative conditions include, but are not limited to, benign, pre-malignant, and malignant cellular proliferation, including but not limited to, neoplasms and tumours (e.g. histocytoma, glioma, astrocyoma, osteoma), cancers (e.g. lung cancer, small cell lung cancer, gastrointestinal cancer, bowel cancer, colon cancer, breast carinoma, ovarian carcinoma, prostate cancer, testicular cancer, liver cancer, kidney cancer, bladder cancer, pancreas cancer, brain cancer, sarcoma, osteosarcoma, Kaposi's sarcoma, melanoma), leukemias, psoriasis, bone diseases, fibroproliferative disorders (e.g. of connective tissues), and atherosclerosis. Cancers of particular interest include, but are not limited to, leukemias and ovarian cancers.</div>
    <div class="description-paragraph style-scope patent-text">Any type of cell may be treated, including but not limited to, lung, gastrointestinal (including, e.g. bowel, colon), breast (mammary), ovarian, prostate, liver (hepatic), kidney (renal), bladder, pancreas, brain, and skin.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the treatment is of a pancreatic cancer.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the treatment is of a tumour having α<sub class="style-scope patent-text">ν</sub>β<sub class="style-scope patent-text">6</sub> integrin on the surface of the cell.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">143</div>
    <div class="description-paragraph style-scope patent-text">It is contemplated that the antibody-drug conjugates (ADC) of the present invention may be used to treat various diseases or disorders, e.g. characterized by the overexpression of a tumor antigen. Exemplary conditions or hyperproliterative disorders include benign or malignant tumors; leukemia, haematological, and lymphoid malignancies. Others include neuronal, glial, astrocytal, hypothalamic, glandular, macrophagal, epithelial, stromal, blastocoelic, inflammatory, angiogenic and immunologic, including autoimmune, disorders.</div>
    <div class="description-paragraph style-scope patent-text">Generally, the disease or disorder to be treated is a hyperproliferative disease such as cancer. Examples of cancer to be treated herein include, but are not limited to, carcinoma, lymphoma, blastoma, sarcoma, and leukemia or lymphoid malignancies. More particular examples of such cancers include squamous cell cancer (e.g. epithelial squamous cell cancer), lung cancer including small-cell lung cancer, non-small cell lung cancer, adenocarcinoma of the lung and squamous carcinoma of the lung, cancer of the peritoneum, hepatocellular cancer, gastric or stomach cancer including gastrointestinal cancer, pancreatic cancer, glioblastoma, cervical cancer, ovarian cancer, liver cancer, bladder cancer, hepatoma, breast cancer, colon cancer, rectal cancer, colorectal cancer, endometrial or uterine carcinoma, salivary gland carcinoma, kidney or renal cancer, prostate cancer, vulval cancer, thyroid cancer, hepatic carcinoma, anal carcinoma, penile carcinoma, as well as head and neck cancer.</div>
    <div class="description-paragraph style-scope patent-text">Autoimmune diseases for which the ADC compounds may be used in treatment include rheumatologic disorders (such as, for example, rheumatoid arthritis, Sjogren's syndrome, scleroderma, lupus such as SLE and lupus nephritis, polymyositis/dermatomyositis, cryoglobulinemia, anti-phospholipid antibody syndrome, and psoriatic arthritis), osteoarthritis, autoimmune gastrointestinal and liver disorders (such as, for example, inflammatory bowel diseases (e.g. ulcerative colitis and Crohn's disease), autoimmune gastritis and pernicious anemia, autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, and celiac disease), vasculitis (such as, for example, ANCAassociated vasculitis, including Churg-Strauss vasculitis, Wegener's granulomatosis, and polyarteriitis), autoimmune neurological disorders (such as, for example, multiple sclerosis, opsoclonus myoclonus syndrome, myasthenia gravis, neuromyelitis optica, Parkinson’s disease, Alzheimer’s disease, and autoimmune polyneuropathies), renal disorders (such as, for example, glomerulonephritis, Goodpasture’s syndrome, and Berger’s disease), autoimmune dermatologic disorders (such as, for example, psoriasis, urticaria, hives, pemphigus vulgaris, bullous pemphigoid, and cutaneous lupus erythematosus),</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">144 hematologic disorders (such as, for example, thrombocytopenic purpura, thrombotic thrombocytopenic purpura, post-transfusion purpura, and autoimmune hemolytic anemia), atherosclerosis, uveitis, autoimmune hearing diseases (such as, for example, inner ear disease and hearing loss), Behcet's disease, Raynaud's syndrome, organ transplant, and autoimmune endocrine disorders (such as, for example, diabetic-related autoimmune diseases such as insulin-dependent diabetes mellitus (IDDM), Addison’s disease, and autoimmune thyroid disease (e.g. Graves’ disease and thyroiditis)). More preferred such diseases include, for example, rheumatoid arthritis, ulcerative colitis, ANCA-associated vasculitis, lupus, multiple sclerosis, Sjogren's syndrome, Graves’ disease, IDDM, pernicious anemia, thyroiditis, and glomerulonephritis.</div>
    <div class="description-paragraph style-scope patent-text">Methods of Treatment</div>
    <div class="description-paragraph style-scope patent-text">The conjugates of the present invention may be used in a method of therapy. Also provided is a method of treatment, comprising administering to a subject in need of treatment a therapeutically-effective amount of a conjugate compound of the invention.</div>
    <div class="description-paragraph style-scope patent-text">The term “therapeutically effective amount” is an amount sufficient to show benefit to a patient. Such benefit may be at least amelioration of at least one symptom. The actual amount administered, and rate and time-course of administration, will depend on the nature and severity of what is being treated. Prescription of treatment, e.g. decisions on dosage, is within the responsibility of general practitioners and other medical doctors.</div>
    <div class="description-paragraph style-scope patent-text">A compound of the invention may be administered alone or in combination with other treatments, either simultaneously or sequentially dependent upon the condition to be treated. Examples of treatments and therapies include, but are not limited to, chemotherapy (the administration of active agents, including, e.g. drugs, such as chemotherapeutics); surgery; and radiation therapy.</div>
    <div class="description-paragraph style-scope patent-text">A “chemotherapeutic agent” is a chemical compound useful in the treatment of cancer, regardless of mechanism of action. Classes of chemotherapeutic agents include, but are not limited to: alkylating agents, antimetabolites, spindle poison plant alkaloids, cytotoxic/antitumor antibiotics, topoisomerase inhibitors, antibodies, photosensitizers, and kinase inhibitors. Chemotherapeutic agents include compounds used in “targeted therapy” and conventional chemotherapy.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">145</div>
    <div class="description-paragraph style-scope patent-text">Examples of chemotherapeutic agents include: erlotinib (TARCEVA®, Genentech/OSI Pharm.), docetaxel (TAXOTERE®, Sanofi-Aventis), 5-FU (fluorouracil, 5-fluorouracil, CAS No. 51-21-8), gemcitabine (GEMZAR®, Lilly), PD-0325901 (CAS No. 391210-10-9, Pfizer), cisplatin (cis-diamine, dichloroplatinum(ll), CAS No. 15663-27-1), carboplatin (CAS No. 41575-94-4), paclitaxel (TAXOL®, Bristol-Myers Squibb Oncology, Princeton, N.J.), trastuzumab (HERCEPTIN®, Genentech), temozolomide (4-methyl-5-oxo- 2,3,4,6,8pentazabicyclo [4.3.0] nona-2,7,9-triene- 9-carboxamide, CAS No. 85622-93-1, TEMODAR®, TEMODAL®, Schering Plough), tamoxifen ((Z)-2-[4-(1,2-diphenylbut-1enyl)phenoxy]-A/,A/-dimethylethanamine, NOLVADEX®, ISTUBAL®, VALODEX®), and doxorubicin (ADRIAMYCIN®), Akti-1/2, HPPD, and rapamycin.</div>
    <div class="description-paragraph style-scope patent-text">More examples of chemotherapeutic agents include: oxaliplatin (ELOXATIN®, Sanofi), bortezomib (VELCADE®, Millennium Pharm.), sutent (SUNITINIB®, SU11248, Pfizer), letrozole (FEMARA®, Novartis), imatinib mesylate (GLEEVEC®, Novartis), XL-518 (Mek inhibitor, Exelixis, WO 2007/044515), ARRY-886 (Mek inhibitor, AZD6244, Array BioPharma, Astra Zeneca), SF-1126 (PI3K inhibitor, Semafore Pharmaceuticals), BEZ-235 (PI3K inhibitor, Novartis), XL-147 (PI3K inhibitor, Exelixis), PTK787/ZK 222584 (Novartis), fulvestrant (FASLODEX®, AstraZeneca), leucovorin (folinic acid), rapamycin (sirolimus, RAPAMUNE®, Wyeth), lapatinib (TYKERB®, GSK572016, Glaxo Smith Kline), lonafarnib (SARASAR™, SCH 66336, Schering Plough), sorafenib (NEXAVAR®, BAY43-9006, Bayer Labs), gefitinib (IRESSA®, AstraZeneca), irinotecan (CAMPTOSAR®, CPT-11, Pfizer), tipifarnib (ZARNESTRA™, Johnson &amp; Johnson), ABRAXANE™ (Cremophor-free), albumin-engineered nanoparticle formulations of paclitaxel (American Pharmaceutical Partners, Schaumberg, II), vandetanib (rINN, ZD6474, ZACTIMA®, AstraZeneca), chloranmbucil, AG1478, AG1571 (SU 5271; Sugen), temsirolimus (TORISEL®, Wyeth), pazopanib (GlaxoSmithKline), canfosfamide (TELCYTA®, Telik), thiotepa and cyclosphosphamide (CYTOXAN®, NEOSAR®); alkyl sulfonates such as busulfan, improsulfan and piposulfan; aziridines such as benzodopa, carboquone, meturedopa, and uredopa; ethylenimines and methylamelamines including altretamine, triethylenemelamine, triethylenephosphoramide, triethylenethiophosphoramide and trimethylomelamine; acetogenins (especially bullatacin and bullatacinone); a camptothecin (including the synthetic analog topotecan); bryostatin; callystatin; CC-1065 (including its adozelesin, carzelesin and bizelesin synthetic analogs); cryptophycins (particularly cryptophycin 1 and cryptophycin 8); dolastatin; duocarmycin (including the synthetic analogs, KW-2189 and CB1-TM1); eleutherobin; pancratistatin; a sarcodictyin; spongistatin; nitrogen mustards such as chlorambucil, chlornaphazine, chlorophosphamide, estramustine, ifosfamide,</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">146 mechlorethamine, mechlorethamine oxide hydrochloride, melphalan, novembichin, phenesterine, prednimustine, trofosfamide, uracil mustard; nitrosoureas such as carmustine, chlorozotocin, fotemustine, lomustine, nimustine, and ranimnustine; antibiotics such as the enediyne antibiotics (e.g. calicheamicin, calicheamicin gammall, calicheamicin omegall (Angew Chem. Inti. Ed. Engl. (1994) 33:183-186); dynemicin, dynemicin A; bisphosphonates, such as clodronate; an esperamicin; as well as neocarzinostatin chromophore and related chromoprotein enediyne antibiotic chromophores), aclacinomysins, actinomycin, authramycin, azaserine, bleomycins, cactinomycin, carabicin, carminomycin, carzinophilin, chromomycinis, dactinomycin, daunorubicin, detorubicin, 6diazo-5-oxo-L-norleucine, morpholino-doxorubicin, cyanomorpholino-doxorubicin, 2pyrrolino-doxorubicin and deoxydoxorubicin), epirubicin, esorubicin, idarubicin, nemorubicin, marcellomycin, mitomycins such as mitomycin C, mycophenolic acid, nogalamycin, olivomycins, peplomycin, porfiromycin, puromycin, quelamycin, rodorubicin, streptonigrin, streptozocin, tubercidin, ubenimex, zinostatin, zorubicin; anti-metabolites such as methotrexate and 5-fluorouracil (5-FU); folic acid analogs such as denopterin, methotrexate, pteropterin, trimetrexate; purine analogs such as fludarabine, 6mercaptopurine, thiamiprine, thioguanine; pyrimidine analogs such as ancitabine, azacitidine, 6-azauridine, carmofur, cytarabine, dideoxyuridine, doxifluridine, enocitabine, floxuridine; androgens such as calusterone, dromostanolone propionate, epitiostanol, mepitiostane, testolactone; anti-adrenals such as aminoglutethimide, mitotane, trilostane; folic acid replenisher such as frolinic acid; aceglatone; aldophosphamide glycoside; aminolevulinic acid; eniluracil; amsacrine; bestrabucil; bisantrene; edatraxate; defofamine; demecolcine; diaziquone; elfornithine; elliptinium acetate; an epothilone; etoglucid; gallium nitrate; hydroxyurea; lentinan; lonidainine; maytansinoids such as maytansine and ansamitocins; mitoguazone; mitoxantrone; mopidanmol; nitraerine; pentostatin; phenamet; pirarubicin; losoxantrone; podophyllinic acid; 2-ethylhydrazide; procarbazine; PSK® polysaccharide complex (JHS Natural Products, Eugene, OR); razoxane; rhizoxin; sizofiran; spirogermanium; tenuazonic acid; triaziquone; 2,2’,2”-trichlorotriethylamine; trichothecenes (especially T-2 toxin, verracurin A, roridin A and anguidine); urethan; vindesine; dacarbazine; mannomustine; mitobronitol; mitolactol; pipobroman; gacytosine; arabinoside (“Ara-C”); cyclophosphamide; thiotepa; 6-thioguanine; mercaptopurine; methotrexate; platinum analogs such as cisplatin and carboplatin; vinblastine; etoposide (VP-16); ifosfamide; mitoxantrone; vincristine; vinorelbine (NAVELBINE®); novantrone; teniposide; edatrexate; daunomycin; aminopterin; capecitabine (XELODA®, Roche); ibandronate; CPT-11; topoisomerase inhibitor RFS 2000; difluoromethylornithine (DMFO);</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">147 retinoids such as retinoic acid; and pharmaceutically acceptable salts, acids and derivatives of any of the above.</div>
    <div class="description-paragraph style-scope patent-text">Also included in the definition of “chemotherapeutic agent” are: (i) anti-hormonal agents that act to regulate or inhibit hormone action on tumors such as anti-estrogens and selective estrogen receptor modulators (SERMs), including, for example, tamoxifen (including NOLVADEX®; tamoxifen citrate), raloxifene, droloxifene, 4-hydroxytamoxifen, trioxifene, keoxifene, LY117018, onapristone, and FARESTON® (toremifine citrate); (ii) aromatase inhibitors that inhibit the enzyme aromatase, which regulates estrogen production in the adrenal glands, such as, for example, 4(5)-imidazoles, aminoglutethimide, MEGASE® (megestrol acetate), AROMASIN® (exemestane; Pfizer), formestanie, fadrozole, RIVISOR® (vorozole), FEMARA® (letrozole; Novartis), and ARIMIDEX® (anastrozole; AstraZeneca); (iii) anti-androgens such as flutamide, nilutamide, bicalutamide, leuprolide, and goserelin; as well as troxacitabine (a 1,3-dioxolane nucleoside cytosine analog); (iv) protein kinase inhibitors such as MEK inhibitors (WO 2007/044515); (v) lipid kinase inhibitors; (vi) antisense oligonucleotides, particularly those which inhibit expression of genes in signaling pathways implicated in aberrant cell proliferation, for example, PKC-alpha, Raf and H-Ras, such as oblimersen (GENASENSE®, Genta Inc.); (vii) ribozymes such as VEGF expression inhibitors (e.g., ANGIOZYME®) and HER2 expression inhibitors; (viii) vaccines such as gene therapy vaccines, for example, ALLOVECTIN®, LEUVECTIN®, and VAXID®; PROLEUKIN® rlL-2; topoisomerase 1 inhibitors such as LURTOTECAN®; ABARELIX® rmRH; (ix) antiangiogenic agents such as bevacizumab (AVASTIN®, Genentech); and pharmaceutically acceptable salts, acids and derivatives of any of the above.</div>
    <div class="description-paragraph style-scope patent-text">Also included in the definition of “chemotherapeutic agent” are therapeutic antibodies such as alemtuzumab (Campath), bevacizumab (AVASTIN®, Genentech); cetuximab (ERBITUX®, Imclone); panitumumab (VECTIBIX®, Amgen), rituximab (RITUXAN®, Genentech/Biogen Idee), pertuzumab (OMNITARG™, 2C4, Genentech), trastuzumab (HERCEPTIN®, Genentech), tositumomab (Bexxar, Corixia), and the antibody drug conjugate, gemtuzumab ozogamicin (MYLOTARG®, Wyeth).</div>
    <div class="description-paragraph style-scope patent-text">Humanized monoclonal antibodies with therapeutic potential as chemotherapeutic agents in combination with the conjugates of the invention include: alemtuzumab, apolizumab, aselizumab, atlizumab, bapineuzumab, bevacizumab, bivatuzumab mertansine, cantuzumab mertansine, cedelizumab, certolizumab pegol, cidfusituzumab, cidtuzumab,</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">148 daclizumab, eculizumab, efalizumab, epratuzumab, erlizumab, felvizumab, fontolizumab, gemtuzumab ozogamicin, inotuzumab ozogamicin, ipilimumab, labetuzumab, lintuzumab, matuzumab, mepolizumab, motavizumab, motovizumab, natalizumab, nimotuzumab, nolovizumab, numavizumab, ocrelizumab, omalizumab, palivizumab, pascolizumab, pecfusituzumab, pectuzumab, pertuzumab, pexelizumab, ralivizumab, ranibizumab, reslivizumab, reslizumab, resyvizumab, rovelizumab, ruplizumab, sibrotuzumab, siplizumab, sontuzumab, tacatuzumab tetraxetan, tadocizumab, talizumab, tefibazumab, tocilizumab, toralizumab, trastuzumab, tucotuzumab celmoleukin, tucusituzumab, umavizumab, urtoxazumab, and visilizumab.</div>
    <div class="description-paragraph style-scope patent-text">Pharmaceutical compositions according to the present invention, and for use in accordance with the present invention, may comprise, in addition to the active ingredient, i.e. a conjugate compound, a pharmaceutically acceptable excipient, carrier, buffer, stabiliser or other materials well known to those skilled in the art. Such materials should be non-toxic and should not interfere with the efficacy of the active ingredient. The precise nature of the carrier or other material will depend on the route of administration, which may be oral, or by injection, e.g. cutaneous, subcutaneous, or intravenous.</div>
    <div class="description-paragraph style-scope patent-text">Pharmaceutical compositions for oral administration may be in tablet, capsule, powder or liquid form. A tablet may comprise a solid carrier or an adjuvant. Liquid pharmaceutical compositions generally comprise a liquid carrier such as water, petroleum, animal or vegetable oils, mineral oil or synthetic oil. Physiological saline solution, dextrose or other saccharide solution or glycols such as ethylene glycol, propylene glycol or polyethylene glycol may be included. A capsule may comprise a solid carrier such a gelatin.</div>
    <div class="description-paragraph style-scope patent-text">For intravenous, cutaneous or subcutaneous injection, or injection at the site of affliction, the active ingredient will be in the form of a parenterally acceptable aqueous solution which is pyrogen-free and has suitable pH, isotonicity and stability. Those of relevant skill in the art are well able to prepare suitable solutions using, for example, isotonic vehicles such as Sodium Chloride Injection, Ringer's Injection, Lactated Ringer's Injection. Preservatives, stabilisers, buffers, antioxidants and/or other additives may be included, as required.</div>
    <div class="description-paragraph style-scope patent-text">Formulations</div>
    <div class="description-paragraph style-scope patent-text">While it is possible for the conjugate compound to be used (e.g., administered) alone, it is often preferable to present it as a composition or formulation.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">149</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the composition is a pharmaceutical composition (e.g., formulation, preparation, medicament) comprising a conjugate compound, as described herein, and a pharmaceutically acceptable carrier, diluent, or excipient.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the composition is a pharmaceutical composition comprising at least one conjugate compound, as described herein, together with one or more other pharmaceutically acceptable ingredients well known to those skilled in the art, including, but not limited to, pharmaceutically acceptable carriers, diluents, excipients, adjuvants, fillers, buffers, preservatives, anti-oxidants, lubricants, stabilisers, solubilisers, surfactants (e.g., wetting agents), masking agents, colouring agents, flavouring agents, and sweetening agents.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the composition further comprises other active agents, for example, other therapeutic or prophylactic agents.</div>
    <div class="description-paragraph style-scope patent-text">Suitable carriers, diluents, excipients, etc. can be found in standard pharmaceutical texts. See, for example, Handbook of Pharmaceutical Additives, 2nd Edition (eds. M. Ash and I. Ash), 2001 (Synapse Information Resources, Inc., Endicott, New York, USA), Remington's Pharmaceutical Sciences, 20th edition, pub. Lippincott, Williams &amp; Wilkins, 2000; and Handbook of Pharmaceutical Excipients, 2nd edition, 1994.</div>
    <div class="description-paragraph style-scope patent-text">Another aspect of the present invention pertains to methods of making a pharmaceutical composition comprising admixing at least one [<sup class="style-scope patent-text">11</sup>C]-radiolabelled conjugate or conjugatelike compound, as defined herein, together with one or more other pharmaceutically acceptable ingredients well known to those skilled in the art, e.g., carriers, diluents, excipients, etc. If formulated as discrete units (e.g., tablets, etc.), each unit contains a predetermined amount (dosage) of the active compound.</div>
    <div class="description-paragraph style-scope patent-text">The term “pharmaceutically acceptable,” as used herein, pertains to compounds, ingredients, materials, compositions, dosage forms, etc., which are, within the scope of sound medical judgment, suitable for use in contact with the tissues of the subject in question (e.g., human) without excessive toxicity, irritation, allergic response, or other problem or complication, commensurate with a reasonable benefit/risk ratio. Each carrier,</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">150 diluent, excipient, etc. must also be “acceptable” in the sense of being compatible with the other ingredients of the formulation.</div>
    <div class="description-paragraph style-scope patent-text">The formulations may be prepared by any methods well known in the art of pharmacy.</div>
    <div class="description-paragraph style-scope patent-text">Such methods include the step of bringing into association the active compound with a carrier which constitutes one or more accessory ingredients. In general, the formulations are prepared by uniformly and intimately bringing into association the active compound with carriers (e.g., liquid carriers, finely divided solid carrier, etc.), and then shaping the product, if necessary.</div>
    <div class="description-paragraph style-scope patent-text">The formulation may be prepared to provide for rapid or slow release; immediate, delayed, timed, or sustained release; or a combination thereof.</div>
    <div class="description-paragraph style-scope patent-text">Formulations suitable for parenteral administration (e.g., by injection), include aqueous or non-aqueous, isotonic, pyrogen-free, sterile liquids (e.g., solutions, suspensions), in which the active ingredient is dissolved, suspended, or otherwise provided (e.g., in a liposome or other microparticulate). Such liquids may additional contain other pharmaceutically acceptable ingredients, such as anti-oxidants, buffers, preservatives, stabilisers, bacteriostats, suspending agents, thickening agents, and solutes which render the formulation isotonic with the blood (or other relevant bodily fluid) of the intended recipient. Examples of excipients include, for example, water, alcohols, polyols, glycerol, vegetable oils, and the like. Examples of suitable isotonic carriers for use in such formulations include Sodium Chloride Injection, Ringer's Solution, or Lactated Ringer's Injection. Typically, the concentration ofthe active ingredient in the liquid is from about 1 ng/ml to about 10 pg/ml, for example from about 10 ng/ml to about 1 pg/ml. The formulations may be presented in unit-dose or multi-dose sealed containers, for example, ampoules and vials, and may be stored in a freeze-dried (lyophilised) condition requiring only the addition of the sterile liquid carrier, for example water for injections, immediately prior to use. Extemporaneous injection solutions and suspensions may be prepared from sterile powders, granules, and tablets.</div>
    <div class="description-paragraph style-scope patent-text">Dosage</div>
    <div class="description-paragraph style-scope patent-text">It will be appreciated by one of skill in the art that appropriate dosages of the conjugate compound, and compositions comprising the conjugate compound, can vary from patient to patient. Determining the optimal dosage will generally involve the balancing of the level of</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">151 therapeutic benefit against any risk or deleterious side effects. The selected dosage level will depend on a variety of factors including, but not limited to, the activity of the particular compound, the route of administration, the time of administration, the rate of excretion of the compound, the duration of the treatment, other drugs, compounds, and/or materials used in combination, the severity of the condition, and the species, sex, age, weight, condition, general health, and prior medical history of the patient. The amount of compound and route of administration will ultimately be at the discretion of the physician, veterinarian, or clinician, although generally the dosage will be selected to achieve local concentrations at the site of action which achieve the desired effect without causing substantial harmful or deleterious side-effects.</div>
    <div class="description-paragraph style-scope patent-text">Administration can be effected in one dose, continuously or intermittently (e.g., in divided doses at appropriate intervals) throughout the course of treatment. Methods of determining the most effective means and dosage of administration are well known to those of skill in the art and will vary with the formulation used for therapy, the purpose of the therapy, the target cell(s) being treated, and the subject being treated. Single or multiple administrations can be carried out with the dose level and pattern being selected by the treating physician, veterinarian, or clinician.</div>
    <div class="description-paragraph style-scope patent-text">In general, a suitable dose of the active compound is in the range of about 100 ng to about 25 mg (more typically about 1 pg to about 10 mg) per kilogram body weight of the subject per day. Where the active compound is a salt, an ester, an amide, a prodrug, or the like, the amount administered is calculated on the basis of the parent compound and so the actual weight to be used is increased proportionately.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the active compound is administered to a human patient according to the following dosage regime: about 100 mg, 3 times daily.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the active compound is administered to a human patient according to the following dosage regime: about 150 mg, 2 times daily.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the active compound is administered to a human patient according to the following dosage regime: about 200 mg, 2 times daily.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">152</div>
    <div class="description-paragraph style-scope patent-text">However in one embodiment, the conjugate compound is administered to a human patient according to the following dosage regime: about 50 or about 75 mg, 3 or 4 times daily.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the conjugate compound is administered to a human patient according to the following dosage regime: about 100 or about 125 mg, 2 times daily.</div>
    <div class="description-paragraph style-scope patent-text">The dosage amounts described above may apply to the conjugate (including the PBD moiety and the linker to the antibody) or to the effective amount of PBD compound provided, for example the amount of compound that is releasable after cleavage of the linker.</div>
    <div class="description-paragraph style-scope patent-text">For the prevention or treatment of disease, the appropriate dosage of an ADC of the invention will depend on the type of disease to be treated, as defined above, the severity and course of the disease, whether the molecule is administered for preventive or therapeutic purposes, previous therapy, the patient's clinical history and response to the antibody, and the discretion of the attending physician. The molecule is suitably administered to the patient at one time or over a series of treatments. Depending on the type and severity of the disease, about 1 pig/kg to 15 mg/kg (e.g. 0.1-20 mg/kg) of molecule is an initial candidate dosage for administration to the patient, whether, for example, by one or more separate administrations, or by continuous infusion. A typical daily dosage might range from about 1 pig/kg to 100 mg/kg or more, depending on the factors mentioned above. An exemplary dosage of ADC to be administered to a patient is in the range of about 0.1 to about 10 mg/kg of patient weight. For repeated administrations over several days or longer, depending on the condition, the treatment is sustained until a desired suppression of disease symptoms occurs. An exemplary dosing regimen comprises a course of administering an initial loading dose of about 4 mg/kg, followed by additional doses every week, two weeks, or three weeks of an ADC. Other dosage regimens may be useful. The progress of this therapy is easily monitored by conventional techniques and assays.</div>
    <div class="description-paragraph style-scope patent-text">Treatment</div>
    <div class="description-paragraph style-scope patent-text">The term “treatment,” as used herein in the context of treating a condition, pertains generally to treatment and therapy, whether of a human or an animal (e.g., in veterinary applications), in which some desired therapeutic effect is achieved, for example, the inhibition of the progress of the condition, and includes a reduction in the rate of progress,</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">153 a halt in the rate of progress, regression of the condition, amelioration of the condition, and cure of the condition. Treatment as a prophylactic measure (i.e., prophylaxis, prevention) is also included.</div>
    <div class="description-paragraph style-scope patent-text">The term “therapeutically-effective amount,” as used herein, pertains to that amount of an active compound, or a material, composition or dosage from comprising an active compound, which is effective for producing some desired therapeutic effect, commensurate with a reasonable benefit/risk ratio, when administered in accordance with a desired treatment regimen.</div>
    <div class="description-paragraph style-scope patent-text">Similarly, the term “prophylactically-effective amount,” as used herein, pertains to that amount of an active compound, or a material, composition or dosage from comprising an active compound, which is effective for producing some desired prophylactic effect, commensurate with a reasonable benefit/risk ratio, when administered in accordance with a desired treatment regimen.</div>
    <div class="description-paragraph style-scope patent-text">The Subject/Patient</div>
    <div class="description-paragraph style-scope patent-text">The subject/patient may be an animal, mammal, a placental mammal, a marsupial (e.g., kangaroo, wombat), a monotreme (e.g., duckbilled platypus), a rodent (e.g., a guinea pig, a hamster, a rat, a mouse), murine (e.g., a mouse), a lagomorph (e.g., a rabbit), avian (e.g., a bird), canine (e.g., a dog), feline (e.g., a cat), equine (e.g., a horse), porcine (e.g., a pig), ovine (e.g., a sheep), bovine (e.g., a cow), a primate, simian (e.g., a monkey or ape), a monkey (e.g., marmoset, baboon), an ape (e.g., gorilla, chimpanzee, orangutang, gibbon), or a human.</div>
    <div class="description-paragraph style-scope patent-text">Furthermore, the subject/patient may be any of its forms of development, for example, a foetus. In one preferred embodiment, the subject/patient is a human.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the patient is a population where each patient has a tumour having α<sub class="style-scope patent-text">ν</sub>β<sub class="style-scope patent-text">6</sub> integrin on the surface of the cell.</div>
    <div class="description-paragraph style-scope patent-text">Includes Other Forms</div>
    <div class="description-paragraph style-scope patent-text">Unless otherwise specified, included in the above are the well known ionic, salt, solvate, and protected forms of these substituents. For example, a reference to carboxylic acid (-COOH) also includes the anionic (carboxylate) form (-COO'), a salt or solvate thereof, as</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">154 well as conventional protected forms. Similarly, a reference to an amino group includes the protonated form (-N<sup class="style-scope patent-text">+</sup>HR<sup class="style-scope patent-text">1</sup>R<sup class="style-scope patent-text">2</sup>), a salt or solvate of the amino group, for example, a hydrochloride salt, as well as conventional protected forms of an amino group. Similarly, a reference to a hydroxyl group also includes the anionic form (-O'), a salt or solvate thereof, as well as conventional protected forms.</div>
    <div class="description-paragraph style-scope patent-text">Salts</div>
    <div class="description-paragraph style-scope patent-text">It may be convenient or desirable to prepare, purify, and/or handle a corresponding salt of the active compound, for example, a pharmaceutically-acceptable salt. Examples of pharmaceutically acceptable salts are discussed in Berge, etal., J. Pharm. Sci., 66, 1-19 (1977).</div>
    <div class="description-paragraph style-scope patent-text">For example, if the compound is anionic, or has a functional group which may be anionic (e.g. -COOH may be -COO'), then a salt may be formed with a suitable cation. Examples of suitable inorganic cations include, but are not limited to, alkali metal ions such as Na<sup class="style-scope patent-text">+ </sup>and K<sup class="style-scope patent-text">+</sup>, alkaline earth cations such a.s Ca<sup class="style-scope patent-text">2+</sup> and Mg<sup class="style-scope patent-text">2+</sup>, and other cations such as Al<sup class="style-scope patent-text">+3</sup>. Examples of suitable organic cations include, but are not limited to, ammonium ion (i.e. NH4<sup class="style-scope patent-text">+</sup>) and substituted ammonium ions (e.g. NH3R<sup class="style-scope patent-text">+</sup>, NH2R2<sup class="style-scope patent-text">+</sup>, NHR3<sup class="style-scope patent-text">+</sup>, NR4<sup class="style-scope patent-text">+</sup>). Examples of some suitable substituted ammonium ions are those derived from: ethylamine, diethylamine, dicyclohexylamine, triethylamine, butylamine, ethylenediamine, ethanolamine, diethanolamine, piperazine, benzylamine, phenylbenzylamine, choline, meglumine, and tromethamine, as well as amino acids, such as lysine and arginine. An example of a common quaternary ammonium ion is N(CH3)<sub class="style-scope patent-text">4</sub> <sup class="style-scope patent-text">+</sup>.</div>
    <div class="description-paragraph style-scope patent-text">If the compound is cationic, or has a functional group which may be cationic (e.g. -NH<sub class="style-scope patent-text">2</sub> may be -NH<sub class="style-scope patent-text">3</sub> <sup class="style-scope patent-text">+</sup>), then a salt may be formed with a suitable anion. Examples of suitable inorganic anions include, but are not limited to, those derived from the following inorganic acids: hydrochloric, hydrobromic, hydroiodic, sulfuric, sulfurous, nitric, nitrous, phosphoric, and phosphorous.</div>
    <div class="description-paragraph style-scope patent-text">Examples of suitable organic anions include, but are not limited to, those derived from the following organic acids: 2-acetyoxybenzoic, acetic, ascorbic, aspartic, benzoic, camphorsulfonic, cinnamic, citric, edetic, ethanedisulfonic, ethanesulfonic, fumaric, glucheptonic, gluconic, glutamic, glycolic, hydroxymaleic, hydroxynaphthalene carboxylic, isethionic, lactic, lactobionic, lauric, maleic, malic, methanesulfonic, mucic, oleic, oxalic,</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">155 palmitic, pamoic, pantothenic, phenylacetic, phenylsulfonic, propionic, pyruvic, salicylic, stearic, succinic, sulfanilic, tartaric, toluenesulfonic, and valeric. Examples of suitable polymeric organic anions include, but are not limited to, those derived from the following polymeric acids: tannic acid, carboxymethyl cellulose.</div>
    <div class="description-paragraph style-scope patent-text">Solvates</div>
    <div class="description-paragraph style-scope patent-text">It may be convenient or desirable to prepare, purify, and/or handle a corresponding solvate of the active compound. The term “solvate” is used herein in the conventional sense to refer to a complex of solute (e.g. active compound, salt of active compound) and solvent. If the solvent is water, the solvate may be conveniently referred to as a hydrate, for example, a mono-hydrate, a di-hydrate, a tri-hydrate, etc.</div>
    <div class="description-paragraph style-scope patent-text">Carbinolamines</div>
    <div class="description-paragraph style-scope patent-text">The invention includes compounds where a solvent adds across the imine bond of the PBD moiety, which is illustrated below where the solvent is water or an alcohol (R<sup class="style-scope patent-text">A</sup>OH, where R<sup class="style-scope patent-text">A</sup> </div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/c6/3b/59/74b8bc3c2892df/AU2013366490B9_D0096.png" class="style-scope patent-text"><img file="AU2013366490B9_D0096.tif" img-format="tif" alt="Figure AU2013366490B9_D0096" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/c6/3b/59/74b8bc3c2892df/AU2013366490B9_D0096.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/81/06/69/676f33a2123590/AU2013366490B9_D0097.png" class="style-scope patent-text"><img file="AU2013366490B9_D0097.tif" img-format="tif" alt="Figure AU2013366490B9_D0097" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/81/06/69/676f33a2123590/AU2013366490B9_D0097.png"></a></div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">A</sup>OH</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/1c/72/37/18177af4b40913/AU2013366490B9_D0098.png" class="style-scope patent-text"><img file="AU2013366490B9_D0098.tif" img-format="tif" alt="Figure AU2013366490B9_D0098" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/1c/72/37/18177af4b40913/AU2013366490B9_D0098.png"></a></div>
    <div class="description-paragraph style-scope patent-text">These forms can be called the carbinolamine and carbinolamine ether forms of the PBD. The balance of these equilibria depend on the conditions in which the compounds are found, as well as the nature of the moiety itself.</div>
    <div class="description-paragraph style-scope patent-text">These particular compounds may be isolated in solid form, for example, by lyophilisation.</div>
    <div class="description-paragraph style-scope patent-text">Isomers</div>
    <div class="description-paragraph style-scope patent-text">Certain compounds may exist in one or more particular geometric, optical, enantiomeric, diasteriomeric, epimeric, atropic, stereoisomeric, tautomeric, conformational, or anomeric forms, including but not limited to, cis- and trans-forms; E- and Z-forms; c-, t-, and r- forms; endo- and exo-forms; R-, S-, and meso-forms; D- and L-forms; d- and l-forms; (+) and (-) forms; keto-, enol-, and enolate-forms; syn- and anti-forms; synclinal- and anticlinal-forms; a- and β-forms; axial and equatorial forms; boat-, chair-, twist-, envelope-, and halfchairforms; and combinations thereof, hereinafter collectively referred to as “isomers” (or “isomeric forms”).</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">156</div>
    <div class="description-paragraph style-scope patent-text">Note that, except as discussed below for tautomeric forms, specifically excluded from the term “isomers”, as used herein, are structural (or constitutional) isomers (i.e. isomers which differ in the connections between atoms rather than merely by the position of atoms in space). For example, a reference to a methoxy group, -OCH<sub class="style-scope patent-text">3</sub>, is not to be construed as a reference to its structural isomer, a hydroxymethyl group, -CH<sub class="style-scope patent-text">2</sub>OH. Similarly, a reference to ortho-chlorophenyl is not to be construed as a reference to its structural isomer, metachlorophenyl. However, a reference to a class of structures may well include structurally isomeric forms falling within that class (e.g. C-i_<sub class="style-scope patent-text">7</sub> alkyl includes n-propyl and iso-propyl; butyl includes η-, iso-, sec-, and tert-butyl; methoxyphenyl includes ortho-, meta-, and paramethoxyphenyl).</div>
    <div class="description-paragraph style-scope patent-text">The above exclusion does not pertain to tautomeric forms, for example, keto-, enol-, and enolate-forms, as in, for example, the following tautomeric pairs: keto/enol (illustrated below), imine/enamine, amide/imino alcohol, amidine/amidine, nitroso/oxime, thioketone/enethiol, N-nitroso/hyroxyazo, and nitro/aci-nitro.</div>
    <div class="description-paragraph style-scope patent-text">H —C-C' &gt;°</div>
    <div class="description-paragraph style-scope patent-text">OH c=c<sup class="style-scope patent-text">z</sup> \</div>
    <div class="description-paragraph style-scope patent-text">O'</div>
    <div class="description-paragraph style-scope patent-text">0=0 \</div>
    <div class="description-paragraph style-scope patent-text">keto enol enolate</div>
    <div class="description-paragraph style-scope patent-text">Note that specifically included in the term “isomer” are compounds with one or more isotopic substitutions. For example, H may be in any isotopic form, including <sup class="style-scope patent-text">1</sup>H, <sup class="style-scope patent-text">2</sup>H (D), and <sup class="style-scope patent-text">3</sup>H (T); C may be in any isotopic form, including <sup class="style-scope patent-text">12</sup>C, <sup class="style-scope patent-text">13</sup>C, and <sup class="style-scope patent-text">14</sup>C; O may be in any isotopic form, including <sup class="style-scope patent-text">16</sup>O and <sup class="style-scope patent-text">18</sup>O; and the like.</div>
    <div class="description-paragraph style-scope patent-text">Unless otherwise specified, a reference to a particular compound includes all such isomeric forms, including (wholly or partially) racemic and other mixtures thereof. Methods for the preparation (e.g. asymmetric synthesis) and separation (e.g. fractional crystallisation and chromatographic means) of such isomeric forms are either known in the art or are readily obtained by adapting the methods taught herein, or known methods, in a known manner.</div>
    <div class="description-paragraph style-scope patent-text">General synthetic routes</div>
    <div class="description-paragraph style-scope patent-text">The synthesis of PBD compounds containing two imine moieties is extensively discussed in the following references, which discussions are incorporated herein by reference:</div>
    <div class="description-paragraph style-scope patent-text">a) WO 00/12508 (pages 14 to 30);</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">157</div>
    <div class="description-paragraph style-scope patent-text">b) WO 2005/023814 (pages 3 to 10);</div>
    <div class="description-paragraph style-scope patent-text">c) WO 2004/043963 (pages 28 to 29);</div>
    <div class="description-paragraph style-scope patent-text">d) WO 2005/085251 (pages 30 to 39);</div>
    <div class="description-paragraph style-scope patent-text">e) WO 2010/043880 (pages 26 to 29);</div>
    <div class="description-paragraph style-scope patent-text">f) WO 2011/130613 (pages 56 to 59); and</div>
    <div class="description-paragraph style-scope patent-text">g) WO 2011/130616 (pages 57 to 61).</div>
    <div class="description-paragraph style-scope patent-text">Synthesis route</div>
    <div class="description-paragraph style-scope patent-text">The compounds of formula I, where either R<sup class="style-scope patent-text">10</sup> and R<sup class="style-scope patent-text">11b</sup> or R<sup class="style-scope patent-text">20</sup> and R<sup class="style-scope patent-text">21b</sup> form a nitrogencarbon double bond between the nitrogen and carbon atoms to which they are bound, can be synthesised from a compound of Formula 2:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/4b/00/50/611277aef3b0c5/AU2013366490B9_D0099.png" class="style-scope patent-text"><img file="AU2013366490B9_D0099.tif" img-format="tif" alt="Figure AU2013366490B9_D0099" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/4b/00/50/611277aef3b0c5/AU2013366490B9_D0099.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where R<sup class="style-scope patent-text">2</sup>, R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7</sup>, R<sup class="style-scope patent-text">9</sup>, R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7</sup>, R<sup class="style-scope patent-text">9</sup>, R<sup class="style-scope patent-text">12</sup>, X, X’ and R” are as defined for compounds of formula I, one of the pairs of R<sup class="style-scope patent-text">11</sup> and Prot<sup class="style-scope patent-text">N1</sup> and R<sup class="style-scope patent-text">21</sup> and Prot<sup class="style-scope patent-text">N2</sup> are OProt° and a carbamate nitrogen protecting group for synthesis and the other pair is selected from:</div>
    <div class="description-paragraph style-scope patent-text">(a) =0 and a hemi-aminal nitrogen protecting group for synthesis;</div>
    <div class="description-paragraph style-scope patent-text">(b) H and a carbamate nitrogen protecting group for synthesis, by applying the necessary conditions to remove the protecting groups.</div>
    <div class="description-paragraph style-scope patent-text">The compound of formula 2 may be used directly to make drug-linkers, and conjugates of the present invention, and thus may be a further aspect of the present invention. Part of the linking group may be added (for example, to form a protected compound of formula III), following which the deprotection discussed above can be carried out.</div>
    <div class="description-paragraph style-scope patent-text">The group X or Q (part of R<sup class="style-scope patent-text">2</sup>) in Formula 2 may be protected during the synthetic steps described below, in which case, it can be removed to give the desired compound of Formula 2.</div>
    <div class="description-paragraph style-scope patent-text">The compound of Formula 2 can be synthesised by the coupling of compounds of Formulae 3a and 4a, or compounds of Formulae 3b and 4b:</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">158</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/03/b4/35/c446960d25bb2b/AU2013366490B9_D0100.png" class="style-scope patent-text"><img file="AU2013366490B9_D0100.tif" img-format="tif" alt="Figure AU2013366490B9_D0100" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/03/b4/35/c446960d25bb2b/AU2013366490B9_D0100.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/55/2b/ed/7cf3c0601990b4/AU2013366490B9_D0101.png" class="style-scope patent-text"><img file="AU2013366490B9_D0101.tif" img-format="tif" alt="Figure AU2013366490B9_D0101" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/55/2b/ed/7cf3c0601990b4/AU2013366490B9_D0101.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where Hal is selected from I, Cl, and Br.</div>
    <div class="description-paragraph style-scope patent-text">The coupling can be achieved, for example, in refluxing acetone with a base, such as K<sub class="style-scope patent-text">2</sub>CO<sub class="style-scope patent-text">3</sub>.</div>
    <div class="description-paragraph style-scope patent-text">The compounds of Formulae 3b and 4a may be synthesised by reacting compounds of Formulae 3a and 4b respectively with a compound of Formula 5:</div>
    <div class="description-paragraph style-scope patent-text">Hal-R”-0 Formula 5 where O is selected from I, Cl, and Br, The reaction can be achieved, for example, in refluxing acetone with a base, such as K<sub class="style-scope patent-text">2</sub>CO<sub class="style-scope patent-text">3</sub>. An excess of the compound of Formula 5 is required to achieve the desired product.</div>
    <div class="description-paragraph style-scope patent-text">The monomer which contains the imine or equivalent group can be synthesised in a similar manner to that described in co-pending PCT application PCT/EP2012/070232, filed 12</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">159</div>
    <div class="description-paragraph style-scope patent-text">October 2012, which is incorporated herein by reference. This approach is described below in relation to the compound of Formula 3a where R<sup class="style-scope patent-text">11</sup> and Prot<sup class="style-scope patent-text">N1</sup> are OProt° and a carbamate nitrogen protecting group for synthesis (Formula 3a-l), but is equally applicable to the compound of Formula 4b, where R<sup class="style-scope patent-text">21</sup> and Prot<sup class="style-scope patent-text">N2</sup> are OProt° and a carbamate nitrogen protecting group for synthesis.</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/75/71/d5/a7c4375d2b3668/AU2013366490B9_D0102.png" class="style-scope patent-text"><img file="AU2013366490B9_D0102.tif" img-format="tif" alt="Figure AU2013366490B9_D0102" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/75/71/d5/a7c4375d2b3668/AU2013366490B9_D0102.png"></a></div>
    <div class="description-paragraph style-scope patent-text">Prot<sup class="style-scope patent-text">N</sup> <sup class="style-scope patent-text">carb</sup> represents a carbamate nitrogen protecting group for synthesis.</div>
    <div class="description-paragraph style-scope patent-text">The compound of Formula 3a-l may be synthesised from a compound of Formula 6-I:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/79/81/8b/c2b1454051a6b6/AU2013366490B9_D0103.png" class="style-scope patent-text"><img file="AU2013366490B9_D0103.tif" img-format="tif" alt="Figure AU2013366490B9_D0103" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/79/81/8b/c2b1454051a6b6/AU2013366490B9_D0103.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where Prot<sup class="style-scope patent-text">Y</sup> is a protecting group for Y that is orthogonal to the other protecting groups in the compound. The synthesis is achieved by deprotection of Y, under standard conditions.</div>
    <div class="description-paragraph style-scope patent-text">The compound of Formula 6-I may be synthesised from a compound of Formula 7-I:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/3b/5f/c4/f603bb69083611/AU2013366490B9_D0104.png" class="style-scope patent-text"><img file="AU2013366490B9_D0104.tif" img-format="tif" alt="Figure AU2013366490B9_D0104" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/3b/5f/c4/f603bb69083611/AU2013366490B9_D0104.png"></a></div>
    <div class="description-paragraph style-scope patent-text">by protecting the OH group with Prot°, under non-racemising conditions.</div>
    <div class="description-paragraph style-scope patent-text">The compound of Formula 7-I may be synthesised from a compound of Formula 8-I:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/36/38/ab/c9e5d6253e170b/AU2013366490B9_D0105.png" class="style-scope patent-text"><img file="AU2013366490B9_D0105.tif" img-format="tif" alt="Figure AU2013366490B9_D0105" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/36/38/ab/c9e5d6253e170b/AU2013366490B9_D0105.png"></a></div>
    <div class="description-paragraph style-scope patent-text">Formula 8-I</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">160 by oxidation. The oxidation may be carried out, for example, with Dess-Martin periodinane (or alternatively TPAP/NMO, TFAA/DMSO, SO<sub class="style-scope patent-text">3</sub>.Pyridine complex/DMSO, PDC, PCC, BAIB/TEMPO or under Swern conditions).</div>
    <div class="description-paragraph style-scope patent-text">The compound of Formula 8-I may be synthesised from a compound of Formula 9-I:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cc/ac/b1/96ae19ee1f2276/AU2013366490B9_D0106.png" class="style-scope patent-text"><img file="AU2013366490B9_D0106.tif" img-format="tif" alt="Figure AU2013366490B9_D0106" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cc/ac/b1/96ae19ee1f2276/AU2013366490B9_D0106.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7a/74/e4/30787997c31cdc/AU2013366490B9_D0107.png" class="style-scope patent-text"><img file="AU2013366490B9_D0107.tif" img-format="tif" alt="Figure AU2013366490B9_D0107" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7a/74/e4/30787997c31cdc/AU2013366490B9_D0107.png"></a></div>
    <div class="description-paragraph style-scope patent-text">Formula 9-I by deprotection of the OH group under standard conditions.</div>
    <div class="description-paragraph style-scope patent-text">The compound of Formula 9-I may be synthesised from a compound of Formula 10-1:</div>
    <div class="description-paragraph style-scope patent-text">Formula 10-I by protection of the amine group by Prot<sup class="style-scope patent-text">N</sup> <sup class="style-scope patent-text">carb</sup> under standard conditions.</div>
    <div class="description-paragraph style-scope patent-text">The compound of Formula 10-1 may be synthesised from a compound of Formula 11-1:</div>
    <div class="description-paragraph style-scope patent-text">Formula 11-1</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/76/80/29/0f8aaf4236d582/AU2013366490B9_D0108.png" class="style-scope patent-text"><img file="AU2013366490B9_D0108.tif" img-format="tif" alt="Figure AU2013366490B9_D0108" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/76/80/29/0f8aaf4236d582/AU2013366490B9_D0108.png"></a></div>
    <div class="description-paragraph style-scope patent-text">by reduction of the nitro group. The reduction can be achieved by standard means, for example with Zn dust with 5% formic acid in methanol.</div>
    <div class="description-paragraph style-scope patent-text">The compound of Formula 11-1 may be synthesised from a compound of Formula 12-1:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/71/bc/0a/c7c843b636ad4f/AU2013366490B9_D0109.png" class="style-scope patent-text"><img file="AU2013366490B9_D0109.tif" img-format="tif" alt="Figure AU2013366490B9_D0109" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/71/bc/0a/c7c843b636ad4f/AU2013366490B9_D0109.png"></a></div>
    <div class="description-paragraph style-scope patent-text">Formula 12-1</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">161 by the palladium mediated coupling of the appropriate compound comprising -R<sup class="style-scope patent-text">2</sup>. This coupling includes, but is not limited to: Suzuki couplings with an appropriate boron derivative; Heck coupling with alkenes, including acrylamides and acrylates; Stilie couplings with organo tin reagents, such as alkyl tin reagents; Sonagishira couplings with alkynes; and hydride transfer using triethyl silanes.</div>
    <div class="description-paragraph style-scope patent-text">The compound of Formula 12-1 may be synthesised from a compound of Formula 13-1:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/c1/0b/b8/0420d8d6ce8df0/AU2013366490B9_D0110.png" class="style-scope patent-text"><img file="AU2013366490B9_D0110.tif" img-format="tif" alt="Figure AU2013366490B9_D0110" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/c1/0b/b8/0420d8d6ce8df0/AU2013366490B9_D0110.png"></a></div>
    <div class="description-paragraph style-scope patent-text">by triflation using triflic anhydride and anhydrous 2,6-lutidine or anhydrous 2,6-<sup class="style-scope patent-text">f</sup>Bu-pyridine at a temperature of -35°C or lower in a dry organic solvent under an inert atmosphere.</div>
    <div class="description-paragraph style-scope patent-text">In the synthesis of compounds of Formula 4b where there is not a double bond between C2’ and C3’, the relevant R<sup class="style-scope patent-text">12</sup> may be introduced at this stage.</div>
    <div class="description-paragraph style-scope patent-text">If the other monomer contains an amine group, it can be synthesised in a similar manner to that described above. This approach is described below in relation to the compound of Formula 3a where R<sup class="style-scope patent-text">11</sup> and Prot<sup class="style-scope patent-text">N1</sup> are H and a carbamate nitrogen protecting group for synthesis (Formula 3a-lI), but is equally applicable to the compound of Formula 4b, where R<sup class="style-scope patent-text">21</sup> and Prot<sup class="style-scope patent-text">N2</sup> are H and a carbamate nitrogen protecting group for synthesis.</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/70/31/56/8408a7860115bf/AU2013366490B9_D0111.png" class="style-scope patent-text"><img file="AU2013366490B9_D0111.tif" img-format="tif" alt="Figure AU2013366490B9_D0111" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/70/31/56/8408a7860115bf/AU2013366490B9_D0111.png"></a></div>
    <div class="description-paragraph style-scope patent-text">The compound of Formula 3a-ll may be synthesised from a compound of Formula 6-II:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/55/65/e0/30009d95901d95/AU2013366490B9_D0112.png" class="style-scope patent-text"><img file="AU2013366490B9_D0112.tif" img-format="tif" alt="Figure AU2013366490B9_D0112" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/55/65/e0/30009d95901d95/AU2013366490B9_D0112.png"></a></div>
    <div class="description-paragraph style-scope patent-text">R‘</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">162 where Prot<sup class="style-scope patent-text">Y</sup> is a protecting group for Y that is orthogonal to the other protecting groups in the compound. The synthesis is achieved by deprotection of Y, under standard conditions</div>
    <div class="description-paragraph style-scope patent-text">The compound of Formula 6-II may be synthesised from a compound of Formula 7-II:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ca/1c/9b/be7e4f35b8fe89/AU2013366490B9_D0113.png" class="style-scope patent-text"><img file="AU2013366490B9_D0113.tif" img-format="tif" alt="Figure AU2013366490B9_D0113" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ca/1c/9b/be7e4f35b8fe89/AU2013366490B9_D0113.png"></a></div>
    <div class="description-paragraph style-scope patent-text">Formula 7-II by protecting the NH group with Prot<sup class="style-scope patent-text">N</sup> <sup class="style-scope patent-text">carb</sup>, under standard conditions.</div>
    <div class="description-paragraph style-scope patent-text">The compound of Formula 7-II may be synthesised from a compound of Formula 8-II:</div>
    <div class="description-paragraph style-scope patent-text">Formula 8-II by reductive amination.</div>
    <div class="description-paragraph style-scope patent-text">The compound of Formula 8-II may be synthesised from a compound of Formula 9-II:</div>
    <div class="description-paragraph style-scope patent-text">Formula 9-II by oxidation of the alcohol.</div>
    <div class="description-paragraph style-scope patent-text">The compound of Formula 9-II may be synthesised from a compound of Formula 11-1:</div>
    <div class="description-paragraph style-scope patent-text">Formula 11-1</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a7/96/cf/bc98f07d1fd7ed/AU2013366490B9_D0114.png" class="style-scope patent-text"><img file="AU2013366490B9_D0114.tif" img-format="tif" alt="Figure AU2013366490B9_D0114" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a7/96/cf/bc98f07d1fd7ed/AU2013366490B9_D0114.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/b7/00/ba/55ba6f828e8097/AU2013366490B9_D0115.png" class="style-scope patent-text"><img file="AU2013366490B9_D0115.tif" img-format="tif" alt="Figure AU2013366490B9_D0115" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/b7/00/ba/55ba6f828e8097/AU2013366490B9_D0115.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/1c/fd/9f/e8684990e874b6/AU2013366490B9_D0116.png" class="style-scope patent-text"><img file="AU2013366490B9_D0116.tif" img-format="tif" alt="Figure AU2013366490B9_D0116" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/1c/fd/9f/e8684990e874b6/AU2013366490B9_D0116.png"></a></div>
    <div class="description-paragraph style-scope patent-text">by deprotection of the OH group under standard conditions.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">163</div>
    <div class="description-paragraph style-scope patent-text">The compound of Formula 6-II may alternatively be synthesised from a compound of formula 12:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/82/55/65/39fa300ae13d20/AU2013366490B9_D0117.png" class="style-scope patent-text"><img file="AU2013366490B9_D0117.tif" img-format="tif" alt="Figure AU2013366490B9_D0117" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/82/55/65/39fa300ae13d20/AU2013366490B9_D0117.png"></a></div>
    <div class="description-paragraph style-scope patent-text">by the palladium mediated coupling of the appropriate compound comprising -R<sup class="style-scope patent-text">2</sup> (as described above).</div>
    <div class="description-paragraph style-scope patent-text">The compound of formula 12 may be synthesised from a compound of formula 13:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/6f/3d/92/04706ce16feb95/AU2013366490B9_D0118.png" class="style-scope patent-text"><img file="AU2013366490B9_D0118.tif" img-format="tif" alt="Figure AU2013366490B9_D0118" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/6f/3d/92/04706ce16feb95/AU2013366490B9_D0118.png"></a></div>
    <div class="description-paragraph style-scope patent-text">by triflation. This may be carried out with the conditions described above, or with standard conditions.</div>
    <div class="description-paragraph style-scope patent-text">The compound of formula 13 may be synthesised from a compound of formula 14:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/14/fe/32/b656b7ba7b6d7c/AU2013366490B9_D0119.png" class="style-scope patent-text"><img file="AU2013366490B9_D0119.tif" img-format="tif" alt="Figure AU2013366490B9_D0119" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/14/fe/32/b656b7ba7b6d7c/AU2013366490B9_D0119.png"></a></div>
    <div class="description-paragraph style-scope patent-text">by oxidation of the alcohol group using standard conditions.</div>
    <div class="description-paragraph style-scope patent-text">The compound of formula 14 may be synthesised from a compound of formula 15:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/fd/e2/0c/10e790ff5fa166/AU2013366490B9_D0120.png" class="style-scope patent-text"><img file="AU2013366490B9_D0120.tif" img-format="tif" alt="Figure AU2013366490B9_D0120" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/fd/e2/0c/10e790ff5fa166/AU2013366490B9_D0120.png"></a></div>
    <div class="description-paragraph style-scope patent-text">by removal of the Prot° group, which group is a alcohol protecting group orthogonal to the other protecting groups in the compound.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">164</div>
    <div class="description-paragraph style-scope patent-text">The compound of formula 15 may be synthesised from a compound of formula 16:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/bb/aa/b2/3c2552943005cf/AU2013366490B9_D0121.png" class="style-scope patent-text"><img file="AU2013366490B9_D0121.tif" img-format="tif" alt="Figure AU2013366490B9_D0121" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/bb/aa/b2/3c2552943005cf/AU2013366490B9_D0121.png"></a></div>
    <div class="description-paragraph style-scope patent-text">by protection of the amine with a carbamate nitrogen protecting group.</div>
    <div class="description-paragraph style-scope patent-text">The compound of formula 16 may be synthesised from a compound of formula 17:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a0/0e/75/5bc0178be96618/AU2013366490B9_D0122.png" class="style-scope patent-text"><img file="AU2013366490B9_D0122.tif" img-format="tif" alt="Figure AU2013366490B9_D0122" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a0/0e/75/5bc0178be96618/AU2013366490B9_D0122.png"></a></div>
    <div class="description-paragraph style-scope patent-text">by reductive amination.</div>
    <div class="description-paragraph style-scope patent-text">The compound of formula 17 may be synthesised from a compound of formula 18:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e9/ae/2d/ca2d723e85868a/AU2013366490B9_D0123.png" class="style-scope patent-text"><img file="AU2013366490B9_D0123.tif" img-format="tif" alt="Figure AU2013366490B9_D0123" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e9/ae/2d/ca2d723e85868a/AU2013366490B9_D0123.png"></a></div>
    <div class="description-paragraph style-scope patent-text">by oxidation of the unprotected alcohol group. The compound of formula 18 can be used to synthesise the compound of Formula 13-1.</div>
    <div class="description-paragraph style-scope patent-text">The compound of formula 18 may be synthesised from a compound of formula 19:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/5e/bf/47/515d93616bbbf8/AU2013366490B9_D0124.png" class="style-scope patent-text"><img file="AU2013366490B9_D0124.tif" img-format="tif" alt="Figure AU2013366490B9_D0124" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/5e/bf/47/515d93616bbbf8/AU2013366490B9_D0124.png"></a></div>
    <div class="description-paragraph style-scope patent-text">by reduction of the ester functionality.</div>
    <div class="description-paragraph style-scope patent-text">The compound of formula 19 may be synthesised from by coupling compounds of formulae 20 and 21:</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">165</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/8b/fd/ac/0d894fff167bcb/AU2013366490B9_D0125.png" class="style-scope patent-text"><img file="AU2013366490B9_D0125.tif" img-format="tif" alt="Figure AU2013366490B9_D0125" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/8b/fd/ac/0d894fff167bcb/AU2013366490B9_D0125.png"></a></div>
    <div class="description-paragraph style-scope patent-text">Formula 20</div>
    <div class="description-paragraph style-scope patent-text">CC&gt;2Me</div>
    <div class="description-paragraph style-scope patent-text">Formula 21</div>
    <div class="description-paragraph style-scope patent-text">OProt° under amide coupling conditions</div>
    <div class="description-paragraph style-scope patent-text">If the other monomer contains an amide group, it can be synthesised in a similar manner to that described above. This approach is described below in relation to the compound of Formula 3a where R<sup class="style-scope patent-text">11</sup> and Prot<sup class="style-scope patent-text">N1</sup> are =0 and a hemi-aminal nitrogen protecting group for synthesis (Formula 3a-l 11), but is equally applicable to the compound of Formula 4b, where R<sup class="style-scope patent-text">21</sup> and Prot<sup class="style-scope patent-text">N2</sup> are =0 and a hemi-aminal nitrogen protecting group for synthesis.</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/04/71/29/1c8811449003ed/AU2013366490B9_D0126.png" class="style-scope patent-text"><img file="AU2013366490B9_D0126.tif" img-format="tif" alt="Figure AU2013366490B9_D0126" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/04/71/29/1c8811449003ed/AU2013366490B9_D0126.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where p<sub class="style-scope patent-text">ro</sub>t<sup class="style-scope patent-text">N</sup> <sup class="style-scope patent-text">amin</sup> represents a hemi-aminal nitrogen protecting group for synthesis.</div>
    <div class="description-paragraph style-scope patent-text">The compound of Formula 3a-lII may be synthesised from a compound of Formula 22:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/50/17/6f/0944a717174e98/AU2013366490B9_D0127.png" class="style-scope patent-text"><img file="AU2013366490B9_D0127.tif" img-format="tif" alt="Figure AU2013366490B9_D0127" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/50/17/6f/0944a717174e98/AU2013366490B9_D0127.png"></a></div>
    <div class="description-paragraph style-scope patent-text">by deprotection of Y, under standard conditions.</div>
    <div class="description-paragraph style-scope patent-text">The compound of Formula 22 may be synthesised from a compound of Formula 23:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f5/41/73/3607ba3114fa65/AU2013366490B9_D0128.png" class="style-scope patent-text"><img file="AU2013366490B9_D0128.tif" img-format="tif" alt="Figure AU2013366490B9_D0128" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f5/41/73/3607ba3114fa65/AU2013366490B9_D0128.png"></a></div>
    <div class="description-paragraph style-scope patent-text">by the palladium mediated coupling of the appropriate compound comprising -R<sup class="style-scope patent-text">2</sup> (as described above).</div>
    <div class="description-paragraph style-scope patent-text">The compound of Formula 23 may be synthesised from a compound of Formula 24:</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">166</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/50/fd/a2/f5d9fe42b3f50b/AU2013366490B9_D0129.png" class="style-scope patent-text"><img file="AU2013366490B9_D0129.tif" img-format="tif" alt="Figure AU2013366490B9_D0129" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/50/fd/a2/f5d9fe42b3f50b/AU2013366490B9_D0129.png"></a></div>
    <div class="description-paragraph style-scope patent-text">by triflation. This may be carried out with the conditions described above, or with standard conditions.</div>
    <div class="description-paragraph style-scope patent-text">The compound of Formula 24 may be synthesised from a compound of Formula 25:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/04/d1/7e/354e4e22d58630/AU2013366490B9_D0130.png" class="style-scope patent-text"><img file="AU2013366490B9_D0130.tif" img-format="tif" alt="Figure AU2013366490B9_D0130" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/04/d1/7e/354e4e22d58630/AU2013366490B9_D0130.png"></a></div>
    <div class="description-paragraph style-scope patent-text">Formula 25</div>
    <div class="description-paragraph style-scope patent-text">OH by oxidation of the alcohol group.</div>
    <div class="description-paragraph style-scope patent-text">The compound of Formula 25 may be synthesised from a compound of Formula 26:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e5/88/0c/6ce2ed0ca586bd/AU2013366490B9_D0131.png" class="style-scope patent-text"><img file="AU2013366490B9_D0131.tif" img-format="tif" alt="Figure AU2013366490B9_D0131" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e5/88/0c/6ce2ed0ca586bd/AU2013366490B9_D0131.png"></a></div>
    <div class="description-paragraph style-scope patent-text">by removal of the Prot° group, which group is a alcohol protecting group orthogonal to the other protecting groups in the compound.</div>
    <div class="description-paragraph style-scope patent-text">The compound of Formula 26 may be synthesised from a compound of Formula 27:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/18/23/1c/08640518e8b614/AU2013366490B9_D0132.png" class="style-scope patent-text"><img file="AU2013366490B9_D0132.tif" img-format="tif" alt="Figure AU2013366490B9_D0132" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/18/23/1c/08640518e8b614/AU2013366490B9_D0132.png"></a></div>
    <div class="description-paragraph style-scope patent-text">by protection of the amine with an hemi-aminal nitrogen protecting group.</div>
    <div class="description-paragraph style-scope patent-text">The compound of Formula 27 may be synthesised from a compound of Formula 19 by reduction of the ester functionality by hydrogen and Pd/C to achieve ring closure.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">167</div>
    <div class="description-paragraph style-scope patent-text">An alternative synthesis strategy is illustrated in Example 1 below.</div>
    <div class="description-paragraph style-scope patent-text">Nitrogen protecting groups for synthesis</div>
    <div class="description-paragraph style-scope patent-text">Nitrogen protecting groups for synthesis are well known in the art. In the present invention, the protecting groups of particular interest are carbamate nitrogen protecting groups and hemi-aminal nitrogen protecting groups.</div>
    <div class="description-paragraph style-scope patent-text">Carbamate nitrogen protecting groups have the following structure:</div>
    <div class="description-paragraph style-scope patent-text">R'<sup class="style-scope patent-text">10</sup>— /0 wherein R’<sup class="style-scope patent-text">10</sup> is R as defined above. A large number of suitable groups are described on pages 503 to 549 of Greene, T.W. and Wuts, G.M., Protective Groups in Organic Synthesis, 3<sup class="style-scope patent-text">rd</sup> Edition, John Wiley &amp; Sons, Inc., 1999, which is incorporated herein by reference.</div>
    <div class="description-paragraph style-scope patent-text">Particularly preferred protecting groups include Troc, Teoc, Fmoc, BOC, Doc, Hoc, TcBOC, 1-Adoc and 2-Adoc.</div>
    <div class="description-paragraph style-scope patent-text">Other possible groups are nitrobenzyloxycarbonyl (e.g. 4- nitrobenzyloxycarbonyl) and 2(phenylsulphonyl)ethoxycarbonyl.</div>
    <div class="description-paragraph style-scope patent-text">Those protecting groups which can be removed with palladium catalysis are not preferred, e.g. Alloc.</div>
    <div class="description-paragraph style-scope patent-text">Hemi-aminal nitrogen protecting groups have the following structure:</div>
    <div class="description-paragraph style-scope patent-text">wherein R’<sup class="style-scope patent-text">10</sup> is R as defined above. A large number of suitable groups are described on pages 633 to 647 as amide protecting groups of Greene, T.W. and Wuts, G.M., Protective Groups in Organic Synthesis, 3<sup class="style-scope patent-text">rd</sup> Edition, John Wiley &amp; Sons, Inc., 1999, which is incorporated herein by reference. The groups disclosed herein can be applied to</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">168 compounds ofthe present invention. Such groups include, but are not limited to, SEM, MOM, MTM, MEM, BOM, nitro or methoxy substituted BOM, ΟΙ<sub class="style-scope patent-text">3</sub>ΟΟΗ<sub class="style-scope patent-text">2</sub>ΟΟΗ<sub class="style-scope patent-text">2</sub>-.</div>
    <div class="description-paragraph style-scope patent-text">Protected oxygen group for synthesis</div>
    <div class="description-paragraph style-scope patent-text">Protected oxygen group for synthesis are well known in the art. A large number of suitable oxygen protecting groups are described on pages 23 to 200 of Greene, T.W. and Wuts, G.M., Protective Groups in Organic Synthesis, 3<sup class="style-scope patent-text">rd</sup> Edition, John Wiley &amp; Sons, Inc., 1999, which is incorporated herein by reference.</div>
    <div class="description-paragraph style-scope patent-text">Classes of particular interest include silyl ethers, methyl ethers, alkyl ethers, benzyl ethers, esters, acetates, benzoates, carbonates, and sulfonates.</div>
    <div class="description-paragraph style-scope patent-text">Preferred oxygen protecting groups include acetates, TBS and THP.</div>
    <div class="description-paragraph style-scope patent-text">Synthesis of Drug Conjugates</div>
    <div class="description-paragraph style-scope patent-text">Conjugates can be prepared as previously described. Linkers having a maleimidyl group (A), a peptide group (L<sup class="style-scope patent-text">1</sup>) and self-immolative group (L<sup class="style-scope patent-text">2</sup>) can be prepared as described in U.S. Patent No. 6,214,345, which is incorporated herein by reference. Linkers having a maleimidyl group (A) and a peptide group (L<sup class="style-scope patent-text">1</sup>) can be prepared as described in WO 2009/0117531, which is incorporated herein by reference. Other linkers can be prepared according to the references cited herein or as known to the skilled artisan.</div>
    <div class="description-paragraph style-scope patent-text">Linker-Drug compounds can be prepared according to methods known in the art. Linkage of amine-based X substituents (of the PDB dimer Drug unit) to active groups of the Linker units can be performed according to methods generally described in U.S. Patent Nos. 6,214,345 and 7,498,298; and WO 2009-0117531, or as otherwise known to the skilled artisan.</div>
    <div class="description-paragraph style-scope patent-text">Antibodies can be conjugated to Linker-Drug compounds as described in Doronina et al., Nature Biotechnology, 2003, 21, 778-784). Briefly, antibodies (4-5 mg/mL) in PBS containing 50 mM sodium borate at pH 7.4 are reduced with tris(carboxyethyl)phosphine hydrochloride (TCEP) at 37 °C. The progress of the reaction, which reduces interchain disulfides, is monitored by reaction with 5,5’-dithiobis(2-nitrobenzoic acid) and allowed to proceed until the desired level of thiols/mAb is achieved. The reduced antibody is then cooled to 0°C and alkylated with 1.5 equivalents of maleimide drug-linker per antibody thiol.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">169</div>
    <div class="description-paragraph style-scope patent-text">After 1 hour, the reaction is quenched by the addition of 5 equivalents of N-acetyl cysteine. Quenched drug-linker is removed by gel filtration over a PD-10 column. The ADC is then sterile-filtered through a 0.22 pm syringe filter. Protein concentration can be determined by spectral analysis at 280 nm and 329 nm, respectively, with correction for the contribution of drug absorbance at 280 nm. Size exclusion chromatography can be used to determine the extent of antibody aggregation, and RP-HPLC can be used to determine the levels of remaining NAC-quenched drug-linker.</div>
    <div class="description-paragraph style-scope patent-text">Antibodies with introduced cysteine residues can be conjugated to Linker-Drug compounds as described in International Patent Publication W02008/070593, which is incorporated herein or as follows. Antibodies containing an introduced cysteine residue in the heavy chain are fully reduced by adding 10 equivalents of TCEP and 1 mM EDTA and adjusting the pH to 7.4 with 1M Tris buffer (pH 9.0). Following a 1 hour incubation at 37°C, the reaction is cooled to 22°C and 30 equivalents of dehydroascorbic acid is added to selectively reoxidize the native disulfides, while leaving the introduced cysteine in the reduced state. The pH is adjusted to 6.5 with 1M Tris buffer (pH 3.7) and the reaction is allowed to proceed for 1 hour at 22°C. The pH of the solution is then raised again to 7.4 by addition of 1 M Tris buffer (pH 9.0). 3.5 equivalents of the PBD drug linker in DMSO is placed in a suitable container for dilution with propylene glycol prior to addition to the reaction. To maintain solubility of the PBD drug linker, the antibody itself is first diluted with propylene glycol to a final concentration of 33% (e.g., if the antibody solution was in a 60 mL reaction volume, 30 mL of propylene glycol was added). This same volume of propylene glycol (30 mL in this example) is added to the PBD drug linker as a diluent. After mixing, the solution of PBD drug linker in propylene glycol is added to the antibody solution to effect the conjugation; the final concentration of propylene glycol is 50%. The reaction is allowed to proceed for 30 minutes and then quenched by addition of 5 equivalents of Nacetyl cysteine. The ADC is purified by ultrafiltration through a 30 kD membrane. (Note that the concentration of propylene glycol used in the reaction can be reduced for any particular PBD, as its sole purpose is to maintain solubility of the drug linker in the aqueous media.)</div>
    <div class="description-paragraph style-scope patent-text">For halo-acetamide-based Linker-Drug compounds, conjugation can be performed generally as follows. To a solution of reduced and reoxidized antibodies (having introduced cysteines in the heavy chain) in 10 mM Tris (pH 7.4), 50 mM NaCl, and 2 mM DTPA is added 0.5 volumes of propylene glycol. A 10mM solution of acetamide-based</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">170</div>
    <div class="description-paragraph style-scope patent-text">Linker-Drug compound in dimethylacetamide is prepared immediately prior to conjugation. An equivalent amount of propylene glycol as added to the antibody solution is added to a 6-fold molar excess of the Linker-Drug compound. The dilute Linker-Drug solution is added to the antibody solution and the pH is adjusted to 8-8.5 using 1 M Tris (pH 9). The conjugation reaction is allowed to proceed for 45 minutes at 37° C. The conjugation is verified by reducing and denaturing reversed phase PLRP-S chromatography. Excess Linker-Drug compound is removed with Quadrasil MP resin and the buffer is exchanged into 10 mM Tris (pH 7.4), 50 mM NaCI, and 5% propylene glycol using a PD-10 desalting column.</div>
    <div class="description-paragraph style-scope patent-text">Illustrative synthesis schemes for Drug linkers</div>
    <div class="description-paragraph style-scope patent-text">The following schemes are illustrative of routes for synthesising drug linkers, wherein PBD represents a compound of formula I of the present invention where X is NH<sub class="style-scope patent-text">2</sub>, which may be varied within the scope of the present invention.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">171</div>
    <div class="description-paragraph style-scope patent-text">Scheme A</div>
    <div class="description-paragraph style-scope patent-text">AND Enantiomer</div>
    <div class="description-paragraph style-scope patent-text">O</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/5d/34/6c/4369cd7f5cd7c4/AU2013366490B9_D0133.png" class="style-scope patent-text"><img file="AU2013366490B9_D0133.tif" img-format="tif" alt="Figure AU2013366490B9_D0133" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/5d/34/6c/4369cd7f5cd7c4/AU2013366490B9_D0133.png"></a></div>
    <div class="description-paragraph style-scope patent-text">S1 h<sub class="style-scope patent-text">2</sub>n <sup class="style-scope patent-text">X</sup>PBD</div>
    <div class="description-paragraph style-scope patent-text">S2 (i) diphosgene, pyridine CH2CI2, -78°C to 0°C</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/86/7e/59/89673b4009228f/AU2013366490B9_D0134.png" class="style-scope patent-text"><img file="AU2013366490B9_D0134.tif" img-format="tif" alt="Figure AU2013366490B9_D0134" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/86/7e/59/89673b4009228f/AU2013366490B9_D0134.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/72/36/82/bf7af6f1a24b21/AU2013366490B9_D0135.png" class="style-scope patent-text"><img file="AU2013366490B9_D0135.tif" img-format="tif" alt="Figure AU2013366490B9_D0135" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/72/36/82/bf7af6f1a24b21/AU2013366490B9_D0135.png"></a></div>
    <div class="description-paragraph style-scope patent-text">The glucuronide linker intermediate S1 (reference: Jeffrey et al., Bioconjugate Chemistry,</div>
    <div class="description-paragraph style-scope patent-text">2006, 17, 831-840) can be treated with diphosgene in dichlroromethane at -78°C to afford the glucuronide chloroformate, which is then reacted with the PBD dimer S2 dissolved in CH<sub class="style-scope patent-text">2</sub>CI<sub class="style-scope patent-text">2</sub> by dropwise addition. Warming the reaction to 0°C over 2 hours followed by extraction will yield the compound S3. Treating a solution of S3 in an equal solvent mixture of MeOH, tetrahydrofuran, and water (cooled to 0°C) with lithium hydroxide monohydrate for 4 hours, followed by reaction with glacial acetic acid will yield the compound S4.</div>
    <div class="description-paragraph style-scope patent-text">Adding maleimidocaproyl NHS ester to a solution of S4 in DMF, followed by diisopropylethylamine and stirring at room temperature under nitrogen for 2 hours will yield the desired drug linker S5.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">172</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/8a/9c/93/6e8229b178981c/AU2013366490B9_D0136.png" class="style-scope patent-text"><img file="AU2013366490B9_D0136.tif" img-format="tif" alt="Figure AU2013366490B9_D0136" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/8a/9c/93/6e8229b178981c/AU2013366490B9_D0136.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/0c/bb/d6/daea3c4feda723/AU2013366490B9_D0137.png" class="style-scope patent-text"><img file="AU2013366490B9_D0137.tif" img-format="tif" alt="Figure AU2013366490B9_D0137" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/0c/bb/d6/daea3c4feda723/AU2013366490B9_D0137.png"></a></div>
    <div class="description-paragraph style-scope patent-text">The maleimide linker S6, which can be synthesised by reacting maleimidocaproyl N5 hydroxysuccinimide and H-Val-Ala-OH, can be linked to the exemplary compounds, S2, in the presence of EEDQ in anhydrous dichloromethane.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">173</div>
    <div class="description-paragraph style-scope patent-text">Scheme C o</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/87/0c/c2/d459e401b89a31/AU2013366490B9_D0138.png" class="style-scope patent-text"><img file="AU2013366490B9_D0138.tif" img-format="tif" alt="Figure AU2013366490B9_D0138" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/87/0c/c2/d459e401b89a31/AU2013366490B9_D0138.png"></a></div>
    <div class="description-paragraph style-scope patent-text">H<sub class="style-scope patent-text">2</sub>N<sub class="style-scope patent-text">x</sub> </div>
    <div class="description-paragraph style-scope patent-text">PBD 'OH</div>
    <div class="description-paragraph style-scope patent-text">S2</div>
    <div class="description-paragraph style-scope patent-text">S8 (i) EEDQ</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/d4/a1/7c/44673deb09bece/AU2013366490B9_D0139.png" class="style-scope patent-text"><img file="AU2013366490B9_D0139.tif" img-format="tif" alt="Figure AU2013366490B9_D0139" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/d4/a1/7c/44673deb09bece/AU2013366490B9_D0139.png"></a></div>
    <div class="description-paragraph style-scope patent-text">S9 (ii) deprotection</div>
    <div class="description-paragraph style-scope patent-text">N.</div>
    <div class="description-paragraph style-scope patent-text">Ν'</div>
    <div class="description-paragraph style-scope patent-text">H</div>
    <div class="description-paragraph style-scope patent-text">PBD</div>
    <div class="description-paragraph style-scope patent-text">S10: R<sup class="style-scope patent-text">1</sup> =H (ii) maleimidocaproyl-NHS ester, DIPEA</div>
    <div class="description-paragraph style-scope patent-text">S11: R<sup class="style-scope patent-text">1</sup> = MC</div>
    <div class="description-paragraph style-scope patent-text">The linker S8 can be linked to the exemplary compounds, S2, in the presence of EEDQ in 5 5% methanol/dichloromethane. The deprotection of S9 can be carried out with the use of</div>
    <div class="description-paragraph style-scope patent-text">Ph<sub class="style-scope patent-text">3</sub>P, pyrollidine and tetrakis palladium in anhydrous dichloromethane. S10 can be converted to the desired products by adding maleimidocaproyl-NHS ester, in the presence of DIPEA in DMF.</div>
    <div class="description-paragraph style-scope patent-text">Further Preferences</div>
    <div class="description-paragraph style-scope patent-text">The following preferences may apply to all aspects of the invention as described above, or may relate to a single aspect. The preferences may be combined together in any combination.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7</sup>, R<sup class="style-scope patent-text">9</sup>, and Y’ are preferably the same as R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7</sup>, R<sup class="style-scope patent-text">9</sup>, and Y respectively.</div>
    <div class="description-paragraph style-scope patent-text">Dimer link</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">174</div>
    <div class="description-paragraph style-scope patent-text">Y and Y’ are preferably 0.</div>
    <div class="description-paragraph style-scope patent-text">R” is preferably a C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">7</sub> alkylene group with no substituents. More preferably R” is a C<sub class="style-scope patent-text">3</sub>, C<sub class="style-scope patent-text">5 </sub>or C<sub class="style-scope patent-text">7</sub> alkylene. Most preferably, R” is a C<sub class="style-scope patent-text">3</sub> or C<sub class="style-scope patent-text">5</sub> alkylene.</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">6</sup> to R<sup class="style-scope patent-text">9</sup> </div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">9</sup> is preferably H.</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">6</sup> is preferably selected from H, OH, OR, SH, NH<sub class="style-scope patent-text">2</sub>, nitro and halo, and is more preferably H or halo, and most preferably is H.</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">7</sup> is preferably selected from H, OH, OR, SH, SR, NH<sub class="style-scope patent-text">2</sub>, NHR, NRR’, and halo, and more preferably independently selected from H, OH and OR, where R is preferably selected from optionally substituted Ci_<sub class="style-scope patent-text">7</sub> alkyl, C3-10 heterocyclyl and C5-10 aryl groups. R may be more preferably a C1-4 alkyl group, which may or may not be substituted. A substituent of interest is a C<sub class="style-scope patent-text">5</sub>-6 aryl group (e.g. phenyl). Particularly preferred substituents at the 7positions are OMe and OCH<sub class="style-scope patent-text">2</sub>Ph. Other substituents of particular interest are dimethylamino (i.e. -NMe<sub class="style-scope patent-text">2</sub>); -(OC<sub class="style-scope patent-text">2</sub>H<sub class="style-scope patent-text">4</sub>)<sub class="style-scope patent-text">q</sub>OMe, where q is from 0 to 2; nitrogen-containing C<sub class="style-scope patent-text">6 </sub>heterocyclyls, including morpholino, piperidinyl and N-methyl-piperazinyl.</div>
    <div class="description-paragraph style-scope patent-text">These preferences apply to R<sup class="style-scope patent-text">9</sup>, R<sup class="style-scope patent-text">6</sup> and R<sup class="style-scope patent-text">7</sup> respectively.</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">2</sup> </div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">2</sup> is of formula Ila.</div>
    <div class="description-paragraph style-scope patent-text">A in R<sup class="style-scope patent-text">2</sup> when it is of formula Ila may be phenyl group or a C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">7</sub> heteroaryl group, for example furanyl, thiophenyl and pyridyl. In some embodiments, A is preferably phenyl.</div>
    <div class="description-paragraph style-scope patent-text">Q<sup class="style-scope patent-text">2</sup>-X may be on any of the available ring atoms of the C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">7</sub> aryl group, but is preferably on a ring atom that is not adjacent the bond to the remainder of the compound, i.e. it is preferably β or γ to the bond to the remainder of the compound. Therefore, where the C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">7 </sub>aryl group (A) is phenyl, the substituent (Q<sup class="style-scope patent-text">2</sup>-X) is preferably in the meta- or para- positions, and more preferably is in the para- position.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">175</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, Q<sup class="style-scope patent-text">1</sup> is a single bond. In these embodiments, Q<sup class="style-scope patent-text">2</sup> is selected from a single bond and -Z-(CH2)n-, where Z is selected from a single bond, O, S and NH and is from 1 to 3. In some of these embodiments, Q<sup class="style-scope patent-text">2</sup> is a single bond. In other embodiments, Q<sup class="style-scope patent-text">2</sup> is -Z-(CH2)<sub class="style-scope patent-text">n</sub>-. In these embodiments, Z may be O or S and n may be 1 or n may be 2. In other of these embodiments, Z may be a single bond and n may be 1.</div>
    <div class="description-paragraph style-scope patent-text">In other embodiments, Q<sup class="style-scope patent-text">1</sup> is -CH=CH-.</div>
    <div class="description-paragraph style-scope patent-text">In other embodiments, R<sup class="style-scope patent-text">2</sup> is of formula lib. In these embodiments, R<sup class="style-scope patent-text">C1</sup>, R<sup class="style-scope patent-text">C2</sup> and R<sup class="style-scope patent-text">C3</sup> are independently selected from H and unsubstituted C-i_<sub class="style-scope patent-text">2</sub> alkyl. In some preferred embodiments, R<sup class="style-scope patent-text">C1</sup>, R<sup class="style-scope patent-text">C2</sup> and R<sup class="style-scope patent-text">C3</sup> are all H. In other embodiments, R<sup class="style-scope patent-text">C1</sup>, R<sup class="style-scope patent-text">C2</sup> and R<sup class="style-scope patent-text">C3</sup> are all methyl. In certain embodiments, R<sup class="style-scope patent-text">C1</sup>, R<sup class="style-scope patent-text">C2</sup> and R<sup class="style-scope patent-text">C3</sup> are independently selected from H and methyl.</div>
    <div class="description-paragraph style-scope patent-text">X is a group selected from the list comprising: OH, SH, CO<sub class="style-scope patent-text">2</sub>H, COH, N=C=O, NHNH<sub class="style-scope patent-text">2</sub>, //</div>
    <div class="description-paragraph style-scope patent-text">NH //</div>
    <div class="description-paragraph style-scope patent-text">NH</div>
    <div class="description-paragraph style-scope patent-text">CONHNH<sub class="style-scope patent-text">2</sub>, '— , '— and NHR<sup class="style-scope patent-text">n</sup>, wherein R<sup class="style-scope patent-text">N</sup> is selected from the group comprising H and alkyl. X may preferably be: OH, SH, CO<sub class="style-scope patent-text">2</sub>H, -N=C=O or NHR<sup class="style-scope patent-text">n</sup>, and may more preferably be: OH, SH, CO<sub class="style-scope patent-text">2</sub>H, -N=C=O or NH<sub class="style-scope patent-text">2</sub>. Particularly preferred groups include: OH, SH and NH<sub class="style-scope patent-text">2</sub>, with NH<sub class="style-scope patent-text">2</sub> being the most preferred group.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments R<sup class="style-scope patent-text">2</sup> is of formula lie. In these embodiments, it is preferred that Q is NR<sup class="style-scope patent-text">n</sup>. In other embodiments, Q is OH. In further embodiments, Q is SH. R<sup class="style-scope patent-text">N</sup> is preferably selected from H and methyl. In some embodiment, R<sup class="style-scope patent-text">N</sup> is H. In other embodiments, R<sup class="style-scope patent-text">N</sup> is methyl.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">2</sup> may be -A-CH<sub class="style-scope patent-text">2</sub>-X and -A-X. In these embodiments, X may be OH, SH, CO<sub class="style-scope patent-text">2</sub>H, COH and NH<sub class="style-scope patent-text">2</sub>. In particularly preferred embodiments, X may be NH<sub class="style-scope patent-text">2</sub>.</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">72</sup> </div>
    <div class="description-paragraph style-scope patent-text">When there is a double bond present between C2’ and C3’, R<sup class="style-scope patent-text">12</sup> is selected from:</div>
    <div class="description-paragraph style-scope patent-text">(a) C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">10</sub> aryl group, optionally substituted by one or more substituents selected from the group comprising: halo, nitro, cyano, ether, Ci.<sub class="style-scope patent-text">7</sub> alkyl, C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">7</sub> heterocyclyl and bis-oxy-C^ alkylene;</div>
    <div class="description-paragraph style-scope patent-text">(b) C-]_<sub class="style-scope patent-text">5</sub> saturated aliphatic alkyl;</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">176 (c) C<sub class="style-scope patent-text">3</sub>-6 saturated cycloalkyl;</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f6/0b/37/52de6afc34370e/AU2013366490B9_D0140.png" class="style-scope patent-text"><img file="AU2013366490B9_D0140.tif" img-format="tif" alt="Figure AU2013366490B9_D0140" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f6/0b/37/52de6afc34370e/AU2013366490B9_D0140.png"></a></div>
    <div class="description-paragraph style-scope patent-text">R' ,23 , wherein each of R<sup class="style-scope patent-text">21</sup>, R<sup class="style-scope patent-text">22</sup> and R<sup class="style-scope patent-text">23</sup> are independently selected from H, Ci_<sub class="style-scope patent-text">3</sub> saturated alkyl, C<sub class="style-scope patent-text">2</sub>-<sub class="style-scope patent-text">3</sub> alkenyl, C<sub class="style-scope patent-text">2</sub>.<sub class="style-scope patent-text">3</sub> alkynyl and cyclopropyl, where the total number of carbon atoms in the R<sup class="style-scope patent-text">12</sup> group is no more than 5;</div>
    <div class="description-paragraph style-scope patent-text">(e) ,25b</div>
    <div class="description-paragraph style-scope patent-text">R' , wherein one of R<sup class="style-scope patent-text">25a</sup> and R<sup class="style-scope patent-text">25b</sup> is H and the other is selected from: phenyl, which phenyl is optionally substituted by a group selected from halo methyl, methoxy; pyridyl; and thiophenyl; and (f) <sup class="style-scope patent-text">R</sup> , where R<sup class="style-scope patent-text">24</sup> is selected from: H; 0^3 saturated alkyl; C<sub class="style-scope patent-text">2</sub>.<sub class="style-scope patent-text">3</sub> alkenyl; C<sub class="style-scope patent-text">2</sub>.<sub class="style-scope patent-text">3</sub> alkynyl; cyclopropyl; phenyl, which phenyl is optionally substituted by a group selected from halo methyl, methoxy; pyridyl; and thiophenyl.</div>
    <div class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">12</sup> is a C5-10 aryl group, it may be a C5-7 aryl group. A C5-7 aryl group may be a phenyl group or a C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">7</sub> heteroaryl group, for example furanyl, thiophenyl and pyridyl. In some embodiments, R<sup class="style-scope patent-text">12</sup> is preferably phenyl. In other embodiments, R<sup class="style-scope patent-text">12</sup> is preferably thiophenyl, for example, thiophen-2-yl and thiophen-3-yl.</div>
    <div class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">12</sup> is a C5-10 aryl group, it may be a Cs-io aryl, for example a quinolinyl or isoquinolinyl group. The quinolinyl or isoquinolinyl group may be bound to the PBD core through any available ring position. For example, the quinolinyl may be quinolin-2-yl, quinolin-3-yl, quinolin-4yl, quinolin-5-yl, quinolin-6-yl, quinolin-7-yl and quinolin-8-yl. Of these quinolin-3-yl and quinolin-6-yl may be preferred. The isoquinolinyl may be isoquinolin-1 -yl, isoquinolin-3-yl, isoquinolin-4yl, isoquinolin-5-yl, isoquinolin-6-yl, isoquinolin-7-yl and isoquinolin-8-yl. Of these isoquinolin-3-yl and isoquinolin-6-yl may be preferred.</div>
    <div class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">12</sup> is a C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">10</sub> aryl group, it may bear any number of substituent groups. It preferably bears from 1 to 3 substituent groups, with 1 and 2 being more preferred, and singly substituted groups being most preferred. The substituents may be any position.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">177</div>
    <div class="description-paragraph style-scope patent-text">Where R<sup class="style-scope patent-text">12</sup> is C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">7</sub> aryl group, a single substituent is preferably on a ring atom that is not adjacent the bond to the remainder of the compound, i.e. it is preferably β or γ to the bond to the remainder of the compound. Therefore, where the C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">7</sub> aryl group is phenyl, the substituent is preferably in the meta- or para- positions, and more preferably is in the paraposition.</div>
    <div class="description-paragraph style-scope patent-text">Where R<sup class="style-scope patent-text">12</sup> is a C<sub class="style-scope patent-text">8</sub>-io aryl group, for example quinolinyl or isoquinolinyl, it may bear any number of substituents at any position of the quinoline or isoquinoline rings. In some embodiments, it bears one, two or three substituents, and these may be on either the proximal and distal rings or both (if more than one substituent).</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">12</sup> substituents, when R<sup class="style-scope patent-text">12</sup> is a C5-10 aryl group</div>
    <div class="description-paragraph style-scope patent-text">If a substituent on R<sup class="style-scope patent-text">12</sup> when R<sup class="style-scope patent-text">12</sup> is a C5.10 aryl group is halo, it is preferably F or Cl, more preferably Cl.</div>
    <div class="description-paragraph style-scope patent-text">If a substituent on R<sup class="style-scope patent-text">12</sup> when R<sup class="style-scope patent-text">12</sup> is a C5.10 aryl group is ether, it may in some embodiments be an alkoxy group, for example, a Ci_<sub class="style-scope patent-text">7</sub> alkoxy group (e.g. methoxy, ethoxy) or it may in some embodiments be a C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">7</sub> aryloxy group (e.g phenoxy, pyridyloxy, furanyloxy). The alkoxy group may itself be further substituted, for example by an amino group (e.g. dimethylamino).</div>
    <div class="description-paragraph style-scope patent-text">If a substituent on R<sup class="style-scope patent-text">12</sup> when R<sup class="style-scope patent-text">12</sup> is a C5-10 aryl group is Ci_<sub class="style-scope patent-text">7</sub> alkyl, it may preferably be a Cm alkyl group (e.g. methyl, ethyl, propryl, butyl).</div>
    <div class="description-paragraph style-scope patent-text">If a substituent on R<sup class="style-scope patent-text">12</sup> when R<sup class="style-scope patent-text">12</sup> is a C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">10</sub> aryl group is C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">7</sub> heterocyclyl, it may in some embodiments be C<sub class="style-scope patent-text">6</sub> nitrogen containing heterocyclyl group, e.g. morpholino, thiomorpholino, piperidinyl, piperazinyl. These groups may be bound to the rest of the PBD moiety via the nitrogen atom. These groups may be further substituted, for example, by Cm alkyl groups. If the C<sub class="style-scope patent-text">6</sub> nitrogen containing heterocyclyl group is piperazinyl, the said further substituent may be on the second nitrogen ring atom.</div>
    <div class="description-paragraph style-scope patent-text">If a substituent on R<sup class="style-scope patent-text">12</sup> when R<sup class="style-scope patent-text">12</sup> is a C5.10 aryl group is bis-oxy-C-i_<sub class="style-scope patent-text">3</sub> alkylene, this is preferably bis-oxy-methylene or bis-oxy-ethylene.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">178</div>
    <div class="description-paragraph style-scope patent-text">If a substituent on R<sup class="style-scope patent-text">12</sup> when R<sup class="style-scope patent-text">12</sup> is a C<sub class="style-scope patent-text">5</sub>_io aryl group is ester, this is preferably methyl ester or ethyl ester.</div>
    <div class="description-paragraph style-scope patent-text">Particularly preferred substituents when R<sup class="style-scope patent-text">12</sup> is a C<sub class="style-scope patent-text">5</sub>_io aryl group include methoxy, ethoxy, fluoro, chloro, cyano, bis-oxy-methylene, methyl-piperazinyl, morpholino and methylthiophenyl. Other particularly preferred substituents for R<sup class="style-scope patent-text">12</sup> are dimethylaminopropyloxy and carboxy.</div>
    <div class="description-paragraph style-scope patent-text">Particularly preferred substituted R<sup class="style-scope patent-text">12</sup> groups when R<sup class="style-scope patent-text">12</sup> is a C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">10</sub> aryl group include, but are not limited to, 4-methoxy-phenyl, 3-methoxyphenyl, 4-ethoxy-phenyl, 3-ethoxy-phenyl, 4fluoro-phenyl, 4-chloro-phenyl, 3,4-bisoxymethylene-phenyl, 4-methylthiophenyl, 4cyanophenyl, 4-phenoxyphenyl, quinolin-3-yl and quinolin-6-yl, isoquinolin-3-yl and isoquinolin-6-yl, 2-thienyl, 2-furanyl, methoxynaphthyl, and naphthyl. Another possible substituted R<sup class="style-scope patent-text">12</sup> group is 4-nitrophenyl. R<sup class="style-scope patent-text">12</sup> groups of particular interest include 4-(4methylpiperazin-1-yl)phenyl and 3,4-bisoxymethylene-phenyl.</div>
    <div class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">12</sup> is Ci_<sub class="style-scope patent-text">5</sub> saturated aliphatic alkyl, it may be methyl, ethyl, propyl, butyl or pentyl. In some embodiments, it may be methyl, ethyl or propyl (n-pentyl or isopropyl). In some of these embodiments, it may be methyl. In other embodiments, it may be butyl or pentyl, which may be linear or branched.</div>
    <div class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">12</sup> is C<sub class="style-scope patent-text">3</sub>-<sub class="style-scope patent-text">6</sub> saturated cycloalkyl, it may be cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl. In some embodiments, it may be cyclopropyl.</div>
    <div class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">12</sup> is</div>
    <div class="description-paragraph style-scope patent-text">R'</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/08/bf/8b/0c0217e2f4aaca/AU2013366490B9_D0141.png" class="style-scope patent-text"><img file="AU2013366490B9_D0141.tif" img-format="tif" alt="Figure AU2013366490B9_D0141" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/08/bf/8b/0c0217e2f4aaca/AU2013366490B9_D0141.png"></a></div>
    <div class="description-paragraph style-scope patent-text">R</div>
    <div class="description-paragraph style-scope patent-text">R</div>
    <div class="description-paragraph style-scope patent-text">Z I each of R<sup class="style-scope patent-text">21</sup>, R<sup class="style-scope patent-text">22</sup> and R<sup class="style-scope patent-text">23</sup> are independently selected from H, Ci_<sub class="style-scope patent-text">3</sub> saturated alkyl, C<sub class="style-scope patent-text">2</sub>-3 alkenyl, C<sub class="style-scope patent-text">2</sub>.<sub class="style-scope patent-text">3</sub> alkynyl and cyclopropyl, where the total number of carbon atoms in the R<sup class="style-scope patent-text">12</sup> group is no more than 5. In some embodiments, the total number of carbon atoms in the R<sup class="style-scope patent-text">12</sup> group is no more than 4 or no more than 3.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, one of R<sup class="style-scope patent-text">21</sup>, R<sup class="style-scope patent-text">22</sup> and R<sup class="style-scope patent-text">23</sup> is H, with the other two groups being selected from H, saturated alkyl, C<sub class="style-scope patent-text">2</sub>-<sub class="style-scope patent-text">3</sub> alkenyl, C<sub class="style-scope patent-text">2</sub>-<sub class="style-scope patent-text">3</sub> alkynyl and cyclopropyl.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">179</div>
    <div class="description-paragraph style-scope patent-text">In other embodiments, two of R<sup class="style-scope patent-text">21</sup>, R<sup class="style-scope patent-text">22</sup> and R<sup class="style-scope patent-text">23</sup> are H, with the other group being selected from H, Ci-<sub class="style-scope patent-text">3</sub> saturated alkyl, C<sub class="style-scope patent-text">2</sub>.<sub class="style-scope patent-text">3</sub> alkenyl, C<sub class="style-scope patent-text">2</sub>.<sub class="style-scope patent-text">3</sub> alkynyl and cyclopropyl.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, the groups that are not H are selected from methyl and ethyl. In some of these embodiments, the groups that re not H are methyl.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">21</sup> is H.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">22</sup> is H.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">23</sup> is H.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">21</sup> and R<sup class="style-scope patent-text">22</sup> are H.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">21</sup> and R<sup class="style-scope patent-text">23</sup> are H.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">22</sup> and R<sup class="style-scope patent-text">23</sup> are H.</div>
    <div class="description-paragraph style-scope patent-text">An R<sup class="style-scope patent-text">12</sup> group of particular interest is:</div>
    <div class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">12</sup> is ,25b</div>
    <div class="description-paragraph style-scope patent-text">R' , one of R<sup class="style-scope patent-text">25a</sup> and R<sup class="style-scope patent-text">25b</sup> is H and the other is selected from: phenyl, which phenyl is optionally substituted by a group selected from halo, methyl, methoxy; pyridyl; and thiophenyl. In some embodiments, the group which is not H is optionally substituted phenyl. If the phenyl optional substituent is halo, it is preferably fluoro. In some embodiment, the phenyl group is unsubstituted.</div>
    <div class="description-paragraph style-scope patent-text">When R<sup class="style-scope patent-text">12</sup> is <sup class="style-scope patent-text">R</sup> , R<sup class="style-scope patent-text">24</sup> is selected from: Η; (/_<sub class="style-scope patent-text">3</sub> saturated alkyl; C<sub class="style-scope patent-text">2</sub>.<sub class="style-scope patent-text">3</sub> alkenyl; C<sub class="style-scope patent-text">2</sub>.<sub class="style-scope patent-text">3</sub> alkynyl; cyclopropyl; phenyl, which phenyl is optionally substituted by a group selected from halo methyl, methoxy; pyridyl; and thiophenyl. If the phenyl optional substituent is halo, it is preferably fluoro. In some embodiment, the phenyl group is unsubstituted.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">180</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">24</sup> is selected from H, methyl, ethyl, ethenyl and ethynyl. In some of these embodiments, R<sup class="style-scope patent-text">24</sup> is selected from H and methyl.</div>
    <div class="description-paragraph style-scope patent-text">When there is a single bond present between C2’ and C3’,</div>
    <div class="description-paragraph style-scope patent-text">R' ,26a</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">12</sup> is H or <sup class="style-scope patent-text">R</sup> , where R<sup class="style-scope patent-text">26a</sup> and R<sup class="style-scope patent-text">26b</sup> are independently selected from H, F, saturated alkyl, C<sub class="style-scope patent-text">2</sub>-3 alkenyl, which alkyl and alkenyl groups are optionally substituted by a group selected from C1-4 alkyl amido and C1-4 alkyl ester; or, when one of R<sup class="style-scope patent-text">26a</sup> and R<sup class="style-scope patent-text">26b</sup> is H, the other is selected from nitrile and a C1-4 alkyl ester.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">12</sup> is H.</div>
    <div class="description-paragraph style-scope patent-text">R' ,26a ,26b</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">12</sup> is <sup class="style-scope patent-text">R</sup> .</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, it is preferred that R<sup class="style-scope patent-text">26a</sup> and R<sup class="style-scope patent-text">26b</sup> are both H.</div>
    <div class="description-paragraph style-scope patent-text">In other embodiments, it is preferred that R<sup class="style-scope patent-text">26a</sup> and R<sup class="style-scope patent-text">26b</sup> are both methyl.</div>
    <div class="description-paragraph style-scope patent-text">In further embodiments, it is preferred that one of R<sup class="style-scope patent-text">26a</sup> and R<sup class="style-scope patent-text">26b</sup> is H, and the other is selected from C1-4 saturated alkyl, C<sub class="style-scope patent-text">2</sub>.<sub class="style-scope patent-text">3</sub> alkenyl, which alkyl and alkenyl groups are optionally substituted. In these further embodiment, it may be further preferred that the group which is not H is selected from methyl and ethyl.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">20</sup> is H and R<sup class="style-scope patent-text">21a</sup> and R<sup class="style-scope patent-text">21b</sup> are both H. Alternatively, R<sup class="style-scope patent-text">20</sup> may be Me when R<sup class="style-scope patent-text">21a</sup> and R<sup class="style-scope patent-text">21b</sup> are both H.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">20</sup> is H and R<sup class="style-scope patent-text">21a</sup> and R<sup class="style-scope patent-text">21b</sup> are together form =0. Alternatively, R<sup class="style-scope patent-text">20 </sup>may be Me when R<sup class="style-scope patent-text">21a</sup> and R<sup class="style-scope patent-text">21b</sup> together form =0.</div>
    <div class="description-paragraph style-scope patent-text">In either of these sets of embodiments, it may be preferred that R<sup class="style-scope patent-text">10</sup> and R<sup class="style-scope patent-text">11b</sup> form a nitrogen-carbon double bond between the nitrogen and carbon atoms to which they are</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">181 bound and R<sup class="style-scope patent-text">11a</sup> is H. It may be alternatively preferred that R<sup class="style-scope patent-text">10</sup> is H, R<sup class="style-scope patent-text">11a</sup> is H and R<sup class="style-scope patent-text">11b</sup> is OH. It may be further alternatively preferred that R<sup class="style-scope patent-text">10</sup> is H, R<sup class="style-scope patent-text">11a</sup> is H and R<sup class="style-scope patent-text">11b</sup> is SO<sub class="style-scope patent-text">Z</sub>M, where z is 2 or 3 and M is a monovalent pharmaceutically acceptable cation.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">10</sup> is H and R<sup class="style-scope patent-text">11a</sup> and R<sup class="style-scope patent-text">11b</sup> are both H. Alternatively, R<sup class="style-scope patent-text">10</sup> may be Me when R<sup class="style-scope patent-text">11a</sup> and R<sup class="style-scope patent-text">11b</sup> are both H.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, R<sup class="style-scope patent-text">10</sup> is H and R<sup class="style-scope patent-text">11a</sup> and R<sup class="style-scope patent-text">11b</sup> together form =0. Alternatively, R<sup class="style-scope patent-text">10</sup> may be Me when R<sup class="style-scope patent-text">11a</sup> and R<sup class="style-scope patent-text">11b</sup> together form =0.</div>
    <div class="description-paragraph style-scope patent-text">In either of these sets of embodiments, it may be preferred that R<sup class="style-scope patent-text">20</sup> and R<sup class="style-scope patent-text">21b</sup> form a nitrogen-carbon double bond between the nitrogen and carbon atoms to which they are bound and R<sup class="style-scope patent-text">21a</sup> is H. It may be alternatively preferred that R<sup class="style-scope patent-text">20</sup> is H, R<sup class="style-scope patent-text">21a</sup> is H and R<sup class="style-scope patent-text">21b</sup> is OH. It may be further alternatively preferred that R<sup class="style-scope patent-text">20</sup> is H, R<sup class="style-scope patent-text">21a</sup> is H and R<sup class="style-scope patent-text">21b</sup> is SO<sub class="style-scope patent-text">Z</sub>M, where z is 2 or 3 and M is a monovalent pharmaceutically acceptable cation.</div>
    <div class="description-paragraph style-scope patent-text">M and z</div>
    <div class="description-paragraph style-scope patent-text">It is preferred that M is a monovalent pharmaceutically acceptable cation, and is more preferably Na<sup class="style-scope patent-text">+</sup>.</div>
    <div class="description-paragraph style-scope patent-text">z is preferably 3.</div>
    <div class="description-paragraph style-scope patent-text">Fourth aspect</div>
    <div class="description-paragraph style-scope patent-text">L<sup class="style-scope patent-text">4</sup> </div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, L<sup class="style-scope patent-text">4</sup> is a single bond.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, L<sup class="style-scope patent-text">4</sup> is:</div>
    <div class="description-paragraph style-scope patent-text">H wherein n is 0 to 3. In these embodiments, n can be 0, 1,2 or 3. n=0 and n=1 may be preferred.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, L<sup class="style-scope patent-text">4</sup> is:</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">182</div>
    <div class="description-paragraph style-scope patent-text">Η</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/c5/1a/c8/c07d59feb6bb1d/AU2013366490B9_D0142.png" class="style-scope patent-text"><img file="AU2013366490B9_D0142.tif" img-format="tif" alt="Figure AU2013366490B9_D0142" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/c5/1a/c8/c07d59feb6bb1d/AU2013366490B9_D0142.png"></a></div>
    <div class="description-paragraph style-scope patent-text">wherein n is 0 to 3. In these embodiments, n can be 0, 1,2 or 3. n=0 and n=1 may be preferred.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, L<sup class="style-scope patent-text">4</sup> is:</div>
    <div class="description-paragraph style-scope patent-text">H</div>
    <div class="description-paragraph style-scope patent-text">O wherein n is 0 to 3. In these embodiments, n can be 0, 1,2 or 3. n=0 and n=1 may be preferred.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, L<sup class="style-scope patent-text">4</sup> is:</div>
    <div class="description-paragraph style-scope patent-text">o wherein n is 0 to 3. In these embodiments, n can be 0, 1,2 or 3. n=0 and n=1 may be preferred. In one of these embodiments, D is N. In other of these embodiments, D is CH In one of these embodiments, E is O or S. In one these embodiments, F is CH.</div>
    <div class="description-paragraph style-scope patent-text">L<sup class="style-scope patent-text">3</sup> </div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, L<sup class="style-scope patent-text">3</sup> is an amino acid residue. The amino acid may a natural amino acids or a non-natural amino acid.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, L<sup class="style-scope patent-text">3</sup> is selected from: Phe, Lys, Val, Ala, Cit, Leu, lie, Arg, and Trp, where Cit is citrulline.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, L<sup class="style-scope patent-text">3</sup> comprises a dipeptide residue. The amino acids in the dipeptide may be any combination of natural amino acids and non-natural amino acids. In some embodiments, the dipeptide comprises natural amino acids. Where the linker is a cathepsin labile linker, the dipeptide is the site of action for cathepsin-mediated cleavage. The dipeptide then is a recognition site for cathepsin.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">183</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, L<sup class="style-scope patent-text">3</sup> is selected from: <sup class="style-scope patent-text">Prot</sup>-Phe-Lys-<sup class="style-scope patent-text">L4</sup>, <sup class="style-scope patent-text">Prot</sup>-Val-Ala-<sup class="style-scope patent-text">L4</sup>, <sup class="style-scope patent-text">Prot</sup>-Val-Lys-<sup class="style-scope patent-text">L4</sup>, <sup class="style-scope patent-text">Prot</sup>-Ala-Lys-<sup class="style-scope patent-text">L4</sup>, <sup class="style-scope patent-text">Prot</sup>-Val-Cit-<sup class="style-scope patent-text">L4</sup>, <sup class="style-scope patent-text">Prot</sup>-Phe-Cit-<sup class="style-scope patent-text">L4</sup>, <sup class="style-scope patent-text">Prot</sup>-Leu-Cit-<sup class="style-scope patent-text">L4</sup>, <sup class="style-scope patent-text">Prot</sup>-lle-Cit-<sup class="style-scope patent-text">L4</sup>, <sup class="style-scope patent-text">Prot</sup>-Phe-Arg-<sup class="style-scope patent-text">L4</sup>, and <sup class="style-scope patent-text">Prot</sup>-Trp-Cit-<sup class="style-scope patent-text">L4</sup>;</div>
    <div class="description-paragraph style-scope patent-text">where Cit is citrulline.</div>
    <div class="description-paragraph style-scope patent-text">Preferably, L<sup class="style-scope patent-text">3</sup> is selected from:</div>
    <div class="description-paragraph style-scope patent-text"> <sup class="style-scope patent-text">Prot</sup>-Phe-Lys-<sup class="style-scope patent-text">L4</sup>, <sup class="style-scope patent-text">Prot</sup>-Val-Ala-<sup class="style-scope patent-text">L4</sup>, <sup class="style-scope patent-text">Prot</sup>-Val-Lys-<sup class="style-scope patent-text">L4</sup>, <sup class="style-scope patent-text">Prot</sup>-Ala-Lys-<sup class="style-scope patent-text">L4</sup>, and <sup class="style-scope patent-text">Prot</sup>-Val-Cit-<sup class="style-scope patent-text">L4</sup>.</div>
    <div class="description-paragraph style-scope patent-text">Most preferably, L<sup class="style-scope patent-text">3</sup> is selected from <sup class="style-scope patent-text">Prot</sup>-Phe-Lys-<sup class="style-scope patent-text">L4</sup>, <sup class="style-scope patent-text">Prot</sup>-Val-Cit-<sup class="style-scope patent-text">L4</sup> or <sup class="style-scope patent-text">Prot</sup>-Val-Ala-<sup class="style-scope patent-text">L4</sup>.</div>
    <div class="description-paragraph style-scope patent-text">Other dipeptide combinations of interest include:</div>
    <div class="description-paragraph style-scope patent-text"> <sup class="style-scope patent-text">Prot</sup>-Gly-Gly-<sup class="style-scope patent-text">L4</sup>, <sup class="style-scope patent-text">Prot</sup>-Pro-Pro-<sup class="style-scope patent-text">L4</sup>, and <sup class="style-scope patent-text">Prot</sup>-Val-Glu-<sup class="style-scope patent-text">L4</sup>.</div>
    <div class="description-paragraph style-scope patent-text">Other dipeptide combinations may be used, including those described by Dubowchik et al., Bioconjugate Chemistry, 2002, 13,855-869, which is incorporated herein by reference.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, L<sup class="style-scope patent-text">3</sup> is a tripeptide residue. The amino acids in the tripeptide may be any combination of natural amino acids and non-natural amino acids. In some embodiments, the tripeptide comprises natural amino acids. Where the linker is a</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">184 cathepsin labile linker, the tripeptide is the site of action for cathepsin-mediated cleavage. The tripeptide then is a recognition site for cathepsin.</div>
    <div class="description-paragraph style-scope patent-text">In one embodiment, the amino acid side chain is chemically protected, where appropriate.</div>
    <div class="description-paragraph style-scope patent-text">The side chain protecting group may be a group as discussed below. Protected amino acid sequences are cleavable by enzymes. For example, a dipeptide sequence comprising a Boc side chain-protected Lys residue is cleavable by cathepsin.</div>
    <div class="description-paragraph style-scope patent-text">Protecting groups for the side chains of amino acids are well known in the art and are 10 described in the Novabiochem Catalog, and as described above.</div>
    <div class="description-paragraph style-scope patent-text">Prot</div>
    <div class="description-paragraph style-scope patent-text">Prot is selected from Fmoc (fluorenylmethyloxycarbonyl), Teoc (2(trimethylsilyl)ethoxycarbonyl), Boc (t-butoxycarbonyl) and Alloc (alylocycarbonyl). In some embodiments, Prot is selected from Fmoc and Teoc.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, Prot is Fmoc.</div>
    <div class="description-paragraph style-scope patent-text">In some embodiments, Prot is Teoc.</div>
    <div class="description-paragraph style-scope patent-text">Particularly preferred compounds of the first aspect of the present invention are of formula la-1, la-2, la-3 or la-4:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ef/ab/24/33ce5d7a55c8a1/AU2013366490B9_D0143.png" class="style-scope patent-text"><img file="AU2013366490B9_D0143.tif" img-format="tif" alt="Figure AU2013366490B9_D0143" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ef/ab/24/33ce5d7a55c8a1/AU2013366490B9_D0143.png"></a></div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">185</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ee/95/7e/6e96613d6e3682/AU2013366490B9_D0144.png" class="style-scope patent-text"><img file="AU2013366490B9_D0144.tif" img-format="tif" alt="Figure AU2013366490B9_D0144" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ee/95/7e/6e96613d6e3682/AU2013366490B9_D0144.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where R<sup class="style-scope patent-text">12a</sup> is selected from:</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e3/29/ed/6d8478da562475/AU2013366490B9_D0145.png" class="style-scope patent-text"><img file="AU2013366490B9_D0145.tif" img-format="tif" alt="Figure AU2013366490B9_D0145" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e3/29/ed/6d8478da562475/AU2013366490B9_D0145.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f0/ac/a5/a20a27bc0af99b/AU2013366490B9_D0146.png" class="style-scope patent-text"><img file="AU2013366490B9_D0146.tif" img-format="tif" alt="Figure AU2013366490B9_D0146" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f0/ac/a5/a20a27bc0af99b/AU2013366490B9_D0146.png"></a></div>
    <div class="description-paragraph style-scope patent-text">the amino group is at either the meta or para positions of the phenyl group.</div>
    <div class="description-paragraph style-scope patent-text">Further particularly preferred compounds of the first aspect of the present invention are of formula lb-1, lb-2, lb-3 or lb-4:</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">186</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/06/46/ce/537a71c420031b/AU2013366490B9_D0147.png" class="style-scope patent-text"><img file="AU2013366490B9_D0147.tif" img-format="tif" alt="Figure AU2013366490B9_D0147" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/06/46/ce/537a71c420031b/AU2013366490B9_D0147.png"></a></div>
    <div class="description-paragraph style-scope patent-text">Ο Ο where η is 1 or 3;</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">1a</sup> is methyl or phenyl; R<sup class="style-scope patent-text">12a</sup> is selected from:</div>
    <div class="description-paragraph style-scope patent-text">(a)</div>
    <div class="description-paragraph style-scope patent-text">MeO</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/50/76/92/38c275ec11e0a0/AU2013366490B9_D0148.png" class="style-scope patent-text"><img file="AU2013366490B9_D0148.tif" img-format="tif" alt="Figure AU2013366490B9_D0148" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/50/76/92/38c275ec11e0a0/AU2013366490B9_D0148.png"></a></div>
    <div class="description-paragraph style-scope patent-text">(b)</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/87/ca/57/291b515e0eae6d/AU2013366490B9_D0149.png" class="style-scope patent-text"><img file="AU2013366490B9_D0149.tif" img-format="tif" alt="Figure AU2013366490B9_D0149" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/87/ca/57/291b515e0eae6d/AU2013366490B9_D0149.png"></a></div>
    <div class="description-paragraph style-scope patent-text">(f)</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">187</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/0f/24/14/ee25cab0949634/AU2013366490B9_D0150.png" class="style-scope patent-text"><img file="AU2013366490B9_D0150.tif" img-format="tif" alt="Figure AU2013366490B9_D0150" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/0f/24/14/ee25cab0949634/AU2013366490B9_D0150.png"></a></div>
    <div class="description-paragraph style-scope patent-text">Further particularly preferred compounds of the first aspect of the present invention are of formula lc-1, lc-2, lc-3 or lc-4:</div>
    <div class="description-paragraph style-scope patent-text">H</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/5b/1b/6e/04e40bce49d21f/AU2013366490B9_D0151.png" class="style-scope patent-text"><img file="AU2013366490B9_D0151.tif" img-format="tif" alt="Figure AU2013366490B9_D0151" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/5b/1b/6e/04e40bce49d21f/AU2013366490B9_D0151.png"></a></div>
    <div class="description-paragraph style-scope patent-text">H</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/4c/29/23/07648e2a62a081/AU2013366490B9_D0152.png" class="style-scope patent-text"><img file="AU2013366490B9_D0152.tif" img-format="tif" alt="Figure AU2013366490B9_D0152" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/4c/29/23/07648e2a62a081/AU2013366490B9_D0152.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where n is 1 or 3;</div>
    <div class="description-paragraph style-scope patent-text">R<sup class="style-scope patent-text">1a</sup> is methyl or phenyl; 10 R<sup class="style-scope patent-text">12a</sup> is selected from:</div>
    <div class="description-paragraph style-scope patent-text">(a)</div>
    <div class="description-paragraph style-scope patent-text">MeO</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/5e/05/f8/5821d74fbe6dc9/AU2013366490B9_D0153.png" class="style-scope patent-text"><img file="AU2013366490B9_D0153.tif" img-format="tif" alt="Figure AU2013366490B9_D0153" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/5e/05/f8/5821d74fbe6dc9/AU2013366490B9_D0153.png"></a></div>
    <div class="description-paragraph style-scope patent-text">(b)</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">188</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/6d/36/fd/95f5addce290fa/AU2013366490B9_D0154.png" class="style-scope patent-text"><img file="AU2013366490B9_D0154.tif" img-format="tif" alt="Figure AU2013366490B9_D0154" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/6d/36/fd/95f5addce290fa/AU2013366490B9_D0154.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/b3/d8/95/a5d222aafdc960/AU2013366490B9_D0155.png" class="style-scope patent-text"><img file="AU2013366490B9_D0155.tif" img-format="tif" alt="Figure AU2013366490B9_D0155" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/b3/d8/95/a5d222aafdc960/AU2013366490B9_D0155.png"></a></div>
    <div class="description-paragraph style-scope patent-text">Fifth aspect</div>
    <div class="description-paragraph style-scope patent-text">The preferences for compounds of formula I apply as appropriate to D in the fifth aspect of the invention. . For example, in the fifth aspect, the PBD dimer is any of the compounds of formula I, or a pharmaceutically acceptable salt or solvate thereof, described herein expect</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/f7/ee/d7/c1315a8b67ca7b/AU2013366490B9_D0156.png" class="style-scope patent-text"><img file="AU2013366490B9_D0156.tif" img-format="tif" alt="Figure AU2013366490B9_D0156" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/f7/ee/d7/c1315a8b67ca7b/AU2013366490B9_D0156.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/b9/83/3a/e086a9d28d1d7d/AU2013366490B9_D0157.png" class="style-scope patent-text"><img file="AU2013366490B9_D0157.tif" img-format="tif" alt="Figure AU2013366490B9_D0157" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/b9/83/3a/e086a9d28d1d7d/AU2013366490B9_D0157.png"></a></div>
    <div class="description-paragraph style-scope patent-text">NH is replaced with</div>
    <div class="description-paragraph style-scope patent-text">N-S- *—N(R<sup class="style-scope patent-text">n</sup>)-;</div>
    <div class="description-paragraph style-scope patent-text">, and * NHR<sup class="style-scope patent-text">n</sup> is replaced with · indicates the point of attachment to the Linker Unit.</div>
    <div class="description-paragraph style-scope patent-text">/</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a1/94/11/212ac485e00fd5/AU2013366490B9_D0158.png" class="style-scope patent-text"><img file="AU2013366490B9_D0158.tif" img-format="tif" alt="Figure AU2013366490B9_D0158" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a1/94/11/212ac485e00fd5/AU2013366490B9_D0158.png"></a></div>
    <div class="description-paragraph style-scope patent-text">where the wavy line</div>
    <div class="description-paragraph style-scope patent-text">Accordingly, the Conjugates of the present invention include those having the following formula (V)</div>
    <div class="description-paragraph style-scope patent-text">L-(LU-D)<sub class="style-scope patent-text">P</sub> (V) or a pharmaceutically acceptable salt or solvate thereof, wherein L is a Ligand unit (i.e., a targeting agent), LU is a Linker unit and the PBD dimer D. D is any of the compounds of formula I, or a pharmaceutically acceptable salt or solvate thereof, described herein expect</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/57/df/b8/617bd1beff5d10/AU2013366490B9_D0159.png" class="style-scope patent-text"><img file="AU2013366490B9_D0159.tif" img-format="tif" alt="Figure AU2013366490B9_D0159" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/57/df/b8/617bd1beff5d10/AU2013366490B9_D0159.png"></a></div>
    <div class="description-paragraph style-scope patent-text">that, is replaced with is replaced with</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">189 *</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/6b/66/c7/ff396878452898/AU2013366490B9_D0160.png" class="style-scope patent-text"><img file="AU2013366490B9_D0160.tif" img-format="tif" alt="Figure AU2013366490B9_D0160" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/6b/66/c7/ff396878452898/AU2013366490B9_D0160.png"></a></div>
    <div class="description-paragraph style-scope patent-text">, and * NHR<sup class="style-scope patent-text">n</sup> is replaced with —N(R<sup class="style-scope patent-text">n</sup>)-|where the wavy line indicates the point of attachment to the Linker Unit.</div>
    <div class="description-paragraph style-scope patent-text">(a) Conjugates of the present invention include, for example, those of the formula:</div>
    <div class="description-paragraph style-scope patent-text">CBA-A<sup class="style-scope patent-text">1</sup>- L<sup class="style-scope patent-text">1</sup>-* where the asterisk indicates the point of attachment to the PBD dimer (D), CBA is the Cell Binding Agent, L<sup class="style-scope patent-text">1</sup> is a Specificity unit that is cleavable by the action of an enzyme, and A<sup class="style-scope patent-text">1</sup> is a Stretcher unit connecting L<sup class="style-scope patent-text">1</sup> to the Cell Binding Agent.</div>
    <div class="description-paragraph style-scope patent-text">(b) Conjugates of the present invention include, for example, those of the formula:</div>
    <div class="description-paragraph style-scope patent-text">CBA-A<sup class="style-scope patent-text">1</sup>- L<sup class="style-scope patent-text">1</sup>-* where the asterisk indicates the point of attachment to the PBD dimer (D), CBA is the Cell Binding Agent, A<sup class="style-scope patent-text">1</sup> is a Stretcher unit connecting L<sup class="style-scope patent-text">1</sup> to the Cell Binding Agent and L<sup class="style-scope patent-text">1</sup> is a Specificity unit that is cleavable by the action of cathepsin, L<sup class="style-scope patent-text">1</sup> is a dipeptide, L<sup class="style-scope patent-text">1</sup> is a dipeptide that is cleavable by the action of cathepsin or L<sup class="style-scope patent-text">1</sup> is a dipeptide selected from Phe-Lys-, -Val-Ala-, -Val-Lys-, -Ala-Lys-, and -Val-Cit-.</div>
    <div class="description-paragraph style-scope patent-text">Preferred conjugates of the present invention include any of those described in (a) and (b) wherein A<sup class="style-scope patent-text">1</sup> is where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, the wavy line indicates the point of attachment to CBA, and n is 0 to 6 (preferably n is 5).</div>
    <div class="description-paragraph style-scope patent-text">Illustrative Synthetic Schemes</div>
    <div class="description-paragraph style-scope patent-text">The following schemes illustrate a way of making certain compounds of the present invention, in which certain groups are illustrated generically as R, R’ and R<sub class="style-scope patent-text">2</sub>. The groups of which these form a part should be interpreted in accordance with the disclosure of the</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">190 invention. In schemes where protecting groups are explicitly described, these may also be varied within the scope of the present invention.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">191</div>
    <div class="description-paragraph style-scope patent-text">Scheme 1a- synthesis of amine building block</div>
    <div class="description-paragraph style-scope patent-text">TIPSO.</div>
    <div class="description-paragraph style-scope patent-text">NO?</div>
    <div class="description-paragraph style-scope patent-text">„OTBS ,OTBS</div>
    <div class="description-paragraph style-scope patent-text">MeO-^^Y<sup class="style-scope patent-text">N</sup>CX</div>
    <div class="description-paragraph style-scope patent-text">Triflation</div>
    <div class="description-paragraph style-scope patent-text">TIPSO.</div>
    <div class="description-paragraph style-scope patent-text">MeO'</div>
    <div class="description-paragraph style-scope patent-text">NO,</div>
    <div class="description-paragraph style-scope patent-text">Suzuki TIPSO.</div>
    <div class="description-paragraph style-scope patent-text"> <sub class="style-scope patent-text">X</sub>OTBS</div>
    <div class="description-paragraph style-scope patent-text">OTf</div>
    <div class="description-paragraph style-scope patent-text">MeO'</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/3c/78/11/c1f92956d1376f/AU2013366490B9_D0161.png" class="style-scope patent-text"><img file="AU2013366490B9_D0161.tif" img-format="tif" alt="Figure AU2013366490B9_D0161" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/3c/78/11/c1f92956d1376f/AU2013366490B9_D0161.png"></a></div>
    <div class="description-paragraph style-scope patent-text">ά</div>
    <div class="description-paragraph style-scope patent-text">NO<sub class="style-scope patent-text">2</sub> =</div>
    <div class="description-paragraph style-scope patent-text">N<sup class="style-scope patent-text">Z</sup>^</div>
    <div class="description-paragraph style-scope patent-text">O ~R „OH</div>
    <div class="description-paragraph style-scope patent-text">TBS TIPSO^^NO, z Oxidation TIPSO^_NO<sub class="style-scope patent-text">2</sub>Y <sup class="style-scope patent-text">Reductive</sup> <sub class="style-scope patent-text">r</sub> </div>
    <div class="description-paragraph style-scope patent-text">Deprotection MeO''^<sup class="style-scope patent-text">xii</sup>^j'' MeO'^<sup class="style-scope patent-text">x</sup>&lt;^Y'<sup class="style-scope patent-text">N</sup>0i<sub class="style-scope patent-text">s</sub> </div>
    <div class="description-paragraph style-scope patent-text">Amination</div>
    <div class="description-paragraph style-scope patent-text">R,O^ -O</div>
    <div class="description-paragraph style-scope patent-text">TIPSO.</div>
    <div class="description-paragraph style-scope patent-text">MeO'</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/6f/3f/bc/30862602bd189f/AU2013366490B9_D0162.png" class="style-scope patent-text"><img file="AU2013366490B9_D0162.tif" img-format="tif" alt="Figure AU2013366490B9_D0162" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/6f/3f/bc/30862602bd189f/AU2013366490B9_D0162.png"></a></div>
    <div class="description-paragraph style-scope patent-text">Y</div>
    <div class="description-paragraph style-scope patent-text">N10 TIPSO. .N</div>
    <div class="description-paragraph style-scope patent-text">RpO^^O</div>
    <div class="description-paragraph style-scope patent-text">Protection</div>
    <div class="description-paragraph style-scope patent-text">MeO'</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/b6/b0/ade62826e56780/AU2013366490B9_D0163.png" class="style-scope patent-text"><img file="AU2013366490B9_D0163.tif" img-format="tif" alt="Figure AU2013366490B9_D0163" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/b6/b0/ade62826e56780/AU2013366490B9_D0163.png"></a></div>
    <div class="description-paragraph style-scope patent-text">o</div>
    <div class="description-paragraph style-scope patent-text">TIPS '\Y<sub class="style-scope patent-text">n</sub> Deprotection r\</div>
    <div class="description-paragraph style-scope patent-text">HO. <sub class="style-scope patent-text">X</sub>N</div>
    <div class="description-paragraph style-scope patent-text">MeO'</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/5e/49/1a/62b49addd9d95e/AU2013366490B9_D0164.png" class="style-scope patent-text"><img file="AU2013366490B9_D0164.tif" img-format="tif" alt="Figure AU2013366490B9_D0164" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/5e/49/1a/62b49addd9d95e/AU2013366490B9_D0164.png"></a></div>
    <div class="description-paragraph style-scope patent-text">\^°·</div>
    <div class="description-paragraph style-scope patent-text">MeO'</div>
    <div class="description-paragraph style-scope patent-text">Y</div>
    <div class="description-paragraph style-scope patent-text">M</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/13/b2/d2/02b9d562faf7d0/AU2013366490B9_D0165.png" class="style-scope patent-text"><img file="AU2013366490B9_D0165.tif" img-format="tif" alt="Figure AU2013366490B9_D0165" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/13/b2/d2/02b9d562faf7d0/AU2013366490B9_D0165.png"></a></div>
    <div class="description-paragraph style-scope patent-text">/,</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">192</div>
    <div class="description-paragraph style-scope patent-text">Scheme 1b - synthesis of protected carbinolamine building block</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ef/31/31/303ba84258e996/AU2013366490B9_D0166.png" class="style-scope patent-text"><img file="AU2013366490B9_D0166.tif" img-format="tif" alt="Figure AU2013366490B9_D0166" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ef/31/31/303ba84258e996/AU2013366490B9_D0166.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/64/92/5a/c21f43129d2585/AU2013366490B9_D0167.png" class="style-scope patent-text"><img file="AU2013366490B9_D0167.tif" img-format="tif" alt="Figure AU2013366490B9_D0167" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/64/92/5a/c21f43129d2585/AU2013366490B9_D0167.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a9/5c/65/eb03cbd52b29d8/AU2013366490B9_D0168.png" class="style-scope patent-text"><img file="AU2013366490B9_D0168.tif" img-format="tif" alt="Figure AU2013366490B9_D0168" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a9/5c/65/eb03cbd52b29d8/AU2013366490B9_D0168.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7c/63/33/e326c74779bf42/AU2013366490B9_D0169.png" class="style-scope patent-text"><img file="AU2013366490B9_D0169.tif" img-format="tif" alt="Figure AU2013366490B9_D0169" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7c/63/33/e326c74779bf42/AU2013366490B9_D0169.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/2d/ba/6c/9a3715257823c0/AU2013366490B9_D0170.png" class="style-scope patent-text"><img file="AU2013366490B9_D0170.tif" img-format="tif" alt="Figure AU2013366490B9_D0170" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/2d/ba/6c/9a3715257823c0/AU2013366490B9_D0170.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/b8/43/3f/867403ca632e54/AU2013366490B9_D0171.png" class="style-scope patent-text"><img file="AU2013366490B9_D0171.tif" img-format="tif" alt="Figure AU2013366490B9_D0171" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/b8/43/3f/867403ca632e54/AU2013366490B9_D0171.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/be/75/50/35ad4036da6885/AU2013366490B9_D0172.png" class="style-scope patent-text"><img file="AU2013366490B9_D0172.tif" img-format="tif" alt="Figure AU2013366490B9_D0172" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/be/75/50/35ad4036da6885/AU2013366490B9_D0172.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/51/90/f0/958e763594a5e5/AU2013366490B9_D0173.png" class="style-scope patent-text"><img file="AU2013366490B9_D0173.tif" img-format="tif" alt="Figure AU2013366490B9_D0173" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/51/90/f0/958e763594a5e5/AU2013366490B9_D0173.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/50/f2/9e/aec5719ba0cfe0/AU2013366490B9_D0174.png" class="style-scope patent-text"><img file="AU2013366490B9_D0174.tif" img-format="tif" alt="Figure AU2013366490B9_D0174" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/50/f2/9e/aec5719ba0cfe0/AU2013366490B9_D0174.png"></a></div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">193</div>
    <div class="description-paragraph style-scope patent-text">Scheme 1c- synthesis of dimer with linker attached (drug-linker)</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/7f/a3/63/0b048dd2ea7c34/AU2013366490B9_D0175.png" class="style-scope patent-text"><img file="AU2013366490B9_D0175.tif" img-format="tif" alt="Figure AU2013366490B9_D0175" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/7f/a3/63/0b048dd2ea7c34/AU2013366490B9_D0175.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/83/89/b9/270881a48dce6e/AU2013366490B9_D0176.png" class="style-scope patent-text"><img file="AU2013366490B9_D0176.tif" img-format="tif" alt="Figure AU2013366490B9_D0176" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/83/89/b9/270881a48dce6e/AU2013366490B9_D0176.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/01/5f/a0/871854d0776f9c/AU2013366490B9_D0177.png" class="style-scope patent-text"><img file="AU2013366490B9_D0177.tif" img-format="tif" alt="Figure AU2013366490B9_D0177" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/01/5f/a0/871854d0776f9c/AU2013366490B9_D0177.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/2c/8b/ed/15edd58d2bbc87/AU2013366490B9_D0178.png" class="style-scope patent-text"><img file="AU2013366490B9_D0178.tif" img-format="tif" alt="Figure AU2013366490B9_D0178" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/2c/8b/ed/15edd58d2bbc87/AU2013366490B9_D0178.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/5b/7e/9c/14d5058c33e8c6/AU2013366490B9_D0179.png" class="style-scope patent-text"><img file="AU2013366490B9_D0179.tif" img-format="tif" alt="Figure AU2013366490B9_D0179" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/5b/7e/9c/14d5058c33e8c6/AU2013366490B9_D0179.png"></a></div>
    <div class="description-paragraph style-scope patent-text">Maleimidocaproic acid</div>
    <div class="description-paragraph style-scope patent-text">Coupling</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/8c/ee/81/3d5d9cc3e06200/AU2013366490B9_D0180.png" class="style-scope patent-text"><img file="AU2013366490B9_D0180.tif" img-format="tif" alt="Figure AU2013366490B9_D0180" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/8c/ee/81/3d5d9cc3e06200/AU2013366490B9_D0180.png"></a></div>
    <div class="description-paragraph style-scope patent-text">JH,</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a5/d5/cf/76eaa879bd58d4/AU2013366490B9_D0181.png" class="style-scope patent-text"><img file="AU2013366490B9_D0181.tif" img-format="tif" alt="Figure AU2013366490B9_D0181" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a5/d5/cf/76eaa879bd58d4/AU2013366490B9_D0181.png"></a></div>
    <div class="description-paragraph style-scope patent-text">O</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">194</div>
    <div class="description-paragraph style-scope patent-text">Scheme 2 - alternative synthesis of secondary amine building block</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e8/85/91/7eef4f35a19bdb/AU2013366490B9_D0182.png" class="style-scope patent-text"><img file="AU2013366490B9_D0182.tif" img-format="tif" alt="Figure AU2013366490B9_D0182" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e8/85/91/7eef4f35a19bdb/AU2013366490B9_D0182.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e9/a9/1d/54b1363bce87cb/AU2013366490B9_D0183.png" class="style-scope patent-text"><img file="AU2013366490B9_D0183.tif" img-format="tif" alt="Figure AU2013366490B9_D0183" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e9/a9/1d/54b1363bce87cb/AU2013366490B9_D0183.png"></a></div>
    <div class="description-paragraph style-scope patent-text">Ester Reduction</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/4e/b5/07/0a15d88a56714f/AU2013366490B9_D0184.png" class="style-scope patent-text"><img file="AU2013366490B9_D0184.tif" img-format="tif" alt="Figure AU2013366490B9_D0184" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/4e/b5/07/0a15d88a56714f/AU2013366490B9_D0184.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/92/b0/2d/a21b2f2ef3b8f2/AU2013366490B9_D0185.png" class="style-scope patent-text"><img file="AU2013366490B9_D0185.tif" img-format="tif" alt="Figure AU2013366490B9_D0185" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/92/b0/2d/a21b2f2ef3b8f2/AU2013366490B9_D0185.png"></a></div>
    <div class="description-paragraph style-scope patent-text">TBS Deprotection</div>
    <div class="description-paragraph style-scope patent-text">-►</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/d3/80/34/a2f53f85457c7c/AU2013366490B9_D0186.png" class="style-scope patent-text"><img file="AU2013366490B9_D0186.tif" img-format="tif" alt="Figure AU2013366490B9_D0186" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/d3/80/34/a2f53f85457c7c/AU2013366490B9_D0186.png"></a></div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">195</div>
    <div class="description-paragraph style-scope patent-text">Scheme 3a - synthesis of dilactam building block</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a7/94/24/440f122dd4df38/AU2013366490B9_D0187.png" class="style-scope patent-text"><img file="AU2013366490B9_D0187.tif" img-format="tif" alt="Figure AU2013366490B9_D0187" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a7/94/24/440f122dd4df38/AU2013366490B9_D0187.png"></a></div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/1d/3e/8e/ac2f557201511b/AU2013366490B9_D0188.png" class="style-scope patent-text"><img file="AU2013366490B9_D0188.tif" img-format="tif" alt="Figure AU2013366490B9_D0188" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/1d/3e/8e/ac2f557201511b/AU2013366490B9_D0188.png"></a></div>
    <div class="description-paragraph style-scope patent-text">o</div>
    <div class="description-paragraph style-scope patent-text">Scheme 3b - synthesis of protected carbinolamine building block with tether</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/57/f6/9f/e8421ab62b580c/AU2013366490B9_D0189.png" class="style-scope patent-text"><img file="AU2013366490B9_D0189.tif" img-format="tif" alt="Figure AU2013366490B9_D0189" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/57/f6/9f/e8421ab62b580c/AU2013366490B9_D0189.png"></a></div>
    <div class="description-paragraph style-scope patent-text">NHCO<sub class="style-scope patent-text">2</sub>R'</div>
    <div class="description-paragraph style-scope patent-text">NHCO<sub class="style-scope patent-text">2</sub>R'</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">196</div>
    <div class="description-paragraph style-scope patent-text">Scheme 3c - synthesis of dimer with linker attached (drug-linker)</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/48/26/54/e39b50ed895327/AU2013366490B9_D0190.png" class="style-scope patent-text"><img file="AU2013366490B9_D0190.tif" img-format="tif" alt="Figure AU2013366490B9_D0190" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/48/26/54/e39b50ed895327/AU2013366490B9_D0190.png"></a></div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">197</div>
    <div class="description-paragraph style-scope patent-text">In the above schemes, the protecting groups may be orthogonal to one another to provide for synthetic flexibility.</div>
    <div class="description-paragraph style-scope patent-text">Examples</div>
    <div class="description-paragraph style-scope patent-text">General Experimental Methods</div>
    <div class="description-paragraph style-scope patent-text">Reaction progress was monitored by thin-layer chromatography (TLC) using Merck Kieselgel 60 F254 silica gel, with fluorescent indicator on aluminium plates. Visualisation of TLC was achieved with UV light or iodine vapour unless otherwise stated. Flash chromatography was performed using Merck Kieselgel 60 F254 silica gel. Extraction and chromatography solvents were bought and used without further purification from Fisher Scientific, U.K. All chemicals were purchased from Aldrich, Lancaster or BDH.</div>
    <div class="description-paragraph style-scope patent-text"> <sup class="style-scope patent-text">1</sup>H and <sup class="style-scope patent-text">13</sup>C NMR spectra were obtained on a Bruker Avance 400 spectrometer. Coupling constants are quoted in hertz (Hz). Chemical shifts are recorded in parts per million (ppm) downfield from tetramethylsilane. Spin multiplicities are described as s (singlet), bs (broad singlet), d (doublet), t (triplet), q (quartet), p (pentuplet) and m (multiplet). IR spectra were recorded on a Perkin-Elmer FT/IR paragon 1000 spectrophotometer by application of the sample in a solution of chloroform using the ATR “golden gate” system. Optical rotations were measured at ambient temperature using a Bellingham and Stanley ADP 220 polarimeter. Mass spectrometry was performed on a ThermoQuest Navigator from Thermo Electron, Electrospray (ES) spectra were obtained at 20 to 30 V. Accurate mass measurements were performed using Micromass Q-TOF global tandem. All samples were run under electrospray ionization mode using 50% acetonitrile in water and 0.1% formic acid as a solvent. Samples were run on W mode which gives a typical resolution of 19000 at FWHH. The instrument was calibrated with [Glu]-Fibrinopeptide B immediately prior to measurement.</div>
    <div class="description-paragraph style-scope patent-text">General LC/MS conditions:</div>
    <div class="description-paragraph style-scope patent-text">Method 1 (default method, used unless stated otherwise)</div>
    <div class="description-paragraph style-scope patent-text">The HPLC (Waters Alliance 2695) was run using a mobile phase of water (A) (formic acid 0.1%) and acetonitrile (B) (formic acid 0.1%). Gradient: initial composition 5% B held over 1.0 min, then increase from 5% B to 95% B over a 3 min period. The composition was held for 0.1 min at 95% B, then returned to 5% B in 0.03 minutes and hold there for 0.87 min. Total gradient run time equals 5 minutes.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">198</div>
    <div class="description-paragraph style-scope patent-text">Flow rate 3.0 mL/min, 400pL was split via a zero dead volume tee piece which passes into the mass spectrometer. Wavelength detection range: 220 to 400 nm. Function type: diode array (535 scans). Column: Phenomenex Onyx Monolithic C18 50 x 4.60 mm.</div>
    <div class="description-paragraph style-scope patent-text">The reverse phase flash purification conditions were as follows: The Flash purification system (Varian 971-Fp) was run using a mobile phase of water (A) and acetonitrile (B). Gradient: initial composition 5% B over 20 C.V. (Column Volume) then 5% B to 70% B within 60 C.V. The composition was held for 15 C.V. at 95% B, and then returned to 5% B in 5 C.V. and held at 5%B for 10 C.V. Total gradient run time equals 120 C.V. Flow rate 6.0 mL/min. Wavelength detection range: 254 nm. Column: Agilent AX1372-1 SF105.5gC8.</div>
    <div class="description-paragraph style-scope patent-text">Fast Formic:</div>
    <div class="description-paragraph style-scope patent-text">Positive mode electrospray mass spectrometry (ESI-MS) was performed using a Shimazu LCMS-2020 (single quadrupole mass spectrometer). Mobile phase used were water (A) (formic acid 0.1%) and acetonitrile (B) (formic acid 0.1%). Gradient: initial composition 5% B held over 0.25 min, then increase from 5% B to 100% B over a 2 min period. The composition was held for 0.50 min at 100% B, then returned to 5% B in 0.05 minutes and hold there for 0.05 min. Total gradient run time equals 3 min. Flow rate 0.8 mL/min. Wavelength detection range: 220 to 400 nm. Column: Waters Acquity UPLC BEH Shield RP18 1.7pm 2.1x50mm.</div>
    <div class="description-paragraph style-scope patent-text">C18 15min formic:</div>
    <div class="description-paragraph style-scope patent-text">Positive mode electrospray mass spectrometry (ESI-MS) was performed using a Shimazu LCMS-2020 (single quadrupole mass spectrometer). Oven temperature 50°C. Mobile phase used were water (A) (formic acid 0.1%) and acetonitrile (B) (formic acid 0.1%). Gradient: initial composition 5% B held over 1 min, then increase from 5% B to 100% B over a 9 min period. The composition was held for 2 min at 100% B, then returned to 5% B in 0.10 minutes and hold there for 2.90 min. Total gradient run time equals 15 min. Flow rate 0.6 mL/min. Wavelength detection range: 220 to 400 nm. Column: Gemini-NX UPLC C18 3pm 2x100mm.</div>
    <div class="description-paragraph style-scope patent-text">Preparative HPLC: Reverse-phase ultra-high-performance liquid chromatography (UPLC) was carried out on Phenomenex Gemini NX 5p C-18 columns of the following dimensions: 150 x 4.6 mm for analysis, and 150 x 21.20 mm for preparative work. All UPLC</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">199 experiments were performed with gradient conditions: initial fixed composition 13% B to 75% B over 15 min, held for 2.0 min at 75% B, then 75% B to 13% B within 0.10 min held at 13% for 2.90 min. Total duration of gradient run was 20.00 min. Eluents used were solvent A (H<sub class="style-scope patent-text">2</sub>O with 0.1% Formic acid) and solvent B (CH<sub class="style-scope patent-text">3</sub>CN with 0.1% Formic acid). Flow rates used were 1.0 ml/min for analytical, and 20.0 ml/min for preparative HPLC. Detection was at 254 and 280 nm.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">200</div>
    <div class="description-paragraph style-scope patent-text">Example 1</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/a6/9b/1d/76364c1f0e5336/AU2013366490B9_D0191.png" class="style-scope patent-text"><img file="AU2013366490B9_D0191.tif" img-format="tif" alt="Figure AU2013366490B9_D0191" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/a6/9b/1d/76364c1f0e5336/AU2013366490B9_D0191.png"></a></div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">201</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/34/a3/70/ac4d9ef41d1420/AU2013366490B9_D0192.png" class="style-scope patent-text"><img file="AU2013366490B9_D0192.tif" img-format="tif" alt="Figure AU2013366490B9_D0192" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/34/a3/70/ac4d9ef41d1420/AU2013366490B9_D0192.png"></a></div>
    <div class="description-paragraph style-scope patent-text">(a) (R)-2-((R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-methylbutanamido) propanoic acid (2)</div>
    <div class="description-paragraph style-scope patent-text">HO-Ala-Val-H 1 (350 mg, 1.86 mmol) and Na<sub class="style-scope patent-text">2</sub>CO<sub class="style-scope patent-text">3</sub> (493 mg, 4.65 mmol) were dissolved in distilled H<sub class="style-scope patent-text">2</sub>O (15 mL) and the mixture was cooled to 0°C before dioxane (15 mL) was added (partial precipitation of the amino acid salt occurred). A solution of Fmoc-CI (504 mg, 1.95 mmol) in dioxane (15 mL) was added dropwise with vigorous stirring over 10 minutes. The resulting mixture was stirred at 0°C for 2 hours before the ice bath was removed and stirring was maintained for 16 hours. The solvent was removed by rotary evaporation under reduced pressure and the residue dissolved in water (150 mL). The pH was adjusted from 9 to 2 with 1N HCI and the aqueous layer was subsequently extracted with EtOAc (3x100 mL). The combined organics were washed with brine (100 mL), dried with MgSO<sub class="style-scope patent-text">4</sub>, filtered and the volatiles removed by rotary evaporation under reduced pressure to afford pure HOAla-Val-Fmoc 2 (746 mg, 97% yield). LC/MS 2.85 min (ES+) m/z (relative intensity) 410.60 ; <sup class="style-scope patent-text">1</sup>H-NMR (400 MHz, CDCI<sub class="style-scope patent-text">3</sub>) δ 7.79 (d, J=7.77 Hz, 2H), 7.60(d, J=7.77 Hz, 2H), 7.43(d,</div>
    <div class="description-paragraph style-scope patent-text">J=7.5 Hz, 2H), 7.34 (d, J=7.5 Hz, 2H), 6.30 (bs, 1H), 5.30 (bs, 1H), 4.71-7.56 (m, 1H), 4.54-4.36 (m, 2H), 4.08-3.91 (m, 1H), 2.21-2.07 (m, 1H), 1.50 (d, J=7.1 Hz, 3H), 1.06-0.90 (m, 6H).</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">202 (b) (9H-fluoren-9-yl)methyl ((S)-3-methyl-1-oxo-1-(((S)-1-oxo-1-((4-(4,4,5,5-tetramethyl1,3,2-dioxaborolan-2-yl)phenyl)amino)propan-2-yl)amino)butan-2-yl)carbamate (3) 4-Aminophenylboronic acid pinacol ester was added (146.9 mg, 0.67 mmol) was added to a solution of HO-Ala-Val-Fmoc 2 (330mg, 0.8 mmol), DCC (166 mg, 0.8 mmol) and DMAP (5 mg, cat.) in dry DCM (8 mL) previously stirred for 30 minutes at room temperature in a flask flushed with argon. The reaction mixture was then allowed to stir at room temperature overnight. The reaction was followed by LCMS and TLC. The reaction mixture was diluted with CH<sub class="style-scope patent-text">2</sub>CI<sub class="style-scope patent-text">2</sub>and the organics were washed with H<sub class="style-scope patent-text">2</sub>O and brine before being dried with MgSO<sub class="style-scope patent-text">4</sub>, filtered and the solvent removed by rotary evaporation under reduced pressure. The crude product was dryloaded on a silicagel chromatography column (Hexane/EtOAc, 6:4) and pure product 3 was isolated as a white solid in 88% yield (360 mg).</div>
    <div class="description-paragraph style-scope patent-text">(c) 8-(3-((2-(4-((S)-2-((S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3methylbutanamido)propanamido)phenyl)-7-methoxy-5,11-dioxo-10-((2(trimethylsilyl)ethoxy)methyl)-5,10,11,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2a][1,4]diazepin-8-yl)oxy)propoxy)-7-methoxy-5,11-dioxo-10-((2(trimethylsilyl)ethoxy)methyl)-5,10,11,11a-tetrahydro-1 H-benzo[e]pyrrolo[1,2a][1,4]diazepin-2-yl trifluoromethanesulfonate (5)</div>
    <div class="description-paragraph style-scope patent-text">1,1 ’-[[(Propane-1,3-d iy I )d ioxy] bis( 11 aS)-7-methoxy-2-[[(trifluoromethyl)sulfonyl]oxy]-10-((2(trimethylsilyl)ethoxy)methyl)-1,10,11,11 a-tetrahydro-5H-pyrrolo[2,1 -c] [ 1,4]-benzodiazepin5,11-dione] 4 (2.03g, 1.81 mmol), boronic pinacol ester (1 g, 1.63 mmol) and Na<sub class="style-scope patent-text">2</sub>CO<sub class="style-scope patent-text">3</sub> (881 mg, 8.31 mmol) were dissolved in a mixture of toluene/MeOH/H<sub class="style-scope patent-text">2</sub>O, 2:1:1 (40 mL). The reaction flask was purged and filled with argon three times before fefra/i/s(triphenylphosphine)palladium(0) (41 mg, 0.035 mmol) was added and the reaction mixture heated to 30°C overnight. The solvents were removed under reduce pressure and the residue was taken up in H<sub class="style-scope patent-text">2</sub>O (100 mL) and extracted with EtOAc (3 x 100 mL). The combined organics were washed with brine (100 mL), dried with MgSO<sub class="style-scope patent-text">4</sub>, filtered and the volatiles removed by rotary evaporation under reduced pressure. The crude product was purified by silica gel chromatography column (Hexane/EtOAc, 8:2 to 25:75) to afford pure 5 in 33% yield (885 mg). LC/MS 3.85 min (ES+) m/z (relative intensity) 1452.90 ; <sup class="style-scope patent-text">1</sup>H NMR (400 MHz, CDCIa) δ 7.78 - 7.16 (m, 17H), 7.13 (s, 1H), 6.51 -6.24 (m, 1H), 5.51 (dd, J = 10.0, 5.1 Hz, 2H), 5.36-5.11 (m, 1H), 4.74 (dd, J = 10.1,4.4 Hz, 2H), 4.70-4.53 (m, 2H), 4.47 (d, J = 6.4 Hz, 1H), 4.37 (d, J = 7.2 Hz, 1H), 4.27 (m, 4H), 4.20 - 4.14 (m, 1H), 3.90 (s, 3H), 3.89 (s, 3H), 3.77 (ddd, J = 16.7, 9.0, 6.4 Hz, 3H), 3.71 - 3.61 (m, 2H), 3.24 - 2.91</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">203 (m, 3H), 2.55 - 2.33 (m, 2H), 2.22 - 2.07 (m, 1H), 1.52 - 1.37 (m, 3H), 1.04 - 0.86 (m, 10H), 0.00 (s, 18H).</div>
    <div class="description-paragraph style-scope patent-text">(d) (9H-fluoren-9-yl)methyl((2S)-1-(((2S)-1-((4-(8-(3-((2-cyclopropyl-7-methoxy-5,11-dioxo10-((2-(trimethylsilyl)ethoxy)methyl)-5,10,11,11a-tetrahydro-1 H-benzo[e]pyrrolo[1,2a][1,4]diazepin-8-yl)oxy)propoxy)-7-methoxy-5,11-dioxo-10-((2(trimethylsilyl)ethoxy)methyl)-5,10,11,11a-tetrahydro-1 H-benzo[e]pyrrolo[1,2a][1,4]diazepin-2-yl)phenyl)amino)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2yl)carbamate (6)</div>
    <div class="description-paragraph style-scope patent-text">Triphenylarsine (42 mg, 0.137 mmol) was added to a mixture of PBD-triflate 5 (250 mg, 0.172 mmol), cyclopropylboronic acid (73.9 mg, 0.86 mmol), silver oxide (159 mg, 0.688 mmol) and potassium phosphate tribasic (438 mg, 2.06 mmol) in dry dioxane (10 mL) under an argon atmosphere. The reaction was flushed with argon 3 times and b/s(benzonitrile)palladium(ll) chloride (13.2 mg, 0.034 mmol) was added. The reaction was flushed with Argon 3 more times before being warmed to 75°C and stirred for 10 minutes. The reaction mixture was filtered through a pad of celite which was subsequently rinsed with ethyl acetate. The solvent was removed by rotary evaporation under reduced pressure. The resulting residue was subjected to flash column chromatography (silica gel;</div>
    <div class="description-paragraph style-scope patent-text">% methanol/chloroform). Pure fractions were collected and combined, and excess eluent was removed by rotary evaporation under reduced pressure to afford the desired product 22 (132 mg, 50 % yield). LC/MS 3.83 min (ES+) m/z (relative intensity) 1345.91 ; <sup class="style-scope patent-text">1</sup>H NMR (400 MHz, CDCI<sub class="style-scope patent-text">3</sub>) δ 7.88 - 7.14 (m, 17H), 6.69 (s, 1H), 6.45-6.25 (m, 1H), 5.57-5.41 (m, 2H), 5.34-5.14 (m, 1H), 4.78-4.67 (m, 2H), 4.62-4.55 (m, 1H), 4.50-4.45 (m, 2H), 4.51 -4.44 (m, 1H), 4.31 -4.21 (m, 4H), 4.16 (m, 1H), 3.92 (s, 3H), 3.86 (s, 3H), 3.823.71 (m, 2H), 3.66 (m, 3H), 3.40 - 3.28 (m, 1H), 3.07 (m, 1H), 2.70 - 2.57 (m, 1H), 2.47 2.36 (m, 2H), 2.15 (m, 1H), 1.51 - 1.40 (m, 3H), 1.03-0.87 (m, 11H), 0.77-0.71 (m, 2H), 0.60 - 0.54 (m, 2H), 0.00 (t, J = 3.0 Hz, 18H).</div>
    <div class="description-paragraph style-scope patent-text">(e) (9H-fluoren-9-yl)methyl((2S)-1-(((2S)-1-((4-(8-(3-((2-cyclopropyl-7-methoxy-5-oxo5,11 a-dihydro-1 H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl)oxy)prc&gt;poxy)-7-rnethoxy-5-oxo5,11 a-dihydro-1 H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-2-yl)phenyl)amino)-1 -oxopropan-2yl)amino)-3-methyl-1-oxobutan-2-yl)carbamate (7)</div>
    <div class="description-paragraph style-scope patent-text">A solution of Super-Hydride® (0.5 mL, 1M in THF) was added dropwise to a solution of SEM dilactam 6 (265 mg g, 0.19 mmol) in THF (10 mL) at -78°C under an argon atmosphere. The addition was completed over 5 minutes in order to maintain the internal</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">204 temperature of the reaction mixture constant. After 20 minutes, an aliquot was quenched with water for LC/MS analysis, which revealed that the reaction was complete. Water (20 mL) was added to the reaction mixture and the cold bath was removed. The organic layer was extracted with EtOAc (3 x 30 mL) and the combined organics were washed with brine (50 mL), dried with MgSO<sub class="style-scope patent-text">4</sub>, filtered and the solvent removed by rotary evaporation under reduced pressure. The crude product was dissolved in MeOH (12 mL), CH<sub class="style-scope patent-text">2</sub>CI<sub class="style-scope patent-text">2</sub> (6 mL), water (2 mL) and enough silica gel to form a thick stirring suspension. After 5 days, the suspension was filtered through a sintered funnel and washed with CH<sub class="style-scope patent-text">2</sub>CI<sub class="style-scope patent-text">2</sub>/MeOH (9:1) (200 mL) until the elution of the product was complete. The organic layer was washed with brine (2 x 70 mL), dried with MgSO<sub class="style-scope patent-text">4</sub>, filtered and the solvent removed by rotary evaporation under reduced pressure. Purification by silica gel column chromatography (100% CHCI<sub class="style-scope patent-text">3</sub> to 96% CHCI<sub class="style-scope patent-text">3</sub>/ 4% MeOH) afforded the product 23 as a yellow solid (162 mg, 78%). LC/MS 3.02 min (ES+) m/z (relative intensity) 1052.37.</div>
    <div class="description-paragraph style-scope patent-text">(f) Imine reduction</div>
    <div class="description-paragraph style-scope patent-text">A solution of Super-Hydride® (95 pL, 1 eq, 1M in THF) was added dropwise to a solution of bis imine 7 (100 mg, 0.095 mmol) in THF (10 mL) at -78°C under an argon atmosphere. After 20 minutes, an aliquot was quenched with water for LC/MS analysis, which revealed that the reaction was complete, with some over-reduction towards the bis amine 10. (Observed LC: Bis-imine 7 19%, Imine-Amine 8 + 9 36%, bis-amine 10 45%; theoretical target for 1 eq of reducing agent is 7 25%, 8+9 50%, 10 25%). Water (20 mL) was added to the reaction mixture and the cold bath was removed. The organic layer was extracted with chloroform (40 mL) and the combined organics were washed with water (1 x 40 mL), brine (50 mL), dried with Na<sub class="style-scope patent-text">2</sub>SO<sub class="style-scope patent-text">4</sub>, filtered and the solvent removed by rotary evaporation under reduced pressure. Purification by silica gel column chromatography (100% CHCI<sub class="style-scope patent-text">3</sub> to 96% CHCI<sub class="style-scope patent-text">3</sub>/ 4% MeOH) improved the ratio of 8+9 to: 7 25%, 8+9 50%, 10 25% (20 mg, 25%, as a mixture).</div>
    <div class="description-paragraph style-scope patent-text">LC/MS (Fast Formic, 2.5 min system) Bis-Imine 7 1.66 min (ES+) m/z (relative intensity) 1052.15 ; Hybrids Amine-Imine 8+9 (no separation on the 2.5 min system) 1.71 min (ES+) m/z (relative intensity) 1054.45; Bis-Amine 10 1.66 min (ES+) m/z (relative intensity) 1056.95, in a 1/2/1 ratio.</div>
    <div class="description-paragraph style-scope patent-text">(g) Fmoc deprotection</div>
    <div class="description-paragraph style-scope patent-text">Excess piperidine was added (0.1 mL, 1 mmol) to a 1/2/1 mixture of Fmoc protected 7, 8+9 and 10 (20 mg, 0.019 mmol) in DMF (1 mL). The mixture was allowed to stir at room</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">205 temperature for 20 minutes, at which point the reaction had gone to completion (as monitored by LC/MS). The reaction mixture was diluted with CH<sub class="style-scope patent-text">2</sub>CI<sub class="style-scope patent-text">2</sub> (30 mL) and the organic phase was washed with H<sub class="style-scope patent-text">2</sub>O (2x30 mL) until complete piperidine removal. The organic phase was dried over MgSO<sub class="style-scope patent-text">4</sub>, filtered and excess solvent removed by rotary evaporation under reduced pressure to afford crude products 11,12 + 13 and 14 (1/2/1 ratio), which were used as such in the next step.</div>
    <div class="description-paragraph style-scope patent-text">LC/MS (Fast Formic, 2.5 min system) Bis-Imine 11 1.12 min (ES+) m/z (relative intensity) 830.45 ; Hybrids Amine-Imine 12+13 (no separation) 1.15 min (ES+) m/z (relative intensity) 832.35; Bis-Amine 14 1.19 min (ES+) m/z (relative intensity) 834.35, in a 1/2/1 ratio.</div>
    <div class="description-paragraph style-scope patent-text">Example 2</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/cd/bd/dc/361a4db3f31058/AU2013366490B9_D0193.png" class="style-scope patent-text"><img file="AU2013366490B9_D0193.tif" img-format="tif" alt="Figure AU2013366490B9_D0193" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/cd/bd/dc/361a4db3f31058/AU2013366490B9_D0193.png"></a></div>
    <div class="description-paragraph style-scope patent-text">PEG maleimide coupling</div>
    <div class="description-paragraph style-scope patent-text">EDCI hydrochloride (5.46 mg, 0.028 mmol, 1.5 eq) was added to a suspension of 15 Maleimide-PEGs-acid (11.3 mg, 0.019 mmol, 1 eq) in chloroform (5 mL) under argon atmosphere. The mixture was stirred for 1h at room temperature before crude PBD mixture 11+12+13+14 (20 mg, 0.019 mmol, 1eq) was added. Stirring was maintained until the reaction was complete (usually 2 hours). The reaction was diluted with CH<sub class="style-scope patent-text">2</sub>CI<sub class="style-scope patent-text">2</sub>and the</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">206 organic phase was washed with H<sub class="style-scope patent-text">2</sub>O and brine before being dried over MgSO<sub class="style-scope patent-text">4</sub>, filtered and excess solvent removed by rotary evaporation under reduced pressure. The four products were purified and separated individually by reverse phase chromatography (see method below). The bis-imine 15 was isolated (2.0 mg, 7.5%), followed by the two separable amine-imine hybrids 16 (3.8 mg, 14.2%) and 17 (2.7 mg, 10.1%), and the bis-amine 18 (2.2 mg, 8.2%). <sup class="style-scope patent-text">1</sup>H NMR analysis unambiguously identified 16 from 17. One key feature is the imine proton (d, J = 4.0 Hz, 1H), which is at 7.78 ppm on the cyclopropyl side, and 7.88 ppm on the aromatic side of the molecule.</div>
    <div class="description-paragraph style-scope patent-text">LC/MS C18 15 min formic:</div>
    <div class="description-paragraph style-scope patent-text">Bis-Imine 15 5.23 min (ES+) m/z (relative intensity) 703.20 (100, (M+2H)/2), 1404.55 (10, M+H); <sup class="style-scope patent-text">1</sup>H NMR (400 MHz, CDCI<sub class="style-scope patent-text">3</sub>) δ 8.96 (s, 1H), 7.89 (d, J = 4.0 Hz, 1H), 7.78 (d, J = 4.0 Hz, 1H), 7.77 - 7.64 (m, 2H), 7.53 - 7.47 (m, 2H), 7.44 (s, 1H), 7.33 (d, J = 8.7 Hz, 2H),</div>
    <div class="description-paragraph style-scope patent-text">7.12 (s, 1H), 6.89 - 6.81 (m, 2H), 6.74 (s, 1H), 6.69 (d, J = 1.6 Hz, 2H), 6.50 (s, 1H), 4.72 4.57 (m, 1H), 4.43 - 4.14 (m, 7H), 4.11 - 4.03 (m, 1H), 3.93 (d, J = 4.6 Hz, 6H), 3.83 (t, J = 7.2 Hz, 2H), 3.80 - 3.71 (m, 2H), 3.68 - 3.56 (m, 28H), 3.55 - 3.48 (m, 3H), 3.44 - 3.34 (m, 3H), 3.16-3.04 (m, 1H), 2.95-2.84 (m, 1H), 2.58-2.47 (m, 4H), 2.47-2.37 (m, 2H), 2.33-2.16 (m, 1H), 1.51 - 1.41 (m, 4H), 1.05-0.94 (m, 6H), 0.77 (dt, J = 5.5, 4.8 Hz, 2H), 0.55 (dd, J = 9.3, 4.9 Hz, 2H).</div>
    <div class="description-paragraph style-scope patent-text">Hybrid Amine-Imine 16 5.48 min (ES+) m/z (relative intensity) 704.20 (100, (M+2H)/2), 1406.70 (5, M+H); <sup class="style-scope patent-text">1</sup>H NMR (400 MHz, CDCI<sub class="style-scope patent-text">3</sub>) δ 8.97 (s, 1H), 7.88 (d, J = 3.9 Hz, 1H), 7.78</div>
    <div class="description-paragraph style-scope patent-text">- 7.64 (m, 2H), 7.55 - 7.48 (m, 2H), 7.43 (s, 1H), 7.36 - 7.29 (m, 2H), 7.12 (s, 1H), 6.93 6.80 (m, 3H), 6.69 (d, J= 1.7 Hz, 2H), 6.49 (s, 1H), 6.10 (s, 1H), 4.72-4.58 (m, 1H), 4.41 -4.32 (m, 1H), 4.32-4.24 (m, 2H), 4.24-4.16 (m, 2H), 4.15-4.02 (m, 2H), 3.94 (s, 3H), 3.87 - 3.80 (m, 5H), 3.79 - 3.71 (m, 2H), 3.69 - 3.55 (m, 28H), 3.55 - 3.49 (m, 2H), 3.46 3.34 (m, 4H), 2.93 - 2.81 (m, 2H), 2.60 - 2.46 (m, 4H), 2.42 - 2.34 (m, 2H), 2.24 (dd, J = 14.0, 6.5 Hz, 2H), 1.52 - 1.38 (m, 4H), 1.07 - 0.92 (m, 6H), 0.75 - 0.66 (m, 2H), 0.53 0.44 (m, 2H).</div>
    <div class="description-paragraph style-scope patent-text">Hybrid Imine-Amine 17 5.41 min (ES+) m/z (relative intensity) 704.25 (100, (M+2H)/2), 1406.45 (3, M+H); <sup class="style-scope patent-text">1</sup>H NMR (400 MHz, CDCI<sub class="style-scope patent-text">3</sub>) δ 8.90 (s, 1H), 7.78 (d, J = 4.0 Hz, 1H), 7.74</div>
    <div class="description-paragraph style-scope patent-text">- 7.58 (m, 2H), 7.56 (s, 1H), 7.53 - 7.49 (m, 2H), 7.36 - 7.27 (m, 2H), 7.17 - 7.04 (m, 1H), 6.95-6.86 (m, 1H), 6.83 (s, 1H), 6.74 (s, 1H), 6.71 -6.65 (m, 2H), 6.53 (s, 1H), 6.12 (s,</div>
    <div class="description-paragraph style-scope patent-text">1H), 4.74-4.57 (m, 2H), 4.40-4.14 (m, 7H), 4.13-4.05 (m, 1H), 3.93 (s, 3H), 3.883.79 (m, 5H), 3.79 - 3.68 (m, 2H), 3.69 - 3.55 (m, 28H), 3.55 - 3.48 (m, 3H), 3.46 - 3.29 (m, 3H), 3.16-3.03 (m, 1H), 2.91 (s, 1H), 2.71 (s, 1H), 2.60-2.45 (m, 4H), 2.42-2.33</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">207 (m, 2H), 2.29-2.19 (m, 1H), 1.51 - 1.39 (m, 4H), 1.08-0.92 (m, 6H), 0.81 -0.74 (m, 2H), 0.55 (dd, J = 9.3, 5.4 Hz, 2H).</div>
    <div class="description-paragraph style-scope patent-text">Bis-amine 18 5.72 min (ES+) m/z (relative intensity) 705.15 (100, (M+2H)/2), 1408.45 (3, M+H); <sup class="style-scope patent-text">1</sup>H NMR (400 MHz, CDCI<sub class="style-scope patent-text">3</sub>) δ 8.91 (s, 1H), 7.73 - 7.59 (m, 2H), 7.57 - 7.49 (m, 3H),</div>
    <div class="description-paragraph style-scope patent-text">7.29 (d, J = 2.5 Hz, 2H), 7.13 (s, 1H), 6.91 (s, 1H), 6.84 (s, 1H), 6.68 (d, J = 2.0 Hz, 2H),</div>
    <div class="description-paragraph style-scope patent-text">6.49 (s, 1H), 6.08 (d, J = 3.9 Hz, 3H), 4.72-4.57 (m, 2H), 4.19 (dd, J= 10.6, 4.3 Hz, 5H), 4.09 (dd, J = 12.6, 5.8 Hz, 2H), 3.88 - 3.80 (m, 8H), 3.79 - 3.69 (m, 2H), 3.68 - 3.56 (m, 28H), 3.54 - 3.46 (m, 2H), 3.44 - 3.26 (m, 4H), 2.85 (dd, J = 15.9, 10.4 Hz, 2H), 2.73 (dd, J = 16.2, 4.7 Hz, 2H), 2.61 -2.43 (m, 4H), 2.38-2.16 (m, 5H), 1.51 - 1.38 (m, 4H), 1.0510 0.93 (m, 6H), 0.69 (dt, J = 4.9, 4.3 Hz, 2H), 0.49 (dd, J = 5.1, 3.3 Hz, 2H).</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">208</div>
    <div class="description-paragraph style-scope patent-text">Example 3 (a) tert-butyl (11 S)-2-(4-((S)-2-((S)-2-((((9/-/-fluoren-9-vl)methoxv)carbonvl)amino)-3methylbutanamido)propanamido)phenyl)-1 1-((ter/-butyldimethvlsilvl)oxv)-8-hvdroxy-7methoxy-5-oxo-11,11a-dihvdro-1/-/-benzoie1pyrroloi1,2-a1i1,41diazepine-10(5/-/)-carboxvlate (27)</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/86/bc/82/7db82fe8cfaa5a/AU2013366490B9_D0194.png" class="style-scope patent-text"><img file="AU2013366490B9_D0194.tif" img-format="tif" alt="Figure AU2013366490B9_D0194" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/86/bc/82/7db82fe8cfaa5a/AU2013366490B9_D0194.png"></a></div>
    <div class="description-paragraph style-scope patent-text">(i) (S)-(4-(4-aminophenyl)-2-(((tert-butyldimethylsilyl)oxy)methyl)-2,3-dihydro-1H-pyrrol-110 yl)(5-methoxy-2-nitro-4-((triisopropylsilyl)oxy)phenyl)methanone (20)</div>
    <div class="description-paragraph style-scope patent-text">Pd(PPh<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">4</sub> (609 mg, 0.52 mmol) was added to a stirred mixture of triflate 19 (18.8 g, 26.3 mmol), 4-aminophenylboronic acid pinacol ester (8.64 g, 39.4 mmol), Na<sub class="style-scope patent-text">2</sub>CO<sub class="style-scope patent-text">3</sub> (12.78 g,</div>
    <div class="description-paragraph style-scope patent-text">120 mmol), MeOH (80 mL), toluene (160 mL) and water (80 mL). The reaction mixture was</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">209 allowed to stir at 30°C under a nitrogen atmosphere for 24 hours after which time all the boronic ester has consumed. The reaction mixture was then evaporated to dryness before the residue was taken up in EtOAc (100 mL) and washed with H<sub class="style-scope patent-text">2</sub>O (100 mL), brine (100 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated under reduced pressure to provide the crude product. Purification by silica gel chromatography (Hexane/EtOAc ; 100% to 70:30) afforded product 20 as a yellowish foam (11.06 g, 64%). <sup class="style-scope patent-text">1</sup> H-NMR (400 MHz, CDCI3) δ 7.74 (s, 1H), 7.00 (d, J = 8.3 Hz, 2H), 6.81 (s, 1H), 6.58 (d, J = 8.3 Hz, 2H), 6.06 (s, 1H), 4.77 (bm, 1H), 3.91 (d, J = 6.7 Hz, 3H), 3.68 (bs, 2H), 3.13 (bm, 1H), 2.97 (d, J= 14.5 Hz, 1H), 1.36-1.21 (m, 3H), 1.12 (d, J = 7.3 Hz, 18H), 0.89 (s, 10H), 0.10 (s, 6H). ); ES<sup class="style-scope patent-text">+</sup>= 2.27 min, m/z 698 [M + CH3CN]<sup class="style-scope patent-text">+</sup> (ii) (9H-fluoren-9-yl)methyl ((S)-1-(((S)-1-((4-((S)-5-(((tert-butyldimethylsilyl)oxy)methyl)-1(5-methoxy-2-nitro-4-((triisopropylsilyl)oxy)benzoyl)-4,5-dihydro-1H-pyrrol-3yl)phenyl)amino)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)carbamate (21)</div>
    <div class="description-paragraph style-scope patent-text">To a dry round bottom flask previously flushed with argon was added aniline 20 (10.05 g, 15.3 mmol), the dipeptide (6.3 g, 15.3 mmol) and dry CH<sub class="style-scope patent-text">2</sub>CI<sub class="style-scope patent-text">2</sub> (500 mL). The flask was then purged three times with argon before EEDQ (3.79 g, 15.3 mmol) was added and the mixture left to stir at room temperature. The reaction was followed by LCMS and after 3.5 hours the reaction was complete. The reaction was quenched with H<sub class="style-scope patent-text">2</sub>O (200 mL) and extracted twice with CH<sub class="style-scope patent-text">2</sub>CI<sub class="style-scope patent-text">2</sub> (250 mL). The combined organics were washed with brine (150 mL), dried over MgSO<sub class="style-scope patent-text">4</sub>, filtered and the solvent removed in vacuo. The crude product was purified by silica gel chromatography (Hexane/EtOAc ; 100% to 55:45) to afford pure product 21 (13.821 g, 86%). <sup class="style-scope patent-text">1</sup>H-NMR (400 MHz, CDCI<sub class="style-scope patent-text">3</sub>) δ 8.26 (s, 1H), 7.64 (s + d, J = 4.9 Hz, 3H), 7.43 (t, J = 7.3 Hz, 1H), 7.36 (d, J = 7.3 Hz, 1H), 7.28 (t, J = 7.3 Hz, 1H), 7.19 (d, J = 7.7 Hz, 1H), 6.99 (d, J = 7.9 Hz, 1H), 6.71 (s, 1H), 6.27 (d, J = 6.3 Hz, 1H), 6.08 (s, 1H), 5.11 (d, J = 6.6 Hz, 1H), 4.69 (bs, 1H), 4.52 (bm, 1H), 4.36 (d, J = 6.5 Hz, 2H), 4.08 (t, J = 5.9 Hz, 1H), 3.89 (m, 1H), 3.80 (s, 3H), 3.11 -2.97 (bm, 1H), 2.88 (bd, J= 15.2 Hz, 1H), 2.03 (bs, 1H), 1.33 (d, J = 6.9 Hz, 3H), 1.24-1.11 (m, 3H), 1.01 (d, J = 7.4 Hz, 18H), 0.86 - 0.79 (m, 6H), 0.77 (s, 9H), 0.00 (s, 6H); ES<sup class="style-scope patent-text">+</sup> = 2.37 min, no mass.</div>
    <div class="description-paragraph style-scope patent-text">(iii) (9H-fluoren-9-yl)methyl ((S)-1-(((S)-1-((4-((S)-1-(2-amino-5-methoxy-4((triisopropylsilyl)oxy)benzoyl)-5-(((tert-butyldimethylsilyl)oxy)methyl)-4,5-dihydro-1H-pyrrol3-yl)phenyl)amino)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)carbamate (22)</div>
    <div class="description-paragraph style-scope patent-text">In a dry two-neck round bottom flask previously flushed with argon and fitted with a thermometer, nitrophenyl 21 (2.97g, 2.8 mmol) was solubilised in a solution of 5% formic</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">210 acid in methanol (50 mL). Zinc (1.85g, 28 mmol) was rapidly poured into the solution. The temperature instantaneously rose to 40°C and slowly cooled down back to room temperature at which point the reaction is complete (=15 minutes, reaction monitored by LCMS). The reaction mixture was then filtered through celite and the pad further washed with EtOAc (2 x 150 mL). The combined organics were subsequently washed with saturated NaHCO<sub class="style-scope patent-text">3</sub>(aq)(100 mL), H<sub class="style-scope patent-text">2</sub>O (100 mL) and brine (100 mL), before being dried over MgSO<sub class="style-scope patent-text">4</sub>, filtered and the volatiles removed in vacuo. The crude material was purified silica gel chromatography (Hexane/EtOAC 75:25 to 50:50) and pure product 22 was isolated as a pale yellow oil (2.291 g, 79% yield). <sup class="style-scope patent-text">1</sup>H-NMR (400 MHz, CDCI<sub class="style-scope patent-text">3</sub>) δ 8.37 (s, 1H), 7.74 (s+d, J = 4.9 Hz, 3H), 7.53 (t, J = 7.4 Hz, 2H), 7.46 (d, J = 11.3 Hz, 2H), 7.39 (t, J = 7.3 Hz, 2H), 7.28 (t, J = 11.3 Hz, 2H), 7.09 (d, J = 7.9 Hz, 2H), 6.38 (d, J = 6.3 Hz, 1H), 6.18 (s, 1H),</div>
    <div class="description-paragraph style-scope patent-text">5.21 (d, J = 2.9 Hz, 1H), 4.81 (bs, 1H), 4.72-4.57 (m, 1H), 4.47 (d, J = 6.5 Hz, 2H), 4.19 (t, J = 5.0 Hz, 1H), 4.00-3.94 (m, 1H), 3.91 (s, 3H), 3.23-3.07 (m, 1H), 2.98 (d, J = 16.8 Hz, 1H), 2.15 (s, 1H), 1.43 (d, J = 6.9 Hz, 3H), 1.36-1.18 (m, 3H), 1.12 (d, J = 7.4 Hz, 18H), 0.97 - 0.89 (m, 6H), 0.88 (s, 9H), 0.10 (s, 6H). ES<sup class="style-scope patent-text">+</sup> = 2.37 min, m/z no mass.</div>
    <div class="description-paragraph style-scope patent-text">(iv) (9H-fluoren-9-yl)methyl ((S)-1-(((S)-1-((4-((S)-1-(2-((tert-butoxycarbonyl)amino)-5methoxy-4-((triisopropylsilyl)oxy)benzoyl)-5-( ((tert-butyldimethylsilyl)oxy)methyl)-4,5dihydro-1H-pyrrol-3-yl)phenyl)amino)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2yl)carbamate (23)</div>
    <div class="description-paragraph style-scope patent-text">Amine 22 (14.913 g, 14.6 mmol) and Boc<sub class="style-scope patent-text">2</sub>O (3.83 g, 17.5 mmol) were heated together at 70°C in a round bottom flask. To help with solubility, CHCI<sub class="style-scope patent-text">3</sub> (25 mL) was added and the mixture left to stir until the reaction was complete (followed by LCMS). The thick crude solution was left to cool down to room temperature before being directly loaded on a silica gel chromatography column (Hexane/EtOAc ; 100% to 65:35). Product 23 was isolated as a cream foam (13.2 g, 80% yield). <sup class="style-scope patent-text">1</sup>H-NMR (400 MHz, CDCI<sub class="style-scope patent-text">3</sub>) δ 8.40 (s, 1H), 8.21 (s, 1H), 7.74 (d, J = 7.8 Hz, 3H), 7.54 (t, J = 7.0 Hz, 2H), 7.48 (d, J = 7.7 Hz, 2H), 7.38 (t, J = 7.4 Hz, 2H), 7.31 - 7.25 (m, 3H), 7.14 (d, J = 6.7 Hz, 2H), 6.84 (bs, 1H), 6.80 (s, 1H), 6.50 (d, J = 6.4 Hz, 1H), 5.28 (d, J = 6.0 Hz, 1H), 4.77 (d, J = 2.6 Hz, 1H), 4.70 - 4.58 (m, 1H), 4.47 (t, J = 5.7 Hz, 2H), 4.19 (t, J = 6.1 Hz, 1H), 4.00 (m, 2H), 3.88 (bs, 1H), 3.73 (s, 3H), 3.05 (m, 1H), 2.98 (dd, J = 15.4, 3.3 Hz, 1H), 2.15 (bm, 1H), 1.46 (s, 9H), 1.43 (d, J=11.7 Hz, 3H), 1.36- 1.22 (m, 3H), 1.12 (d, J = 7.4 Hz, 18H), 1.00-0.89 (m, 6H), 0.84 (s, 9H), 0.05 (d, J = 6.0 Hz, 6H)); ES<sup class="style-scope patent-text">+</sup> = 2.53 min, no mass.</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">211 (v) (9H-fluoren-9-yl)methyl ((S)-1-(((S)-1-((4-((S)-1-(2-((tert-butoxycarbonyl)amino)-5methoxy-4-((triisopropylsilyl)oxy)benzoyl)-5-(hydroxymethyl)-4,5-dihydro-1 H-pyrrol-3yl)phenyl)amino)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)carbamate (24)</div>
    <div class="description-paragraph style-scope patent-text">Silyl ether 23 (13.2 g, 11.8 mmol) was solubilised in a 7:2:1:1 mixture of AcOH/H<sub class="style-scope patent-text">2</sub>O/MeOH/THF (220 mL) and the mixture was stirred at room temperature until the reaction was complete (left overnight). The volatiles were removed in vacuo and the residue was taken up in EtOAc (400 mL). The organic phase was washed with saturated NaHC0<sub class="style-scope patent-text">3(</sub>aq)(200 mL), H<sub class="style-scope patent-text">2</sub>O (200 mL) and brine (10 mL) before being dried over MgSO<sub class="style-scope patent-text">4</sub>, filtered and concentrated in vacuo. The crude material was purified by silica gel chromatography (Hex/EtOAc ; 50:50 to 0:100) and pure product 24 was isolated as a light yellow foam (11.168 g, 94% yield). <sup class="style-scope patent-text">1</sup>H-NMR (400 MHz, CDCI<sub class="style-scope patent-text">3</sub>) δ 8.45 (s, 1H), 7.93 (s, 1H), 7.74 (d, J = 7.4 Hz, 2H), 7.64 (s, 1H), 7.52 (dd, J = 17.9, 8.9 Hz, 4H), 7.39 (t, J = 7.4 Hz, 2H), 7.33 - 7.26 (m, 3H), 7.13 (d, J = 7.4 Hz, 2H), 6.81 (s, 1H), 6.45 (s, 1H), 5.26 (s, 1H), 4.84 (s, 1H), 4.69-4.58 (m, 1H), 4.47 (d, J = 6.2 Hz, 2H), 4.43 (s, 1H), 4.17 (d, J = 14.2 Hz, 1H), 3.99 (s, 1H), 3.89 (s, 2H), 3.74 (s, 3H), 3.30-3.17 (m, 1H), 2.64 (d, J = 16.9 Hz, 1H), 2.23-2.09 (m, 1H), 1.44 (s, 9H), 1.44 (d, J= 10.9 Hz, 2H), 1.29 (ddd, J = 14.3, 13.0, 7.4 Hz, 3H), 1.12 (d, J = 7.4 Hz, 18H), 0.92 (m, 6H); ES<sup class="style-scope patent-text">+</sup> = 2.23 min, no mass.</div>
    <div class="description-paragraph style-scope patent-text">(vi) tert-butyl (11S)-2-(4-((S)-2-((S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3methylbutanamido)propanamido)phenyl)-11-hydroxy-7-methoxy-5-oxo-8((triisopropylsilyl)oxy)-11,11 a-dihydro-1 H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10(5H)carboxylate (25)</div>
    <div class="description-paragraph style-scope patent-text">DMSO (1.55 L, 21.9 mmol) was added to a cooled solution of oxallyl chloride (0.89 mL, 10.5 mmol) in CH<sub class="style-scope patent-text">2</sub>CI<sub class="style-scope patent-text">2</sub> (50 mL) at -78°C. After 15 minutes, a solution of alcohol 24 (8.8 mg, 8.76 mmol) in CH<sub class="style-scope patent-text">2</sub>CI<sub class="style-scope patent-text">2</sub> (100 mL) was added dropwise to the oxidising mixture. The reaction was left to stir at -78°C for 1 hour before NEt<sub class="style-scope patent-text">3</sub> (6.11 mL, 43.8 mmol) was added and the mixture allowed to warm to room temperature. Upon completion, the reaction mixture was diluted with CH<sub class="style-scope patent-text">2</sub>CI<sub class="style-scope patent-text">2</sub> (100 mL) and the solution was washed with 0.1 M HCI(aq.) (250 mL), H<sub class="style-scope patent-text">2</sub>O (250 mL), saturated NaHCO<sub class="style-scope patent-text">3</sub>(<sub class="style-scope patent-text">aq</sub>.) (250 mL) and brine (200 mL). The organics were dried with MgSO<sub class="style-scope patent-text">4</sub>, filtered and the volatiles removed in vacuo. The crude material was purified by silica gel chromatography (CH<sub class="style-scope patent-text">2</sub>CI<sub class="style-scope patent-text">2</sub>/EtOAc ; 100% to 50:50) to provide pure 25 as a yellow oil (8.8 mg, 100%). <sup class="style-scope patent-text">1</sup> H-NMR (400 MHz, CDCI<sub class="style-scope patent-text">3</sub>) δ 8.71 (s, 1H), 7.74 (t, J = 8.4 Hz, 3H), 7.52 (d, J = 7.4 Hz, 5H), 7.43 - 7.33 (m, 4H), 7.23 - 7.17 (m, 2H), 6.69 (s, 1H), 6.42 (d, J = 7.9 Hz, 1H), 5.78 (d, J = 7.8 Hz, 1H), 5.62 (s, 1H), 5.23 (d, J = 7.7 Hz, 1H), 4.84 - 4.69 (m, 1H), 4.65 (d, J = 22.5 Hz, 1H), 4.45 - 4.29 (m, 2H), 3.91 (dd, J = 11.3, 8.1</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">212</div>
    <div class="description-paragraph style-scope patent-text">Hz, 1H), 3.86 (s, 3H), 3.28 (q, J = 11.9 Hz, 1H), 2.98 (t, J = 12.6 Hz, 1H), 2.14 (dd, J =</div>
    <div class="description-paragraph style-scope patent-text">12.9, 10.0 Hz, 1H), 1.52- 1.42 (m, 3H), 1.38 (s, 9H), 1.26 (m, 3H), 1.16-1.05 (m, 18H), 0.93 (d, J = 6.0 Hz, 6H); ES<sup class="style-scope patent-text">+</sup> = 2.19 min, no mass.</div>
    <div class="description-paragraph style-scope patent-text">(vii) tert-butyl (11S)-2-(4-((S)-2-((S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3methylbutanamido)propanamido)phenyl)-11-((tert-butyldimethylsilyl)oxy)-7-methoxy-5-oxo8-((triisopropylsilyl)oxy)-11,11a-dihydro-1 H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10(5H)carboxylate (26)</div>
    <div class="description-paragraph style-scope patent-text">Alcohol 25 (8.8 g, 8.78 mmol) was solubilised in dry CH<sub class="style-scope patent-text">2</sub>CI<sub class="style-scope patent-text">2</sub> (150 mL) in a sealed round bottom flask previously flushed three times with argon. The solution was cooled to 0°C before lutidine (4 mL, 35.1 mmol) and TBS-OTf (6 mL, 26.3 mmol) were subsequently added. The reaction mixture was left to warm to room temperature and stirred until complete (monitored by LCMS). Upon completion, the solution was diluted with CH<sub class="style-scope patent-text">2</sub>CI<sub class="style-scope patent-text">2 </sub>(100 mL), washed with saturated NH<sub class="style-scope patent-text">4</sub>CI(<sub class="style-scope patent-text">a</sub>q.) (150 mL), H<sub class="style-scope patent-text">2</sub>O (100 mL), saturated NaHCO<sub class="style-scope patent-text">3</sub>(aq.) (100 mL) and brine (100 mL). The organics were dried with MgSO<sub class="style-scope patent-text">4</sub>, filtered and the volatiles removed in vacuo. The crude material was purified by silica gel chromatography (Hexane/EtOAc : 100% to 80:20) to provide pure 26 as a colourless oil (6.18 mg, 70%). <sup class="style-scope patent-text">1</sup>H-NMR (400 MHz, CDCI<sub class="style-scope patent-text">3</sub>) δ 8.40 (s, 1H), 7.76 (d, J = 7.5 Hz, 2H), 7.55 (dd, J = 13.0, 6.7 Hz, 4H), 7.40 (t, J = 7.3 Hz, 4H), 7.33 - 7.27 (m, 3H), 7.21 (s, 1H), 6.67 (s, 1H), 6.49 (s, 1H), 5.87 (d, J = 8.8 Hz, 1H), 5.30 (d, J = 5.7 Hz, 1H), 4.71 - 4.59 (m, 1H), 4.48 (d, J = 6.8 Hz, 2H), 4.20 (t, J = 6.7 Hz, 1H), 4.04 - 3.96 (m, 1H), 3.86 (s, 3H), 3.84 3.77 (m, 1H), 3.25 (m, 1H), 2.79 (d, J = 1.5 Hz, 1H), 2.26 - 2.11 (m, 1H), 1.46 (d, J = 6.9 Hz, 3H), 1.33 (s, 9H), 1.27 (dd, J= 17.1, 9.7 Hz, 3H), 1.11 (dd, J = 7.4, 4.0 Hz, 18H), 0.93 (s, 6H), 0.89 (s, 9H), 0.27 (s, 3H), 0.22 (s, 3H); ES<sup class="style-scope patent-text">+</sup> = 2.55 min, m/z 116.30 [M+H]<sup class="style-scope patent-text">+</sup> (viii) tert-butyl (11S)-2-(4-((S)-2-((S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3methylbutanamido)propanamido)phenyl)-11-((tert-butyldimethylsilyl)oxy)-8-hydroxy-7methoxy-5-oxo-11,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10(5H)-carboxylate (27)</div>
    <div class="description-paragraph style-scope patent-text">Monomer 26 (1 g, 0.89 mmol) was solubilised in wet DMF (5 mL +0.5 mL H<sub class="style-scope patent-text">2</sub>O) before LiOAc (91 mg, 0.89 mmol) was added and the mixture left to stir at room temperature until complete (=3h, followed by LCMS). The mixture was subsequently diluted with EtOAc (50 mL), quenched with citric acid(aq.) (pH=3, 40 mL), then washed with H<sub class="style-scope patent-text">2</sub>O (50 mL) and brine (50 mL). The organic layer was dried over MgSO<sub class="style-scope patent-text">4</sub>, filtered and the volatiles removed in vacuo. The crude product was purified by silica gel chromatography</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">213 (Hexane/EtOAc/MeOH ; 60:40:0 to 60:30:10) and pure product 27 was isolated as a cream solid (675 mg, 78% yield). <sup class="style-scope patent-text">1</sup>H-NMR (400 MHz, CDCI<sub class="style-scope patent-text">3</sub>) δ 8.36 (s, 1H), 7.76 (d, J = 7.6 Hz, 2H), 7.55 (dd, J = 16.0, 7.5 Hz, 4H), 7.40 (t, J = 7.4 Hz, 4H), 7.30 (ddd, J = 14.7, 7.4, 1.1 Hz, 3H), 7.24 (s, 1H), 6.72 (s, 1H), 6.38 (d, J = 5.3 Hz, 1H), 5.87 (s, 1H), 5.23 (d, J = 6.2 Hz, 1H), 4.69 - 4.57 (m, 1H), 4.49 (d, J = 6.6 Hz, 2H), 4.20 (t, J = 5.3 Hz, 1H), 4.04 - 3.96 (m, 1H), 3.96 (s, 3H), 3.87 (dd, J = 10.1, 3.5 Hz, 1H), 3.29 (dd, J = 18.0, 8.5 Hz, 1H), 2.80 (d, J= 19.4 Hz, 1H), 2.24-2.08 (m, 1H), 1.46 (d, J= 10.5 Hz, 3H), 1.33 (s, 9H), 1.000.91 (m, 6H), 0.90 (s, 9H), 0.25 (d, J = 8.6 Hz, 6H).; ES<sup class="style-scope patent-text">+</sup> = 2.08 min, m/z 960.35 [M+H]<sup class="style-scope patent-text">+</sup> (b) (S)-8-((5-iodopentvl)oxv)-7-methoxv-1,2,3,11a-tetrahvdro-5/-/-pvrrolo[2,1c1[1,41benzodiazepine-5,11(10/-/)-dione (33)</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/75/a5/99/5407401bff4074/AU2013366490B9_D0195.png" class="style-scope patent-text"><img file="AU2013366490B9_D0195.tif" img-format="tif" alt="Figure AU2013366490B9_D0195" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/75/a5/99/5407401bff4074/AU2013366490B9_D0195.png"></a></div>
    <div class="description-paragraph style-scope patent-text">(/) (S)-8-(benzyloxy)-7-methoxy-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine 5,11(10H)-dione (30)</div>
    <div class="description-paragraph style-scope patent-text">A suspension of benzyl isatoic anhydride 28 (1.34 g, 4.48 mmol, 1.0 eq.)and L-proline 29 (0.705 g, 6.12 mmol, 1.36 eq.) in anhydrous DMSO (20 mL), in a sealed vial, was heated under microwave irradiation at 150°C with stirring for 12 minutes. The resultant yellow solution was allowed to cool to room temperature and poured onto ice. The precipitated product was collected by filtration, dissolved in DCM (200 mL) and the solution was washed with saturated NaCI solution (200 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>) and evaporated under reduced pressure to give the product 30 as a yellow solid (1.35 g, 85%). Analytical Data: RT 1.39 min; MS (ES<sup class="style-scope patent-text">+</sup>) m/z (relative intensity) 353 ([M + H]<sup class="style-scope patent-text">+</sup> ,100 ).</div>
    <div class="description-paragraph style-scope patent-text">(ii) (S)-8-hydroxy-7-methoxy-1,2,3,11 a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine5,11(10H)-dione (31)</div>
    <div class="description-paragraph style-scope patent-text">A slurry of 10% Palladium on carbon (0.27 g, 20 wt.%) in ethylacetate (10 mL) was added to a suspension of benzyl dilactam 30 (1.35 g, 3.8 mmol) in a mixture of ethanol (60 mL),</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">214 ethylacetate (40 mL) and DMF (5 mL). The mixture was hydrogenated at 45 psi for 2 hours The reaction mixture was filtered through celite and the solvent evaporated under reduced pressure to give a viscous gum. The gum was sonicated with diethyl ether (50 mL) and the resultant product collected by filtration. This gave the desired product 31 as an off-white powder (0.86 g, 85%). Analytical Data: RT 1.02 min; MS (ES<sup class="style-scope patent-text">+</sup>) m/z (relative intensity) 263 ([M + H]<sup class="style-scope patent-text">+</sup>,100 ).</div>
    <div class="description-paragraph style-scope patent-text">(iii) (S)-8-((5-iodopentyl)oxy)-7-methoxy-1,2,3,11 a-tetrahydro-5H-pyrrolo[2,1c][1,4]benzodiazepine-5,11 (10H)-dione (33)</div>
    <div class="description-paragraph style-scope patent-text">To a solution of 31 (400mg, 1.5 mmol) in anhydrous DMF (4 mL), in a flask purged with argon, was added K<sub class="style-scope patent-text">2</sub>CO<sub class="style-scope patent-text">3</sub> (320 mg, 1.5 mmol) and 1,5-diiodopentane 32 (1.1 mL, 7.6 mmol). The reaction mixture was heated to 60°C until complete (30 minutes). The solution was diluted with CH<sub class="style-scope patent-text">2</sub>CI<sub class="style-scope patent-text">2</sub> (50 mL) and washed with H<sub class="style-scope patent-text">2</sub>O (50 mL) and brine (50 mL) before the organics were dried with MgSO<sub class="style-scope patent-text">4</sub>, filtered and the volatiles remove in vacuo. The crude material was purified by silica gel column chromatography (Hexane/EtOAc ; 100% to 3:7) to afford pure product 33 as a light brown foamy gum (611 mg, 87% yield). Analytical Data: RT 1.51 min; MS (ES<sup class="style-scope patent-text">+</sup>) m/z (relative intensity) 458.95 ([M + H]<sup class="style-scope patent-text">+</sup> ,100 ).</div>
    <div class="description-paragraph style-scope patent-text">WO 2014/096365</div>
    <div class="description-paragraph style-scope patent-text">PCT/EP2013/077695</div>
    <div class="description-paragraph style-scope patent-text">215 (c) 1-(3-(2,5-dioxo-2,5-dihvdro-1H-pvrrol-1-vl)propanamido)-N-((S)-1-(((S)-1-((4-((S)-7methoxv-8-((5-(((S)-7-methoxv-5,11-dioxo-2,3,5,10,11,11 a-hexahydro-1/-/-pyrrolol^.lc1f1,41benzodiazepin-8-vl)oxv)pentvl)oxv)-5-oxo-5,11a-dihvdro-1/-/-pyrrolof2,1clf1,41benzodiazepin-2-vl)phenyl)amino)-1-oxopropan-2-vl)amino)-3-methyl-1-oxobutan-25 vl)-3,6,9,12,15,18,21 -heptaoxatetracosan-24-amide (36)</div>
    <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/ef/16/b1/7654b28cc0c2d7/AU2013366490B9_D0196.png" class="style-scope patent-text"><img file="AU2013366490B9_D0196.tif" img-format="tif" alt="Figure AU2013366490B9_D0196" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/ef/16/b1/7654b28cc0c2d7/AU2013366490B9_D0196.png"></a></div>
    <div class="description-paragraph style-scope patent-text">(/) tert-butyl (11S,11aS)-2-(4-((S)-2-((S)-2-amino-3methylbutanamido)propanamido)phenyl)-11-((tert-butyldimethylsilyl)oxy)-7-methoxy-8-( (510 (((S)-7-methoxy-5,1 l-dioxo-2,3,5,10,11,11 a-hexahydro-1 H-pyrrolo[2,1c][1,4]benzodiazepin-8-yl)oxy)pentyl)oxy)-5-oxo-11,11 a-dihydro-1 H-pyrrolo[2,1c][1,4]benzodiazepine-10(5H)-carboxylate (34)</div>
    <div class="description-paragraph style-scope patent-text">To a solution of 33 (250mg, 0.545 mmol) and 27 (570 mg, 0.6mmol) in anhydrous DMF (4 mL), in a flask purged with argon, was added K<sub class="style-scope patent-text">2</sub>CO<sub class="style-scope patent-text">3</sub> (115 mg, 0.545 mmol) and the mixture was heated to 60°C until reaction was complete (45 minutes). The solution was diluted with CH<sub class="style-scope patent-text">2</sub>CI<sub class="style-scope patent-text">2</sub> (50 mL) and washed with H<sub class="style-scope patent-text">2</sub>O (50 mL) and brine (50 mL) before the organics were dried with MgSO<sub class="style-scope patent-text">4</sub>, filtered and the volatiles remove in vacuo. The crude material was purified by silica gel column chromatography (CHCI<sub class="style-scope patent-text">3</sub>/MeOH ; 100% to 95:5) to afford pure</div>
    <div class="description-paragraph style-scope patent-text">216</div>
    <div class="description-paragraph style-scope patent-text">2013366490 24 Nov 2017 product 34 as a white foam (337 mg, 58% yield). Analytical Data: RT 1.42 min; MS (ES<sup class="style-scope patent-text">+</sup>) m/z (relative intensity) 1069.05 ([M + H]<sup class="style-scope patent-text">+</sup> ,80).</div>
    <div class="description-paragraph style-scope patent-text">(ii) ferf-butyl (11S)-11-((ferf-butyldimethylsilyl)oxy)-2-(4-((2S,5S)-37-(2,5-dioxo-2,5-dihydro5 1/-/-pyrrol-1-yl)-5-/'sopropyl-2-methyl-4,7,35-trioxo-10,13,16,19,22,25,28,31-octaoxa-3,6,34triazaheptatriacontanamido)phenyl)-7-methoxy-8-((5-(((S)-7-methoxy-5,11-dioxo2,3,5,10,11,11a-hexahydro-1/7-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl)oxy)pentyl)oxy)-5oxo-11,11 a-dihydro-1 H-benzo[e]pyrrolo[1,2-a][ 1,4]diazepine-10(5/7)-carboxylate (35)</div>
    <div class="description-paragraph style-scope patent-text">To a solution of 34 (337mg, 0.31 mmol) in dry CH<sub class="style-scope patent-text">2</sub>CI<sub class="style-scope patent-text">2</sub> (5 mL) was added the PEG moiety 3 (186 mg, 0.31 mmol) and EDCI.HCI (60 mg, 0.31 mmol). The mixture was stirred at room temperature under an atmosphere of argon until completion. The mixture was subsequently diluted with CH<sub class="style-scope patent-text">2</sub>CI<sub class="style-scope patent-text">2</sub> (50 mL) and washed with H<sub class="style-scope patent-text">2</sub>O (50 mL) and brine (50 mL) before removing the volatiles in vacuo. . The crude material was purified by silica gel column chromatography (CHCI<sub class="style-scope patent-text">3</sub>/MeOH ; 100% to 95:5) to afford pure product 35 as a light 5 yellow foam (408.8 mg, 58% yield). Analytical Data: RT 1.75 min; MS (ES<sup class="style-scope patent-text">+</sup>) m/z (relative intensity) 1643.15 ([M + H]<sup class="style-scope patent-text">+</sup> ,10) 822.25 ([M + 2H]<sup class="style-scope patent-text">2+</sup>, 100).</div>
    <div class="description-paragraph style-scope patent-text">(iii) 1-(3-(2,5-dioxo- 2,5-dihydro-1H-pyrrol-1-yl)propanamido)-N-((S)-1-(((S)-1-((4-((S)-7methoxy-8-((5-(((S)-7-methoxy-5,11-dioxo-2,3,5,10,11,11 a-hexahydro-1 H-pyrrolo[2,13 c][1,4]benzodiazepin-8-yl)oxy)pentyl)oxy)-5-oxo-5,11 a-dihydro-1 H-pyrrolo[2,1c][1,4]benzodiazepin-2-yl)phenyl)amino)-1 -oxopropan-2-yl)amino)-3-methyl-1 -oxobutan-2yl)-3,6,9,12,15,18,21 -heptaoxatetracosan-24-amide (36)</div>
    <div class="description-paragraph style-scope patent-text">To a flask containing 35 (400 mg, 0.24 mmol) cooled to 0°C were subsequently added H<sub class="style-scope patent-text">2</sub>O (160 pL) and TFA (3.5 mL). The mixture was left to stir until complete before quenching with ice cold NaHCO<sub class="style-scope patent-text">3</sub> (50 mL) and extracting with CH<sub class="style-scope patent-text">2</sub>CI<sub class="style-scope patent-text">2</sub> (50 mL + 25 mL). The organics were then washed with brine (25 mL), dried over MgSO<sub class="style-scope patent-text">4</sub>, filtered and the volatiles were removed in vacuo to give crude product 36 without further purification. Analytical Data: RT 1.40 min; MS (ES<sup class="style-scope patent-text">+</sup>) m/z (relative intensity) 1410.60 ([M + H]<sup class="style-scope patent-text">+</sup> ,5) 706.10 ([M + 2H]<sup class="style-scope patent-text">2+</sup>, 100).</div>
    <div class="description-paragraph style-scope patent-text">Throughout this specification and the claims which follow, unless the context requires otherwise, the word “comprise”, and variations such as “comprises” and “comprising”, will be understood to imply the inclusion of a stated integer or step or group of integers or steps but not the exclusion of any other integer or step or group of integers or steps.</div>
    <div class="description-paragraph style-scope patent-text">2013366490 24 Nov 2017</div>
    <div class="description-paragraph style-scope patent-text">216A</div>
    <div class="description-paragraph style-scope patent-text">The reference in this specification to any prior publication (or information derived from it), or to any matter which is known, is not, and should not be taken as an acknowledgment or admission or any form of suggestion that that prior publication (or information derived from it) or known matter forms part of the common general knowledge in the field of endeavour to which this specification relates.</div>
    <div class="description-paragraph style-scope patent-text">217</div>
    <div class="description-paragraph style-scope patent-text">2013366490 24 Nov 2017</div>
  </div>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
            <div class="flex flex-width style-scope patent-result">
              <section id="claims" class="style-scope patent-result">
                <h3 class="style-scope patent-result">
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Claims <span class="style-scope patent-result">(24)</span></div>
                    <div class="collapse style-scope patent-result">
                      Hide Dependent <iron-icon style="height: 15px; width: 15px;" icon="expand-less" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 8l-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </div>
                  </div>
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result"></div>
                    <div class="righthead style-scope patent-result" hidden="">translated from </div>
                  </div>
                </h3>
                <patent-text name="claims" enable-text-selection="" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><ol mxw-id="PCLM235368613" lang="EN" load-source="patent-office" class="claims style-scope patent-text">
    <li class="claim-dependent style-scope patent-text"> <div num="1" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">THE CLAIMS DEFINING THE INVENTION ARE AS FOLLOWS:</div>
      <div class="claim-text style-scope patent-text">1. A compound of formula III:</div>
      <div class="claim-text style-scope patent-text">or a pharmaceutically acceptable salt or solvate thereof, wherein:</div>
      <div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">22</sup> is selected from:</div>
      <div class="claim-text style-scope patent-text">(a) formula IVa:</div>
      <div class="claim-text style-scope patent-text">'Prat</div>
      <div class="claim-text style-scope patent-text">IVa wherein A is a C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">7</sub> aryl group, and either (i) O<sup class="style-scope patent-text">1</sup> is a single bond, and O<sup class="style-scope patent-text">2</sup> is selected from a single bond and -Z-(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n </sub>, where Z is selected from a single bond, O, S and NH and n is from 1 to 3; or (ii) O<sup class="style-scope patent-text">1</sup> is -CH=CH-, and O<sup class="style-scope patent-text">2</sup> is a single bond;</div>
      <div class="claim-text style-scope patent-text">(b) formula IVb:</div>
      <div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">C2</sup> wherein R<sup class="style-scope patent-text">C1</sup>, R<sup class="style-scope patent-text">C2</sup> and R<sup class="style-scope patent-text">C3</sup> are independently selected from H and unsubstituted C-i_<sub class="style-scope patent-text">2</sub> alkyl;</div>
      <div class="claim-text style-scope patent-text">(c) formula IVc:</div>
      <div class="claim-text style-scope patent-text">20 L<sup class="style-scope patent-text">4</sup> is selected from a single bond and a group of:</div>
      <div class="claim-text style-scope patent-text">(a):</div>
      <div class="claim-text style-scope patent-text">218</div>
      <div class="claim-text style-scope patent-text">2013366490 24 Nov 2017 wherein n is 0 to 3; (b) (c) , wherein n is as defined above;</div>
      <div class="claim-text style-scope patent-text">(d) , wherein n is as defined above; and </div>
      <div class="claim-text style-scope patent-text">, wherein n is as defined above, E is O, S or NR, D is N, CH, or CR, and F is N, CH, or CR;</div>
      <div class="claim-text style-scope patent-text">L<sup class="style-scope patent-text">3</sup> is:</div>
      <div class="claim-text style-scope patent-text"> <sup class="style-scope patent-text">X</sup>x A,</div>
      <div class="claim-text style-scope patent-text">N ' Prot H <sup class="style-scope patent-text">0</sup> , where X is such that L<sup class="style-scope patent-text">3</sup> is an amino-acid residue, a dipeptide residue or a tripeptide residue;</div>
      <div class="claim-text style-scope patent-text">Prot is selected from Fmoc (fluorenylmethyloxycarbonyl), Teoc (</div>
    </div>
    </li> <li class="claim style-scope patent-text"> <div num="2" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">2(trimethylsilyl)ethoxycarbonyl) and Boc (t-butoxycarbonyl);</div>
      <div class="claim-text style-scope patent-text">and either:</div>
      <div class="claim-text style-scope patent-text">when there is a double bond present between C2’ and C3’, R<sup class="style-scope patent-text">12</sup> is selected from the group consisting of:</div>
      <div class="claim-text style-scope patent-text">(ia) C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">10</sub> aryl group, optionally substituted by one or more substituents selected from the group comprising: halo, nitro, cyano, ether, carboxy, ester, Cp alkyl, C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">7</sub> heterocyclyl and bis-oxy-C^ alkylene;</div>
      <div class="claim-text style-scope patent-text">(ib) Ci-<sub class="style-scope patent-text">5</sub> saturated aliphatic alkyl;</div>
      <div class="claim-text style-scope patent-text">(ic) C<sub class="style-scope patent-text">3</sub>-<sub class="style-scope patent-text">6</sub> saturated cycloalkyl;</div>
      <div class="claim-text style-scope patent-text">219</div>
      <div class="claim-text style-scope patent-text">2013366490 24 Nov 2017 , wherein each of R<sup class="style-scope patent-text">21</sup>, R<sup class="style-scope patent-text">22</sup> and R<sup class="style-scope patent-text">23</sup> are independently selected from H, C-i_<sub class="style-scope patent-text">3 </sub>saturated alkyl, C<sub class="style-scope patent-text">2</sub>-<sub class="style-scope patent-text">3</sub> alkenyl, C<sub class="style-scope patent-text">2</sub>.<sub class="style-scope patent-text">3</sub> alkynyl and cyclopropyl, where the total number of carbon atoms in the R<sup class="style-scope patent-text">12</sup> group is no more than 5;</div>
      <div class="claim-text style-scope patent-text">,25b</div>
      <div class="claim-text style-scope patent-text">R'</div>
      <div class="claim-text style-scope patent-text">25a wherein one of R<sup class="style-scope patent-text">25a</sup> and R<sup class="style-scope patent-text">25b</sup> is H and the other is selected from:</div>
      <div class="claim-text style-scope patent-text">(ie) phenyl, which phenyl is optionally substituted by a group selected from halo, methyl, methoxy; pyridyl; and thiophenyl; and (if) <sup class="style-scope patent-text">K</sup> , where R<sup class="style-scope patent-text">24</sup> is selected from: H; Ci_<sub class="style-scope patent-text">3</sub> saturated alkyl; C<sub class="style-scope patent-text">2</sub>.<sub class="style-scope patent-text">3</sub> alkenyl; C<sub class="style-scope patent-text">2</sub>.<sub class="style-scope patent-text">3</sub> alkynyl; cyclopropyl; phenyl, which phenyl is optionally substituted by a group selected from halo, methyl, methoxy; pyridyl; and thiophenyl;</div>
      <div class="claim-text style-scope patent-text">when there is a single bond present between C2’ and C3’, ,26 a</div>
      <div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">12</sup> is H or <sup class="style-scope patent-text">R</sup> , where R<sup class="style-scope patent-text">26a</sup> and R<sup class="style-scope patent-text">26b</sup> are independently selected from H, F, C<sub class="style-scope patent-text">M </sub>saturated alkyl, C<sub class="style-scope patent-text">2</sub>.<sub class="style-scope patent-text">3</sub> alkenyl, which alkyl and alkenyl groups are optionally substituted by a group selected from C« alkyl amido and C« alkyl ester; or, when one of R<sup class="style-scope patent-text">26a</sup> and R<sup class="style-scope patent-text">26b</sup> is H, the other is selected from nitrile and a C1-4 alkyl ester;</div>
      <div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">6</sup> and R<sup class="style-scope patent-text">9</sup> are independently selected from H, R, OH, OR, SH, SR, NH<sub class="style-scope patent-text">2</sub>, NHR, NRR’, nitro, Me<sub class="style-scope patent-text">3</sub>Sn and halo;</div>
      <div class="claim-text style-scope patent-text">where R and R’ are independently selected from optionally substituted C-i_i<sub class="style-scope patent-text">2</sub> alkyl, C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">20 </sub>heterocyclyl and C5-20 aryl groups;</div>
      <div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">7</sup> is selected from H, R, OH, OR, SH, SR, NH<sub class="style-scope patent-text">2</sub>, NHR, NHRR’, nitro, Me<sub class="style-scope patent-text">3</sub>Sn and halo;</div>
      <div class="claim-text style-scope patent-text">R is a C<sub class="style-scope patent-text">3</sub>_i<sub class="style-scope patent-text">2</sub> alkylene group, which chain is interrupted by one or more aromatic rings, e.g. benzene or pyridine;</div>
      <div class="claim-text style-scope patent-text">Y and Y’ are selected from O, S, or NH;</div>
      <div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7</sup>, R<sup class="style-scope patent-text">9</sup> are selected from the same groups as R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7</sup> and R<sup class="style-scope patent-text">9</sup> respectively;</div>
      <div class="claim-text style-scope patent-text">either:</div>
      <div class="claim-text style-scope patent-text">(A) R<sup class="style-scope patent-text">20</sup> is H or Me and R<sup class="style-scope patent-text">21a</sup> and R<sup class="style-scope patent-text">21b</sup> are both H or together form =0 and either:</div>
      <div class="claim-text style-scope patent-text">(i) R<sup class="style-scope patent-text">10</sup> is H, R<sup class="style-scope patent-text">11a</sup> is H and R<sup class="style-scope patent-text">11b</sup> is OH or OR<sup class="style-scope patent-text">A</sup>, where R<sup class="style-scope patent-text">A</sup> is C-m alkyl; or (ii) R<sup class="style-scope patent-text">10</sup> and R<sup class="style-scope patent-text">11b</sup> form a nitrogen-carbon double bond between the nitrogen and carbon atoms to which they are bound and R<sup class="style-scope patent-text">11a</sup> is H; or</div>
      <div class="claim-text style-scope patent-text">220</div>
      <div class="claim-text style-scope patent-text">2013366490 24 Nov 2017 (iii) R<sup class="style-scope patent-text">10</sup> is H, R<sup class="style-scope patent-text">11a</sup> is H and R<sup class="style-scope patent-text">11b</sup> is SO<sub class="style-scope patent-text">Z</sub>M, where z is 2 or 3 and M is a monovalent pharmaceutically acceptable cation; or (B) R<sup class="style-scope patent-text">10</sup> is H or Me and R<sup class="style-scope patent-text">11a</sup> and R<sup class="style-scope patent-text">11b</sup> are both H or together form =0 and either:</div>
      <div class="claim-text style-scope patent-text">(i) R<sup class="style-scope patent-text">20</sup> is H, R<sup class="style-scope patent-text">21a</sup> is H and R<sup class="style-scope patent-text">21b</sup> is OH or OR<sup class="style-scope patent-text">A</sup>, where R<sup class="style-scope patent-text">A</sup> is alkyl; or (ii) R<sup class="style-scope patent-text">20</sup> and R<sup class="style-scope patent-text">21b</sup> form a nitrogen-carbon double bond between the nitrogen and carbon atoms to which they are bound and R<sup class="style-scope patent-text">11a</sup> is H; or (iii) R<sup class="style-scope patent-text">20</sup> is H, R<sup class="style-scope patent-text">21a</sup> is H and R<sup class="style-scope patent-text">21b</sup> is SO<sub class="style-scope patent-text">Z</sub>M, where z is 2 or 3 and M is a monovalent pharmaceutically acceptable cation.</div>
    </div>
    </li> <li class="claim-dependent style-scope patent-text"> <div num="3" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">3 2. A compound according to any claim 1, wherein R<sup class="style-scope patent-text">7</sup> is a Ci_</div>
    </div>
    </li> <li class="claim-dependent style-scope patent-text"> <div num="4" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">4 alkyloxy group.</div>
      <div class="claim-text style-scope patent-text">3. A compound according to either claim 1 or claim 2, wherein Y is O and R” is C<sub class="style-scope patent-text">3</sub>.<sub class="style-scope patent-text">7 </sub>alkylene.</div>
    </div>
    </li> <li class="claim-dependent style-scope patent-text"> <div num="5" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">5 4. A compound according to any one of claims 1 to 3, wherein R<sup class="style-scope patent-text">6</sup> and R<sup class="style-scope patent-text">9</sup> are H.</div>
      <div class="claim-text style-scope patent-text">5. A compound according to any one of claims 1 to 4, wherein there is a double bond between C2’ and C3’, and R<sup class="style-scope patent-text">12</sup> is:</div>
      <div class="claim-text style-scope patent-text">(a) a C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">7</sub> aryl group, which may bear one to three substituent groups selected from</div>
      <div class="claim-text style-scope patent-text">3 methoxy, ethoxy, fluoro, chloro, cyano, bis-oxy-methylene, methyl-piperazinyl, morpholino and methyl-thiophenyl; or (b) methyl, ethyl or propyl; or (c) cyclopropyl; or (d) a group of formula:</div>
      <div class="claim-text style-scope patent-text">R' ,22</div>
      <div class="claim-text style-scope patent-text">R' ,23 , wherein the total number of carbon atoms in the R<sup class="style-scope patent-text">12</sup> group is no more than 4;</div>
      <div class="claim-text style-scope patent-text">or (e) the group:</div>
      <div class="claim-text style-scope patent-text">; or (f) a group of formula:</div>
      <div class="claim-text style-scope patent-text"> <sup class="style-scope patent-text">R</sup> , wherein R<sup class="style-scope patent-text">24</sup> is selected from H and methyl.</div>
      <div class="claim-text style-scope patent-text">221</div>
      <div class="claim-text style-scope patent-text">2013366490 24 Nov 2017</div>
    </div>
    </li> <li class="claim-dependent style-scope patent-text"> <div num="6" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">6.</div>
      <div class="claim-text style-scope patent-text">A compound according to any one of claims 1 to 4, wherein there is a single bond</div>
      <div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">26a</sup> between C2’ and C3’, R<sup class="style-scope patent-text">12</sup> is <sup class="style-scope patent-text">R</sup> and:</div>
      <div class="claim-text style-scope patent-text">(a) R<sup class="style-scope patent-text">26a</sup> and R<sup class="style-scope patent-text">26b</sup> are both H; or (b) R<sup class="style-scope patent-text">26a</sup> and R<sup class="style-scope patent-text">26b</sup> are both methyl; or (c) one of R<sup class="style-scope patent-text">26a</sup> and R<sup class="style-scope patent-text">26b</sup> is H, and the other is selected from C-m saturated alkyl, C<sub class="style-scope patent-text">2</sub>-3 alkenyl, which alkyl and alkenyl groups are optionally substituted.</div>
    </div>
    </li> <li class="claim-dependent style-scope patent-text"> <div num="7" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">7. A compound according to any one of claims 1 to 6, wherein R<sup class="style-scope patent-text">2</sup> is of formula Ila, and 3 A is phenyl, Q<sup class="style-scope patent-text">1</sup> is a single bond, and Q<sup class="style-scope patent-text">2</sup> is a single bond.</div>
    </div>
    </li> <li class="claim-dependent style-scope patent-text"> <div num="8" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">8. A compound according to any one of claims 1 to 6, wherein R<sup class="style-scope patent-text">2</sup> is of formula lib, and R<sup class="style-scope patent-text">C1</sup>, R<sup class="style-scope patent-text">C2</sup> and R<sup class="style-scope patent-text">C3</sup> are all H.</div>
      <div class="claim-text style-scope patent-text">5</div>
    </div>
    </li> <li class="claim-dependent style-scope patent-text"> <div num="9" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">9. A compound according to either claim 7 or claim 8, wherein X is NH<sub class="style-scope patent-text">2</sub>.</div>
    </div>
    </li> <li class="claim-dependent style-scope patent-text"> <div num="10" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">10. A compound according to any one of claims 1 to 6, wherein R<sup class="style-scope patent-text">2</sup> is of formula lie, and Q is NR<sup class="style-scope patent-text">n</sup>, wherein R<sup class="style-scope patent-text">N</sup> is H or methyl.</div>
      <div class="claim-text style-scope patent-text">3</div>
    </div>
    </li> <li class="claim-dependent style-scope patent-text"> <div num="11" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">11. A compound according to any one of claims 1 to 10, wherein R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7</sup>, R<sup class="style-scope patent-text">9</sup> and Y’ are the same as R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7</sup>, R<sup class="style-scope patent-text">9</sup>, and Y respectively.</div>
    </div>
    </li> <li class="claim-dependent style-scope patent-text"> <div num="12" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">12. A compound according to any one of claims 1 to 11, wherein R<sup class="style-scope patent-text">20</sup> is H or Me and R<sup class="style-scope patent-text">21a</sup> and R<sup class="style-scope patent-text">21b</sup> are both H.</div>
    </div>
    </li> <li class="claim-dependent style-scope patent-text"> <div num="13" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">13. A compound according to any one of claims 1 to 12, wherein R<sup class="style-scope patent-text">20</sup> is H or Me and R<sup class="style-scope patent-text">21a</sup> and R<sup class="style-scope patent-text">21b</sup> together form =0.</div>
    </div>
    </li> <li class="claim-dependent style-scope patent-text"> <div num="14" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">14. A compound according to either claim 12 or claim 13, wherein R<sup class="style-scope patent-text">10</sup> and R<sup class="style-scope patent-text">11b</sup> form a 30 nitrogen-carbon double bond between the nitrogen and carbon atoms to which they are bound and R<sup class="style-scope patent-text">11a</sup> is H.</div>
    </div>
    </li> <li class="claim-dependent style-scope patent-text"> <div num="15" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">15. A compound according to any one of claims 1 to 11, wherein R<sup class="style-scope patent-text">10</sup> is H or Me and R<sup class="style-scope patent-text">11a</sup> and R<sup class="style-scope patent-text">11b</sup> are both H.</div>
      <div class="claim-text style-scope patent-text">222</div>
      <div class="claim-text style-scope patent-text">2013366490 24 Nov 2017</div>
    </div>
    </li> <li class="claim-dependent style-scope patent-text"> <div num="16" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">16. A compound according to any one of claims 1 to 11, wherein R<sup class="style-scope patent-text">10</sup> is H or Me and R<sup class="style-scope patent-text">11a</sup> and R<sup class="style-scope patent-text">11b</sup> together form =0.</div>
      <div class="claim-text style-scope patent-text">5</div>
    </div>
    </li> <li class="claim-dependent style-scope patent-text"> <div num="17" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">17. A compound according to either claim 15 or claim 16, wherein R<sup class="style-scope patent-text">20</sup> and R<sup class="style-scope patent-text">21b</sup> form a nitrogen-carbon double bond between the nitrogen and carbon atoms to which they are bound and R<sup class="style-scope patent-text">11a</sup> is H.</div>
    </div>
    </li> <li class="claim-dependent style-scope patent-text"> <div num="18" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">18. The use of a compound according to any one of claims 1 to 17 in the manufacture 3 of a medicament for treating a proliferative disease.</div>
    </div>
    </li> <li class="claim-dependent style-scope patent-text"> <div num="19" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">19. A method of treating a mammal having a proliferative disease, comprising administering an effective amount of a compound according to any one of claims 1 to 17.</div>
      <div class="claim-text style-scope patent-text">5</div>
    </div>
    </li> <li class="claim-dependent style-scope patent-text"> <div num="20" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">20. A conjugate comprising a compound of formula I according to any one of claims 1 to 17, or a pharmaceutically acceptable salt or solvate thereof, linked to a targeting agent.</div>
    </div>
    </li> <li class="claim-dependent style-scope patent-text"> <div num="21" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">21. A Conjugate having formula V:</div>
      <div class="claim-text style-scope patent-text">L-(LU-D)<sub class="style-scope patent-text">P</sub> (V) wherein L is an antibody or antibody fragment, p is 1 to 20; and</div>
      <div class="claim-text style-scope patent-text">D is a Drug unit which is a PBD dimer according to formula I:</div>
      <div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">12</sup>, R<sup class="style-scope patent-text">20</sup>, wherein R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">6</sup>, R<sup class="style-scope patent-text">7</sup>, R<sup class="style-scope patent-text">7</sup>, R<sup class="style-scope patent-text">9</sup>, R<sup class="style-scope patent-text">9</sup>, R<sup class="style-scope patent-text">10</sup>, R<sup class="style-scope patent-text">11a</sup>, R<sup class="style-scope patent-text">11b</sup>, defined in any one of claims 1 to 17; and R<sup class="style-scope patent-text">2</sup> is of formula Ila, formula lib or formula lie:</div>
      <div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">21a</sup>, R<sup class="style-scope patent-text">21b</sup>, Y, Y’ and R” are as (a/a’-'V* Ila where A is a C<sub class="style-scope patent-text">5</sub>.<sub class="style-scope patent-text">7</sub> aryl group, and either (i) Q<sup class="style-scope patent-text">1</sup> is a single bond, and Q<sup class="style-scope patent-text">2</sup> is selected from a single bond and -Z-(CH<sub class="style-scope patent-text">2</sub>)<sub class="style-scope patent-text">n</sub>-, where Z is selected from a single bond, O, S and NH and n is from 1 to 3; or</div>
      <div class="claim-text style-scope patent-text">223</div>
      <div class="claim-text style-scope patent-text">2013366490 24 Nov 2017 (ii) Q<sup class="style-scope patent-text">1</sup> is -CH=CH-, and Q<sup class="style-scope patent-text">2</sup> is a single bond;</div>
      <div class="claim-text style-scope patent-text">where;</div>
      <div class="claim-text style-scope patent-text">R<sup class="style-scope patent-text">C1</sup>, R<sup class="style-scope patent-text">C2</sup> and R<sup class="style-scope patent-text">C3</sup> are independently selected from H and unsubstituted C-i_<sub class="style-scope patent-text">2</sub> alkyl;</div>
      <div class="claim-text style-scope patent-text">(c) where Q is selected from OH, SH and NR<sup class="style-scope patent-text">n</sup>, and R<sup class="style-scope patent-text">N</sup> is selected from H, methyl and ethyl X is selected from the group comprising: OH, SH, CO<sub class="style-scope patent-text">2</sub>H, COH, N=C=O, NHNH<sub class="style-scope patent-text">2</sub>,</div>
      <div class="claim-text style-scope patent-text">NH</div>
      <div class="claim-text style-scope patent-text">CONHNH<sub class="style-scope patent-text">2</sub>, , NHR<sup class="style-scope patent-text">n</sup>, wherein R<sup class="style-scope patent-text">N</sup> is selected from the group comprising H and C<sub class="style-scope patent-text">14</sub> alkyl;</div>
      <div class="claim-text style-scope patent-text">wherein LU is connected to D via the X substituent of R<sup class="style-scope patent-text">2</sup>, wherein LU has the formula (Va):</div>
      <div class="claim-text style-scope patent-text">-A<sup class="style-scope patent-text">1</sup>a-L<sup class="style-scope patent-text">1</sup>s-L<sup class="style-scope patent-text">2</sup>y-, (Va) wherein:</div>
      <div class="claim-text style-scope patent-text">a is 1 or 2,</div>
      <div class="claim-text style-scope patent-text">5 s is an integer ranging from 0 to 12, y is 0, 1 or 2, and p is from 1- 20;</div>
      <div class="claim-text style-scope patent-text">L<sup class="style-scope patent-text">1</sup> comprises an amino acid sequence;</div>
      <div class="claim-text style-scope patent-text">L<sup class="style-scope patent-text">2</sup> is selected from the groups</div>
      <div class="claim-text style-scope patent-text">O</div>
      <div class="claim-text style-scope patent-text">224</div>
      <div class="claim-text style-scope patent-text">Γο</div>
      <div class="claim-text style-scope patent-text">CM &gt;</div>
      <div class="claim-text style-scope patent-text">Ο</div>
      <div class="claim-text style-scope patent-text">Ζ</div>
      <div class="claim-text style-scope patent-text">CM</div>
      <div class="claim-text style-scope patent-text">Ο</div>
      <div class="claim-text style-scope patent-text">Ok kO kO</div>
      <div class="claim-text style-scope patent-text">CO</div>
      <div class="claim-text style-scope patent-text">CO o</div>
      <div class="claim-text style-scope patent-text">CM wherein the asterisk indicates the point of attachment to the Drug unit, and the wavy line indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>,</div>
      <div class="claim-text style-scope patent-text">Y is -N(H)-, -0-, -C(=0)N(H)- or-0(=0)0-, n is 0 to 3</div>
      <div class="claim-text style-scope patent-text">EisO, SorNH,</div>
      <div class="claim-text style-scope patent-text">D is N orCH,</div>
      <div class="claim-text style-scope patent-text">F is N orCH;</div>
      <div class="claim-text style-scope patent-text">-A<sup class="style-scope patent-text">1</sup>- is selected from where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, the wavy line indicates the point of attachment to L, and n is 0 to 6;</div>
      <div class="claim-text style-scope patent-text">225</div>
      <div class="claim-text style-scope patent-text">2013366490 24 Nov 2017 where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, the wavy line indicates the point of attachment to L, and n is 0 to 6;</div>
      <div class="claim-text style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, the wavy line indicates the point of attachment to L, n is 0 or 1, and m is 0 to 30; or where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, the wavy line indicates the point of attachment to L, n is 0 or 1, and m is 0 to 30.</div>
    </div>
    </li> <li class="claim-dependent style-scope patent-text"> <div num="22" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">22. The use of a Conjugate according to claim 20 or 21, in the manufacture of a medicament for treating a proliferative disease or an autoimmune disease.</div>
    </div>
    </li> <li class="claim-dependent style-scope patent-text"> <div num="23" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">23. A method of treating a mammal having a proliferative disease or an autoimmune disease, comprising administering an effective amount of the Conjugate of claim 20 or claim 21.</div>
    </div>
    </li> <li class="claim-dependent style-scope patent-text"> <div num="24" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text">24. A drug linker of formula VI:</div>
      <div class="claim-text style-scope patent-text">LU-D (VI) or a pharmaceutically acceptable salt or solvate thereof, wherein D is a Drug unit which is a PBD dimer according to formula I as defined in claim 21, but where X is selected from *-Oq, *_<sub class="style-scope patent-text">s</sub>_q, *.<sub class="style-scope patent-text">C</sub>o<sub class="style-scope patent-text">2</sub>.q<sub class="style-scope patent-text">i</sub> *-CO-<sup class="style-scope patent-text">q</sup>, *-NH(C=O)-<sup class="style-scope patent-text">q</sup>, *-NHNH-<sup class="style-scope patent-text">q</sup>, *-CONHNH-<sup class="style-scope patent-text">q</sup>,</div>
      <div class="claim-text style-scope patent-text">226</div>
      <div class="claim-text style-scope patent-text">2013366490 24 Nov 2017</div>
      <div class="claim-text style-scope patent-text">-Ν</div>
      <div class="claim-text style-scope patent-text">N-£- *—N(R<sup class="style-scope patent-text">n</sup>)\-/ , <sup class="style-scope patent-text">p</sup> , wherein R<sup class="style-scope patent-text">N</sup> is selected from the group comprising H and</div>
      <div class="claim-text style-scope patent-text">C1-4 alkyl, and the asterix indicates the point of attachment to the remainder of the Drug unit and the wavy line or<sup class="style-scope patent-text">q</sup> indicates the point of attachment to LU;</div>
      <div class="claim-text style-scope patent-text">wherein LU is selected from:</div>
      <div class="claim-text style-scope patent-text">G<sup class="style-scope patent-text">1</sup>-L<sup class="style-scope patent-text">1</sup>-L<sup class="style-scope patent-text">2</sup>- and wherein L<sup class="style-scope patent-text">1</sup> and L<sup class="style-scope patent-text">2</sup> are as defined in claim 21;</div>
      <div class="claim-text style-scope patent-text">and -G<sup class="style-scope patent-text">1</sup>- is selected from</div>
      <div class="claim-text style-scope patent-text">O</div>
      <div class="claim-text style-scope patent-text">N L Jn</div>
      <div class="claim-text style-scope patent-text">7) where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup> and n is 0 to 6; O 'N'</div>
      <div class="claim-text style-scope patent-text">O</div>
      <div class="claim-text style-scope patent-text">O where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup> and n is 0 to 6;</div>
      <div class="claim-text style-scope patent-text">where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, n is 0 or 1, and m is 0 to</div>
      <div class="claim-text style-scope patent-text">30; or</div>
      <div class="claim-text style-scope patent-text">O</div>
      <div class="claim-text style-scope patent-text">227</div>
      <div class="claim-text style-scope patent-text">2013366490 24 Nov 2017 where the asterisk indicates the point of attachment to L<sup class="style-scope patent-text">1</sup>, n is 0 or 1, and m is 0 to 30</div>
    </div>
  </li> </ol>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
          </div>

          <div class="footer style-scope patent-result">

            
            <h3 id="patentCitations" class="scroll-target style-scope patent-result">
              Patent Citations (329)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2010043880A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2010043880A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-10-17</span>
                    <span class="td style-scope patent-result">2010-04-22</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2012112708A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2012112708A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-02-15</span>
                    <span class="td style-scope patent-result">2012-08-23</span>
                    <span class="td style-scope patent-result">Immunogen, Inc.</span>
                    <span class="td style-scope patent-result">Cytotoxic benzodiazepine derivatives and methods of preparation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2013041606A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2013041606A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-09-20</span>
                    <span class="td style-scope patent-result">2013-03-28</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines as unsymmetrical dimeric pbd compounds for inclusion in targeted conjugates 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPS58180487U/en"><a id="link" href="#" class="style-scope state-modifier">JPS58180487U</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1982-05-28</span>
                    <span class="td style-scope patent-result">1983-12-02</span>
                    <span class="td style-scope patent-result">松下電工株式会社</span>
                    <span class="td style-scope patent-result">
  Light beam alarm assembly
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4816567A/en"><a id="link" href="#" class="style-scope state-modifier">US4816567A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1983-04-08</span>
                    <span class="td style-scope patent-result">1989-03-28</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Recombinant immunoglobin preparations 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5583024A/en"><a id="link" href="#" class="style-scope state-modifier">US5583024A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1985-12-02</span>
                    <span class="td style-scope patent-result">1996-12-10</span>
                    <span class="td style-scope patent-result">The Regents Of The University Of California</span>
                    <span class="td style-scope patent-result">Recombinant expression of Coleoptera luciferase 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH053790Y2/en"><a id="link" href="#" class="style-scope state-modifier">JPH053790Y2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1988-08-03</span>
                    <span class="td style-scope patent-result">1993-01-29</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1991002536A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1991002536A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1989-08-23</span>
                    <span class="td style-scope patent-result">1991-03-07</span>
                    <span class="td style-scope patent-result">Scripps Clinic And Research Foundation</span>
                    <span class="td style-scope patent-result">Compositions and methods for detection and treatment of epstein-barr virus infection and immune disorders 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5256643A/en"><a id="link" href="#" class="style-scope state-modifier">US5256643A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-05-29</span>
                    <span class="td style-scope patent-result">1993-10-26</span>
                    <span class="td style-scope patent-result">The Government Of The United States</span>
                    <span class="td style-scope patent-result">Human cripto protein 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1992007574A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1992007574A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-10-25</span>
                    <span class="td style-scope patent-result">1992-05-14</span>
                    <span class="td style-scope patent-result">Tanox Biosystems, Inc.</span>
                    <span class="td style-scope patent-result">Glycoproteins associated with membrane-bound immunoglobulins as antibody targets on b cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1992017497A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1992017497A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-03-29</span>
                    <span class="td style-scope patent-result">1992-10-15</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Human pf4a receptors and their use 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5440021A/en"><a id="link" href="#" class="style-scope state-modifier">US5440021A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-03-29</span>
                    <span class="td style-scope patent-result">1995-08-08</span>
                    <span class="td style-scope patent-result">Chuntharapai; Anan</span>
                    <span class="td style-scope patent-result">Antibodies to human IL-8 type B receptor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5543503A/en"><a id="link" href="#" class="style-scope state-modifier">US5543503A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-03-29</span>
                    <span class="td style-scope patent-result">1996-08-06</span>
                    <span class="td style-scope patent-result">Genentech Inc.</span>
                    <span class="td style-scope patent-result">Antibodies to human IL-8 type A receptor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP3050424B2/en"><a id="link" href="#" class="style-scope state-modifier">JP3050424B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-07-12</span>
                    <span class="td style-scope patent-result">2000-06-12</span>
                    <span class="td style-scope patent-result">塩野義製薬株式会社</span>
                    <span class="td style-scope patent-result">
  Human endothelin receptor
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5264557A/en"><a id="link" href="#" class="style-scope state-modifier">US5264557A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-08-23</span>
                    <span class="td style-scope patent-result">1993-11-23</span>
                    <span class="td style-scope patent-result">The United States Of America As Represented By The Department Of Health And Human Services</span>
                    <span class="td style-scope patent-result">Polypeptide of a human cripto-related gene, CR-3 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5362852A/en"><a id="link" href="#" class="style-scope state-modifier">US5362852A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-09-27</span>
                    <span class="td style-scope patent-result">1994-11-08</span>
                    <span class="td style-scope patent-result">Pfizer Inc.</span>
                    <span class="td style-scope patent-result">Modified peptide derivatives conjugated at 2-hydroxyethylamine moieties 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5976551A/en"><a id="link" href="#" class="style-scope state-modifier">US5976551A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-11-15</span>
                    <span class="td style-scope patent-result">1999-11-02</span>
                    <span class="td style-scope patent-result">Institut Pasteur And Institut Nationale De La Sante Et De La Recherche Medicale</span>
                    <span class="td style-scope patent-result">Altered major histocompatibility complex (MHC) determinant and method of using the determinant 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6153408A/en"><a id="link" href="#" class="style-scope state-modifier">US6153408A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-11-15</span>
                    <span class="td style-scope patent-result">2000-11-28</span>
                    <span class="td style-scope patent-result">Institut Pasteur And Institut National De La Sante Et De La Recherche Medicale</span>
                    <span class="td style-scope patent-result">Altered major histocompatibility complex (MHC) determinant and methods of using the determinant 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/IL107366A/en"><a id="link" href="#" class="style-scope state-modifier">IL107366A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-10-23</span>
                    <span class="td style-scope patent-result">2003-03-12</span>
                    <span class="td style-scope patent-result">Chugai Pharmaceutical Co Ltd</span>
                    <span class="td style-scope patent-result">Genes coding for megakaryocyte potentiator 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5644033A/en"><a id="link" href="#" class="style-scope state-modifier">US5644033A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-12-22</span>
                    <span class="td style-scope patent-result">1997-07-01</span>
                    <span class="td style-scope patent-result">Health Research, Inc.</span>
                    <span class="td style-scope patent-result">Monoclonal antibodies that define a unique antigen of human B cell antigen receptor complex and methods of using same for diagnosis and treatment 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5801005A/en"><a id="link" href="#" class="style-scope state-modifier">US5801005A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-03-17</span>
                    <span class="td style-scope patent-result">1998-09-01</span>
                    <span class="td style-scope patent-result">University Of Washington</span>
                    <span class="td style-scope patent-result">Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5869445A/en"><a id="link" href="#" class="style-scope state-modifier">US5869445A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-03-17</span>
                    <span class="td style-scope patent-result">1999-02-09</span>
                    <span class="td style-scope patent-result">University Of Washington</span>
                    <span class="td style-scope patent-result">Methods for eliciting or enhancing reactivity to HER-2/neu protein 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6214345B1/en"><a id="link" href="#" class="style-scope state-modifier">US6214345B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-05-14</span>
                    <span class="td style-scope patent-result">2001-04-10</span>
                    <span class="td style-scope patent-result">Bristol-Myers Squibb Co.</span>
                    <span class="td style-scope patent-result">Lysosomal enzyme-cleavable antitumor drug conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5773223A/en"><a id="link" href="#" class="style-scope state-modifier">US5773223A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-09-02</span>
                    <span class="td style-scope patent-result">1998-06-30</span>
                    <span class="td style-scope patent-result">Chiron Corporation</span>
                    <span class="td style-scope patent-result">Endothelin B1, (ETB1) receptor polypeptide and its encoding nucleic acid methods, and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0647450A1/en"><a id="link" href="#" class="style-scope state-modifier">EP0647450A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-09-09</span>
                    <span class="td style-scope patent-result">1995-04-12</span>
                    <span class="td style-scope patent-result">BEHRINGWERKE Aktiengesellschaft</span>
                    <span class="td style-scope patent-result">Improved prodrugs for enzyme mediated activation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5750370A/en"><a id="link" href="#" class="style-scope state-modifier">US5750370A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-06-06</span>
                    <span class="td style-scope patent-result">1998-05-12</span>
                    <span class="td style-scope patent-result">Human Genome Sciences, Inc.</span>
                    <span class="td style-scope patent-result">Nucleic acid encoding human endothlein-bombesin receptor and method of producing the receptor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH08336393A/en"><a id="link" href="#" class="style-scope state-modifier">JPH08336393A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-04-13</span>
                    <span class="td style-scope patent-result">1996-12-24</span>
                    <span class="td style-scope patent-result">Mitsubishi Chem Corp</span>
                    <span class="td style-scope patent-result">Production of optically active gamma-substituted-beta-hydroxybutyric ester 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5707829A/en"><a id="link" href="#" class="style-scope state-modifier">US5707829A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-08-11</span>
                    <span class="td style-scope patent-result">1998-01-13</span>
                    <span class="td style-scope patent-result">Genetics Institute, Inc.</span>
                    <span class="td style-scope patent-result">DNA sequences and secreted proteins encoded thereby 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20020193567A1/en"><a id="link" href="#" class="style-scope state-modifier">US20020193567A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-08-11</span>
                    <span class="td style-scope patent-result">2002-12-19</span>
                    <span class="td style-scope patent-result">Genetics Institute, Inc.</span>
                    <span class="td style-scope patent-result">Secreted proteins and polynucleotides encoding them 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP3646191B2/en"><a id="link" href="#" class="style-scope state-modifier">JP3646191B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-03-19</span>
                    <span class="td style-scope patent-result">2005-05-11</span>
                    <span class="td style-scope patent-result">大塚製薬株式会社</span>
                    <span class="td style-scope patent-result">
  Human gene
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6218519B1/en"><a id="link" href="#" class="style-scope state-modifier">US6218519B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-04-12</span>
                    <span class="td style-scope patent-result">2001-04-17</span>
                    <span class="td style-scope patent-result">Pro-Neuron, Inc.</span>
                    <span class="td style-scope patent-result">Compounds and methods for the selective treatment of cancer and bacterial infections 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1997044452A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1997044452A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-05-17</span>
                    <span class="td style-scope patent-result">1997-11-27</span>
                    <span class="td style-scope patent-result">Schering Corporation</span>
                    <span class="td style-scope patent-result">Human b-cell antigens, related reagents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2264227A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2264227A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-09-27</span>
                    <span class="td style-scope patent-result">1998-04-02</span>
                    <span class="td style-scope patent-result">Raymond A. Firestone</span>
                    <span class="td style-scope patent-result">Hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6759509B1/en"><a id="link" href="#" class="style-scope state-modifier">US6759509B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-11-05</span>
                    <span class="td style-scope patent-result">2004-07-06</span>
                    <span class="td style-scope patent-result">Bristol-Myers Squibb Company</span>
                    <span class="td style-scope patent-result">Branched peptide linkers 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5945511A/en"><a id="link" href="#" class="style-scope state-modifier">US5945511A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-02-20</span>
                    <span class="td style-scope patent-result">1999-08-31</span>
                    <span class="td style-scope patent-result">Zymogenetics, Inc.</span>
                    <span class="td style-scope patent-result">Class II cytokine receptor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7033827B2/en"><a id="link" href="#" class="style-scope state-modifier">US7033827B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-02-25</span>
                    <span class="td style-scope patent-result">2006-04-25</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Prostate-specific polynucleotide compositions 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030185830A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030185830A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-02-25</span>
                    <span class="td style-scope patent-result">2003-10-02</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of prostate cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2281877C/en"><a id="link" href="#" class="style-scope state-modifier">CA2281877C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-03-10</span>
                    <span class="td style-scope patent-result">2010-01-05</span>
                    <span class="td style-scope patent-result">The Regents Of The University Of California</span>
                    <span class="td style-scope patent-result">Psca: prostate stem cell antigen 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6261791B1/en"><a id="link" href="#" class="style-scope state-modifier">US6261791B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-03-10</span>
                    <span class="td style-scope patent-result">2001-07-17</span>
                    <span class="td style-scope patent-result">The Regents Of The University Of California</span>
                    <span class="td style-scope patent-result">Method for diagnosing cancer using specific PSCA antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6541212B2/en"><a id="link" href="#" class="style-scope state-modifier">US6541212B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-03-10</span>
                    <span class="td style-scope patent-result">2003-04-01</span>
                    <span class="td style-scope patent-result">The Regents Of The University Of California</span>
                    <span class="td style-scope patent-result">Methods for detecting prostate stem cell antigen protein 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6555339B1/en"><a id="link" href="#" class="style-scope state-modifier">US6555339B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-04-14</span>
                    <span class="td style-scope patent-result">2003-04-29</span>
                    <span class="td style-scope patent-result">Arena Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Non-endogenous, constitutively activated human protein-coupled receptors 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6319688B1/en"><a id="link" href="#" class="style-scope state-modifier">US6319688B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-04-28</span>
                    <span class="td style-scope patent-result">2001-11-20</span>
                    <span class="td style-scope patent-result">Smithkline Beecham Corporation</span>
                    <span class="td style-scope patent-result">Polynucleotide encoding human sodium dependent phosphate transporter (IPT-1) 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6890749B2/en"><a id="link" href="#" class="style-scope state-modifier">US6890749B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-05-15</span>
                    <span class="td style-scope patent-result">2005-05-10</span>
                    <span class="td style-scope patent-result">Abbott Laboratories</span>
                    <span class="td style-scope patent-result">Reagents and methods useful for detecting diseases of the prostate 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1998051824A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1998051824A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-05-15</span>
                    <span class="td style-scope patent-result">1998-11-19</span>
                    <span class="td style-scope patent-result">Abbott Laboratories</span>
                    <span class="td style-scope patent-result">Reagents and methods useful for detecting disease of the urinary tract 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6602677B1/en"><a id="link" href="#" class="style-scope state-modifier">US6602677B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-09-19</span>
                    <span class="td style-scope patent-result">2003-08-05</span>
                    <span class="td style-scope patent-result">Promega Corporation</span>
                    <span class="td style-scope patent-result">Thermostable luciferases and methods of production 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030060612A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030060612A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-10-28</span>
                    <span class="td style-scope patent-result">2003-03-27</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Compositions and methods for the diagnosis and treatment of tumor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20020034749A1/en"><a id="link" href="#" class="style-scope state-modifier">US20020034749A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-11-18</span>
                    <span class="td style-scope patent-result">2002-03-21</span>
                    <span class="td style-scope patent-result">Billing-Medel Patricia A.</span>
                    <span class="td style-scope patent-result">Reagents and methods useful for detecting diseases of the breast 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6110695A/en"><a id="link" href="#" class="style-scope state-modifier">US6110695A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-12-02</span>
                    <span class="td style-scope patent-result">2000-08-29</span>
                    <span class="td style-scope patent-result">The Regents Of The University Of California</span>
                    <span class="td style-scope patent-result">Modulating the interaction of the chemokine, B Lymphocyte Hemoattractant, and its Receptor, BLR1 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU762991B2/en"><a id="link" href="#" class="style-scope state-modifier">AU762991B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-03-13</span>
                    <span class="td style-scope patent-result">2003-07-10</span>
                    <span class="td style-scope patent-result">Burnham Institute, The</span>
                    <span class="td style-scope patent-result">Molecules that home to various selected organs or tissues 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2685270C/en"><a id="link" href="#" class="style-scope state-modifier">CA2685270C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-05-13</span>
                    <span class="td style-scope patent-result">2014-07-29</span>
                    <span class="td style-scope patent-result">Pharmexa Inc.</span>
                    <span class="td style-scope patent-result">Expression vectors for stimulating an immune response and methods of using the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030064397A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030064397A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-05-22</span>
                    <span class="td style-scope patent-result">2003-04-03</span>
                    <span class="td style-scope patent-result">Incyte Genomics, Inc.</span>
                    <span class="td style-scope patent-result">Transmembrane protein differentially expressed in prostate and lung tumors 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1080732A4/en"><a id="link" href="#" class="style-scope state-modifier">EP1080732A4</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-05-22</span>
                    <span class="td style-scope patent-result">2004-08-25</span>
                    <span class="td style-scope patent-result">Daiichi Seiyaku Co</span>
                    <span class="td style-scope patent-result">Drug composites 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20020187472A1/en"><a id="link" href="#" class="style-scope state-modifier">US20020187472A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-03-09</span>
                    <span class="td style-scope patent-result">2002-12-12</span>
                    <span class="td style-scope patent-result">Preeti Lal</span>
                    <span class="td style-scope patent-result">Steap-related protein 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2000012130A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2000012130A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-08-27</span>
                    <span class="td style-scope patent-result">2000-03-09</span>
                    <span class="td style-scope patent-result">Smithkline Beecham Corporation</span>
                    <span class="td style-scope patent-result">Rp105 agonists and antagonists 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB9818730D0/en"><a id="link" href="#" class="style-scope state-modifier">GB9818730D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-08-27</span>
                    <span class="td style-scope patent-result">1998-10-21</span>
                    <span class="td style-scope patent-result">Univ Portsmouth</span>
                    <span class="td style-scope patent-result">Collections of compounds 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1193270B1/en"><a id="link" href="#" class="style-scope state-modifier">EP1193270B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-08-27</span>
                    <span class="td style-scope patent-result">2003-05-14</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB9818732D0/en"><a id="link" href="#" class="style-scope state-modifier">GB9818732D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-08-27</span>
                    <span class="td style-scope patent-result">1998-10-21</span>
                    <span class="td style-scope patent-result">Univ Portsmouth</span>
                    <span class="td style-scope patent-result">Collection of compounds 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB9818731D0/en"><a id="link" href="#" class="style-scope state-modifier">GB9818731D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-08-27</span>
                    <span class="td style-scope patent-result">1998-10-21</span>
                    <span class="td style-scope patent-result">Univ Portsmouth</span>
                    <span class="td style-scope patent-result">Compounds 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP4689781B2/en"><a id="link" href="#" class="style-scope state-modifier">JP4689781B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-09-03</span>
                    <span class="td style-scope patent-result">2011-05-25</span>
                    <span class="td style-scope patent-result">独立行政法人科学技術振興機構</span>
                    <span class="td style-scope patent-result">
  Amino acid transport protein and its gene
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU5963699A/en"><a id="link" href="#" class="style-scope state-modifier">AU5963699A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-10-02</span>
                    <span class="td style-scope patent-result">2000-04-26</span>
                    <span class="td style-scope patent-result">Mcmaster University</span>
                    <span class="td style-scope patent-result">Spliced form of (erb)b-2/neu oncogene 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001057188A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001057188A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-02-03</span>
                    <span class="td style-scope patent-result">2001-08-09</span>
                    <span class="td style-scope patent-result">Hyseq, Inc.</span>
                    <span class="td style-scope patent-result">Novel nucleic acids and polypeptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20020119158A1/en"><a id="link" href="#" class="style-scope state-modifier">US20020119158A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-12-17</span>
                    <span class="td style-scope patent-result">2002-08-29</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6858710B2/en"><a id="link" href="#" class="style-scope state-modifier">US6858710B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-12-17</span>
                    <span class="td style-scope patent-result">2005-02-22</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030091580A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030091580A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-18</span>
                    <span class="td style-scope patent-result">2003-05-15</span>
                    <span class="td style-scope patent-result">Mitcham Jennifer L.</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6468546B1/en"><a id="link" href="#" class="style-scope state-modifier">US6468546B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-12-17</span>
                    <span class="td style-scope patent-result">2002-10-22</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for therapy and diagnosis of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6962980B2/en"><a id="link" href="#" class="style-scope state-modifier">US6962980B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-09-24</span>
                    <span class="td style-scope patent-result">2005-11-08</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1141017B1/en"><a id="link" href="#" class="style-scope state-modifier">EP1141017B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-12-30</span>
                    <span class="td style-scope patent-result">2008-09-10</span>
                    <span class="td style-scope patent-result">Beth Israel Deaconess Medical Center, Inc.</span>
                    <span class="td style-scope patent-result">Characterization of the soc/crac calcium channel protein family 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CZ20012587A3/en"><a id="link" href="#" class="style-scope state-modifier">CZ20012587A3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-01-29</span>
                    <span class="td style-scope patent-result">2002-05-15</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Isolated protein, nucleic acid, virus vector, pharmaceutical preparation, isolated population of T cells, method of reinforcing immune response, method of removing tumor cells, method of stimulating and/or propagating T cells and process for preparing a fusion protein 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB9905124D0/en"><a id="link" href="#" class="style-scope state-modifier">GB9905124D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-03-05</span>
                    <span class="td style-scope patent-result">1999-04-28</span>
                    <span class="td style-scope patent-result">Smithkline Beecham Biolog</span>
                    <span class="td style-scope patent-result">Novel compounds 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7232889B2/en"><a id="link" href="#" class="style-scope state-modifier">US7232889B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-03-08</span>
                    <span class="td style-scope patent-result">2007-06-19</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">PRO300 antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU3395900A/en"><a id="link" href="#" class="style-scope state-modifier">AU3395900A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-03-12</span>
                    <span class="td style-scope patent-result">2000-10-04</span>
                    <span class="td style-scope patent-result">Human Genome Sciences, Inc.</span>
                    <span class="td style-scope patent-result">Human lung cancer associated gene sequences and polypeptides 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7312303B2/en"><a id="link" href="#" class="style-scope state-modifier">US7312303B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-05-11</span>
                    <span class="td style-scope patent-result">2007-12-25</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Anti-PRO4980 antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6268488B1/en"><a id="link" href="#" class="style-scope state-modifier">US6268488B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-05-25</span>
                    <span class="td style-scope patent-result">2001-07-31</span>
                    <span class="td style-scope patent-result">Barbas, Iii Carlos F.</span>
                    <span class="td style-scope patent-result">Prodrug activation using catalytic antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2000075655A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2000075655A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-06-03</span>
                    <span class="td style-scope patent-result">2000-12-14</span>
                    <span class="td style-scope patent-result">Takeda Chemical Industries, Ltd.</span>
                    <span class="td style-scope patent-result">Screening method with the use of cd100 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DK2803367T3/en"><a id="link" href="#" class="style-scope state-modifier">DK2803367T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-06-25</span>
                    <span class="td style-scope patent-result">2018-04-16</span>
                    <span class="td style-scope patent-result">Immunogen Inc</span>
                    <span class="td style-scope patent-result">
  Methods of treatment using anti-ERBB antibody-maytansinoid conjugates
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030119113A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030119113A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-07-20</span>
                    <span class="td style-scope patent-result">2003-06-26</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7297770B2/en"><a id="link" href="#" class="style-scope state-modifier">US7297770B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-08-10</span>
                    <span class="td style-scope patent-result">2007-11-20</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">PRO6496 polypeptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7294696B2/en"><a id="link" href="#" class="style-scope state-modifier">US7294696B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-08-17</span>
                    <span class="td style-scope patent-result">2007-11-13</span>
                    <span class="td style-scope patent-result">Genentech Inc.</span>
                    <span class="td style-scope patent-result">PRO7168 polypeptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6909006B1/en"><a id="link" href="#" class="style-scope state-modifier">US6909006B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-08-27</span>
                    <span class="td style-scope patent-result">2005-06-21</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Cyclopropylindole derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1208202A2/en"><a id="link" href="#" class="style-scope state-modifier">EP1208202A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-09-01</span>
                    <span class="td style-scope patent-result">2002-05-29</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030232056A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030232056A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-09-10</span>
                    <span class="td style-scope patent-result">2003-12-18</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030206918A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030206918A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-09-10</span>
                    <span class="td style-scope patent-result">2003-11-06</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030129192A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030129192A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-09-10</span>
                    <span class="td style-scope patent-result">2003-07-10</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6750054B2/en"><a id="link" href="#" class="style-scope state-modifier">US6750054B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-05-18</span>
                    <span class="td style-scope patent-result">2004-06-15</span>
                    <span class="td style-scope patent-result">Lexicon Genetics Incorporated</span>
                    <span class="td style-scope patent-result">Human semaphorin homologs and polynucleotides encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/BR0015224A/en"><a id="link" href="#" class="style-scope state-modifier">BR0015224A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-10-29</span>
                    <span class="td style-scope patent-result">2002-07-09</span>
                    <span class="td style-scope patent-result">Genentech Inc</span>
                    <span class="td style-scope patent-result">
  Isolated prostatic stem cell (psca) anti-antigen, monoclonal anti-psca antibody, isolated nucleic acid, expression vector, cell, host cell, antibody production method, in vitro method composition to kill a cancer cell that expresses psca , use of an anti-psca monoclonal antibody and industrialized article
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2393126C/en"><a id="link" href="#" class="style-scope state-modifier">CA2393126C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-11-29</span>
                    <span class="td style-scope patent-result">2016-05-24</span>
                    <span class="td style-scope patent-result">The Trustees Of Columbia University In The City Of New York</span>
                    <span class="td style-scope patent-result">Isolation of five novel genes coding for new fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2392510A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2392510A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-11-30</span>
                    <span class="td style-scope patent-result">2001-06-07</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for therapy and diagnosis of breast cancer 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2393738A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2393738A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-12-10</span>
                    <span class="td style-scope patent-result">2001-06-14</span>
                    <span class="td style-scope patent-result">Epimmune Inc.</span>
                    <span class="td style-scope patent-result">Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2295079A3/en"><a id="link" href="#" class="style-scope state-modifier">EP2295079A3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-12-23</span>
                    <span class="td style-scope patent-result">2011-03-23</span>
                    <span class="td style-scope patent-result">ZymoGenetics, L.L.C.</span>
                    <span class="td style-scope patent-result">Method for treating inflammation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2395539C/en"><a id="link" href="#" class="style-scope state-modifier">CA2395539C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-12-23</span>
                    <span class="td style-scope patent-result">2009-08-25</span>
                    <span class="td style-scope patent-result">Zymogenetics, Inc.</span>
                    <span class="td style-scope patent-result">Soluble interleukin-20 receptor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/NZ502058A/en"><a id="link" href="#" class="style-scope state-modifier">NZ502058A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-12-23</span>
                    <span class="td style-scope patent-result">2003-11-28</span>
                    <span class="td style-scope patent-result">Ovita Ltd</span>
                    <span class="td style-scope patent-result">Isolated mutated nucleic acid molecule for regulation of ovulation rate 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6610286B2/en"><a id="link" href="#" class="style-scope state-modifier">US6610286B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-12-23</span>
                    <span class="td style-scope patent-result">2003-08-26</span>
                    <span class="td style-scope patent-result">Zymogenetics, Inc.</span>
                    <span class="td style-scope patent-result">Method for treating inflammation using soluble receptors to interleukin-20 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1240337B1/en"><a id="link" href="#" class="style-scope state-modifier">EP1240337B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-12-24</span>
                    <span class="td style-scope patent-result">2006-08-23</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Methods and compositions for prolonging elimination half-times of bioactive compounds 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040001827A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040001827A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-28</span>
                    <span class="td style-scope patent-result">2004-01-01</span>
                    <span class="td style-scope patent-result">Dennis Mark S.</span>
                    <span class="td style-scope patent-result">Serum albumin binding peptides for tumor targeting 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7297333B2/en"><a id="link" href="#" class="style-scope state-modifier">US7297333B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-01-20</span>
                    <span class="td style-scope patent-result">2007-11-20</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Anti-PRO10268 antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030224379A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030224379A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-01-21</span>
                    <span class="td style-scope patent-result">2003-12-04</span>
                    <span class="td style-scope patent-result">Tang Y. Tom</span>
                    <span class="td style-scope patent-result">Novel nucleic acids and polypeptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001053463A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001053463A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-01-21</span>
                    <span class="td style-scope patent-result">2001-07-26</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">COMPOUNDS AND METHODS FOR PREVENTION AND TREATMENT OF HER-2/neu ASSOCIATED MALIGNANCIES 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001062794A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001062794A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-02-22</span>
                    <span class="td style-scope patent-result">2001-08-30</span>
                    <span class="td style-scope patent-result">Millennium Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">18607, a human calcium channel 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030219806A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030219806A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-02-22</span>
                    <span class="td style-scope patent-result">2003-11-27</span>
                    <span class="td style-scope patent-result">Millennium Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040052793A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040052793A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-02-22</span>
                    <span class="td style-scope patent-result">2004-03-18</span>
                    <span class="td style-scope patent-result">Carter Paul J.</span>
                    <span class="td style-scope patent-result">Caspase activivated prodrugs therapy 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040002068A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040002068A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-03-01</span>
                    <span class="td style-scope patent-result">2004-01-01</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the detection, diagnosis and therapy of hematological malignancies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040005561A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040005561A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-03-01</span>
                    <span class="td style-scope patent-result">2004-01-08</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the detection, diagnosis and therapy of hematological malignancies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2402293A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2402293A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-03-07</span>
                    <span class="td style-scope patent-result">2001-09-13</span>
                    <span class="td style-scope patent-result">Hyseq, Inc.</span>
                    <span class="td style-scope patent-result">Novel nucleic acids and polypeptides 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2001249411B2/en"><a id="link" href="#" class="style-scope state-modifier">AU2001249411B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-03-24</span>
                    <span class="td style-scope patent-result">2007-02-15</span>
                    <span class="td style-scope patent-result">Fahri Saatcioglu</span>
                    <span class="td style-scope patent-result">Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides,and diagnostic and therapeutic methods 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1268554A2/en"><a id="link" href="#" class="style-scope state-modifier">EP1268554A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-03-31</span>
                    <span class="td style-scope patent-result">2003-01-02</span>
                    <span class="td style-scope patent-result">IPF Pharmaceuticals GmbH</span>
                    <span class="td style-scope patent-result">Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2001253140A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2001253140A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-04-03</span>
                    <span class="td style-scope patent-result">2001-10-15</span>
                    <span class="td style-scope patent-result">The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services</span>
                    <span class="td style-scope patent-result">Tumor markers in ovarian cancer 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/IL152136A0/en"><a id="link" href="#" class="style-scope state-modifier">IL152136A0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-04-07</span>
                    <span class="td style-scope patent-result">2003-05-29</span>
                    <span class="td style-scope patent-result">Arena Pharm Inc</span>
                    <span class="td style-scope patent-result">Non-endogenous, constitutively activated known g protein-coupled receptors 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030119115A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030119115A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-05-17</span>
                    <span class="td style-scope patent-result">2003-06-26</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2001274888A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2001274888A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-05-19</span>
                    <span class="td style-scope patent-result">2001-12-03</span>
                    <span class="td style-scope patent-result">Human Genome Sciences, Inc.</span>
                    <span class="td style-scope patent-result">Nucleic acids, proteins, and antibodies 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2001094641A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2001094641A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-06-09</span>
                    <span class="td style-scope patent-result">2001-12-13</span>
                    <span class="td style-scope patent-result">Idec Pharmaceuticals Corporation</span>
                    <span class="td style-scope patent-result">Gene targets and ligands that bind thereto for treatment and diagnosis of ovarian carcinomas 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1297130A2/en"><a id="link" href="#" class="style-scope state-modifier">EP1297130A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-06-16</span>
                    <span class="td style-scope patent-result">2003-04-02</span>
                    <span class="td style-scope patent-result">Incyte Genomics, Inc.</span>
                    <span class="td style-scope patent-result">G-protein coupled receptors 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2413262A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2413262A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-06-30</span>
                    <span class="td style-scope patent-result">2002-01-10</span>
                    <span class="td style-scope patent-result">Amgen, Inc.</span>
                    <span class="td style-scope patent-result">B7-like molecules and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2001271714A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2001271714A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-06-30</span>
                    <span class="td style-scope patent-result">2002-01-14</span>
                    <span class="td style-scope patent-result">Human Genome Sciences, Inc.</span>
                    <span class="td style-scope patent-result">B7-like polynucleotides, polypeptides, and antibodies 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002006339A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002006339A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-07-03</span>
                    <span class="td style-scope patent-result">2002-01-24</span>
                    <span class="td style-scope patent-result">Curagen Corporation</span>
                    <span class="td style-scope patent-result">Proteins and nucleic acids encoding same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040044179A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040044179A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-07-25</span>
                    <span class="td style-scope patent-result">2004-03-04</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002010187A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2002010187A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-07-27</span>
                    <span class="td style-scope patent-result">2002-02-07</span>
                    <span class="td style-scope patent-result">Mayo Foundation For Medical Education And Research</span>
                    <span class="td style-scope patent-result">B7-h3 and b7-h4, novel immunoregulatory molecules 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2001287639A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2001287639A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-07-28</span>
                    <span class="td style-scope patent-result">2002-02-13</span>
                    <span class="td style-scope patent-result">Ulrich Wissenbach</span>
                    <span class="td style-scope patent-result">Trp8, trp9 and trp10, markers for cancer 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7229623B1/en"><a id="link" href="#" class="style-scope state-modifier">US7229623B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-08-03</span>
                    <span class="td style-scope patent-result">2007-06-12</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Her-2/neu fusion proteins 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2001283360A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2001283360A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-08-14</span>
                    <span class="td style-scope patent-result">2002-02-25</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Methods for diagnosis and therapy of hematological and virus-associated malignancies 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20030048009A/en"><a id="link" href="#" class="style-scope state-modifier">KR20030048009A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-08-14</span>
                    <span class="td style-scope patent-result">2003-06-18</span>
                    <span class="td style-scope patent-result">코릭사 코포레이션</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of HER-2/NEU-associated malignancies 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0020953D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0020953D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-08-24</span>
                    <span class="td style-scope patent-result">2000-10-11</span>
                    <span class="td style-scope patent-result">Smithkline Beecham Biolog</span>
                    <span class="td style-scope patent-result">Vaccine 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20030029847A/en"><a id="link" href="#" class="style-scope state-modifier">KR20030029847A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-08-24</span>
                    <span class="td style-scope patent-result">2003-04-16</span>
                    <span class="td style-scope patent-result">제넨테크, 인크.</span>
                    <span class="td style-scope patent-result">Compositions and methods for the diagnosis and treatment of tumor 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2421949A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2421949A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-09-11</span>
                    <span class="td style-scope patent-result">2002-03-21</span>
                    <span class="td style-scope patent-result">Hyseq, Inc.</span>
                    <span class="td style-scope patent-result">Novel nucleic acids and polypeptides 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1351703B1/en"><a id="link" href="#" class="style-scope state-modifier">EP1351703B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-09-15</span>
                    <span class="td style-scope patent-result">2006-07-26</span>
                    <span class="td style-scope patent-result">ZymoGenetics, Inc.</span>
                    <span class="td style-scope patent-result">Use of a polypeptide comprising the extracellular domains of il-20ra and il-20rb for the treatment of inflammation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7491797B2/en"><a id="link" href="#" class="style-scope state-modifier">US7491797B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-09-15</span>
                    <span class="td style-scope patent-result">2009-02-17</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">PRO6308 polypeptide 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6613567B1/en"><a id="link" href="#" class="style-scope state-modifier">US6613567B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-09-15</span>
                    <span class="td style-scope patent-result">2003-09-02</span>
                    <span class="td style-scope patent-result">Isis Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Antisense inhibition of Her-2 expression 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/NZ525380A/en"><a id="link" href="#" class="style-scope state-modifier">NZ525380A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-09-18</span>
                    <span class="td style-scope patent-result">2008-06-30</span>
                    <span class="td style-scope patent-result">Biogen Idec Inc</span>
                    <span class="td style-scope patent-result">Non-fucosylated forms of Cripto and their use as tumor blocking agents 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/UA83458C2/en"><a id="link" href="#" class="style-scope state-modifier">UA83458C2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-09-18</span>
                    <span class="td style-scope patent-result">2008-07-25</span>
                    <span class="td style-scope patent-result">Байоджен Айдек Ма Інк.</span>
                    <span class="td style-scope patent-result">The isolated polypeptide baff-r (the receptor of the factor of activation of b-cells of the family tnf) 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002030894A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002030894A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-09-19</span>
                    <span class="td style-scope patent-result">2002-04-18</span>
                    <span class="td style-scope patent-result">Taiho Pharmaceutical Co., Ltd.</span>
                    <span class="td style-scope patent-result">Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2425569A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2425569A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-10-13</span>
                    <span class="td style-scope patent-result">2002-04-18</span>
                    <span class="td style-scope patent-result">Eos Biotechnology, Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002038766A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002038766A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-11-07</span>
                    <span class="td style-scope patent-result">2002-05-16</span>
                    <span class="td style-scope patent-result">Zymogenetics, Inc.</span>
                    <span class="td style-scope patent-result">Human tumor necrosis factor receptor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20020150573A1/en"><a id="link" href="#" class="style-scope state-modifier">US20020150573A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-11-10</span>
                    <span class="td style-scope patent-result">2002-10-17</span>
                    <span class="td style-scope patent-result">The Rockefeller University</span>
                    <span class="td style-scope patent-result">Anti-Igalpha-Igbeta antibody for lymphoma therapy 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040018194A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040018194A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-11-28</span>
                    <span class="td style-scope patent-result">2004-01-29</span>
                    <span class="td style-scope patent-result">Francisco Joseph A.</span>
                    <span class="td style-scope patent-result">Recombinant anti-CD30 antibodies and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002061087A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002061087A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-12-19</span>
                    <span class="td style-scope patent-result">2002-08-08</span>
                    <span class="td style-scope patent-result">Lifespan Biosciences, Inc.</span>
                    <span class="td style-scope patent-result">Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2002243495A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2002243495A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-01-12</span>
                    <span class="td style-scope patent-result">2002-07-24</span>
                    <span class="td style-scope patent-result">University Of Medicine And Dentistry Of New Jersey</span>
                    <span class="td style-scope patent-result">Bone morphogenetic protein-2 in the treatment and diagnosis of cancer 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030119133A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030119133A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-01-16</span>
                    <span class="td style-scope patent-result">2003-06-26</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030119125A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030119125A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-01-16</span>
                    <span class="td style-scope patent-result">2003-06-26</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7754208B2/en"><a id="link" href="#" class="style-scope state-modifier">US7754208B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-01-17</span>
                    <span class="td style-scope patent-result">2010-07-13</span>
                    <span class="td style-scope patent-result">Trubion Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Binding domain-immunoglobulin fusion proteins 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1425302A2/en"><a id="link" href="#" class="style-scope state-modifier">EP1425302A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-01-24</span>
                    <span class="td style-scope patent-result">2004-06-09</span>
                    <span class="td style-scope patent-result">Protein Design Labs</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030073144A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030073144A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-01-30</span>
                    <span class="td style-scope patent-result">2003-04-17</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of pancreatic cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002064798A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2002064798A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-02-12</span>
                    <span class="td style-scope patent-result">2002-08-22</span>
                    <span class="td style-scope patent-result">Bionomics Limited</span>
                    <span class="td style-scope patent-result">Dna sequences differentially expressed in tumour cell lines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2002258518A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2002258518A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-03-14</span>
                    <span class="td style-scope patent-result">2002-09-24</span>
                    <span class="td style-scope patent-result">Millennium Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1243276A1/en"><a id="link" href="#" class="style-scope state-modifier">EP1243276A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-03-23</span>
                    <span class="td style-scope patent-result">2002-09-25</span>
                    <span class="td style-scope patent-result">Franciscus Marinus Hendrikus De Groot</span>
                    <span class="td style-scope patent-result">Elongated and multiple spacers containing activatible prodrugs 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2002311787A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2002311787A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-03-28</span>
                    <span class="td style-scope patent-result">2002-10-15</span>
                    <span class="td style-scope patent-result">Zycos Inc.</span>
                    <span class="td style-scope patent-result">Translational profiling 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6362331B1/en"><a id="link" href="#" class="style-scope state-modifier">US6362331B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-03-30</span>
                    <span class="td style-scope patent-result">2002-03-26</span>
                    <span class="td style-scope patent-result">Council Of Scientific And Industrial Research</span>
                    <span class="td style-scope patent-result">Process for the preparation of antitumor agents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003008537A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003008537A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-04-06</span>
                    <span class="td style-scope patent-result">2003-01-30</span>
                    <span class="td style-scope patent-result">Mannkind Corporation</span>
                    <span class="td style-scope patent-result">Epitope sequences 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6820011B2/en"><a id="link" href="#" class="style-scope state-modifier">US6820011B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-04-11</span>
                    <span class="td style-scope patent-result">2004-11-16</span>
                    <span class="td style-scope patent-result">The Regents Of The University Of Colorado</span>
                    <span class="td style-scope patent-result">Three-dimensional structure of complement receptor type 2 and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2002254615A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2002254615A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-04-17</span>
                    <span class="td style-scope patent-result">2002-10-28</span>
                    <span class="td style-scope patent-result">The Board Of Trustees Of The University Of Arkansas</span>
                    <span class="td style-scope patent-result">Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2002309583A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2002309583A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-04-18</span>
                    <span class="td style-scope patent-result">2002-11-05</span>
                    <span class="td style-scope patent-result">Protein Desing Labs, Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003083041A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003083041A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-22</span>
                    <span class="td style-scope patent-result">2003-10-09</span>
                    <span class="td style-scope patent-result">Biogen, Inc.</span>
                    <span class="td style-scope patent-result">Cripto-specific antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DK1390389T3/en"><a id="link" href="#" class="style-scope state-modifier">DK1390389T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-04-26</span>
                    <span class="td style-scope patent-result">2009-04-20</span>
                    <span class="td style-scope patent-result">Biogen Idec Inc</span>
                    <span class="td style-scope patent-result">
  Crypto-blocking antibodies and uses thereof
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6884869B2/en"><a id="link" href="#" class="style-scope state-modifier">US6884869B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-04-30</span>
                    <span class="td style-scope patent-result">2005-04-26</span>
                    <span class="td style-scope patent-result">Seattle Genetics, Inc.</span>
                    <span class="td style-scope patent-result">Pentapeptide compounds and uses related thereto 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002089747A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002089747A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-05-09</span>
                    <span class="td style-scope patent-result">2002-11-14</span>
                    <span class="td style-scope patent-result">Corixa Corporation</span>
                    <span class="td style-scope patent-result">Compositions and methods for the therapy and diagnosis of prostate cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030078399A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030078399A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-05-11</span>
                    <span class="td style-scope patent-result">2003-04-24</span>
                    <span class="td style-scope patent-result">Sloan-Kettering Institute For Cancer Research</span>
                    <span class="td style-scope patent-result">Nucleic acid sequence encoding ovarian antigen, CA125, and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/PT1436003E/en"><a id="link" href="#" class="style-scope state-modifier">PT1436003E</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-05-24</span>
                    <span class="td style-scope patent-result">2010-03-12</span>
                    <span class="td style-scope patent-result">Zymogenetics Inc</span>
                    <span class="td style-scope patent-result">Taci-immunoglobulin fusion proteins 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2002098358A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2002098358A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-04</span>
                    <span class="td style-scope patent-result">2002-12-12</span>
                    <span class="td style-scope patent-result">Eos Biotechnology, Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis and treatment of androgen-dependent prostate cancer, prostate cancer undergoing androgen-withdrawal, and androgen-independent prostate cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003000842A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003000842A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-04</span>
                    <span class="td style-scope patent-result">2003-01-03</span>
                    <span class="td style-scope patent-result">Curagen Corporation</span>
                    <span class="td style-scope patent-result">Novel proteins and nucleic acids encoding same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2004528046A/en"><a id="link" href="#" class="style-scope state-modifier">JP2004528046A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-05</span>
                    <span class="td style-scope patent-result">2004-09-16</span>
                    <span class="td style-scope patent-result">エクセリクシス・インコーポレイテッド</span>
                    <span class="td style-scope patent-result">
  DGKs as Modifiers of the p53 Pathway and Methods of Use
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2449289A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2449289A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-05</span>
                    <span class="td style-scope patent-result">2002-12-12</span>
                    <span class="td style-scope patent-result">Exelixis, Inc.</span>
                    <span class="td style-scope patent-result">Gfats as modifiers of the p53 pathway and methods of use 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7235358B2/en"><a id="link" href="#" class="style-scope state-modifier">US7235358B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-08</span>
                    <span class="td style-scope patent-result">2007-06-26</span>
                    <span class="td style-scope patent-result">Expression Diagnostics, Inc.</span>
                    <span class="td style-scope patent-result">Methods and compositions for diagnosing and monitoring transplant rejection 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7125663B2/en"><a id="link" href="#" class="style-scope state-modifier">US7125663B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-13</span>
                    <span class="td style-scope patent-result">2006-10-24</span>
                    <span class="td style-scope patent-result">Millenium Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7189507B2/en"><a id="link" href="#" class="style-scope state-modifier">US7189507B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-18</span>
                    <span class="td style-scope patent-result">2007-03-13</span>
                    <span class="td style-scope patent-result">Pdl Biopharma, Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1517998A2/en"><a id="link" href="#" class="style-scope state-modifier">EP1517998A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-18</span>
                    <span class="td style-scope patent-result">2005-03-30</span>
                    <span class="td style-scope patent-result">EOS Biotechnology, Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003004989A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003004989A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-21</span>
                    <span class="td style-scope patent-result">2003-01-16</span>
                    <span class="td style-scope patent-result">Millennium Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030108958A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030108958A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-28</span>
                    <span class="td style-scope patent-result">2003-06-12</span>
                    <span class="td style-scope patent-result">Rene De Waal Malefyt</span>
                    <span class="td style-scope patent-result">Biological activity of AK155 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030120040A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030120040A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-06-29</span>
                    <span class="td style-scope patent-result">2003-06-26</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Secreted and Transmembrane polypeptides and nucleic acids encoding the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003004529A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003004529A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-07-02</span>
                    <span class="td style-scope patent-result">2003-01-16</span>
                    <span class="td style-scope patent-result">Licentia Ltd.</span>
                    <span class="td style-scope patent-result">Ephrin-tie receptor materials and methods 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040076955A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040076955A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-07-03</span>
                    <span class="td style-scope patent-result">2004-04-22</span>
                    <span class="td style-scope patent-result">Eos Biotechnology, Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003003984A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003003984A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-07-05</span>
                    <span class="td style-scope patent-result">2003-01-16</span>
                    <span class="td style-scope patent-result">Curagen Corporation</span>
                    <span class="td style-scope patent-result">Novel proteins and nucleic acids encoding same 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003055439A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003055439A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-07-18</span>
                    <span class="td style-scope patent-result">2003-07-10</span>
                    <span class="td style-scope patent-result">The Regents Of The University Of California</span>
                    <span class="td style-scope patent-result">Her2/neu target antigen and use of same to stimulate an immune response 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003009814A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003009814A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-07-25</span>
                    <span class="td style-scope patent-result">2003-02-06</span>
                    <span class="td style-scope patent-result">Millennium Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20040019105A/en"><a id="link" href="#" class="style-scope state-modifier">KR20040019105A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-08-03</span>
                    <span class="td style-scope patent-result">2004-03-04</span>
                    <span class="td style-scope patent-result">제넨테크, 인크.</span>
                    <span class="td style-scope patent-result">TACIs and BR3 Polypeptides and Uses Thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2002324700A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2002324700A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-08-14</span>
                    <span class="td style-scope patent-result">2003-03-03</span>
                    <span class="td style-scope patent-result">Bayer Ag</span>
                    <span class="td style-scope patent-result">Nucleic acid and amino acid sequences involved in pain 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030092013A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030092013A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-08-16</span>
                    <span class="td style-scope patent-result">2003-05-15</span>
                    <span class="td style-scope patent-result">Vitivity, Inc.</span>
                    <span class="td style-scope patent-result">Diagnosis and treatment of vascular disease 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003018621A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003018621A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-08-23</span>
                    <span class="td style-scope patent-result">2003-03-06</span>
                    <span class="td style-scope patent-result">Oxford Biomedica (Uk) Limited</span>
                    <span class="td style-scope patent-result">Genes 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6902930B2/en"><a id="link" href="#" class="style-scope state-modifier">US6902930B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-08-29</span>
                    <span class="td style-scope patent-result">2005-06-07</span>
                    <span class="td style-scope patent-result">Vanderbilt University</span>
                    <span class="td style-scope patent-result">Human Mob-5 (IL-24) receptors and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030124579A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030124579A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-05</span>
                    <span class="td style-scope patent-result">2003-07-03</span>
                    <span class="td style-scope patent-result">Eos Biotechnology, Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2005505271A/en"><a id="link" href="#" class="style-scope state-modifier">JP2005505271A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-06</span>
                    <span class="td style-scope patent-result">2005-02-24</span>
                    <span class="td style-scope patent-result">アジェンシス，  インコーポレイテッド</span>
                    <span class="td style-scope patent-result">
  Nucleic acids and corresponding proteins given the name STEAP-1 useful in the treatment and detection of cancer
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2005518782A/en"><a id="link" href="#" class="style-scope state-modifier">JP2005518782A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-17</span>
                    <span class="td style-scope patent-result">2005-06-30</span>
                    <span class="td style-scope patent-result">プロテイン  デザイン  ラブス，  インコーポレイテッド</span>
                    <span class="td style-scope patent-result">
  Cancer diagnosis method, cancer modulator screening composition and method
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/IL160933A0/en"><a id="link" href="#" class="style-scope state-modifier">IL160933A0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-18</span>
                    <span class="td style-scope patent-result">2004-08-31</span>
                    <span class="td style-scope patent-result">Proteologics Inc</span>
                    <span class="td style-scope patent-result">Methods and compositions for treating ?cap associated diseases 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/NZ573740A/en"><a id="link" href="#" class="style-scope state-modifier">NZ573740A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-18</span>
                    <span class="td style-scope patent-result">2010-07-30</span>
                    <span class="td style-scope patent-result">Genentech Inc</span>
                    <span class="td style-scope patent-result">Compositions and methods for the diagnosis and treatment of tumor, particularly kidney tumor - TAT184 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2460621A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2460621A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-19</span>
                    <span class="td style-scope patent-result">2003-03-27</span>
                    <span class="td style-scope patent-result">Nuvelo, Inc.</span>
                    <span class="td style-scope patent-result">Novel nucleic acids and polypeptides 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003026577A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003026577A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-24</span>
                    <span class="td style-scope patent-result">2003-04-03</span>
                    <span class="td style-scope patent-result">Seattle Genetics, Inc.</span>
                    <span class="td style-scope patent-result">P-amidobenzylethers in drug delivery agents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7091186B2/en"><a id="link" href="#" class="style-scope state-modifier">US7091186B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-24</span>
                    <span class="td style-scope patent-result">2006-08-15</span>
                    <span class="td style-scope patent-result">Seattle Genetics, Inc.</span>
                    <span class="td style-scope patent-result">p-Amidobenzylethers in drug delivery agents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030077644A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030077644A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-09-28</span>
                    <span class="td style-scope patent-result">2003-04-24</span>
                    <span class="td style-scope patent-result">Bing Yang</span>
                    <span class="td style-scope patent-result">Diagnosis and treatment of diseases caused by mutations in CD72 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2002362436A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2002362436A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-10-03</span>
                    <span class="td style-scope patent-result">2003-04-14</span>
                    <span class="td style-scope patent-result">Rigel Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Modulators of lymphocyte activation and migration 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040249144A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040249144A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-10-03</span>
                    <span class="td style-scope patent-result">2004-12-09</span>
                    <span class="td style-scope patent-result">Zairen Sun</span>
                    <span class="td style-scope patent-result">Regulated breast cancer genes 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20050123925A1/en"><a id="link" href="#" class="style-scope state-modifier">US20050123925A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-15</span>
                    <span class="td style-scope patent-result">2005-06-09</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Compositions and methods for the diagnosis and treatment of tumor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2005522986A/en"><a id="link" href="#" class="style-scope state-modifier">JP2005522986A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-10-19</span>
                    <span class="td style-scope patent-result">2005-08-04</span>
                    <span class="td style-scope patent-result">ジェネンテック・インコーポレーテッド</span>
                    <span class="td style-scope patent-result">
  Compositions and methods for diagnosis and treatment of inflammatory bowel disease
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2465268A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2465268A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-10-24</span>
                    <span class="td style-scope patent-result">2003-05-01</span>
                    <span class="td style-scope patent-result">National Jewish Medical And Research Center</span>
                    <span class="td style-scope patent-result">Three-dimensional structures of tall-1 and its cognate receptors and modified proteins and methods related thereto 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2278079T3/en"><a id="link" href="#" class="style-scope state-modifier">ES2278079T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-10-31</span>
                    <span class="td style-scope patent-result">2007-08-01</span>
                    <span class="td style-scope patent-result">Alcon, Inc.</span>
                    <span class="td style-scope patent-result">
  OSEAS MORPHOGENIC PROTEINS (BMP), BMP RECEPTORS AND BMP UNION PROTEINS AND ITS USE IN DIAGNOSIS AND GLAUCOMA TREATMENT.
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003042661A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003042661A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-11-13</span>
                    <span class="td style-scope patent-result">2003-05-22</span>
                    <span class="td style-scope patent-result">Protein Design Labs, Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030232350A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030232350A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-11-13</span>
                    <span class="td style-scope patent-result">2003-12-18</span>
                    <span class="td style-scope patent-result">Eos Biotechnology, Inc.</span>
                    <span class="td style-scope patent-result">Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1482972A4/en"><a id="link" href="#" class="style-scope state-modifier">EP1482972A4</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-11-20</span>
                    <span class="td style-scope patent-result">2005-11-23</span>
                    <span class="td style-scope patent-result">Seattle Genetics Inc</span>
                    <span class="td style-scope patent-result">Treatment of immunological disorders using anti-cd30 antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2002339691A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2002339691A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-11-29</span>
                    <span class="td style-scope patent-result">2003-06-10</span>
                    <span class="td style-scope patent-result">Genset</span>
                    <span class="td style-scope patent-result">Agonists and antagonists of prolixin for the treatment of metabolic disorders 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003048202A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003048202A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-12-03</span>
                    <span class="td style-scope patent-result">2003-06-12</span>
                    <span class="td style-scope patent-result">Asahi Kasei Pharma Corporation</span>
                    <span class="td style-scope patent-result">Nf-kappab activating genes 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003054152A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003054152A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-12-10</span>
                    <span class="td style-scope patent-result">2003-07-03</span>
                    <span class="td style-scope patent-result">Nuvelo, Inc.</span>
                    <span class="td style-scope patent-result">Novel nucleic acids and polypeptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030134790A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030134790A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-01-11</span>
                    <span class="td style-scope patent-result">2003-07-17</span>
                    <span class="td style-scope patent-result">University Of Medicine And Dentistry Of New Jersey</span>
                    <span class="td style-scope patent-result">Bone Morphogenetic Protein-2 And Bone Morphogenetic Protein-4 In The Treatment And Diagnosis Of Cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7452675B2/en"><a id="link" href="#" class="style-scope state-modifier">US7452675B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-01-25</span>
                    <span class="td style-scope patent-result">2008-11-18</span>
                    <span class="td style-scope patent-result">The Queen's Medical Center</span>
                    <span class="td style-scope patent-result">Methods of screening for TRPM4b modulators 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2476776A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2476776A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-02-21</span>
                    <span class="td style-scope patent-result">2003-09-04</span>
                    <span class="td style-scope patent-result">Duke University</span>
                    <span class="td style-scope patent-result">Reagents and treatment methods for autoimmune diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040258678A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040258678A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-02-22</span>
                    <span class="td style-scope patent-result">2004-12-23</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Compositions and methods for the treatment of immune related diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030215849A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030215849A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-01</span>
                    <span class="td style-scope patent-result">2003-11-20</span>
                    <span class="td style-scope patent-result">Marcia Belvin</span>
                    <span class="td style-scope patent-result">PDPK1s as modifiers of the p53 pathway and methods of use 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2258712A3/en"><a id="link" href="#" class="style-scope state-modifier">EP2258712A3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-15</span>
                    <span class="td style-scope patent-result">2011-05-04</span>
                    <span class="td style-scope patent-result">Multicell Immunotherapeutics, Inc.</span>
                    <span class="td style-scope patent-result">Compositions and Methods to Initiate or Enhance Antibody and Major-histocompatibility Class I or Class II-restricted T Cell Responses by Using Immunomodulatory, Non-coding RNA Motifs 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2486490A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2486490A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-19</span>
                    <span class="td style-scope patent-result">2003-12-31</span>
                    <span class="td style-scope patent-result">Curagen Corporation</span>
                    <span class="td style-scope patent-result">Therapeutic polypeptides, nucleic acids encoding same, and methods of use 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2478981A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2478981A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-21</span>
                    <span class="td style-scope patent-result">2003-10-02</span>
                    <span class="td style-scope patent-result">Sunesis Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Identification of kinase inhibitors 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7193069B2/en"><a id="link" href="#" class="style-scope state-modifier">US7193069B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-22</span>
                    <span class="td style-scope patent-result">2007-03-20</span>
                    <span class="td style-scope patent-result">Research Association For Biotechnology</span>
                    <span class="td style-scope patent-result">Full-length cDNA 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2003245239A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2003245239A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-25</span>
                    <span class="td style-scope patent-result">2003-11-03</span>
                    <span class="td style-scope patent-result">Uab Research Foundation</span>
                    <span class="td style-scope patent-result">FC receptor homolog, reagents, and uses thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2003222103A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2003222103A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-03-28</span>
                    <span class="td style-scope patent-result">2003-10-13</span>
                    <span class="td style-scope patent-result">Idec Pharmaceuticals Corporation</span>
                    <span class="td style-scope patent-result">Novel gene targets and ligands that bind thereto for treatment and diagnosis of colon carcinomas 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030194704A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030194704A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-04-03</span>
                    <span class="td style-scope patent-result">2003-10-16</span>
                    <span class="td style-scope patent-result">Penn Sharron Gaynor</span>
                    <span class="td style-scope patent-result">Human genome-derived single exon nucleic acid probes useful for gene expression analysis two 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003087306A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003087306A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-04-05</span>
                    <span class="td style-scope patent-result">2003-10-23</span>
                    <span class="td style-scope patent-result">Agensys, Inc.</span>
                    <span class="td style-scope patent-result">Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040101874A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040101874A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-04-12</span>
                    <span class="td style-scope patent-result">2004-05-27</span>
                    <span class="td style-scope patent-result">Mitokor Inc.</span>
                    <span class="td style-scope patent-result">Targets for therapeutic intervention identified in the mitochondrial proteome 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2003230874A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2003230874A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-04-16</span>
                    <span class="td style-scope patent-result">2003-11-03</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Compositions and methods for the diagnosis and treatment of tumor 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003089904A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003089904A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-04-17</span>
                    <span class="td style-scope patent-result">2003-10-30</span>
                    <span class="td style-scope patent-result">Baylor College Of Medicine</span>
                    <span class="td style-scope patent-result">Aib1 as a prognostic marker and predictor of resistance to encocrine therapy 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2003228869A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2003228869A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-05-03</span>
                    <span class="td style-scope patent-result">2003-11-17</span>
                    <span class="td style-scope patent-result">Incyte Corporation</span>
                    <span class="td style-scope patent-result">Transporters and ion channels 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2485983A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2485983A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-05-15</span>
                    <span class="td style-scope patent-result">2003-11-27</span>
                    <span class="td style-scope patent-result">Avalon Pharmaceuticals</span>
                    <span class="td style-scope patent-result">Cancer-linked gene as target for chemotherapy 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030224454A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030224454A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-05-30</span>
                    <span class="td style-scope patent-result">2003-12-04</span>
                    <span class="td style-scope patent-result">Ryseck Rolf Peter</span>
                    <span class="td style-scope patent-result">Human solute carrier family 7, member 11 (hSLC7A11) 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2488284A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2488284A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-04</span>
                    <span class="td style-scope patent-result">2003-12-11</span>
                    <span class="td style-scope patent-result">Avalon Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Cancer-linked gene as target for chemotherapy 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003101283A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003101283A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-04</span>
                    <span class="td style-scope patent-result">2003-12-11</span>
                    <span class="td style-scope patent-result">Incyte Corporation</span>
                    <span class="td style-scope patent-result">Diagnostics markers for lung cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003104270A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003104270A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-06</span>
                    <span class="td style-scope patent-result">2003-12-18</span>
                    <span class="td style-scope patent-result">Ingenium Pharmaceuticals Ag</span>
                    <span class="td style-scope patent-result">Dudulin 2 genes, expression products, non-human animal model: uses in human hematological disease 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2488404C/en"><a id="link" href="#" class="style-scope state-modifier">CA2488404C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-06</span>
                    <span class="td style-scope patent-result">2012-11-27</span>
                    <span class="td style-scope patent-result">Oncotherapy Science, Inc.</span>
                    <span class="td style-scope patent-result">Genes and polypeptides relating to human colon cancers 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2488629A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2488629A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-07</span>
                    <span class="td style-scope patent-result">2003-12-18</span>
                    <span class="td style-scope patent-result">Avalon Pharmaceuticals, Inc</span>
                    <span class="td style-scope patent-result">Cancer-linked gene as target for chemotherapy 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2003245441A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2003245441A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-12</span>
                    <span class="td style-scope patent-result">2003-12-31</span>
                    <span class="td style-scope patent-result">Avalon Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Cancer-linked gene as target for chemotherapy 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1552002A4/en"><a id="link" href="#" class="style-scope state-modifier">EP1552002A4</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-18</span>
                    <span class="td style-scope patent-result">2006-02-08</span>
                    <span class="td style-scope patent-result">Archemix Corp</span>
                    <span class="td style-scope patent-result">Aptamer-toxin molecules and methods for using same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040249130A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040249130A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-18</span>
                    <span class="td style-scope patent-result">2004-12-09</span>
                    <span class="td style-scope patent-result">Martin Stanton</span>
                    <span class="td style-scope patent-result">Aptamer-toxin molecules and methods for using same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004000221A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004000221A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-20</span>
                    <span class="td style-scope patent-result">2003-12-31</span>
                    <span class="td style-scope patent-result">The Regents Of The University Of California</span>
                    <span class="td style-scope patent-result">Compositions and methods for modulating lymphocyte activity 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20060275287A1/en"><a id="link" href="#" class="style-scope state-modifier">US20060275287A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-06-21</span>
                    <span class="td style-scope patent-result">2006-12-07</span>
                    <span class="td style-scope patent-result">Brad St Croix</span>
                    <span class="td style-scope patent-result">Scroll compressor 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004009622A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004009622A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-07-19</span>
                    <span class="td style-scope patent-result">2004-01-29</span>
                    <span class="td style-scope patent-result">Cellzome Ag</span>
                    <span class="td style-scope patent-result">Protein complexes of cellular networks underlying the development of cancer and other diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20050043516A1/en"><a id="link" href="#" class="style-scope state-modifier">US20050043516A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-07-25</span>
                    <span class="td style-scope patent-result">2005-02-24</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">TACI antibodies and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2003294210A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2003294210A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-07-31</span>
                    <span class="td style-scope patent-result">2004-05-04</span>
                    <span class="td style-scope patent-result">Seattle Genetics, Inc</span>
                    <span class="td style-scope patent-result">Anti-cd20 antibody-drug conjugates for the treatment of cancer and immune disorders 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004015426A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2004015426A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-08-06</span>
                    <span class="td style-scope patent-result">2004-02-19</span>
                    <span class="td style-scope patent-result">Bayer Healthcare Ag</span>
                    <span class="td style-scope patent-result">Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 5(cxcr5) 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2004121218A/en"><a id="link" href="#" class="style-scope state-modifier">JP2004121218A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-08-06</span>
                    <span class="td style-scope patent-result">2004-04-22</span>
                    <span class="td style-scope patent-result">Jenokkusu Soyaku Kenkyusho:Kk</span>
                    <span class="td style-scope patent-result">Method for testing bronchial asthma or chronic obstructive pulmonary disease 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MXPA05001933A/en"><a id="link" href="#" class="style-scope state-modifier">MXPA05001933A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-08-19</span>
                    <span class="td style-scope patent-result">2005-04-28</span>
                    <span class="td style-scope patent-result">Genentech Inc</span>
                    <span class="td style-scope patent-result">Compositions and methods for the diagnosis and treatment of tumor. 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7504211B2/en"><a id="link" href="#" class="style-scope state-modifier">US7504211B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-08-27</span>
                    <span class="td style-scope patent-result">2009-03-17</span>
                    <span class="td style-scope patent-result">Bristol-Myers Squibb Company</span>
                    <span class="td style-scope patent-result">Methods of using EPHA2 for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004020595A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004020595A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-08-29</span>
                    <span class="td style-scope patent-result">2004-03-11</span>
                    <span class="td style-scope patent-result">Five Prime Therapeutics, Inc.</span>
                    <span class="td style-scope patent-result">Novel human polypeptides encoded by polynucleotides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004019993A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2004019993A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-08-30</span>
                    <span class="td style-scope patent-result">2004-03-11</span>
                    <span class="td style-scope patent-result">Ramot At Tel Aviv University Ltd.</span>
                    <span class="td style-scope patent-result">Self-immolative dendrimers releasing many active moieties upon a single activating event 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2002951346A0/en"><a id="link" href="#" class="style-scope state-modifier">AU2002951346A0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-09-05</span>
                    <span class="td style-scope patent-result">2002-09-26</span>
                    <span class="td style-scope patent-result">Garvan Institute Of Medical Research</span>
                    <span class="td style-scope patent-result">Diagnosis of ovarian cancer 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040180354A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040180354A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-09-06</span>
                    <span class="td style-scope patent-result">2004-09-16</span>
                    <span class="td style-scope patent-result">Simard John J.L.</span>
                    <span class="td style-scope patent-result">Epitope sequences 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2006513702A/en"><a id="link" href="#" class="style-scope state-modifier">JP2006513702A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-09-09</span>
                    <span class="td style-scope patent-result">2006-04-27</span>
                    <span class="td style-scope patent-result">ヌラ  インコーポレーティッド</span>
                    <span class="td style-scope patent-result">
  G protein-coupled receptor and use thereof
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2004113151A/en"><a id="link" href="#" class="style-scope state-modifier">JP2004113151A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-09-27</span>
                    <span class="td style-scope patent-result">2004-04-15</span>
                    <span class="td style-scope patent-result">Sankyo Co Ltd</span>
                    <span class="td style-scope patent-result">Oncogene and its application 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1554309A2/en"><a id="link" href="#" class="style-scope state-modifier">EP1554309A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-10-03</span>
                    <span class="td style-scope patent-result">2005-07-20</span>
                    <span class="td style-scope patent-result">McGILL UNIVERSITY</span>
                    <span class="td style-scope patent-result">Antibodies and cyclic peptides which bind cea (carcinoembryonic antigen) and their use as cancer therapeutics 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2501131A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2501131A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-10-04</span>
                    <span class="td style-scope patent-result">2004-04-22</span>
                    <span class="td style-scope patent-result">Van Andel Research Institute</span>
                    <span class="td style-scope patent-result">Molecular sub-classification of kidney tumors and the discovery of new diagnostic markers 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2006516094A/en"><a id="link" href="#" class="style-scope state-modifier">JP2006516094A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-08</span>
                    <span class="td style-scope patent-result">2006-06-22</span>
                    <span class="td style-scope patent-result">ジェネンテック・インコーポレーテッド</span>
                    <span class="td style-scope patent-result">
  Compositions and methods for treatment of natural killer cell related diseases
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1578940A4/en"><a id="link" href="#" class="style-scope state-modifier">EP1578940A4</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-13</span>
                    <span class="td style-scope patent-result">2007-12-12</span>
                    <span class="td style-scope patent-result">Genentech Inc</span>
                    <span class="td style-scope patent-result">Methods and compositions for diagnosing dysplasia 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2006507322A/en"><a id="link" href="#" class="style-scope state-modifier">JP2006507322A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-14</span>
                    <span class="td style-scope patent-result">2006-03-02</span>
                    <span class="td style-scope patent-result">シンタルガ・ビーブイ</span>
                    <span class="td style-scope patent-result">
  Prodrugs constructed as multiple self-detaching release spacers
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0226593D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0226593D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-14</span>
                    <span class="td style-scope patent-result">2002-12-24</span>
                    <span class="td style-scope patent-result">Consultants Ltd</span>
                    <span class="td style-scope patent-result">Compounds 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2003298650B2/en"><a id="link" href="#" class="style-scope state-modifier">AU2003298650B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-15</span>
                    <span class="td style-scope patent-result">2010-03-11</span>
                    <span class="td style-scope patent-result">Musc Foundation For Research Development</span>
                    <span class="td style-scope patent-result">Complement receptor 2 targeted complement modulators 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MXPA05005237A/en"><a id="link" href="#" class="style-scope state-modifier">MXPA05005237A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-15</span>
                    <span class="td style-scope patent-result">2005-08-16</span>
                    <span class="td style-scope patent-result">Univ Arkansas</span>
                    <span class="td style-scope patent-result">Ca125 gene and its use for diagnostic and therapeutic interventions. 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004046342A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004046342A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-20</span>
                    <span class="td style-scope patent-result">2004-06-03</span>
                    <span class="td style-scope patent-result">Biogen Idec Inc.</span>
                    <span class="td style-scope patent-result">Novel gene targets and ligands that bind thereto for treatment and diagnosis of carcinomas 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2507044A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2507044A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-21</span>
                    <span class="td style-scope patent-result">2004-06-10</span>
                    <span class="td style-scope patent-result">Mary Lucero</span>
                    <span class="td style-scope patent-result">Purinergic modulation of smell 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2003298786A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2003298786A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-11-26</span>
                    <span class="td style-scope patent-result">2004-06-18</span>
                    <span class="td style-scope patent-result">Protein Design Labs, Inc.</span>
                    <span class="td style-scope patent-result">Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004053079A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004053079A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-12-06</span>
                    <span class="td style-scope patent-result">2004-06-24</span>
                    <span class="td style-scope patent-result">Diadexus, Inc.</span>
                    <span class="td style-scope patent-result">Compositions, splice variants and methods relating to ovarian specific genes and proteins 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20040157278A1/en"><a id="link" href="#" class="style-scope state-modifier">US20040157278A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-12-13</span>
                    <span class="td style-scope patent-result">2004-08-12</span>
                    <span class="td style-scope patent-result">Bayer Corporation</span>
                    <span class="td style-scope patent-result">Detection methods using TIMP 1 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP4898120B2/en"><a id="link" href="#" class="style-scope state-modifier">JP4898120B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-12-20</span>
                    <span class="td style-scope patent-result">2012-03-14</span>
                    <span class="td style-scope patent-result">アボット  バイオセラピューティクス  コーポレイション</span>
                    <span class="td style-scope patent-result">
  Antibodies against GPR64 and methods of use thereof
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004058309A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2004058309A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-12-23</span>
                    <span class="td style-scope patent-result">2004-07-15</span>
                    <span class="td style-scope patent-result">Human Genome Sciences, Inc.</span>
                    <span class="td style-scope patent-result">Neutrokine-alpha conjugate, neutrokine-alpha complex, and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2007520995A/en"><a id="link" href="#" class="style-scope state-modifier">JP2007520995A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-01-08</span>
                    <span class="td style-scope patent-result">2007-08-02</span>
                    <span class="td style-scope patent-result">ブリストル−マイヤーズ　スクイブ　カンパニー</span>
                    <span class="td style-scope patent-result">
  Biomarkers and methods for determining susceptibility to epidermal growth factor receptor modulators
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20050181375A1/en"><a id="link" href="#" class="style-scope state-modifier">US20050181375A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-01-10</span>
                    <span class="td style-scope patent-result">2005-08-18</span>
                    <span class="td style-scope patent-result">Natasha Aziz</span>
                    <span class="td style-scope patent-result">Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of metastatic cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20050227301A1/en"><a id="link" href="#" class="style-scope state-modifier">US20050227301A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-01-10</span>
                    <span class="td style-scope patent-result">2005-10-13</span>
                    <span class="td style-scope patent-result">Polgen</span>
                    <span class="td style-scope patent-result">Cell cycle progression proteins 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004065577A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004065577A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-01-14</span>
                    <span class="td style-scope patent-result">2004-08-05</span>
                    <span class="td style-scope patent-result">Bristol-Myers Squibb Company</span>
                    <span class="td style-scope patent-result">Polynucleotides and polypeptides associated with the nf-kb pathway 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004065576A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004065576A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-01-15</span>
                    <span class="td style-scope patent-result">2004-08-05</span>
                    <span class="td style-scope patent-result">Millennium Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Methods and compositions for the treatment of urological disorder using differential expressed polypeptides 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2516128A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2516128A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-02-14</span>
                    <span class="td style-scope patent-result">2004-09-02</span>
                    <span class="td style-scope patent-result">Sagres Discovery, Inc.</span>
                    <span class="td style-scope patent-result">Therapeutic targets in cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20030224411A1/en"><a id="link" href="#" class="style-scope state-modifier">US20030224411A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-03-13</span>
                    <span class="td style-scope patent-result">2003-12-04</span>
                    <span class="td style-scope patent-result">Stanton Lawrence W.</span>
                    <span class="td style-scope patent-result">Genes that are up- or down-regulated during differentiation of human embryonic stem cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2520898C/en"><a id="link" href="#" class="style-scope state-modifier">CA2520898C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-03-31</span>
                    <span class="td style-scope patent-result">2009-10-20</span>
                    <span class="td style-scope patent-result">Council Of Scientific And Industrial Research</span>
                    <span class="td style-scope patent-result">Non-cross-linking pyrrolo(2,1-c)(1,4)benzodiazepines as potential antitumour agents and process thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0321295D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0321295D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-09-11</span>
                    <span class="td style-scope patent-result">2003-10-15</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Synthesis of protected pyrrolobenzodiazepines 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0416511D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0416511D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-10-22</span>
                    <span class="td style-scope patent-result">2004-08-25</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7375078B2/en"><a id="link" href="#" class="style-scope state-modifier">US7375078B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-02-23</span>
                    <span class="td style-scope patent-result">2008-05-20</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Heterocyclic self-immolative linkers and conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0404574D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0404574D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-03-01</span>
                    <span class="td style-scope patent-result">2004-04-07</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Amino acids 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2005085251A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2005085251A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-03-01</span>
                    <span class="td style-scope patent-result">2005-09-15</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">11-hydroxy-5h-pyrrolo[2,1-c][1,4]benzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0404577D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0404577D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-03-01</span>
                    <span class="td style-scope patent-result">2004-04-07</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0404578D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0404578D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-03-01</span>
                    <span class="td style-scope patent-result">2004-04-07</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7528126B2/en"><a id="link" href="#" class="style-scope state-modifier">US7528126B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-03-09</span>
                    <span class="td style-scope patent-result">2009-05-05</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/FR2869231B1/en"><a id="link" href="#" class="style-scope state-modifier">FR2869231B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-04-27</span>
                    <span class="td style-scope patent-result">2008-03-14</span>
                    <span class="td style-scope patent-result">Sod Conseils Rech Applic</span>
                    <span class="td style-scope patent-result">
  THERAPEUTIC COMPOSITION CONTAINING AT LEAST ONE PYRROLOBENZODIAZEPINE DERIVATIVE AND FLUDARABINE
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0410725D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0410725D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-05-13</span>
                    <span class="td style-scope patent-result">2004-06-16</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine therapeutic agents 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR101270829B1/en"><a id="link" href="#" class="style-scope state-modifier">KR101270829B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-09-23</span>
                    <span class="td style-scope patent-result">2013-06-07</span>
                    <span class="td style-scope patent-result">제넨테크, 인크.</span>
                    <span class="td style-scope patent-result">Cystein engineered antibodies and conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DK1879901T3/en"><a id="link" href="#" class="style-scope state-modifier">DK1879901T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-04-21</span>
                    <span class="td style-scope patent-result">2010-05-03</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">
  pyrrolobenzodiazepines
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0508084D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0508084D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-04-21</span>
                    <span class="td style-scope patent-result">2005-06-01</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20070154906A1/en"><a id="link" href="#" class="style-scope state-modifier">US20070154906A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-10-05</span>
                    <span class="td style-scope patent-result">2007-07-05</span>
                    <span class="td style-scope patent-result">Spirogen Ltd.</span>
                    <span class="td style-scope patent-result">Methods to identify therapeutic candidates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ATE427949T1/en"><a id="link" href="#" class="style-scope state-modifier">ATE427949T1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-10-05</span>
                    <span class="td style-scope patent-result">2009-04-15</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">
  4-A4-(5-OXO-2,3,5,11A-TETRAHYDRO-5H-PYRROLO A2, 1-CUA1,4UBENZODIAZEPINE-8-YLOXY)-BUTYRYLAMINOU-1 - PYRROLE-2-CARBONATE ALKYL ESTER DERIVATIVES AND RELATED COMPOUND FOR THE TREATMENT OF A PROLIFERATIVE DISEASE
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ATE504565T1/en"><a id="link" href="#" class="style-scope state-modifier">ATE504565T1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-10-07</span>
                    <span class="td style-scope patent-result">2011-04-15</span>
                    <span class="td style-scope patent-result">Exelixis Inc</span>
                    <span class="td style-scope patent-result">
  AZETIDINES AS MEK INHIBITORS IN THE TREATMENT OF PROLIFERATIVE DISEASES
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2374964T3/en"><a id="link" href="#" class="style-scope state-modifier">ES2374964T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-01-25</span>
                    <span class="td style-scope patent-result">2012-02-23</span>
                    <span class="td style-scope patent-result">Sanofi</span>
                    <span class="td style-scope patent-result">
  CYTOTOXIC AGENTS UNDERSTANDING NEW TOMAIMYCIN DERIVATIVES.
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2008050140A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2008050140A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-10-27</span>
                    <span class="td style-scope patent-result">2008-05-02</span>
                    <span class="td style-scope patent-result">Spirogen Limited</span>
                    <span class="td style-scope patent-result">Compounds for treatment of parasitic infection 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP5290276B2/en"><a id="link" href="#" class="style-scope state-modifier">JP5290276B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-05-08</span>
                    <span class="td style-scope patent-result">2013-09-18</span>
                    <span class="td style-scope patent-result">ジェネンテック，  インコーポレイテッド</span>
                    <span class="td style-scope patent-result">
  Cysteine-modified anti-MUC16 antibody and antibody-drug conjugate
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MX2010003718A/en"><a id="link" href="#" class="style-scope state-modifier">MX2010003718A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-10-19</span>
                    <span class="td style-scope patent-result">2010-04-21</span>
                    <span class="td style-scope patent-result">Genentech Inc</span>
                    <span class="td style-scope patent-result">Cysteine engineered anti-tenb2 antibodies and antibody drug conjugates. 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0722087D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0722087D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-11-09</span>
                    <span class="td style-scope patent-result">2007-12-19</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Polyamides 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0722088D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0722088D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-11-09</span>
                    <span class="td style-scope patent-result">2007-12-19</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0813432D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0813432D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-07-22</span>
                    <span class="td style-scope patent-result">2008-08-27</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0819097D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0819097D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-10-17</span>
                    <span class="td style-scope patent-result">2008-11-26</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2010210646B2/en"><a id="link" href="#" class="style-scope state-modifier">AU2010210646B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-02-05</span>
                    <span class="td style-scope patent-result">2015-10-29</span>
                    <span class="td style-scope patent-result">Immunogen, Inc.</span>
                    <span class="td style-scope patent-result">Novel benzodiazepine derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201006340D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201006340D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-15</span>
                    <span class="td style-scope patent-result">2010-06-02</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Synthesis method and intermediates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2558475A1/en"><a id="link" href="#" class="style-scope state-modifier">EP2558475A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-15</span>
                    <span class="td style-scope patent-result">2013-02-20</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines used to treat proliferative diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20130028917A1/en"><a id="link" href="#" class="style-scope state-modifier">US20130028917A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-15</span>
                    <span class="td style-scope patent-result">2013-01-31</span>
                    <span class="td style-scope patent-result">Spirogen Developments Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP5870400B2/en"><a id="link" href="#" class="style-scope state-modifier">JP5870400B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-15</span>
                    <span class="td style-scope patent-result">2016-03-01</span>
                    <span class="td style-scope patent-result">シアトル ジェネティクス，インコーポレーテッド</span>
                    <span class="td style-scope patent-result">
  Targeted pyrrolobenzodiazepine conjugates
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2013055990A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2013055990A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2013-04-18</span>
                    <span class="td style-scope patent-result">Seattle Genetics, Inc.</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and targeted conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN110183470A/en"><a id="link" href="#" class="style-scope state-modifier">CN110183470A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2019-08-30</span>
                    <span class="td style-scope patent-result">麦迪穆有限责任公司</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines are tall and erect 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN103997893B/en"><a id="link" href="#" class="style-scope state-modifier">CN103997893B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2019-04-12</span>
                    <span class="td style-scope patent-result">西雅图基因公司</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines Zhuo and targeting conjugate 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2013053872A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2013053872A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2013-04-18</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR101891859B1/en"><a id="link" href="#" class="style-scope state-modifier">KR101891859B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2018-08-24</span>
                    <span class="td style-scope patent-result">메디뮨 리미티드</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2012322607B2/en"><a id="link" href="#" class="style-scope state-modifier">AU2012322607B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2017-02-16</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2871172C/en"><a id="link" href="#" class="style-scope state-modifier">CA2871172C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-04-30</span>
                    <span class="td style-scope patent-result">2020-08-25</span>
                    <span class="td style-scope patent-result">Spirogen Sarl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MX2014013144A/en"><a id="link" href="#" class="style-scope state-modifier">MX2014013144A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-04-30</span>
                    <span class="td style-scope patent-result">2015-05-11</span>
                    <span class="td style-scope patent-result">Ucl Business Plc</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines. 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2013177481A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2013177481A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-05-25</span>
                    <span class="td style-scope patent-result">2013-11-28</span>
                    <span class="td style-scope patent-result">Immunogen, Inc.</span>
                    <span class="td style-scope patent-result">Benzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2869849A1/en"><a id="link" href="#" class="style-scope state-modifier">EP2869849A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-07-09</span>
                    <span class="td style-scope patent-result">2015-05-13</span>
                    <span class="td style-scope patent-result">Genentech, Inc.</span>
                    <span class="td style-scope patent-result">Immunoconjugates comprising anti-cd22 antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AR091700A1/en"><a id="link" href="#" class="style-scope state-modifier">AR091700A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-07-09</span>
                    <span class="td style-scope patent-result">2015-02-25</span>
                    <span class="td style-scope patent-result">Genentech Inc</span>
                    <span class="td style-scope patent-result">
  ANTI-CD79B ANTIBODIES AND IMMUNOCATION
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MX2015001399A/en"><a id="link" href="#" class="style-scope state-modifier">MX2015001399A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-08-02</span>
                    <span class="td style-scope patent-result">2015-09-07</span>
                    <span class="td style-scope patent-result">Genentech Inc</span>
                    <span class="td style-scope patent-result">Anti-etbr antibodies and immunoconjugates. 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ME03486B/en"><a id="link" href="#" class="style-scope state-modifier">ME03486B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2020-01-20</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA3060520C/en"><a id="link" href="#" class="style-scope state-modifier">CA3060520C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2022-05-17</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2906249B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2906249B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2018-06-27</span>
                    <span class="td style-scope patent-result">MedImmune Limited</span>
                    <span class="td style-scope patent-result">Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/PT2906296T/en"><a id="link" href="#" class="style-scope state-modifier">PT2906296T</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2018-06-01</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2906298B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2906298B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2018-10-03</span>
                    <span class="td style-scope patent-result">ADC Therapeutics SA</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014057118A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2014057118A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2014-04-17</span>
                    <span class="td style-scope patent-result">Adc Therapeutics Sarl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-anti-cd22 antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2887899C/en"><a id="link" href="#" class="style-scope state-modifier">CA2887899C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2020-03-31</span>
                    <span class="td style-scope patent-result">Adc Therapeutics Sarl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-anti-cd22 antibody conjugates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2906297B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2906297B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2017-12-06</span>
                    <span class="td style-scope patent-result">ADC Therapeutics SA</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2016502504A/en"><a id="link" href="#" class="style-scope state-modifier">JP2016502504A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2016-01-28</span>
                    <span class="td style-scope patent-result">エイディーシー・セラピューティクス・エス・アー・エール・エルＡｄｃ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｓａｒｌ</span>
                    <span class="td style-scope patent-result">
  Pyrrolobenzodiazepine-antibody conjugate
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/LT2906253T/en"><a id="link" href="#" class="style-scope state-modifier">LT2906253T</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2018-10-10</span>
                    <span class="td style-scope patent-result">Adc Therapeutics Sa</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine - anti-psma antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ES2680153T3/en"><a id="link" href="#" class="style-scope state-modifier">ES2680153T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2018-09-04</span>
                    <span class="td style-scope patent-result">Adc Therapeutics Sa</span>
                    <span class="td style-scope patent-result">
  Anti-PSMA-pyrrolobenzodiazepine antibody conjugates
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9567340B2/en"><a id="link" href="#" class="style-scope state-modifier">US9567340B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-12-21</span>
                    <span class="td style-scope patent-result">2017-02-14</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EA031585B1/en"><a id="link" href="#" class="style-scope state-modifier">EA031585B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-12-21</span>
                    <span class="td style-scope patent-result">2019-01-31</span>
                    <span class="td style-scope patent-result">Медимьюн Лимитед</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/RS58873B1/en"><a id="link" href="#" class="style-scope state-modifier">RS58873B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-02-22</span>
                    <span class="td style-scope patent-result">2019-08-30</span>
                    <span class="td style-scope patent-result">Abbvie Stemcentrx Llc</span>
                    <span class="td style-scope patent-result">Antidll3-antibody-pbd conjugates and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AR096287A1/en"><a id="link" href="#" class="style-scope state-modifier">AR096287A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-03-13</span>
                    <span class="td style-scope patent-result">2015-12-23</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">
  PIRROLOBENZODIACEPINS AND CONJUGATES
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2904044C/en"><a id="link" href="#" class="style-scope state-modifier">CA2904044C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-03-13</span>
                    <span class="td style-scope patent-result">2020-03-31</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN105209077B/en"><a id="link" href="#" class="style-scope state-modifier">CN105209077B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-03-13</span>
                    <span class="td style-scope patent-result">2019-06-11</span>
                    <span class="td style-scope patent-result">麦迪穆有限责任公司</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines Zhuo and its conjugate 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20160106861A1/en"><a id="link" href="#" class="style-scope state-modifier">US20160106861A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-04-26</span>
                    <span class="td style-scope patent-result">2016-04-21</span>
                    <span class="td style-scope patent-result">Spirogen Sarl</span>
                    <span class="td style-scope patent-result">Axl antibody-drug conjugate and its use for the treatment of cancer 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015052532A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015052532A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">2015-04-16</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP3054986B1/en"><a id="link" href="#" class="style-scope state-modifier">EP3054986B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">2019-03-20</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015052534A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015052534A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">2015-04-16</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20160256561A1/en"><a id="link" href="#" class="style-scope state-modifier">US20160256561A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">2016-09-08</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201317982D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201317982D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">2013-11-27</span>
                    <span class="td style-scope patent-result">Spirogen Sarl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201317981D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201317981D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">2013-11-27</span>
                    <span class="td style-scope patent-result">Spirogen Sarl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10533058B2/en"><a id="link" href="#" class="style-scope state-modifier">US10533058B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-12-16</span>
                    <span class="td style-scope patent-result">2020-01-14</span>
                    <span class="td style-scope patent-result">Genentech Inc.</span>
                    <span class="td style-scope patent-result">Peptidomimetic compounds and antibody-drug conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201406767D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201406767D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-04-15</span>
                    <span class="td style-scope patent-result">2014-05-28</span>
                    <span class="td style-scope patent-result">Cancer Rec Tech Ltd</span>
                    <span class="td style-scope patent-result">Humanized anti-Tn-MUC1 antibodies anf their conjugates 
     </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="citedBy" class="scroll-target style-scope patent-result">
              Cited By (54)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP3388086B1/en"><a id="link" href="#" class="style-scope state-modifier">EP3388086B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-08-17</span>
                    <span class="td style-scope patent-result">2020-10-07</span>
                    <span class="td style-scope patent-result">Purdue Research Foundation</span>
                    <span class="td style-scope patent-result">Psma binding ligand-linker conjugates and methods for using 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB0819095D0/en"><a id="link" href="#" class="style-scope state-modifier">GB0819095D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-10-17</span>
                    <span class="td style-scope patent-result">2008-11-26</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9951324B2/en"><a id="link" href="#" class="style-scope state-modifier">US9951324B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-02-25</span>
                    <span class="td style-scope patent-result">2018-04-24</span>
                    <span class="td style-scope patent-result">Purdue Research Foundation</span>
                    <span class="td style-scope patent-result">PSMA binding ligand-linker conjugates and methods for using 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP5870400B2/en"><a id="link" href="#" class="style-scope state-modifier">JP5870400B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-15</span>
                    <span class="td style-scope patent-result">2016-03-01</span>
                    <span class="td style-scope patent-result">シアトル ジェネティクス，インコーポレーテッド</span>
                    <span class="td style-scope patent-result">
  Targeted pyrrolobenzodiazepine conjugates
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2558475A1/en"><a id="link" href="#" class="style-scope state-modifier">EP2558475A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-15</span>
                    <span class="td style-scope patent-result">2013-02-20</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines used to treat proliferative diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2012311505B2/en"><a id="link" href="#" class="style-scope state-modifier">AU2012311505B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-09-20</span>
                    <span class="td style-scope patent-result">2016-09-29</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines as unsymmetrical dimeric PBD compounds for inclusion in targeted conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN110183470A/en"><a id="link" href="#" class="style-scope state-modifier">CN110183470A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2019-08-30</span>
                    <span class="td style-scope patent-result">麦迪穆有限责任公司</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines are tall and erect 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN103997893B/en"><a id="link" href="#" class="style-scope state-modifier">CN103997893B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2019-04-12</span>
                    <span class="td style-scope patent-result">西雅图基因公司</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines Zhuo and targeting conjugate 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR101891859B1/en"><a id="link" href="#" class="style-scope state-modifier">KR101891859B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2018-08-24</span>
                    <span class="td style-scope patent-result">메디뮨 리미티드</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2013055990A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2013055990A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2013-04-18</span>
                    <span class="td style-scope patent-result">Seattle Genetics, Inc.</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and targeted conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2906249B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2906249B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2018-06-27</span>
                    <span class="td style-scope patent-result">MedImmune Limited</span>
                    <span class="td style-scope patent-result">Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA3060520C/en"><a id="link" href="#" class="style-scope state-modifier">CA3060520C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2022-05-17</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ME03486B/en"><a id="link" href="#" class="style-scope state-modifier">ME03486B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2020-01-20</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN108042811A/en"><a id="link" href="#" class="style-scope state-modifier">CN108042811A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-11-15</span>
                    <span class="td style-scope patent-result">2018-05-18</span>
                    <span class="td style-scope patent-result">恩多塞特公司</span>
                    <span class="td style-scope patent-result">For treating the conjugate of the disease as caused by PSMA expression cells 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9567340B2/en"><a id="link" href="#" class="style-scope state-modifier">US9567340B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-12-21</span>
                    <span class="td style-scope patent-result">2017-02-14</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EA031585B1/en"><a id="link" href="#" class="style-scope state-modifier">EA031585B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-12-21</span>
                    <span class="td style-scope patent-result">2019-01-31</span>
                    <span class="td style-scope patent-result">Медимьюн Лимитед</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AR096287A1/en"><a id="link" href="#" class="style-scope state-modifier">AR096287A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-03-13</span>
                    <span class="td style-scope patent-result">2015-12-23</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">
  PIRROLOBENZODIACEPINS AND CONJUGATES
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2904044C/en"><a id="link" href="#" class="style-scope state-modifier">CA2904044C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-03-13</span>
                    <span class="td style-scope patent-result">2020-03-31</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201317981D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201317981D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">2013-11-27</span>
                    <span class="td style-scope patent-result">Spirogen Sarl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201317982D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201317982D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-11</span>
                    <span class="td style-scope patent-result">2013-11-27</span>
                    <span class="td style-scope patent-result">Spirogen Sarl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/LT4095130T/en"><a id="link" href="#" class="style-scope state-modifier">LT4095130T</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-18</span>
                    <span class="td style-scope patent-result">2024-04-25</span>
                    <span class="td style-scope patent-result">Novartis Ag</span>
                    <span class="td style-scope patent-result">Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10188746B2/en"><a id="link" href="#" class="style-scope state-modifier">US10188746B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-09-10</span>
                    <span class="td style-scope patent-result">2019-01-29</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MX2017003126A/en"><a id="link" href="#" class="style-scope state-modifier">MX2017003126A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-09-12</span>
                    <span class="td style-scope patent-result">2017-08-28</span>
                    <span class="td style-scope patent-result">Genentech Inc</span>
                    <span class="td style-scope patent-result">Anti-her2 antibodies and immunoconjugates. 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201416112D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201416112D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-09-12</span>
                    <span class="td style-scope patent-result">2014-10-29</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN107124870A/en"><a id="link" href="#" class="style-scope state-modifier">CN107124870A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-09-17</span>
                    <span class="td style-scope patent-result">2017-09-01</span>
                    <span class="td style-scope patent-result">基因泰克公司</span>
                    <span class="td style-scope patent-result">Immunoconjugates comprising Anti-HER 2 and Pyrrolobenzodiazepines * 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2968447A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2968447A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-11-25</span>
                    <span class="td style-scope patent-result">2016-06-02</span>
                    <span class="td style-scope patent-result">Adc Therapeutics Sa</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates and their use to treat neoplasms 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10188759B2/en"><a id="link" href="#" class="style-scope state-modifier">US10188759B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-01-07</span>
                    <span class="td style-scope patent-result">2019-01-29</span>
                    <span class="td style-scope patent-result">Endocyte, Inc.</span>
                    <span class="td style-scope patent-result">Conjugates for imaging 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2016115201A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2016115201A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-01-14</span>
                    <span class="td style-scope patent-result">2016-07-21</span>
                    <span class="td style-scope patent-result">Bristol-Myers Squibb Company</span>
                    <span class="td style-scope patent-result">Heteroarylene-bridged benzodiazepine dimers, conjugates thereof, and methods of making and using 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EA201791550A1/en"><a id="link" href="#" class="style-scope state-modifier">EA201791550A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-01-14</span>
                    <span class="td style-scope patent-result">2017-11-30</span>
                    <span class="td style-scope patent-result">Бристол-Маерс Сквибб Компани</span>
                    <span class="td style-scope patent-result">
  DYMERAS OF BENZODIAZEPINS, THEIR CONJUGATES AND METHODS OF THEIR RECEPTION AND APPLICATION
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN107847609A/en"><a id="link" href="#" class="style-scope state-modifier">CN107847609A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-03-13</span>
                    <span class="td style-scope patent-result">2018-03-27</span>
                    <span class="td style-scope patent-result">恩多塞特公司</span>
                    <span class="td style-scope patent-result">For treating the conjugate of disease 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/BR112017027258A2/en"><a id="link" href="#" class="style-scope state-modifier">BR112017027258A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-06-23</span>
                    <span class="td style-scope patent-result">2018-08-28</span>
                    <span class="td style-scope patent-result">Bristol-Myers Squibb Company</span>
                    <span class="td style-scope patent-result">
  macrocyclic benzodiazepine dimers, conjugates thereof, preparation and uses
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MA43345A/en"><a id="link" href="#" class="style-scope state-modifier">MA43345A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-10-02</span>
                    <span class="td style-scope patent-result">2018-08-08</span>
                    <span class="td style-scope patent-result">Hoffmann La Roche</span>
                    <span class="td style-scope patent-result">
  PYRROLOBENZODIAZEPINE ANTIBODY-DRUG CONJUGATES AND METHODS OF USE
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201601431D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201601431D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-01-26</span>
                    <span class="td style-scope patent-result">2016-03-09</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201602359D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201602359D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-02-10</span>
                    <span class="td style-scope patent-result">2016-03-23</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine Conjugates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201602356D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201602356D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-02-10</span>
                    <span class="td style-scope patent-result">2016-03-23</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine Conjugates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2017172930A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2017172930A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-03-29</span>
                    <span class="td style-scope patent-result">2017-10-05</span>
                    <span class="td style-scope patent-result">Endocyte, Inc.</span>
                    <span class="td style-scope patent-result">Pbd conjugates for treating diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201607478D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201607478D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-04-29</span>
                    <span class="td style-scope patent-result">2016-06-15</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine Conjugates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/TW201808936A/en"><a id="link" href="#" class="style-scope state-modifier">TW201808936A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-05-18</span>
                    <span class="td style-scope patent-result">2018-03-16</span>
                    <span class="td style-scope patent-result">美商梅爾莎納醫療公司</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2017223275A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2017223275A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-06-24</span>
                    <span class="td style-scope patent-result">2017-12-28</span>
                    <span class="td style-scope patent-result">Mersana Therapeutics, Inc.</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201617466D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201617466D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-10-14</span>
                    <span class="td style-scope patent-result">2016-11-30</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20200032243A/en"><a id="link" href="#" class="style-scope state-modifier">KR20200032243A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-02-08</span>
                    <span class="td style-scope patent-result">2020-03-25</span>
                    <span class="td style-scope patent-result">에이디씨 테라퓨틱스 에스에이</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201702031D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201702031D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-02-08</span>
                    <span class="td style-scope patent-result">2017-03-22</span>
                    <span class="td style-scope patent-result">Medlmmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-antibody conjugates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/PT3612537T/en"><a id="link" href="#" class="style-scope state-modifier">PT3612537T</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-04-18</span>
                    <span class="td style-scope patent-result">2022-08-29</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/UA127900C2/en"><a id="link" href="#" class="style-scope state-modifier">UA127900C2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-06-14</span>
                    <span class="td style-scope patent-result">2024-02-07</span>
                    <span class="td style-scope patent-result">Ейдісі Терапьютікс Са</span>
                    <span class="td style-scope patent-result">Dosage regimes for the administration of an anti-cd19 adc 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DK3668874T3/en"><a id="link" href="#" class="style-scope state-modifier">DK3668874T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-08-18</span>
                    <span class="td style-scope patent-result">2022-02-14</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">
  Pyrrolobenzodiazepine conjugates
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201714115D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201714115D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-09-04</span>
                    <span class="td style-scope patent-result">2017-10-18</span>
                    <span class="td style-scope patent-result">Femtogenix Ltd</span>
                    <span class="td style-scope patent-result">Cytotoxic agents 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN117003875A/en"><a id="link" href="#" class="style-scope state-modifier">CN117003875A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-09-29</span>
                    <span class="td style-scope patent-result">2023-11-07</span>
                    <span class="td style-scope patent-result">第一三共株式会社</span>
                    <span class="td style-scope patent-result">Antibody or functional fragment thereof, polynucleotide, expression vector, host cell, sugar chain reconstruction antibody, pharmaceutical composition and application 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP3717021A1/en"><a id="link" href="#" class="style-scope state-modifier">EP3717021A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-11-27</span>
                    <span class="td style-scope patent-result">2020-10-07</span>
                    <span class="td style-scope patent-result">Mersana Therapeutics, Inc.</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2019126691A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2019126691A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-12-21</span>
                    <span class="td style-scope patent-result">2019-06-27</span>
                    <span class="td style-scope patent-result">Mersana Therapeutics, Inc.</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201803342D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201803342D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-03-01</span>
                    <span class="td style-scope patent-result">2018-04-18</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Methods 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201806022D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201806022D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-04-12</span>
                    <span class="td style-scope patent-result">2018-05-30</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2020079239A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2020079239A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-10-19</span>
                    <span class="td style-scope patent-result">2020-04-23</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2021080608A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2021080608A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-10-25</span>
                    <span class="td style-scope patent-result">2021-04-29</span>
                    <span class="td style-scope patent-result">Medimmune, Llc</span>
                    <span class="td style-scope patent-result">Branched moiety for use in conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2022353890A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2022353890A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2021-09-30</span>
                    <span class="td style-scope patent-result">2024-04-04</span>
                    <span class="td style-scope patent-result">Jiangsu Hengrui Pharmaceuticals Co., Ltd.</span>
                    <span class="td style-scope patent-result">Pyrrolo benzodiazepine derivative, and conjugate, preparation method and use thereof 
     </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>

              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party, ‡ Family to family citation</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="similarDocuments" class="scroll-target style-scope patent-result">
              Similar Documents
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication</span>
                    <span class="th style-scope patent-result">Publication Date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2013366490B9/en"><a id="link" href="#" class="style-scope state-modifier">AU2013366490B9</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-02-01</span>
                    <span class="td style-scope patent-result">Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US11690918B2/en"><a id="link" href="#" class="style-scope state-modifier">US11690918B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023-07-04</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-anti-CD22 antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2968585B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2968585B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-07-18</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10420777B2/en"><a id="link" href="#" class="style-scope state-modifier">US10420777B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-09-24</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10188746B2/en"><a id="link" href="#" class="style-scope state-modifier">US10188746B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-01-29</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2935268B2/en"><a id="link" href="#" class="style-scope state-modifier">EP2935268B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2021-02-17</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9649390B2/en"><a id="link" href="#" class="style-scope state-modifier">US9649390B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-05-16</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20150273077A1/en"><a id="link" href="#" class="style-scope state-modifier">US20150273077A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-10-01</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine-anti-her2 antibody conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20180092985A1/en"><a id="link" href="#" class="style-scope state-modifier">US20180092985A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2018-04-05</span>
                    <span class="td style-scope patent-result">Site-specific antibody-drug conjugates 
     </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="relatedApplications" class="scroll-target style-scope patent-result">Priority And Related Applications</h3>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="appsClaimingPriority" class="scroll-target style-scope patent-result">
              Applications Claiming Priority (3)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US201261740605P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2012-12-21</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US61/740,605<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2012-12-21</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2014096365A1/en"><a id="link" href="#" class="style-scope state-modifier">PCT/EP2013/077695</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2013-12-20</span>
                    <span class="td style-scope patent-result">Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="legalEvents" class="scroll-target style-scope patent-result">
              Legal Events
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Date</span>
                    <span class="th style-scope patent-result">Code</span>
                    <span class="th style-scope patent-result">Title</span>
                    <span class="th style-scope patent-result">Description</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2015-11-19</span>
                    <span class="td nowrap style-scope patent-result">PC1</span>
                    <span class="td nowrap style-scope patent-result">Assignment before grant (sect. 113)</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Owner name</strong>: MEDIMMUNE LIMITED</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: FORMER APPLICANT(S): SPIROGEN SARL</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-02-01</span>
                    <span class="td nowrap style-scope patent-result">SREP</span>
                    <span class="td nowrap style-scope patent-result">Specification republished</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-05-17</span>
                    <span class="td nowrap style-scope patent-result">FGA</span>
                    <span class="td nowrap style-scope patent-result">Letters patent sealed or granted (standard patent)</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2023-07-13</span>
                    <span class="td nowrap style-scope patent-result">MK14</span>
                    <span class="td nowrap style-scope patent-result">Patent ceased section 143(a) (annual fees not paid) or expired</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
              <h3 id="concepts" class="scroll-target layout horizontal style-scope patent-result">
                <div class="flex style-scope patent-result">Concepts</div>
                <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
              </h3>
              <div class="layout horizontal style-scope patent-result">
                <div class="flex style-scope patent-result">
                  <span id="conceptsWarning" class="righthead tooltip-hint style-scope patent-result">machine-extracted</span>
                  <overlay-tooltip positioning-target="#conceptsWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The concepts are extracted by a computer and may be incomplete or incorrect.
    </div>
  </overlay-tooltip>
                </div>
                <span class="headerButton style-scope patent-result"><a href="#" target="_blank" style="display: inline-block;" class="style-scope patent-result"><iron-icon icon="icons:file-download" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M19 9h-4V3H9v6H5l7 7 7-7zM5 18v2h14v-2H5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download</a></span>
                <span class="style-scope patent-result">
                  <dropdown-menu multi="true" label="Filter table" show-label="true" change-action="RESULT_CONCEPT_MENU" class="style-scope patent-result">
    
    <span class="label style-scope dropdown-menu">
      <span class="style-scope dropdown-menu">Filter table</span>
      <span id="selected" class="style-scope dropdown-menu" hidden="">
        <span style="margin: 0 4px 0 2px" class="style-scope dropdown-menu">·</span>
        <span class="style-scope dropdown-menu"></span>
      </span>
      <iron-icon icon="icons:arrow-drop-down" class="style-scope dropdown-menu x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 10l5 5 5-5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><iron-icon icon="icons:arrow-drop-up" class="style-scope dropdown-menu x-scope iron-icon-0" hidden=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
    </span>
    <iron-dropdown allow-outside-scroll="" horizontal-align="left" vertical-align="top" class="style-scope dropdown-menu" aria-disabled="false" aria-hidden="true" style="outline: none; display: none;">
    

    <div id="contentWrapper" class="style-scope iron-dropdown">
      <div class="dropdown-content style-scope dropdown-menu" slot="dropdown-content" id="menu" multi="">
        <div class="style-scope dropdown-menu">
          
            <div class="item style-scope dropdown-menu">Chemical compound</div>
          <template is="dom-repeat" class="style-scope dropdown-menu"></template>
        </div>
      </div>
    </div>
  </iron-dropdown>
  </dropdown-menu>
                </span>
              </div>
              <div class="responsive-table style-scope patent-result">
                <div class="table style-scope patent-result">
                  <div class="thead style-scope patent-result">
                    <div class="tr style-scope patent-result">
                      <span class="th style-scope patent-result">Name</span>
                      <span class="th style-scope patent-result">Image</span>
                      <span class="th style-scope patent-result">Sections</span>
                      <span class="th style-scope patent-result">Count</span>
                      <span class="th style-scope patent-result">Query match</span>
                    </div>
                  </div>
                  <div class="tbody style-scope patent-result">
                    <template is="dom-repeat" initial-count="25" class="style-scope patent-result"></template>
                    
                      <div class$="tr layout horizontal conceptDomain" class="style-scope patent-result">
                        <a href="#" class="td flex style-scope patent-result">
                          Show all concepts from the description section
                        </a>
                      </div>
                    <template is="dom-if" class="style-scope patent-result"></template>
                  </div>
                </div>
              </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <div id="notices" class="vertical layout center style-scope patent-result">
              
                <span class="style-scope patent-result">Data provided by IFI CLAIMS Patent Services</span>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
          </div>
          <div class="bottombar style-scope patent-result">
            <bottom-bar class="style-scope patent-result"><template is="dom-if" class="style-scope bottom-bar"></template>
</bottom-bar>
          </div>
        </div>
      </div>
      <template is="dom-if" class="style-scope patent-result"></template>
    </div>
  </patent-result>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
  </result-container>
        </div>
      </div>
    
        </div>
      </div>
      <search-footer class="style-scope search-ui">
    
    

    <div id="footer" class="vertical layout center style-scope search-footer">
        <span class="links style-scope search-footer">
          <overlay-tooltip positioning-target="#footerAbout" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Learn more about data coverage, search syntax and other features.
    </div>
  </overlay-tooltip>
          <a id="footerAbout" data-proto="ABOUT" href="https://support.google.com/faqs/answer/6390996" target="_blank" class="style-scope search-footer">About</a>
          <overlay-tooltip positioning-target="#footerFeedback" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Send feedback about technical issues or feature requests for Google Patents.
    </div>
  </overlay-tooltip>
          <a id="footerFeedback" data-proto="SEND_FEEDBACK" href="#" onclick="sendFeedback();" class="style-scope search-footer">Send Feedback</a>
          <a data-proto="PUBLIC_DATASETS" href="https://console.cloud.google.com/marketplace/product/google_patents_public_datasets/google-patents-public-data" target="_blank" class="style-scope search-footer">Public Datasets</a>
          <a data-proto="TERMS" href="https://www.google.com/policies/terms/" target="_blank" class="style-scope search-footer">Terms</a>
          <a data-proto="PRIVACY_POLICY" href="https://www.google.com/privacy/privacy-policy.html" target="blank" class="style-scope search-footer">Privacy Policy</a>
          <a data-proto="SEARCH_HELP" href="https://support.google.com/websearch/" target="_blank" class="style-scope search-footer">Help</a>
        </span>
    </div>
  </search-footer>
    </div>

  </search-ui>
  </search-result>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <paper-toast id="toast" duration="3000" class="style-scope search-app x-scope paper-toast-0" aria-hidden="true" style="outline: none; display: none;">
    

    <span id="label" class="style-scope paper-toast"></span>
    
      <div id="noticeContent" class="style-scope search-app"></div>
    
  </paper-toast>
  </search-app>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  

<iframe id="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.2734349393" name="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.2734349393" style="width: 1px; height: 1px; position: absolute; top: -100px; display: none;" src="https://scone-pa.clients6.google.com/static/proxy.html?usegapi=1&amp;jsh=m%3B%2F_%2Fscs%2Fabc-static%2F_%2Fjs%2Fk%3Dgapi.lb.en.IKZeRvoAYNY.O%2Fam%3DAAAQ%2Fd%3D1%2Frs%3DAHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw%2Fm%3D__features__#parent=https%3A%2F%2Fpatents.google.com&amp;rpctoken=244866826" tabindex="-1" aria-hidden="true"></iframe><iron-a11y-announcer>
    
    <div class="style-scope iron-a11y-announcer" aria-live="polite"></div>
  </iron-a11y-announcer></body></html>